 {"id": "3708949_1","context": "After therapy with parenteral amiodarone (2300 mg in 3 days) and other measures, signs of congestive heart failure disappeared; subsequently the patient developed jaundice, marked increase in serum transaminase levels and fall in prothrombin time, and histologic changes of severe centrilobular necrosis were observed in hepatic biopsy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "parenteral amiodarone"},{"annotation": "Effect","text": "hepatic damage"},{"annotation": "Treatment","text": "parenteral amiodarone"},{"annotation": "Treatment.Drug","text": "amiodarone"},{"annotation": "Treatment.Duration","text": "2300 mg in 3 days"},{"annotation": "Attribute","text": "severity","value": "high"},{"annotation": "Attribute","text": "negated","value": "no"}]}]
 {"id": "8467620_3","context": "We report one case of non-Hodgkin lymphoma in a patient, with a 30-year history of rheumatoid arthritis, taking low dose methotrexate weekly over a 10-month period.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "taking"},{"annotation": "Disorder","text": "non-Hodgkin lymphoma"},{"annotation": "Treatment","text": "low dose methotrexate weekly"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Duration","text": "10-month period"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Disorder","text": "rheumatoid arthritis"}]}]
 {"id": "1422497_6","context": "We recommend the cautious use of alum irrigation in patients with renal impairment and monitoring of serum aluminum levels to prevent excessive accumulation and toxicity.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "excessive accumulation and toxicity"},{"annotation": "Treatment","text": "alum irrigation"},{"annotation": "Treatment.Drug","text": "alum"},{"annotation": "Effect","text": "toxicity"},{"annotation": "Subject","text": "patients with renal impairment"},{"annotation": "Subject.Disorder","text": "renal impairment"}]}]
 {"id":"10082597_3","context":"RESULTS: A 44-year-old man taking naproxen for chronic low back pain and a 20-year-old woman on oxaprozin for rheumatoid arthritis presented with tense bullae and cutaneous fragility on the face and the back of the hands.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"presented"},{"annotation":"Effect","text":"tense bullae and cutaneous fragility"},{"annotation":"Treatment","text":"naproxen and oxaprozin"},{"annotation":"Treatment.Drug","text":"naproxen"},{"annotation":"Treatment.Drug","text":"oxaprozin"},{"annotation":"Treatment.Disorder","text":"rheumatoid arthritis"},{"annotation":"Treatment.Disorder","text":"chronic low back pain"},{"annotation":"Subject","text":"a 44-year-old man and a 20-year-old woman"},{"annotation":"Subject.Age","text":"44 and 20"},{"annotation":"Subject.Gender","text":"not specified"},{"annotation":"Subject.Population","text":"2 patients"},{"annotation":"Subject.Race","text":"not specified"},{"annotation":"Treatment.Disorder","text":"rheumatoid arthritis and chronic low back pain"},{"annotation":"Treatment.Drug","text":"naproxen and oxaprozin"},{"annotation":"Treatment.Dosage","text":"not specified"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"not specified"},{"annotation":"Treatment.Disorder","text":"rheumatoid arthritis and chronic low back pain"},{"annotation":"Effect","text":"tense bullae and cutaneous fragility"},{"annotation":"Attribute Attributes","text":"not specified"},{"annotation":"Attribute Attributes.negated","text":"not specified"},{"annotation":"Attribute Attributes.speculated","text":"not specified"},{"annotation":"Attribute Attributes.severity","text":"not specified"},{"annotation":"Event type","text":"Adverse_event"}]}]}
 {"id":"16018164_1","context":"CASE REPORT: We report a case of intracerebral hemorrhage occurring in a middle-aged man who suffered from chronic sinusitis and had been ingesting pseudoephedrine daily for one year.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurring"},{"annotation":"Treatment","text":"pseudoephedrine"},{"annotation":"Treatment.Drug","text":"pseudoephedrine"},{"annotation":"Treatment.Duration","text":"daily for one year"},{"annotation":"Effect","text":"intracerebral hemorrhage"},{"annotation":"Subject","text":"a middle-aged man"},{"annotation":"Subject.Disorder","text":"chronic sinusitis"},{"annotation":"Subject.Age","text":"middle-aged"},{"annotation":"Treatment.Disorder","text":"pseudoephedrine"}]}]}
 {"id": "8467620_1","context": "Lymphoma developing in a patient with rheumatoid arthritis taking methotrexate.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developing"},{"annotation": "Effect","text": "lymphoma"},{"annotation": "Treatment","text": "methotrexate"},{"annotation": "Subject","text": "patient with rheumatoid arthritis"},{"annotation": "Subject.Disorder","text": "rheumatoid arthritis"},{"annotation": "Treatment.Drug","text": "methotrexate"}]}]
 {"id":"14742791_4","context":"The Naranjo probability scale suggests a highly probable relationship between AIN and pantoprazole therapy in this patient.","events":[{"type":"Potential_therapeutic_event","annotations":[{"annotation":"Trigger","text":"Naranjo probability scale"},{"annotation":"Treatment","text":"pantoprazole therapy"},{"annotation":"Treatment.Disorder","text":"AIN"},{"annotation":"Treatment.Drug","text":"pantoprazole"},{"annotation":"Attribute","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.Attribute_type","text":"probable relationship"},{"annotation":"Attribute.
 {"id": "8442800_11","context": "In one case, disulfiram was the only potential teratogen exposed to the fetus.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "exposed"},{"annotation": "Effect","text": "teratogenic"},{"annotation": "Treatment","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Teratogen","text": "disulfiram"},{"annotation": "Treatment.Teratogen.Type","text": "disulfiram"},{"annotation": "Treatment.Teratogen.Duration","text": "only"},{"annotation": "Treatment.Teratogen.Dosage","text": "disulfiram"},{"annotation": "Treatment.Teratogen.Frequency","text": "disulfiram"},{"annotation": "Treatment.Route","text": "disulfiram"},{"annotation": "Treatment.Time_elapsed","text": "disulfiram"},{"annotation": "Treatment.Duration","text": "disulfiram"},{"annotation": "Treatment.Disorder","text": "teratogenic"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Teratogen","text": "disulfiram"},{"annotation": "Treatment.Teratogen.Type","text": "disulfiram"},{"annotation": "Treatment.Teratogen.Duration","text": "only"},{"annotation": "Treatment.Teratogen.Dosage","text": "disulfiram"},{"annotation": "Treatment.Teratogen.Frequency","text": "disulfiram"},{"annotation": "Treatment.Route","text": "disulfiram"},{"annotation": "Treatment.Time_elapsed","text": "disulfiram"},{"annotation": "Treatment.Duration","text": "disulfiram"},{"annotation": "Treatment.Disorder","text": "teratogenic"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Teratogen","text": "disulfiram"},{"annotation": "Treatment.Teratogen.Type","text": "disulfiram"},{"annotation": "Treatment.Teratogen.Duration","text": "only"},{"annotation": "Treatment.Teratogen.Dosage","text": "disulfiram"},{"annotation": "Treatment.Teratogen.Frequency","text": "disulfiram"},{"annotation": "Treatment.Route","text": "disulfiram"},{"annotation": "Treatment.Time_elapsed","text": "disulfiram"},{"annotation": "Treatment.Duration","text": "disulfiram"},{"annotation": "Treatment.Disorder","text": "teratogenic"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Teratogen","text": "disulfiram"},{"annotation": "Treatment.Teratogen.Type","text": "disulfiram"},{"annotation": "Treatment.Teratogen.Duration","text": "only"},{"annotation": "Treatment.Teratogen.Dosage","text": "disulfiram"},{"annotation": "Treatment.Teratogen.Frequency","text": "disulfiram"},{
 {"id": "15368548_4","context": "Pancreatitis has been noted to be a complication in 2-16% of patients undergoing treatment with L-asparaginase for a variety of pediatric neoplasms.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "treatment with L-asparaginase"},{"annotation": "Effect","text": "pancreatitis"},{"annotation": "Treatment","text": "L-asparaginase"},{"annotation": "Treatment.Disorder","text": "pediatric neoplasms"},{"annotation": "Treatment.Drug","text": "L-asparaginase"},{"annotation": "Treatment.Drug","text": "pediatric neoplasms"},{"annotation": "Treatment.Combination.Trigger","text": "for"},{"annotation": "Treatment.Combination.Drug","text": "L-asparaginase"},{"annotation": "Treatment.Combination.Drug","text": "pediatric neoplasms"},{"annotation": "Subject","text": "patients"},{"annotation": "Subject.Disorder","text": "pediatric neoplasms"}],"attributes": {"negated": false,"speculated": false,"severity": "high"}}
 {"id": "21630612_2","context": "Myopathy, including rhabdomyolysis, is a well-known, albeit rare complication of statin therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "complication"},{"annotation": "Treatment","text": "statin therapy"},{"annotation": "Treatment.Drug","text": "statins"},{"annotation": "Effect","text": "myopathy"},{"annotation": "Effect","text": "rhabdomyolysis"}]}]
 {"id": "18855892_1","context": "Management and successful desensitization in methotrexate-induced anaphylaxis.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"}, {"annotation": "Effect", "text": "anaphylaxis"}, {"annotation": "Treatment", "text": "methotrexate"}, {"annotation": "Treatment.Disorder", "text": "anaphylaxis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Route", "text": "intravenous"}, {"annotation": "Treatment.Time_elapsed", "text": "immediately after administration"}, {"annotation": "Treatment.Duration", "text": "not applicable"}, {"annotation": "Treatment.Dosage", "text": "not applicable"}, {"annotation": "Treatment.Frequency", "text": "not applicable"}, {"annotation": "Attribute", "text": "negated"}, {"annotation": "Attribute.negated", "text": "not applicable"}, {"annotation": "Attribute.severity", "text": "not applicable"}]}, {"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "management"}, {"annotation": "Effect", "text": "desensitization"}, {"annotation": "Treatment", "text": "methotrexate"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced anaphylaxis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Route", "text": "intravenous"}, {"annotation": "Treatment.Time_elapsed", "text": "not applicable"}, {"annotation": "Treatment.Duration", "text": "not applicable"}, {"annotation": "Treatment.Dosage", "text": "not applicable"}, {"annotation": "Treatment.Frequency", "text": "not applicable"}, {"annotation": "Attribute", "text": "negated"}, {"annotation": "Attribute.negated", "text": "not applicable"}, {"annotation": "Attribute.severity", "text": "not applicable"}]}]}
 {"id": "12166705_1","context": "Mitomycin-C induced hemolytic uremic syndrome: a case report.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "hemolytic uremic syndrome"},{"annotation": "Treatment","text": "Mitomycin-C"}]}]
 {"id": "15588385_1","context": "Acute hepatic failure is a rare and potentially lethal complication of propylthiouracil (PTU) use for hyperthyroidism.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "use of propylthiouracil (PTU)"},{"annotation": "Effect","text": "acute hepatic failure"}]}]}
 {"id": "748238_1","context": "Monoclonal gammopathy and subsequent multiple myeloma in a patient on chronic diphenylhydantoin therapy.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "monoclonal gammopathy"},{"annotation": "Treatment", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Disorder", "text": "monoclonal gammopathy"},{"annotation": "Treatment.Drug", "text": "diphenylhydantoin"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},{"annotation": "Treatment.Dosage", "text": "chronic"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Disorder", "text": "multiple myeloma"},{"annotation": "Treatment.Drug", "text": "chronic diphenylhydantoin therapy"},
 {"id": "3359700_3","context": "Unexpected severe reversible cyclosporine A-induced nephrotoxicity in a patient with systemic lupus erythematosus and tubulointerstitial renal disease.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "cyclosporine A"},{"annotation": "Treatment.Drug","text": "cyclosporine A"},{"annotation": "Effect","text": "nephrotoxicity"},{"annotation": "Treatment.Disorder","text": "systemic lupus erythematosus and tubulointerstitial renal disease"},{"annotation": "Treatment.Drug","text": "cyclosporine A"},{"annotation": "Treatment.Drug","text": "cyclosporine A"},{"annotation": "Treatment.Drug","text": "cyclosporine A"}]}
 {"id": "9352164_2","context": "As far as we know, this is the first case report of acute hemorrhagic gastritis associated with AZ intoxication.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "intoxication"},{"annotation": "Treatment", "text": "AZ intoxication"},{"annotation": "Treatment.Drug", "text": "AZ"},{"annotation": "Effect", "text": "hemorrhagic gastritis"},{"annotation": "Treatment.Drug", "text": "AZ"},{"annotation": "Subject", "text": "patient"},{"annotation": "Subject.Disorder", "text": "acute hemorrhagic gastritis"}]}]}
 {"id": "3693034_1","context": "Toxic epidermal necrolysis resulted after 19 days of treatment with 5-fluorocytosine and amphotericin B.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "resulted"},{"annotation": "Effect","text": "toxic epidermal necrolysis"},{"annotation": "Treatment","text": "5-fluorocytosine and amphotericin B"},{"annotation": "Treatment.Drug","text": "5-fluorocytosine"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Duration","text": "19 days"}]}}
 {"id": "16018164_4","context": "Since 1979, over 30 published case reports have documented the relationship between phenylpropanolamine and stroke.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "Since 1979"},{"annotation": "Treatment","text": "phenylpropanolamine"},{"annotation": "Treatment.Disorder","text": "stroke"},{"annotation": "Treatment.Drug","text": "phenylpropanolamine"}]}]
 {"id": "18523232_1","context": "CASE SUMMARY: A 61-year-old woman with no apparent risk factors for liver injury developed acute hepatitis one week after the final dose of a long-term course of pulse itraconazole therapy (200 mg orally twice daily, 1 wk on, 3 wk off, for 24 wk) for onychomycosis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "pulse itraconazole therapy"},{"annotation": "Effect","text": "acute hepatitis"},{"annotation": "Treatment","text": "pulse itraconazole therapy"},{"annotation": "Treatment.Drug","text": "itraconazole"},{"annotation": "Treatment.Dosage","text": "200 mg orally twice daily"},{"annotation": "Treatment.Frequency","text": "1 wk on, 3 wk off"},{"annotation": "Treatment.Duration","text": "24 wk"},{"annotation": "Treatment.Disorder","text": "onychomycosis"},{"annotation": "Subject","text": "a 61-year-old woman"},{"annotation": "Subject.Age","text": "61"},{"annotation": "Subject.Gender","text": "female"},{"annotation": "Subject.Population","text": "1 woman"},{"annotation": "Subject.Race","text": "unknown"}]}
 {"id": "9352164_4","context": "We experienced a case of chronic renal failure in a patient suffering from acute hemorrhagic gastritis associated with AZ intoxication.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Treatment","text": "AZ intoxication"},{"annotation": "Treatment.Disorder","text": "acute hemorrhagic gastritis"},{"annotation": "Treatment.Drug","text": "AZ"},{"annotation": "Effect","text": "chronic renal failure"},{"annotation": "Subject","text": "a patient"}]}]
 {"id": "16192734_1","context": "Rhabdomyolysis caused by tocolysis with oral ritodrine hydrochloride in a pregnant patient with myotonic dystrophy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "caused by"},{"annotation": "Treatment","text": "tolysis with oral ritodrine hydrochloride"},{"annotation": "Treatment.Drug","text": "ritodrine hydrochloride"},{"annotation": "Effect","text": "rhabdomyolysis"},{"annotation": "Subject","text": "pregnant patient"},{"annotation": "Subject.Disorder","text": "myotonic dystrophy"}]}]}
 {"id": "536470_2","context": "While sulindac failed to affect significantly warfarin-induced hypoprothrombinemia in normal male volunteers, it markedly prolonged prothrombin time in a patient with a renal tubular defect who had been anticoagulated with warfarin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "markedly prolonged prothrombin time"},{"annotation": "Effect","text": "prothrombin time prolongation"},{"annotation": "Treatment","text": "sulindac"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Disorder","text": "renal tubular defect"},{"annotation": "Treatment.Drug","text": "sulindac"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "sulindac"},{"annotation": "Treatment.Combination","text": "warfarin"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Disorder","text": "renal tubular defect"}]}
 {"id": "8912599_7","context": "Painful erosion of psoriatic plaques is a less common sign of methotrexate toxicity that may precede evidence of bone marrow suppression.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "methotrexate"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Disorder","text": "psoriatic plaques"},{"annotation": "Treatment.Side_effect","text": "erosion"},{"annotation": "Treatment.Side_effect","text": "painful"},{"annotation": "Treatment.Duration","text": "less common"},{"annotation": "Treatment.Duration","text": "sign"},{"annotation": "Treatment.Duration","text": "may precede evidence of bone marrow suppression"},{"annotation": "Treatment.Duration","text": "toxicity"}]}
 {"id":"16728538_2","context":"Drug-induced hepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long-acting repeatable attributed to the use of pegvisomant.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Effect","text":"hepatitis"},{"annotation":"Treatment","text":"combined treatment with pegvisomant and octreotide long-acting repeatable"},{"annotation":"Treatment.Disorder","text":"acromegalic"},{"annotation":"Treatment.Drug","text":"pegvisomant"},{"annotation":"Treatment.Drug","text":"octreotide"},{"annotation":"Treatment.Combination.Trigger","text":"and"},{"annotation":"Treatment.Combination.Drug","text":"pegvisomant"},{"annotation":"Treatment.Combination.Drug","text":"octreotide"},{"annotation":"Subject","text":"an acromegalic patient"},{"annotation":"Subject.Disorder","text":"acromegalic"}]}]}
 {"id": "7978578_2","context": "We report the first case of a patient in a promethazine-induced coma responding to treatment with flumazenil.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "promethazine"},{"annotation": "Treatment.Drug","text": "promethazine"},{"annotation": "Effect","text": "coma"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "Response"},{"annotation": "Treatment","text": "flumazenil"},{"annotation": "Treatment.Disorder","text": "promethazine-induced coma"},{"annotation": "Treatment.Drug","text": "flumazenil"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "response"},{"annotation": "Treatment","text": "flumazenil"},{"annotation": "Treatment.Drug","text": "flumazenil"},{"annotation": "Effect","text": "coma"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "promethazine"},{"annotation": "Treatment.Disorder","text": "promethazine-induced coma"},{"annotation": "Treatment.Drug","text": "promethazine"}]}
 {"id": "18425523_3","context": "Ocular hypertension occurred 1 month after the second ranibizumab injection in patients 1 and 3, and 1 month after the first ranibizumab in patient 2.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurred"},{"annotation": "Effect","text": "hypertension"},{"annotation": "Treatment","text": "ranibizumab injection"},{"annotation": "Treatment.Drug","text": "ranibizumab"},{"annotation": "Treatment.Time_elapsed","text": "1 month after"},{"annotation": "Subject","text": "patients"},{"annotation": "Subject.Population","text": "3"},{"annotation": "Treatment.Time_elapsed","text": "1 month after"},{"annotation": "Treatment.Drug","text": "ranibizumab"}]}
 {"id":"12022905_5","context":"Priapism associated with zuclopenthixol.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Effect","text":"priapism"},{"annotation":"Treatment","text":"zuclopenthixol"},{"annotation":"Treatment.Drug","text":"zuclopenthixol"}]}]}
 {"id": "12488741_3","context": "Reversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "associated with"}, {"annotation": "Effect", "text": "abnormalities"}, {"annotation": "Treatment", "text": "metronidazole therapy"}, {"annotation": "Treatment.Drug", "text": "metronidazole"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "negated", "severity": "high
 {"id": "15857283_3","context": "PURPOSE: The aim of this study was to report on the possible development of corneal endothelial deposits resulting from the use of rifabutin.","events": [{"type": "Potential_therapeutic_effect","annotations": ["Trigger": "PURPOSE","Treatment": "rifabutin","Treatment.Disorder": "corneal endothelial deposits","Treatment.Drug": "rifabutin"]}]}
 {"id": "19318596_3","context": "OBJECTIVE: To report a case of calcineurin-induced pain syndrome (CIPS) in a child undergoing his second hematopoietic stem cell transplant (HSCT).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "pain syndrome"},{"annotation": "Treatment","text": "hematopoietic stem cell transplant"},{"annotation": "Treatment.Disorder","text": "calcineurin-induced pain syndrome"},{"annotation": "Treatment.Drug","text": "calcineurin inhibitor"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "pain syndrome"},{"annotation": "Treatment","text": "hematopoietic stem cell transplant"},{"annotation": "Treatment.Disorder","text": "calcineurin-induced pain syndrome"},{"annotation": "Treatment.Drug","text": "calcineurin inhibitor"}]}],"subject": {"Age": "child","Gender": "not specified","Population": "1","Race": "not specified","Disorder": "calcineurin-induced pain syndrome"}}
 {"id": "14684937_4","context": "We experienced a male patient with psoriasis and hypertension whose conditions were treated with tacalcitol ointment and thiazide, respectively, resulting in hypercalciuria and hypercalcemia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "resulting"},{"annotation": "Treatment","text": "tacalcitol ointment and thiazide"},{"annotation": "Treatment.Drug","text": "tacalcitol ointment"},{"annotation": "Treatment.Drug","text": "thiazide"},{"annotation": "Effect","text": "hypercalciuria and hypercalcemia"},{"annotation": "Subject","text": "a male patient"},{"annotation": "Subject.Disorder","text": "psoriasis and hypertension"}]}
 {"id": "16341621_3","context": "To our knowledge, this is the first granulomatous reaction described after calcium hydroxylapatite injection.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "calcium hydroxylapatite injection"},{"annotation": "Effect","text": "granulomatous reaction"}]}]}
 {"id": "15595320_3","context": "Previous studies have demonstrated the interaction of MTX and a variety of non-steroidal, anti-inflammatory drugs (NSAIDs) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "demonstrated"},{"annotation": "Treatment", "text": "MTX and NSAIDs"},{"annotation": "Treatment.Disorder", "text": "clinical manifestations"},{"annotation": "Treatment.Drug", "text": "MTX"},{"annotation": "Treatment.Drug", "text": "NSAIDs"},{"annotation": "Effect", "text": "various clinical manifestations"},{"annotation": "Attribute", "text": "negated", "annotation": {"annotation": "negated", "text": "clinical manifestations"},{"annotation": "Attribute", "text": "negated", "annotation": {"annotation": "negated", "text": "acute renal failure"},{"annotation": "Attribute", "text": "negated", "annotation": {"annotation": "negated", "text": "pancytopenia"},{"annotation": "Attribute", "text": "negated", "annotation": {"annotation": "negated", "text": "vomiting"},{"annotation": "Attribute", "text": "negated", "annotation": {"annotation": "negated", "text": "diarrhea"},{"annotation": "Attribute", "text": "negated", "annotation": {"annotation": "negated", "text": "elevated liver transaminases"},{"annotation": "Attribute", "text": "negated", "annotation": {"annotation": "negated", "text": "jaundice"},{"annotation": "Attribute", "text": "negated", "annotation": {"annotation": "negated", "text": "mucosal ulcerations"},{"annotation": "Attribute", "text": "negated", "annotation": {"annotation": "negated", "text": "pyrexia"}]}]}
 {"id": "3868420_1","context": "We present a case report of a patient with alveolar hydatid disease, whose treatment with mebendazole was brief due to side effects of alopecia and granulocytopenia; and review the features of this disease which, with increasing international migration, may be encountered more frequently in Australia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"}]},{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"}]},{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"}],"annotations": [{"annotation": "Treatment","text": "mebendazole"}]},{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"}],"annotations": [{"annotation": "Treatment","text": "mebendazole"}],"annotations": [{"annotation": "Disorder","text": "alveolar hydatid disease"}],"annotations": [{"annotation": "Treatment","text": "mebendazole"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{"annotation": "Side effects","text": "alopecia and granulocytopenia"},{"annotation": "Negated","text": "negated"}],{"annotation": "Disorder","text": "alveolar hydatid disease"}],{"type": "Adverse_event","annotations": [{
 {"id": "3174043_1","context": "Niacin causes a reversible toxic cystoid maculopathy that occurs in approximately 0.67% of patients taking high doses of the drug.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurs"},{"annotation": "Effect","text": "toxic cystoid maculopathy"},{"annotation": "Treatment","text": "high doses of niacin"},{"annotation": "Treatment.Drug","text": "niacin"},{"annotation": "Treatment.Dosage","text": "high doses"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "maculopathy"}]}]
 {"id": "6854698_1","context": "When tuberculosis patients on isoniazid eat certain varieties of fish they may develop a histamine reaction.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "eat"},{"annotation": "Treatment","text": "isoniazid"},{"annotation": "Treatment.Drug","text": "isoniazid"},{"annotation": "Effect","text": "histamine reaction"},{"annotation": "Treatment.Disorder","text": "tuberculosis"},{"annotation": "Treatment.Food","text": "certain varieties of fish"},{"annotation": "Treatment.Food","text": "histamine"},{"annotation": "Treatment.Dosage","text": "certain varieties of fish"},{"annotation": "Treatment.Dosage","text": "histamine"},{"annotation": "Treatment.Frequency","text": "certain varieties of fish"},{"annotation": "Treatment.Frequency","text": "histamine"},{"annotation": "Treatment.Route","text": "certain varieties of fish"},{"annotation": "Treatment.Route","text": "histamine"},{"annotation": "Treatment.Time_elapsed","text": "certain varieties of fish"},{"annotation": "Treatment.Time_elapsed","text": "histamine"},{"annotation": "Treatment.Duration","text": "certain varieties of fish"},{"annotation": "Treatment.Duration","text": "histamine"},{"annotation": "Treatment.Disorder","text": "tuberculosis"},{"annotation": "Treatment.Drug","text": "isoniazid"},{"annotation": "Treatment.Food","text": "certain varieties of fish"},{"annotation": "Treatment.Food","text": "histamine"},{"annotation": "Treatment.Dosage","text": "certain varieties of fish"},{"annotation": "Treatment.Dosage","text": "histamine"},{"annotation": "Treatment.Frequency","text": "certain varieties of fish"},{"annotation": "Treatment.Frequency","text": "histamine"},{"annotation": "Treatment.Route","text": "certain varieties of fish"},{"annotation": "Treatment.Route","text": "histamine"},{"annotation": "Treatment.Time_elapsed","text": "certain varieties of fish"},{"annotation": "Treatment.Time_elapsed","text": "histamine"},{"annotation": "Treatment.Duration","text": "certain varieties of fish"},{"annotation": "Treatment.Duration","text": "histamine"},{"annotation": "Treatment.Disorder","text": "tuberculosis"},{"annotation": "Treatment.Drug","text": "isoniazid"},{"annotation": "Treatment.Food","text": "certain varieties of fish"},{"annotation": "Treatment.Food","text": "histamine"},{"annotation": "Treatment.Dosage","text": "certain varieties of fish"},{"annotation": "Treatment.Dosage","text": "histamine"},{"annotation": "Treatment.Frequency","text": "certain varieties of fish"},{"annotation": "Treatment.Frequency","text": "histamine"},{"annotation": "Treatment.Route","text": "certain varieties of fish"},{"annotation": "Treatment.Route","text": "histamine"},{"annotation": "Treatment.Time_elapsed","text": "certain varieties of fish"},{"annotation": "Treatment.Time_elapsed","text": "histamine"},{"annotation": "Treatment.Duration","text": "certain varieties of fish"},{"annotation": "Treatment.Duration","text": "histamine"},{"annotation": "Treatment.Disorder","text": "tuberculosis"},{"annotation": "Treatment.Drug","text": "isoniazid"},{"annotation": "Treatment.Food","text": "certain varieties of fish"},{"annotation": "Treatment.Food","text": "histamine"},{"annotation": "Treatment.Dosage","text": "certain varieties of fish"},{"annotation": "Treatment.Dosage","text": "histamine"},{"annotation": "Treatment.Frequency","text": "certain varieties of fish"},{"annotation": "Treatment.Frequency","text": "histamine"},{"annotation": "Treatment.Route","text": "certain varieties of fish"},{"annotation": "Treatment.Route","text": "histamine"},{"annotation": "Treatment.Time_elapsed","text": "certain varieties of fish"},{"annotation": "Treatment.Time_elapsed","text": "histamine"},{"annotation": "Treatment.Duration","text": "certain varieties of fish"},{"annotation": "Treatment.Duration","text": "histamine"},{"annotation": "Treatment.Disorder","text": "tuberculosis"},{"annotation": "Treatment.Drug","text": "isoniazid"},{"annotation": "Treatment.Food","text": "certain varieties of fish"},{"annotation": "Treatment.Food","text": "histamine"},{"annotation": "Treatment.Dosage","text": "certain varieties of fish"},{"annotation": "Treatment.Dosage","text": "histamine"},{"annotation": "Treatment.Frequency","text": "certain varieties of fish"},{"annotation": "Treatment.Frequency","text": "histamine"},{"annotation": "Treatment.Route","text": "certain varieties of fish"},{"annotation": "Treatment.Route","text": "histamine"},{"annotation": "Treatment.Time_elapsed","text": "certain varieties of fish"},{"annotation": "Treatment.Time_elapsed","text": "histamine"},{"annotation": "Treatment.Duration","text": "certain varieties of fish"},{"annotation": "Treatment.Duration","text": "histamine"},{"annotation": "Treatment.Disorder","text": "tuberculosis"},{"annotation": "Treatment.Drug","text": "isoniazid"},{"annotation": "Treatment.Food","text": "certain varieties of fish"},{"annotation": "Treatment.Food","text": "histamine"},{"annotation": "Treatment.Dosage","text": "certain varieties of fish"},{"annotation": "Treatment.Dosage","text": "histamine"},{"annotation": "Treatment.Frequency","text": "certain varieties of fish"},{"annotation": "Treatment.Frequency","text": "histamine"},{"annotation": "Treatment.Route","text": "certain varieties of fish"},{"annotation": "Treatment.Route","text": "histamine"},{"annotation": "Treatment.Time_elapsed","text": "certain varieties of fish"},{"annotation": "Treatment.Time_elapsed","text": "histamine"},{"annotation": "Treatment.Duration","text": "certain varieties of fish"},{"annotation": "Treatment.Duration","text": "histamine"},{"annotation": "Treatment.Disorder","text": "tuberculosis"},{"annotation": "Treatment.Drug","text": "isoniazid"},{"annotation": "Treatment.Food","text": "certain varieties of fish"},{"annotation": "Treatment.Food","text": "histamine"},{"annotation": "Treatment.Dosage","text": "certain varieties of fish"},{"annotation": "Treatment.Dosage","text": "histamine"},{"annotation": "Treatment.Frequency","text": "certain varieties of fish"},{"annotation": "Treatment.Frequency","text": "histamine"},{"annotation": "Treatment.Route","text": "certain varieties of fish"},{"annotation": "Treatment.Route","text": "histamine"},{"annotation": "Treatment.Time_elapsed","text": "certain varieties of fish"},{"annotation": "Treatment.Time_elapsed","text": "histamine"},{"annotation": "Treatment.Duration","text": "certain varieties of fish"},{"annotation": "Treatment.Duration","text": "histamine"},{"annotation": "Treatment.Disorder","text": "Treatment.Drug","text": "isoniazid"},{"annotation": "Treatment.Disorder","text": "Treatment.Food","text": "certain varieties of fish"},{"annotation": "Treatment.Disorder","text": "Treatment.Dosage","text": "certain varieties of fish"},{"annotation": "Treatment.Disorder","text": "Treatment.Frequency","text": "certain varieties of fish"},{"annotation": "Treatment.Disorder","text": "Treatment.Route","text": "certain varieties of fish"},{"annotation": "Treatment.Disorder","text": "Treatment.Time_elapsed","text": "certain varieties of fish"},{"annotation": "Treatment.Disorder","text": "Treatment.Time_elapsed","text": "certain varieties of fish"
 {"id": "12022905_2","context": "CONCLUSIONS: Priapism is an uncommon but potentially serious adverse effect of zuclopenthixol that practitioners, as with many other antipsychotics, should be aware of.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "zuclopenthixol"},{"annotation": "Treatment.Drug","text": "zuclopenthixol"},{"annotation": "Effect","text": "priapism"}]}]}
 {"id": "14766993_2","context": "To report a case of possible interaction of smokeless tobacco with warfarin in a patient treated after several thromboembolic events.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "possible interaction"},{"annotation": "Effect","text": "thromboembolic events"},{"annotation": "Treatment","text": "smokeless tobacco and warfarin"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "smokeless tobacco"}]}]
 {"id": "17167851_1","context": "Hepatotoxicity induced by cyproterone acetate: a report of three cases.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "cyproterone acetate"},{"annotation": "Treatment.Drug","text": "cyproterone acetate"},{"annotation": "Effect","text": "hepatotoxicity"},{"annotation": "Treatment.Disorder","text": "none"},{"annotation": "Subject","text": "three cases"},{"annotation": "Subject.Population","text": "three cases"},{"annotation": "Treatment.Duration","text": "unknown"}]}
 {"id": "14561622_1","context": "Neurotoxicity of intrathecal methotrexate: MR imaging findings.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intrathecal methotrexate"},{"annotation": "Effect","text": "neurotoxicity"}],"attributes": {"negated": false,"speculated": false,"severity": "high"}}]}
 {"id": "11804071_2","context": "Isonicotinic acid hydrazide induced anagen effluvium and associated lichenoid eruption.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"}, {"annotation": "Effect", "text": "anagen effluvium and associated lichenoid eruption"}, {"annotation": "Treatment", "text": "isonicotinic acid hydrazide"}, {"annotation": "Treatment.Drug", "text": "isonicotinic acid hydrazide"}, {"annotation": "Treatment.Disorder", "text": "anagen effluvium and associated lichenoid eruption"}]}]}
 {"id": "18523232_5","context": "Only one case of severe symptomatic hepatitis occurring after pulse therapy with itraconazole for onychomycosis and requiring transplantation has been reported previously.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "pulse therapy with itraconazole"},{"annotation": "Treatment","text": "itraconazole"},{"annotation": "Treatment.Drug","text": "itraconazole"},{"annotation": "Effect","text": "severe symptomatic hepatitis"},{"annotation": "Treatment.Disorder","text": "onychomycosis"},{"annotation": "Treatment.Combination","text": "pulse therapy"},{"annotation": "Treatment.Combination","text": "itraconazole"},{"annotation": "Treatment.Combination","text": "onychomycosis"},{"annotation": "Subject","text": "one case"},{"annotation": "Subject.Disorder","text": "onychomycosis"}]}
 {"id": "4066620_3","context": "The elicitation of a movement disorder by trazodone: case report.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "elicitation"},{"annotation": "Effect","text": "movement disorder"},{"annotation": "Treatment","text": "trazodone"}]}]}
 {"id":"6572542_2","context":"Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"subsequent to"},{"annotation":"Effect","text":"pulmonary fibrosis"},{"annotation":"Treatment","text":"high doses of CCNU for chronic myeloid leukemia"},{"annotation":"Treatment.Drug","text":"CCNU"},{"annotation":"Treatment.Disorder","text":"chronic myeloid leukemia"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"subsequent to"},{"annotation":"Effect","text":"pulmonary fibrosis"},{"annotation":"Treatment","text":"high doses of CCNU for chronic myeloid leukemia"},{"annotation":"Treatment.Drug","text":"CCNU"},{"annotation":"Treatment.Disorder","text":"chronic myeloid leukemia"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"subsequent to"},{"annotation":"Effect","text":"pulmonary fibrosis"},{"annotation":"Treatment","text":"high doses of CCNU for chronic myeloid leukemia"},{"annotation":"Treatment.Drug","text":"CCNU"},{"annotation":"Treatment.Disorder","text":"chronic myeloid leukemia"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"not indicated any textual cues showing the event is negated"},{"annotation":"Attribute","text":"Attribute.negated","text":"negated"},{"annotation":"Attribute.negated","text":"Attribute.negated","text":"negated"},{"annotation":"Attribute","text":"Attribute.negated","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation":"Attribute","text":"Attribute","text":"Attribute"},{"annotation
 {"id": "9007910_2","context": "PURPOSE/OBJECTIVES: To describe the pharmacogenetic syndrome of dihydropyrimidine dehydrogenase (DPD) deficiency, which predisposes patients with cancer to potentially lethal adverse reactions following 5-fluorouracil (5-FU)-based chemotherapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "5-fluorouracil (5-FU)-based chemotherapy"},{"annotation": "Treatment","text": "5-fluorouracil (5-FU)-based chemotherapy"},{"annotation": "Treatment.Disorder","text": "DPD deficiency"},{"annotation": "Effect","text": "potentially lethal adverse reactions"}]}]}
 {"id":"6697887_3","context":"We report a case of sustained hypotension after administration of parenteral verapamil.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"after administration of"},{"annotation":"Effect","text":"hypotension"},{"annotation":"Treatment","text":"parenteral verapamil"},{"annotation":"Treatment.Drug","text":"verapamil"}]}]}
 {"id": "10212021_4","context": "Methadone has two roles in human immunodeficiency viral infection: pain management and treatment of opioid abuse.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "methadone"},{"annotation": "Treatment.Disorder","text": "human immunodeficiency viral infection"},{"annotation": "Treatment.Role","text": "pain management"},{"annotation": "Treatment.Role","text": "treatment of opioid abuse"}]}]}
 {"id":"21515865_9","context":"Each time he arrived at the anticoagulation clinic after his BCG therapy, his INR was supratherapeutic, except after his fourth treatment (INR of 2.5), which can be explained by residual effects from the phytonadione he received a week earlier.","events":[{"type":"Potential_therapeutic_effect","annotations":[{"annotation":"Trigger","text":"arrival"},{"annotation":"Treatment","text":"anticoagulation therapy"},{"annotation":"Treatment.Disorder","text":"BCG therapy"},{"annotation":"Treatment.Drug","text":"phytonadione"},{"annotation":"Treatment.Dosage","text":"residual effects"},{"annotation":"Treatment.Time_elapsed","text":"a week earlier"},{"annotation":"Treatment.Duration","text":"fourth treatment"},{"annotation":"Subject","text":"he"},{"annotation":"Subject.Disorder","text":"BCG therapy"},{"annotation":"Subject.Age","text":"each time"},{"annotation":"Subject.Gender","text":"he"},{"annotation":"Subject.Population","text":"except after his fourth treatment (INR of 2.5)"},{"annotation":"Treatment.Drug","text":"phytonadione"},{"annotation":"Treatment.Dosage","text":"residual effects"},{"annotation":"Treatment.Time_elapsed","text":"a week earlier"},{"annotation":"Treatment.Duration","text":"fourth treatment"},{"annotation":"Treatment.Disorder","text":"BCG therapy"},{"annotation":"Effect","text":"INR was supratherapeutic"},{"annotation":"Attribute","annotation":"negated","text":"except after his fourth treatment (INR of 2.5)"},{"annotation":"Attribute","annotation":"speculated","text":"residual effects"},{"annotation":"Attribute","annotation":"severity","text":"INR was supratherapeutic"}]}]}
 {"id": "22677303_3","context": "A 70-year-old man had been treated with warfarin for atrial fibrillation.","events": [{"type": "Treatment","annotations": [{"annotation": "Drug","text": "warfarin"},{"annotation": "Disorder","text": "atrial fibrillation"}]},{"type": "Subject","annotations": [{"annotation": "Age","text": "70"}]}]}
 {"id": "1703754_1","context": "This is a case report of fatal cryptococcal meningitis in a child with systemic lupus erythematosus being treated with prednisolone and azathioprine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "meningitis"},{"annotation": "Treatment","text": "prednisolone and azathioprine"},{"annotation": "Treatment.Drug","text": "prednisolone"},{"annotation": "Treatment.Drug","text": "azathioprine"},{"annotation": "Effect","text": "fatal"},{"annotation": "Treatment.Disorder","text": "systemic lupus erythematosus"}]}]
 {"id": "9352164_1","context": "Acute hemorrhagic gastritis associated with acetazolamide intoxication in a patient with chronic renal failure.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intoxication"},{"annotation": "Treatment","text": "acetazolamide"},{"annotation": "Treatment.Drug","text": "acetazolamide"},{"annotation": "Effect","text": "hemorrhagic gastritis"},{"annotation": "Treatment.Disorder","text": "chronic renal failure"},{"annotation": "Treatment.Drug","text": "acetazolamide"}]}]
 {"id": "4066620_2","context": "Although the movement disorder could not with certainty be attributed to trazodone alone, the drug at least acted as an eliciting agent.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "movement disorder"}, {"annotation": "Effect", "text": "trazodone"}, {"annotation": "Treatment", "text": "trazodone"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "eliciting agent"}, {"annotation": "Effect", "text": "trazodone"}, {"annotation": "Treatment", "text": "trazodone"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodone"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodone"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodone"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodone"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodone"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Treatment", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Effect", "text": "trazodine"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Effect", "text": "movement disorder"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Effect", "text": "movement disorder"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Effect", "text": "movement disorder"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "trazodine"}, {"annotation": "Effect", "text": "movement disorder"}, {"annotation": "Effect", "text": "movement disorder"}]},{"type": "Adverse_event", "annotations
 {"id":"18523232_2","context":"CONCLUSIONS: Prolonged exposure to itraconazole, administered either continuously or intermittently, may precipitate severe and irreversible hepatotoxic events.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"prolonged exposure"},{"annotation":"Effect","text":"hepatotoxic events"},{"annotation":"Treatment","text":"itraconazole"},{"annotation":"Treatment.Dosage","text":"administered either continuously or intermittently"},{"annotation":"Treatment.Duration","text":"prolonged exposure"},{"annotation":"Treatment.Disorder","text":"severe and irreversible hepatotoxic events"}]}]}
 {"id": "507889_1","context": "In two patients with mycosis fungoides, a squamous cell carcinoma developed during therapy with psoralens plus long-wave ultraviolet radiation (PUVA).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "squamous cell carcinoma"},{"annotation": "Treatment","text": "therapy with psoralens plus long-wave ultraviolet radiation (PUVA)"},{"annotation": "Treatment.Disorder","text": "mycosis fungoides"},{"annotation": "Treatment.Drug","text": "psoralens"},{"annotation": "Treatment.Drug","text": "long-wave ultraviolet radiation (PUVA)"}]}
 {"id": "15663666_1","context": "Scrotal ulceration induced by all-trans retinoic acid in a patient with acute promyelocytic leukemia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "all-trans retinoic acid"},{"annotation": "Treatment.Drug","text": "all-trans retinoic acid"},{"annotation": "Effect","text": "scrotal ulceration"},{"annotation": "Treatment.Disorder","text": "acute promyelocytic leukemia"}]}]}
 {"id": "6693840_1","context": "A 61 year-old male patient developed gynecomastia after starting theophylline.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "started"},{"annotation": "Effect","text": "gynecomastia"},{"annotation": "Treatment","text": "theophylline"},{"annotation": "Treatment.Drug","text": "theophylline"}]}]
 {"id": "2483959_3","context": "Several possible explanations of the mechanism of renal failure associated with the use of dextran-40 are discussed.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Effect","text": "renal failure"},{"annotation": "Treatment","text": "use of dextran-40"}]}]}
 {"id": "20349794_2","context": "We present a case of the syndrome of inappropriate antidiuretic hormone (SIADH) secondary to cisplatin therapy in a patient with advanced-stage large cell neuroendocrine carcinoma of the cervix.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "cisplatin therapy"},{"annotation": "Treatment","text": "cisplatin"},{"annotation": "Treatment.Disorder","text": "large cell neuroendocrine carcinoma of the cervix"},{"annotation": "Treatment.Drug","text": "cisplatin"},{"annotation": "Treatment.Duration","text": "advanced-stage"}]}]
 {"id": "18675768_5","context": "An 80-year-old white female, followed up at the Memory Clinic for mild cognitive impairment, had been taking propafenone 900 mg/d for >10 years for paroxysmal atrial fibrillation without adverse effects.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "propafenone"},{"annotation": "Treatment.Drug","text": "propafenone"},{"annotation": "Treatment.Dosage","text": "900 mg/d"},{"annotation": "Treatment.Duration","text": ">10 years"},{"annotation": "Treatment.Disorder","text": "paroxysmal atrial fibrillation"}]}]
 {"id": "20925534_12","context": "A total of 109 patients had a cardiovascular event, with event rates of 4.9% with omeprazole and 5.7% with placebo (hazard ratio with omeprazole, 0.99; 95% CI, 0.68 to 1.44; P = 0.96); high-risk subgroups did not show significant heterogeneity.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "cardiovascular event"},{"annotation": "Treatment","text": "omeprazole"},{"annotation": "Treatment.Drug","text": "omeprazole"},{"annotation": "Treatment.Drug","text": "placebo"},{"annotation": "Treatment.Combination","text": "omeprazole vs placebo"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation": "Treatment.Disease","text": "cardiovascular disease"},{"annotation":
 {"id": "6731466_10","context": "The mechanism of anaphylactoid reaction to zomepirac in this case, therefore, remains unclear.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "anaphylactoid reaction"}, {"annotation": "Treatment", "text": "zomepirac"}, {"annotation": "Treatment.Drug", "text": "zomepirac"}, {"annotation": "Effect", "text": "anaphylactoid reaction"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "low"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation": "Attribute Attributes", "text": "speculated"}, {"annotation": "Attribute Attributes", "text": "severity", "value": "high"}, {"annotation": "Attribute Attributes", "text": "negated"}, {"annotation
 {"id":"18203308_1","context":"New onset of CD may be considered as an immune-mediated injury induced by etanercept.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"new onset of CD"},{"annotation":"Effect","text":"immune-mediated injury"},{"annotation":"Treatment","text":"etanercept"},{"annotation":"Treatment.Disorder","text":"CD"},{"annotation":"Treatment.Drug","text":"etanercept"}]},{"annotation":"Attribute","text":"negated","attribute":"negated"}]]}
 {"id": "11109149_2","context": "This supports the well-reported potential of bleomycin to trigger acral vascular toxicity.","events": [{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "trigger"},{"annotation": "Treatment", "text": "bleomycin"},{"annotation": "Treatment.Disorder", "text": "acral vascular toxicity"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute.negated", "text": "well-reported potential"},{"annotation": "Attribute.negated", "text": "bleomycin-induced acral vascular toxicity"}]}]}
 {"id": "24918555_1","context": "Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Drug","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Dosage","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Duration","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment.Disorder","text": "severe recalcitrant nodular acne"},{"annotation": "Effect","text": "severe recalcitrant nodular acne"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne."},{"annotation": "Treatment","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Drug","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Disorder","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment.Dosage","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Duration","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment.Disorder","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment.Effect","text": "results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne."},{"annotation": "Treatment.Effect.Negated","text": "results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne."}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Drug","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Dosage","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Duration","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment.Disorder","text": "severe recalcitrant nodular acne"},{"annotation": "Effect","text": "severe recalcitrant nodular acne"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne."},{"annotation": "Treatment","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Drug","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Disorder","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment.Dosage","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Duration","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment.Disorder","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment.Effect","text": "results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne."},{"annotation": "Treatment.Effect.Negated","text": "results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne."}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Drug","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Dosage","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Duration","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment.Disorder","text": "severe recalcitrant nodular acne"},{"annotation": "Effect","text": "severe recalcitrant nodular acne"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne."},{"annotation": "Treatment","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Drug","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Disorder","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment.Dosage","text": "isotretinoin-Lidose"},{"annotation": "Treatment.Duration","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment.Disorder","text": "severe recalcitrant nodular acne"},{"annotation": "Treatment.Effect","text": "results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne."},{"annotation": "Treatment.Effect.Negated","text": "results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne."}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "severe recalcitrant nodular acne"}, {"annotation": "Treatment","text": "isotretinoin-Lidose"}, {"annotation": "Treatment.Drug","text": "isotretinoin-Lidose"}, {"annotation": "Treatment.Dosage","text": "isotretinoin-Lidose"}, {"annotation": "Treatment.Duration","text": "severe recalcitrant nodular acne"}, {"annotation": "Treatment.Disorder","text": "severe recalcitrant nodular acne"}, {"annotation": "Effect","text": "severe recalcitrant nodular acne"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne."}, {"annotation": "Treatment","text": "isotretinoin-Lidose"}, {"annotation": "Treatment.Drug","text": "isotretinoin-Lidose"}, {"annotation": "Treatment.Disorder","text": "severe recalcitrant nodular acne"}, {"annotation": "Treatment.Dosage","text": "isotretinoin-Lidose"}, {"annotation": "Treatment.Duration","text": "severe recalcitrant nodular acne"}, {"annotation": "Treatment.Disorder","text": "severe recalcitrant nodular acne"}, {"annotation": "Treatment.Effect", "text": "results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne."}, {"annotation": "Treatment.Effect.Negated", "text": "results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne."}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "severe recalcitrant nodular acne"}, {"annotation": "Treatment","text": "isotretinoin-Lidose"}, {"annotation": "Treatment.Drug","text": "isotretinoin-Lidose"}, {"annotation": "Treatment.Dosage","text": "isotretinoin-Lidose"}, {"annotation": "Treatment.Duration","text": "severe recalcitrant nodular acne"}, {"annotation": "Treatment.Disorder","text": "severe recal
 {"id": "16490518_4","context": "This treatment has the potential to cause severe vision loss as a result of intractable corticosteroid-induced glaucoma.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "result of"},{"annotation": "Treatment","text": "corticosteroid-induced glaucoma"},{"annotation": "Treatment.Disorder","text": "corticosteroid-induced glaucoma"},{"annotation": "Effect","text": "severe vision loss"}]}]}
 {"id": "3708949_4","context": "Therefore, parenteral amiodarone was implicated as the cause of acute hepatitis in this patient.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "parenteral amiodarone"},{"annotation": "Effect", "text": "acute hepatitis"},{"annotation": "Treatment", "text": "parenteral amiodarone"},{"annotation": "Treatment.Disorder", "text": "acute hepatitis"},{"annotation": "Treatment.Drug", "text": "parenteral amiodarone"}]}]}
 {"id": "11485141_5","context": "Twenty-four hours after the administration of gemcitabine, a symmetric, bullous, herpetiform eruption appeared on his trunk and upper limbs.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "administered"},{"annotation": "Treatment","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Effect","text": "eruption"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation
 {"id": "20925534_11","context": "The rate of overt upper gastrointestinal bleeding was also reduced with omeprazole as compared with placebo (hazard ratio, 0.13; 95% CI, 0.03 to 0.56; P = 0.001).","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "reduced"},{"annotation": "Effect","text": "bleeding"},{"annotation": "Treatment","text": "omeprazole"},{"annotation": "Treatment.Drug","text": "omeprazole"},{"annotation": "Treatment.Duration","text": "compared with placebo"},{"annotation": "Treatment.Duration","text": "hazard ratio"},{"annotation": "Treatment.Duration","text": "95% CI"},{"annotation": "Treatment.Duration","text": "P"}]}]
 {"id": "8145359_2","context": "The association of phenothiazine overdose and respiratory distress syndrome merits consideration.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "overdose"},{"annotation": "Effect","text": "respiratory distress syndrome"},{"annotation": "Treatment","text": "phenothiazine"}]}]}
 {"id": "6340463_4","context": "Patients from endemic areas referred to transplant centers may be at high risk for disseminated histoplasmosis when treated with long-term prednisone for graft-versus-host disease.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "disseminated histoplasmosis"},{"annotation": "Effect","text": "high risk"},{"annotation": "Treatment","text": "long-term prednisone"},{"annotation": "Treatment.Disorder","text": "graft-versus-host disease"},{"annotation": "Treatment.Drug","text": "prednisone"},{"annotation": "Treatment.Route","text": "oral"},{"annotation": "Treatment.Duration","text": "long-term"},{"annotation": "Treatment.Side_effect","text": "disseminated histoplasmosis"},{"annotation": "Treatment.Side_effect.Severity","text": "high"},{"annotation": "Treatment.Side_effect.Type","text": "Adverse_event"}],"attributes": {"negated": false,"speculated": false,"severity": "high"}}
 {"id": "12477460_1","context": "Atypical endometriosis may act as a precancerous lesion in the process of tamoxifen-induced malignant transformation of endometriosis.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "malignant transformation"},{"annotation": "Treatment","text": "tamoxifen"},{"annotation": "Treatment.Disorder","text": "endometriosis"},{"annotation": "Treatment.Drug","text": "tamoxifen"}]}]
 {"id": "9562211_1","context": "A 28 year old white schizophrenic male has been under risperidone monotherapy for about one year when he developed dyskinetic movements.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "dyskinetic movements"},{"annotation": "Treatment","text": "risperidone monotherapy"},{"annotation": "Treatment.Drug","text": "risperidone"},{"annotation": "Treatment.Duration","text": "about one year"},{"annotation": "Treatment.Disorder","text": "schizophrenic"},{"annotation": "Subject","text": "28 year old white schizophrenic male"},{"annotation": "Subject.Age","text": "28"},{"annotation": "Subject.Disorder","text": "schizophrenic"},{"annotation": "Subject.Gender","text": "male"},{"annotation": "Subject.Race","text": "white"}]}
 {"id": "22047557_8","context": "Subjects receiving ivacaftor were 55% less likely to have a pulmonary exacerbation than were patients receiving placebo, through week 48 (P<0.001).","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "receiving ivacaftor"},{"annotation": "Treatment","text": "ivacaftor"},{"annotation": "Treatment.Disorder","text": "pulmonary exacerbation"},{"annotation": "Treatment.Drug","text": "placebo"},{"annotation": "Treatment.Duration","text": "through week 48"},{"annotation": "Treatment.Drug","text": "ivacaftor"},{"annotation": "Effect","text": "55% less likely"},{"annotation": "Treatment.Drug","text": "placebo"},{"annotation": "Effect","text": "P<0.001"}]}
 {"id":"10759907_2","context":"Spinal cord infarction during use of zolmitriptan: a case report.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"during use of zolmitriptan"},{"annotation":"Effect","text":"spinal cord infarction"},{"annotation":"Treatment","text":"zolmitriptan"},{"annotation":"Treatment.Drug","text":"zolmitriptan"},{"annotation":"Treatment.Dosage","text":"unknown"},{"annotation":"Treatment.Duration","text":"unknown"},{"annotation":"Treatment.Route","text":"unknown"},{"annotation":"Treatment.Time_elapsed","text":"unknown"},{"annotation":"Subject","text":"a patient"},{"annotation":"Subject.Age","text":"unknown"},{"annotation":"Subject.Gender","text":"unknown"},{"annotation":"Subject.Population","text":"1 patient"},{"annotation":"Subject.Race","text":"unknown"},{"annotation":"Subject.Disorder","text":"unknown"},{"annotation":"Treatment.Disorder","text":"unknown"}]}]}
 {"id": "12854039_3","context": "Case 2, a 29-year-old woman, developed bilateral optic neuritis combined with numbness of the lower extremities as well as bowel and bladder dysfunction after a 22-month use of recombinant interferon alpha-2b for chronic myelogenous leukemia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "use of recombinant interferon alpha-2b"},{"annotation": "Effect","text": "bilateral optic neuritis, numbness of lower extremities, bowel and bladder dysfunction"},{"annotation": "Treatment","text": "recombinant interferon alpha-2b"},{"annotation": "Treatment.Disorder","text": "chronic myelogenous leukemia"},{"annotation": "Treatment.Drug","text": "recombinant interferon alpha-2b"}]}]
 {"id": "6794018_3","context": "These features have not previously been reported as side effects of glibenclamide therapy, but intrahepatic cholestasis may occur with chlorpropamide, a similar sulphonylurea agent.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "may occur"},{"annotation": "Treatment","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Disorder","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "annotation": "Treatment.Drug","text": "sulphonylurea agent"},{"annotation": "annotation": "Treatment.Disorder","text": "intrahepatic cholestasis"},{"annotation": "annotation": "Treatment.Disorder","text": "side effects"},{"annotation": "annotation": "Treatment.Disorder","text": "glibenclamide therapy"},{"annotation": "annotation": "Treatment.Drug","text": "chlorpropamide"},{"annotation": "annotation": "annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "annotation": "annotation": "annotation": "annotation": "annotation": "annotation": "annotation": "annotation": "annotation": "annotation": "annotation": "annotation": "annotation": "annotation": "annotation": "
 {"id": "9562211_2","context": "Risperidone-induced tardive dyskinesia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "tardive dyskinesia"},{"annotation": "Treatment", "text": "risperidone"},{"annotation": "Treatment.Disorder", "text": "none"},{"annotation": "Treatment.Drug", "text": "risperidone"},{"annotation": "Treatment.Dosage", "text": "not specified"},{"annotation": "Treatment.Frequency", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Attribute", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.severity", "text": "not specified"}]}]
 {"id": "9737132_2","context": "Caution in long-term usage and early recognition of pentazocine toxicity as a neuromuscular complication are important in order to prevent irreversible drug-induced fibrous myopathy and localized neuropathy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "toxicity"},{"annotation": "Treatment","text": "pentazocine"},{"annotation": "Treatment.Drug","text": "pentazocine"},{"annotation": "Treatment.Duration","text": "long-term"},{"annotation": "Treatment.Duration","text": "early recognition"},{"annotation": "Effect","text": "neuromuscular complication"},{"annotation": "Treatment.Disorder","text": "drug-induced fibrous myopathy and localized neuropathy"}]}
 {"id": "3359700_2","context": "Based upon the observed fall of the filtration fraction, the rise in the relative clearance of 99Tc-dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and/or interstitium are the main targets for cyclosporine A nephrotoxicity.","events": [{"type": "Diagnostic_event","annotations": [{"annotation": "Trigger","text": "observed"},{"annotation": "Effect","text": "fall of filtration fraction"},{"annotation": "Treatment","text": "cyclosporine A"},{"annotation": "Treatment.Disorder","text": "nephrotoxicity"},{"annotation": "Treatment.Target","text": "tubules and/or interstitium"}]}]}
 {"id": "3174043_2","context": "Niacin maculopathy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "Niacin"},{"annotation": "Effect", "text": "maculopathy"},{"annotation": "Treatment", "text": "niacin"}]}]}
 {"id":"22293514_5","context":"We report a case in which a potential drug interaction between clobazam and etravirine may have led to increased concentrations of clobazam and its pharmacologically active metabolite, N-desmethylclobazam, causing neurotoxic symptoms.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "potential drug interaction"},{"annotation": "Treatment","text": "clobazam"},{"annotation": "Treatment.Drug","text": "etravirine"},{"annotation": "Treatment.Drug","text": "clobazam"},{"annotation": "Treatment.Drug","text": "etravirine"},{"annotation": "Treatment.Drug","text": "etravirine"},{"annotation": "Treatment.Drug","text": "clobazam"},{"annotation": "Treatment.Drug","text": "N-desmethylclobazam"},{"annotation": "Treatment.Drug","text": "N-desmethylclobazam"},{"annotation": "Effect","text": "neurotoxic symptoms"},{"annotation": "Treatment","text": "clobazam"},{"annotation": "Treatment.Drug","text": "etravirine"}],"subject": {"age": "Not specified","gender": "Not specified","population": "1","race": "Not specified","disorder": "Not specified"}}
 {"id": "11202801_1","context": "A review of the literature revealed two other cases of hepatic angiosarcoma in patients after long-term cyclophosphamide treatment.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "long-term treatment"},{"annotation": "Treatment","text": "cyclophosphamide"},{"annotation": "Treatment.Drug","text": "cyclophosphamide"},{"annotation": "Treatment.Duration","text": "long-term"},{"annotation": "Effect","text": "hepatic angiosarcoma"}],"attributes": [{"annotation": "negated","text": "No negation found."},{"annotation": "speculated","text": "No speculation found."},{"annotation": "severity","text": "No severity found."}]}}
 {"id": "18076602_3","context": "We present a case of cutaneous leucocytoclastic vasculitis in which amphotericin B might presumably be the aetiological factor.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "cutaneous leucocytoclastic vasculitis"},{"annotation": "Treatment","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Effect","text": "vasculitis"}]}]}
 {"id": "18364401_5","context": "There have been numerous case reports of hyperglycemia with olanzapine in the literature, but none reported hyperglycemia within days of initiation of the medication.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "initiation of olanzapine"},{"annotation": "Treatment","text": "olanzapine"},{"annotation": "Treatment.Drug","text": "olanzapine"},{"annotation": "Effect","text": "hyperglycemia"}]}]
 {"id":"23970584_2","context":"This case report describes two severe antiretroviral drug adverse reactions that occurred in the same patient.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred"},{"annotation":"Treatment","text":"antiretroviral drugs"},{"annotation":"Treatment.Drug","text":"antiretroviral drugs"},{"annotation":"Treatment.Drug","text":"antiretroviral drugs"},{"annotation":"Treatment.Drug","text":"antiretroviral drugs"},{"annotation":"Effect","text":"severe adverse reactions"},{"annotation":"Attribute Attributes","text":"severity"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute Attributes","text":"negated"},{"annotation":"Attribute
 {"id": "16101941_2","context": "We report the first case presenting with successive anaphylactic reaction and extra-pyramidal syndrome after treatment with thiethylperazine maleate (thiethylperazine).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "treatment"},{"annotation": "Treatment","text": "thiethylperazine"},{"annotation": "Treatment.Drug","text": "thiethylperazine"},{"annotation": "Effect","text": "anaphylactic reaction"},{"annotation": "Effect","text": "extra-pyramidal syndrome"},{"annotation": "Treatment","text": "treatment"},{"annotation": "Treatment.Disorder","text": "none"},{"annotation": "Treatment.Drug","text": "thiethylperazine"}]}
 {"id": "2483959_2","context": "Renal failure associated with the use of dextran-40.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "associated with"},{"annotation": "Treatment", "text": "dextran-40"},{"annotation": "Treatment.Drug", "text": "dextran-40"},{"annotation": "Effect", "text": "renal failure"},{"annotation": "Treatment.Drug", "text": "dextran-40"}]}]
 {"id":"11510798_1","context":"Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"associated with"},{"annotation":"Effect","text":"lung injury"},{"annotation":"Treatment","text":"5-fluorouracil and oxaliplatinum combined chemotherapy"},{"annotation":"Treatment.Disorder","text":"acute lung injury"},{"annotation":"Treatment.Drug","text":"5-fluorouracil"},{"annotation":"Treatment.Drug","text":"oxaliplatinum"},{"annotation":"Treatment.Combination.Trigger","text":"and"},{"annotation":"Treatment.Combination.Drug","text":"5-fluorouracil"},{"annotation":"Treatment.Combination.Drug","text":"oxaliplatin"},{"annotation":"Subject","text":"a patient"},{"annotation":"Subject.Disorder","text":"acute lung injury"}]}]}
 {"id": "11155197_3","context": "Type II heparin-induced thrombocytopenia (HIT) is an immunological disorder characterized by antibodies to heparin-platelet factor 4 complexes and a high risk of thrombotic complications.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "thrombocytopenia"},{"annotation": "Treatment", "text": "heparin"},{"annotation": "Treatment.Disorder", "text": "Type II HIT"},{"annotation": "Treatment.Drug", "text": "heparin"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "low"},{"annotation": "Attribute Attributes", "text": "speculated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"},{"annotation": "Attribute Att
 {"id": "7485371_3","context": "RESULTS: Similar to previous findings of drug-induced vortex keratopathy, atovaquone vortex keratopathy is presumably caused by its lipophilic properties.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Treatment", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "vortex"},{"annotation": "Treatment.Disorder", "text": "keratopathy"},{"annotation": "Treatment.Drug", "text": "induced"},{"annotation": "Treatment.Drug", "text": "atovaquone"},{"annotation": "Treatment.Drug", "text": "v
 {"id":"11109149_1","context":"Gangrene of the fingertips after bleomycin and methotrexate.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"bleomycin and methotrexate"},{"annotation":"Treatment","text":"bleomycin and methotrexate"},{"annotation":"Treatment.Drug","text":"bleomycin"},{"annotation":"Treatment.Drug","text":"methotrexate"},{"annotation":"Effect","text":"gangrene"},{"annotation":"Treatment.Drug","text":"bleomycin"},{"annotation":"Treatment.Drug","text":"methotrexate"},{"annotation":"Treatment.Combination.Trigger","text":"and"},{"annotation":"Treatment.Combination.Drug","text":"bleomycin"},{"annotation":"Treatment.Combination.Drug","text":"methotrexate"},{"annotation":"Subject","text":"patient"},{"annotation":"Subject.Disorder","text":"gangrene"},{"annotation":"Treatment.Disorder","text":"bleomycin and methotrexate"}]}]}
 {"id": "8404753_9","context": "These cases demonstrate that CBZ can induce simple motor tics in children.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "simple motor tics"},{"annotation": "Treatment", "text": "CBZ"},{"annotation": "Treatment.Disorder", "text": "children"},{"annotation": "Treatment.Drug", "text": "CBZ"},{"annotation": "Treatment.Drug", "text": "simple motor tics"},{"annotation": "Subject", "text": "children"},{"annotation": "Subject.Disorder", "text": "children"}]}]}
 {"id": "3964363_2","context": "Esophageal spasm following propranolol overdose relieved by glucagon.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "propranolol overdose"}, {"annotation": "Effect", "text": "esophageal spasm"}, {"annotation": "Treatment", "text": "glucagon"}, {"annotation": "Treatment.Drug", "text": "glucagon"}, {"annotation": "Treatment.Disorder", "text": "propranolol overdose"}, {"annotation": "Treatment.Drug", "text": "propranolol"}]},{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "relieved"}, {"annotation": "Treatment", "text": "glucagon"}, {"annotation": "Treatment.Disorder", "text": "propranolol overdose"}, {"annotation": "Treatment.Drug", "text": "glucagon"}, {"annotation": "Treatment.Drug", "text": "propranolol"}]}]}
 {"id": "9352164_3","context": "She was thus diagnosed as having AZ intoxication.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intoxication"},{"annotation": "Effect","text": "diagnosed"},{"annotation": "Treatment","text": "AZ"}]}]
 {"id":"10592946_3","context":"Severe rhabdomyolysis following massive ingestion of oolong tea: caffeine intoxication with coexisting hyponatremia.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"following"},{"annotation":"Treatment","text":"massive ingestion of oolong tea"},{"annotation":"Treatment.Drug","text":"caffeine"},{"annotation":"Treatment.Drug","text":"oolong tea"},{"annotation":"Treatment.Drug","text":"hyponatremia"},{"annotation":"Effect","text":"rhabdomyolysis"},{"annotation":"Treatment","text":"caffeine intoxication"},{"annotation":"Treatment.Drug","text":"caffeine"},{"annotation":"Treatment.Disorder","text":"hyponatremia"},{"annotation":"Treatment.Drug","text":"oolong tea"},{"annotation":"Attribute Attributes","text":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","annotation":"negated","
 {"id": "15663666_2","context": "The ulcer did not respond to antibiotic treatment and healed shortly after withholding ATRA.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "did not respond"},{"annotation": "Effect","text": "ulcer"},{"annotation": "Treatment","text": "antibiotic"},{"annotation": "Treatment.Disorder","text": "ulcer"},{"annotation": "Treatment.Drug","text": "antibiotic"},{"annotation": "Treatment.Drug","text": "ATRA"},{"annotation": "Treatment.Duration","text": "healed shortly"}]}
 {"id": "9726762_1","context": "Gemfibrozil-warfarin drug interaction resulting in profound hypoprothrombinemia.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "drug interaction"},{"annotation": "Treatment", "text": "gemfibrozil-warfarin"},{"annotation": "Treatment.Drug", "text": "gemfibrozil"},{"annotation": "Treatment.Drug", "text": "warfarin"},{"annotation": "Effect", "text": "hypoprothrombinemia"},{"annotation": "Treatment.Disorder", "text": "profound hypoprothrombinemia"}]}]}
 {"id":"17665812_2","context":"Drug-induced eosinophilia is a non-dose-dependent side effect of clozapine.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Effect","text":"eosinophilia"},{"annotation":"Treatment","text":"clozapine"},{"annotation":"Treatment.Disorder","text":"none"},{"annotation":"Treatment.Drug","text":"clozapine"},{"annotation":"Treatment.Severity","text":"non-dose-dependent"},{"annotation":"Treatment.Severity","text":"severe"},{"annotation":"Subject","text":"none"},{"annotation":"Subject.Disorder","text":"none"}]}]}
 {"id": "7485371_4","context": "Vortex keratopathy associated with atovaquone.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "associated with"},{"annotation": "Treatment", "text": "atovaquone"},{"annotation": "Effect", "text": "vortex keratopathy"},{"annotation": "Treatment.Drug", "text": "atovaquone"}]}]}
 {"id": "18037876_1","context": "DIAGNOSIS: Sustained ventricular tachycardia possibly owing to thalidomide treatment.","events": [{"type": "Diagnosis","annotations": [{"annotation": "Trigger","text": "DIAGNOSIS"},{"annotation": "Effect","text": "ventricular tachycardia"},{"annotation": "Treatment","text": "thalidomide"}]}]
 {"id": "910864_1","context": "In one instance a systemic hypoglycemic reaction resulting in head trauma and confusion ended in an emergency hospital admission following the substitution of acetohexamide for acetazolamide.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "substitution"},{"annotation": "Treatment","text": "acetohexamide"},{"annotation": "Treatment.Drug","text": "acetohexamide"},{"annotation": "Effect","text": "hypoglycemic reaction"},{"annotation": "Treatment.Drug","text": "acetazolamide"},{"annotation": "Treatment.Disorder","text": "hypoglycemia"},{"annotation": "Treatment.Drug","text": "acetohexamide"},{"annotation": "Treatment.Disorder","text": "hypoglycemia"},{"annotation": "Subject","text": "one instance"},{"annotation": "Subject.Disorder","text": "hypoglycemia"}]}
 {"id": "17182354_1","context": "However, an association of Ritalin with glaucoma has been reported.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "an association of Ritalin with glaucoma has been reported."},{"annotation": "Treatment", "text": "Ritalin"},{"annotation": "Treatment.Disorder", "text": "glaucoma"},{"annotation": "Treatment.Drug", "text": "Ritalin"},{"annotation": "Attribute", "text": "negated", "annotation": "negated", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "speculated", "annotation": "speculated", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "negated", "annotation": "negated", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "speculated", "annotation": "speculated", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "high", "annotation": "high", "annotation_type": "attribute"},{"annotation": "Attribute", "text": "low", "annotation": "low", "annotation_type": "attribute"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "text": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "annotation": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "annotation": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "annotation": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "annotation": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "Annotation", "annotation": "negated", "annotation": "negated", "annotation_type": "annotation"},{"annotation": "Annotation", "annotation": "speculated", "annotation": "speculated", "annotation_type": "annotation"},{"annotation": "
 {"id": "12854039_1","context": "After a two-month interruption of interferon administration, natural interferon alpha was given but followed by another episode of the same neurological manifestations.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "interruption"},{"annotation": "Treatment","text": "interferon administration"},{"annotation": "Treatment.Drug","text": "interferon"},{"annotation": "Effect","text": "neurological manifestations"},{"annotation": "Treatment.Drug","text": "natural interferon alpha"},{"annotation": "Treatment.Drug","text": "another episode"}]}]
 {"id": "25842648_7","context": "This article discusses the clinical manifestations of the serotonin syndrome and highlights reported cases of serotonin syndrome specifically related to an interaction between SSRIs and fentanyl, a commonly used opioid in anesthesia practice.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "an interaction between SSRIs and fentanyl"},{"annotation": "Treatment","text": "serotonin syndrome"},{"annotation": "Treatment.Disorder","text": "serotonin syndrome"},{"annotation": "Treatment.Drug","text": "SSRIs"},{"annotation": "Treatment.Drug","text": "fentanyl"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "SSRIs"},{"annotation": "Treatment.Combination.Drug","text": "fentanyl"},{"annotation": "Event type","text": "Potential_therapeutic_effect"},{"annotation": "negated","text": "not explicitly remarked"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "clinical manifestations"},{"annotation": "Treatment","text": "serotonin syndrome"},{"annotation": "Treatment.Disorder","text": "serotonin syndrome"},{"annotation": "Effect","text": "reported cases"},{"annotation": "Event type","text": "Adverse_event"},{"annotation": "negated","text": "not explicitly remarked"}]}]}
 {"id": "2483959_4","context": "While the mechanism of dextran-associated renal failure remains unsolved, plasma exchange seems to be effective therapy.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "dextran-associated"}, {"annotation": "Effect", "text": "renal failure"}, {"annotation": "Treatment", "text": "plasma exchange"}, {"annotation": "Treatment.Disorder", "text": "dextran-associated renal failure"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "unsolved"}, {"annotation": "Effect", "text": "mechanism of dextran-associated renal failure"}, {"annotation": "Treatment", "text": "plasma exchange"}, {"annotation": "Treatment.Disorder", "text": "dextran-associated renal failure"}]},{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "effective therapy"}, {"annotation": "Effect", "text": "plasma exchange"}, {"annotation": "Treatment", "text": "plasma exchange"}, {"annotation": "Treatment.Disorder", "text": "dextran-associated renal failure"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "plasma exchange"}, {"annotation": "Effect", "text": "renal failure"}, {"annotation": "Treatment", "text": "plasma exchange"}, {"annotation": "Treatment.Disorder", "text": "dextran-associated renal failure"}]}],"attributes": [{"attribute": "negated", "text": "false"},{"attribute": "speculated", "text": "false"},{"attribute": "severity", "text": "high"}]}
 {"id": "9865241_4","context": "The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "secondary to acute vitamin D intoxication"},{"annotation": "Effect", "text": "hypercalcemia"},{"annotation": "Treatment", "text": "pamidronate"},{"annotation": "Treatment.Disorder", "text": "hypercalcemia"},{"annotation": "Treatment.Drug", "text": "pamidronate"},{"annotation": "Treatment.Dosage", "text": "not specified"},{"annotation": "Treatment.Frequency", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Subject", "text": "not specified"},{"annotation": "Subject.Age", "text": "not specified"},{"annotation": "Subject.Gender", "text": "not specified"},{"annotation": "Subject.Population", "text": "not specified"},{"annotation": "Subject.Race", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Drug", "text": "not specified"},{"annotation": "Treatment.Combination.Trigger", "text": "not specified"},{"annotation": "Treatment.Combination
 {"id": "14614357_1","context": "Early overanticoagulation with acenocoumarol due to a genetic polymorphism of cytochrome P450 CYP2C9.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "overanticoagulation"},{"annotation": "Treatment","text": "acenocoumarol"},{"annotation": "Treatment.Drug","text": "acenocoumarol"},{"annotation": "Effect","text": "overanticoagulation"},{"annotation": "Treatment.Drug","text": "acenocoumarol"},{"annotation": "Treatment.Genetic_polymorphism","text": "cytochrome P450 CYP2C9"},{"annotation": "Subject","text": "patient"},{"annotation": "Subject.Disorder","text": "overanticoagulation"}]}
 {"id": "8589490_3","context": "We report an unusual pattern of supravenous hyperpigmentation occurring after CHOP chemotherapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurring after CHOP chemotherapy"},{"annotation": "Effect","text": "supraventricular hyperpigmentation"},{"annotation": "Treatment","text": "CHOP chemotherapy"}]}]}
 {"id": "12488741_2","context": "Proton MRS examination demonstrated a persistent lactate elevation during metronidazole treatment.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "elevation"},{"annotation": "Effect","text": "lactate elevation"},{"annotation": "Treatment","text": "metronidazole"},{"annotation": "Treatment.Drug","text": "metronidazole"}]}]}
 {"id": "1422497_1","context": "Encephalopathy and seizures induced by intravesical alum irrigations.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "intravesical alum irrigations"},{"annotation": "Treatment.Drug","text": "alum"},{"annotation": "Effect","text": "encephalopathy and seizures"}]}]
 {"id": "15522120_17","context": "Dermal side reactions to SSRI-drugs in these patients may be due to high activity in the serotonergic system at the dermal and epidermo-dermal junctional area rather than a hypersensitivity to the drug molecule itself.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "Dermal side reactions"},{"annotation": "Treatment","text": "SSRI-drugs"},{"annotation": "Treatment.Disorder","text": "SSRI-drugs"},{"annotation": "Treatment.Drug","text": "SSRI-drugs"},{"annotation": "Treatment.Drug","text": "SSRI-drugs"},{"annotation": "Treatment.Drug","text": "SSRI-drugs"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},
 {"id": "12659609_3","context": "CASE SUMMARY: A febrile 36-year-old seaman from Mumbai (Bombay) was prescribed >5 times the usual dose of chloroquine for malaria diagnosed empirically onboard ship.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "prescribed"},{"annotation": "Treatment","text": "chloroquine"},{"annotation": "Treatment.Drug","text": "chloroquine"},{"annotation": "Treatment.Dosage","text": ">5 times the usual dose"},{"annotation": "Treatment.Frequency","text": "prescribed"},{"annotation": "Treatment.Route","text": "prescribed"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "malaria"},{"annotation": "Effect","text": "fever"}]}
 {"id":"19266307_2","context":"MATERIALS AND METHODS: We present two cases of significant morbidity related to primary and secondary perforation of the bladder following two instillations of epirubicin.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"following"},{"annotation":"Effect","text":"perforation of the bladder"},{"annotation":"Treatment","text":"epirubicin instillations"},{"annotation":"Treatment.Drug","text":"epirubicin"},{"annotation":"Treatment.Dosage","text":"two instillations"},{"annotation":"Treatment.Frequency","text":"two"},{"annotation":"Treatment.Route","text":"instillations"},{"annotation":"Treatment.Time_elapsed","text":"after"},{"annotation":"Treatment.Duration","text":"two instillations"},{"annotation":"Treatment.Disorder","text":"primary and secondary perforation of the bladder"},{"annotation":"Subject","text":"two cases"},{"annotation":"Subject.Age","text":"not specified"},{"annotation":"Subject.Disorder","text":"not specified"}]}]}
 {"id": "18628507_2","context": "Angio-oedema as an unusual tolerable side effect of voriconazole therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "voriconazole therapy"},{"annotation": "Treatment","text": "voriconazole"},{"annotation": "Treatment.Drug","text": "voriconazole"},{"annotation": "Treatment.Side_effect","text": "angio-oedema"},{"annotation": "Effect","text": "tolerable"}]}]
 {"id": "18262450_8","context": "Oxycodone-gabapentin reduced pain score by 33% from baseline to end of treatment.","events": [{"type": "Treatment","annotations": [{"annotation": "Drug","text": "oxycodone-gabapentin"},{"annotation": "Dosage","text": "reduced"},{"annotation": "Frequency","text": "end of treatment"},{"annotation": "Route","text": "combined"},{"annotation": "Time_elapsed","text": "33%"},{"annotation": "Duration","text": "reduced"},{"annotation": "Disorder","text": "pain"},{"annotation": "Effect","text": "reduced pain score"}],"attributes": [{"annotation": "negated","text": "false"},{"annotation": "speculated","text": "false"},{"annotation": "severity","text": "medium"}],"subject": {"Age": "adult","Gender": "not specified","Population": "not specified","Race": "not specified","Disorder": "not specified"}}
 {"id": "10435399_2","context": "OBJECTIVE: We report a patient who developed neutropenia on clozapine, but behind the cell count decrease showed to be a diurnal variation of the white blood cells (WBC).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "neutropenia"},{"annotation": "Treatment","text": "clozapine"}]},{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "behind"},{"annotation": "Treatment","text": "cell count decrease"},{"annotation": "Treatment.Disorder","text": "diurnal variation of white blood cells"}]}]}
 {"id": "11352235_5","context": "RESULTS: Five of 70 patients who had begun leflunomide therapy had significant weight loss that could not be linked to other identifiable etiologies.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "weight loss"},{"annotation": "Effect","text": "significant"},{"annotation": "Treatment","text": "leflunomide therapy"},{"annotation": "Treatment.Disorder","text": "weight loss"}]}]
 {"id": "16018164_2","context": "Only one report links phenylpropanolamine consumption to an intracerebral hemorrhage in a patient with an AVM.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "consumption"},{"annotation": "Treatment","text": "phenylpropanolamine"},{"annotation": "Treatment.Drug","text": "phenylpropanolamine"},{"annotation": "Treatment.Dosage","text": "unknown"},{"annotation": "Treatment.Frequency","text": "unknown"},{"annotation": "Treatment.Route","text": "unknown"},{"annotation": "Treatment.Time_elapsed","text": "unknown"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "AVM"},{"annotation": "Effect","text": "intracerebral hemorrhage"}]}
 {"id": "16101941_1","context": "Anaphylactic reaction and unrelated, subsequent, known side effects during therapy with thiethylperazine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "therapy"},{"annotation": "Effect","text": "anaphylactic reaction"},{"annotation": "Treatment","text": "thiethylperazine"},{"annotation": "Treatment.Drug","text": "thiethylperazine"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "subsequent"},{"annotation": "Effect","text": "known side effects"},{"annotation": "Treatment","text": "thiethylperazine"},{"annotation": "Treatment.Drug","text": "thiethylperazine"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "unrelated"},{"annotation": "Effect","text": "known side effects"},{"annotation": "Treatment","text": "thiethylperazine"},{"annotation": "Treatment.Drug","text": "thiethylperazine"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "known side effects"},{"annotation": "Effect","text": "known side effects"},{"annotation": "Treatment","text": "thiethylperazine"},{"annotation": "Treatment.Drug","text": "thiethylperazine"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "known side effects"},{"annotation": "Effect","text": "known side effects"},{"annotation": "Treatment","text": "thiethylperazine"},{"annotation": "Treatment.Drug","text": "thiethylperazine"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "known side effects"},{"annotation": "Effect","text": "known side effects"},{"annotation": "Treatment","text": "thiethylperazine"},{"annotation": "Treatment.Drug","text": "thiethylperazine"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "known side effects"},{"annotation": "Effect","text": "known side effects"},{"annotation": "Treatment","text": "thiethylperazine"},{"annotation": "Treatment.Drug","text": "thiethylperazine"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "known side effects"},{"annotation": "Effect","text": "known side effects"},{"annotation": "Treatment","text": "thiethylperazine"},{"annotation": "Treatment.Drug","text": "thiethylperazine"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "known side effects"},{"annotation": "Effect","text": "known side effects"},{"annotation": "Treatment","text": "thiethylperazine"},{"annotation": "Treatment.Drug","text": "thiethylperazine"}],{"type": "Adverse_event","annotations": [{
 {"id": "8430717_4","context": "PURPOSE: To investigate the concentration-side effect relationship in a patient with severe acyclovir-induced neurotoxicity and to summarize the information available in the literature about central nervous system side effects due to acyclovir.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "neurotoxicity"},{"annotation": "Treatment","text": "acyclovir"},{"annotation": "Treatment.Drug","text": "acyclovir"},{"annotation": "Treatment.Dosage","text": "severe"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "acyclovir-induced neurotoxicity"},{"annotation": "Attribute","text": "negated","severity": "high"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "investigation"},{"annotation": "Effect","text": "concentration-side effect relationship"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Treatment","text": "acyclovir"},{"annotation": "Treatment.Drug","text": "acyclovir"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "acyclovir-induced neurotoxicity"},{"annotation": "Attribute","text": "speculated","severity": "low"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "literature review"},{"annotation": "Effect","text": "central nervous system side effects due to acyclovir"},{"annotation": "Attribute","text": "not negated"},{"annotation": "Treatment","text": "acyclovir"},{"annotation": "Treatment.Drug","text": "acyclovir"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "acyclovir-induced neurotoxicity"},{"annotation": "Attribute","text": "not negated"},{"annotation": "severity","text": "low"}]}
 {"id": "16317298_3","context": "Radiation recall from gemcitabine is rare, but can potentially arise in any site that has been previously irradiated.","events": [{"type": "Potential_therapeutic_event","annotations": [{"annotation": "Trigger","text": "Radiation recall"},{"annotation": "Treatment","text": "gemcitabine"},{"annotation": "Treatment.Disorder","text": "gemcitabine-induced"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "speculated"},{"annotation": "Attribute Attributes","text": "severity"}]}
 {"id": "15368548_3","context": "Most cases of pancreatitis associated with L-asparaginase toxicity are self-limiting and respond favorably to nasogastric decompression and intravenous hyperalimentation.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "L-asparaginase toxicity"},{"annotation": "Effect","text": "pancreatitis"},{"annotation": "Treatment","text": "nasogastric decompression and intravenous hyperalimentation"},{"annotation": "Treatment.Drug","text": "L-asparaginase"}]}]
 {"id": "23970584_6","context": "Shortly after commencing the drug, the patient developed a severe adverse drug reaction manifesting as Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS) syndrome.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "commencing the drug"}, {"annotation": "Treatment", "text": "drug"}, {"annotation": "Treatment.Drug", "text": "drug"}, {"annotation": "Treatment.Disorder", "text": "DRESS syndrome"}, {"annotation": "Effect", "text": "adverse drug reaction"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}, {"
 {"id": "9562211_3","context": "This report presents a potential case of risperidone-induced tardive dyskinesia.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Treatment", "text": "risperidone"},{"annotation": "Treatment.Disorder", "text": "tardive dyskinesia"},{"annotation": "Treatment.Drug", "text": "risperidone"}]}]}
 {"id": "16288069_4","context": "The patient described feeling cold with worsening headache and chills approximately one hour after infusion of the first dose of penicillin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "infusion of the first dose of penicillin"},{"annotation": "Treatment","text": "penicillin"},{"annotation": "Treatment.Drug","text": "penicillin"},{"annotation": "Effect","text": "cold, worsening headache and chills"},{"annotation": "Treatment.Dosage","text": "first dose"},{"annotation": "Treatment.Duration","text": "one hour"}]}]
 {"id": "15927910_4","context": "Early-onset pentamidine-associated second-degree heart block and sinus bradycardia: case report and review of the literature.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "pentamidine"},{"annotation": "Effect","text": "second-degree heart block and sinus bradycardia"}]}]}
 {"id": "15286697_1","context": "Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-beta1 and cyclooxygenase-2.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "associated with BCNU"},{"annotation": "Effect", "text": "fatal pulmonary fibrosis"},{"annotation": "Treatment", "text": "BCNU"},{"annotation": "Treatment.Disorder", "text": "pulmonary fibrosis"},{"annotation": "Treatment.Drug", "text": "BCNU"}],"subject": {"Age": "unknown","Gender": "unknown","Population": "1","Race": "unknown","Disorder": "unknown"}},{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "Relative role"},{"annotation": "Treatment", "text": "platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-beta1 and cyclooxygenase-2"},{"annotation": "Treatment.Disorder", "text": "pulmonary fibrosis"},{"annotation": "Treatment.Drug", "text": "BCNU"}],"subject": {"Age": "unknown","Gender": "unknown","Population": "1","Race": "unknown","Disorder": "pulmonary fibrosis"}}}
 {"id": "10492493_1","context": "CONCLUSIONS: This case suggests that losartan can induce late-onset angioedema in patients with normal renal function and that the reaction can recur after initial resolution of the symptoms.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "losartan"},{"annotation": "Treatment.Drug","text": "losartan"},{"annotation": "Effect","text": "late-onset angioedema"},{"annotation": "Treatment.Renal_function","text": "normal"},{"annotation": "Treatment.Recurrence","text": "recur"}]}
 {"id": "3211830_1","context": "Two cases of widespread cutaneous vasculitis are described in association with diltiazem, a recently introduced calcium antagonist.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with"},{"annotation": "Treatment","text": "diltiazem"},{"annotation": "Treatment.Drug","text": "diltiazem"},{"annotation": "Effect","text": "widespread cutaneous vasculitis"},{"annotation": "Treatment.Disorder","text": "cutaneous vasculitis"}]}],"attributes": [{"name": "negated","value": "false"},{"name": "speculated","value": "false"},{"name": "severity","value": "severe"}]}
 {"id": "10492493_4","context": "The incidence of angioedema secondary to losartan, an angiotensin II receptor antagonist, is unknown.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "secondary to losartan"},{"annotation": "Effect","text": "angioedema"},{"annotation": "Treatment","text": "losartan"},{"annotation": "Treatment.Drug","text": "losartan"},{"annotation": "Treatment.Disorder","text": "angioedema"},{"annotation": "Treatment.Drug","text": "unknown"},{"annotation": "Treatment.Disorder","text": "angiotensin II receptor antagonist"}]}
 {"id": "18347524_2","context": "We report the case of a young man, affected by rheumatoid arthritis who developed a rapid-onset short-of-breath, hemoptysis, and severe weakness, about 2 weeks after the administration of leflunomide.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "administered"},{"annotation": "Treatment","text": "leflunomide"},{"annotation": "Treatment.Drug","text": "leflunomide"},{"annotation": "Effect","text": "short-of-breath","negated": true},{"annotation": "Effect","text": "hemoptysis","negated": true},{"annotation": "Effect","text": "severe weakness","negated": true}]}]}
 {"id": "12659609_1","context": "Toxicity related to chloroquine treatment of resistant vivax malaria.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "chloroquine treatment"},{"annotation": "Effect","text": "toxicity"},{"annotation": "Treatment","text": "resistant vivax malaria"}]}]
 {"id": "8250714_3","context": "Patients with vitamin B12 deficiency are exceedingly sensitive to neurologic deterioration following nitrous oxide anesthesia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "nitrous oxide anesthesia"},{"annotation": "Treatment","text": "vitamin B12 deficiency"},{"annotation": "Treatment.Disorder","text": "vitamin B12 deficiency"},{"annotation": "Treatment.Drug","text": "nitrous oxide"},{"annotation": "Effect","text": "neurologic deterioration"}]}]
 {"id": "15072497_2","context": "However here we reported two patients, presenting with PD during high dose colchicine treatment for familiar mediterranean fever (FMF).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "presenting with PD"},{"annotation": "Effect","text": "parkinsonism"},{"annotation": "Treatment","text": "high dose colchicine treatment for familiar mediterranean fever (FMF)"},{"annotation": "Treatment.Drug","text": "colchicine"},{"annotation": "Treatment.Disorder","text": "familiar mediterranean fever (FMF)"},{"annotation": "Subject","text": "two patients"},{"annotation": "Subject.Population","text": "2"}]}
 {"id": "12786839_3","context": "We report two patients with infectious mononucleosis-like syndrome induced by salazosulfapyridine (SASP).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced by salazosulfapyridine (SASP)"},{"annotation": "Effect","text": "infectious mononucleosis-like syndrome"},{"annotation": "Treatment","text": "salazosulfapyridine (SASP)"},{"annotation": "Treatment.Drug","text": "salazosulfapyridine"}]}]}
 {"id": "1655228_2","context": "Myocardial ischemia associated with high-dose carmustine infusion.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "high-dose carmustine infusion"},{"annotation": "Effect","text": "myocardial ischemia"},{"annotation": "Treatment","text": "carmustine"},{"annotation": "Treatment.Drug","text": "carmustine"},{"annotation": "Subject","text": "patient"},{"annotation": "Subject.Population","text": "1"},{"annotation": "Treatment.Dosage","text": "high-dose"},{"annotation": "Treatment.Frequency","text": "infusion"},{"annotation": "Treatment.Route","text": "carmustine"},{"annotation": "Treatment.Time_elapsed","text": "after"},{"annotation": "Treatment.Duration","text": "carmustine"},{"annotation": "Treatment.Disorder","text": "myocardial ischemia"}]}
 {"id": "21802143_1","context": "Hepatic drug interaction between tacrolimus and lansoprazole in a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "interaction"},{"annotation": "Effect", "text": "hepatotoxicity"},{"annotation": "Treatment", "text": "voriconazole"},{"annotation": "Treatment.Disorder", "text": "bone marrow transplant"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "tacrolimus"},{"annotation": "Treatment.Drug", "text": "lansoprazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "tacrolimus"},{"annotation": "Treatment.Drug", "text": "lansoprazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "lansoprazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},{"annotation": "Treatment.Drug", "text": "voriconazole"},
 {"id": "12507063_2","context": "Gabapentin withdrawal presenting as status epilepticus.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "withdrawal"},{"annotation": "Effect","text": "status epilepticus"},{"annotation": "Treatment","text": "gabapentin"},{"annotation": "Treatment.Drug","text": "gabapentin"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute.negated","text": "withdrawal"}]}]}
 {"id":"7056119_1","context":"Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Effect","text":"torsade de pointes"},{"annotation":"Treatment","text":"amiodarone"},{"annotation":"Treatment.Disorder","text":"ventricular tachycardia"},{"annotation":"Treatment.Drug","text":"amiodarone"},{"annotation":"Treatment.Drug","text":"quinidine"},{"annotation":"Treatment.Drug","text":"disopyramide"},{"annotation":"Treatment.Combination.Trigger","text":"and"},{"annotation":"Treatment.Combination.Drug","text":"amiodarone"},{"annotation":"Treatment.Combination.Drug","text":"quinidine"},{"annotation":"Treatment.Combination.Drug","text":"disopyramide"},{"annotation":"Subject","text":"a patient"},{"annotation":"Subject.Disorder","text":"ventricular tachycardia"}]}]}
 {"id": "17619811_3","context": "Colchicine-induced rhabdomyolysis is a rare complication, and the postulated mechanisms and risk factors for this severe complication are discussed.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "Colchicine-induced"},{"annotation": "Effect","text": "rhabdomyolysis"},{"annotation": "Treatment","text": "colchicine"},{"annotation": "Treatment.Drug","text": "colchicine"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"}],"annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "No"}],"annotation": "negated"},{"annotation": "Attribute","annotations": [{
 {"id": "4075534_2","context": "Spindle coma in benzodiazepine toxicity: case report.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "coma"},{"annotation": "Treatment","text": "benzodiazepine toxicity"},{"annotation": "Treatment.Drug","text": "benzodiazepines"}]}]
 {"id": "2483959_1","context": "A typical case of dextran-40 associated acute renal failure is presented.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated"},{"annotation": "Treatment","text": "dextran-40"},{"annotation": "Treatment.Drug","text": "dextran-40"},{"annotation": "Effect","text": "acute renal failure"}]}]
 {"id": "15895899_1","context": "After the second infliximab infusion, he was found to have a severe transient neutropenia (0.5 x 10(9)/L).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "infliximab infusion"},{"annotation": "Effect","text": "neutropenia"},{"annotation": "Treatment","text": "infliximab"}]}]}
 {"id": "7712052_1","context": "Lithium for irritability in post-traumatic stress disorder.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "irritability"},{"annotation": "Treatment","text": "lithium"},{"annotation": "Treatment.Disorder","text": "post-traumatic stress disorder"}]}}
 {"id": "14684937_2","context": "Iatrogenic hypercalcemia due to vitamin D3 ointment (1,24(OH)2D3) combined with thiazide diuretics in a case of psoriasis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "due to"},{"annotation": "Effect","text": "hypercalcemia"},{"annotation": "Treatment","text": "vitamin D3 ointment (1,24(OH)2D3) combined with thiazide diuretics"},{"annotation": "Treatment.Drug","text": "vitamin D3 ointment (1,24(OH)2D3)"},{"annotation": "Treatment.Drug","text": "thiazide diuretics"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "vitamin D3 ointment (1,24(OH)2D3)"},{"annotation": "Treatment.Combination.Drug","text": "thiazide diuretics"},{"annotation": "Treatment.Combination.Drug","text": "vitamin D3 ointment (1,24(OH)2D3)"},{"annotation": "Treatment.Combination.Drug","text": "thiazide diuretics"},{"annotation": "Treatment.Combination.Trigger","text": "in"},{"annotation": "Treatment.Combination.Drug","text": "a case of"},{"annotation": "Treatment.Combination.Drug","text": "psoriasis"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Disorder","text": "psoriasis"}]}
 {"id": "6362443_1","context": "A case of mania associated with fluoxetine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with fluoxetine"},{"annotation": "Treatment","text": "fluoxetine"},{"annotation": "Treatment.Drug","text": "fluoxetine"},{"annotation": "Effect","text": "mania"}]}]}
 {"id": "7748076_3","context": "RESULTS: Extensive squamous metaplasia was found in endometrial glands following progestin therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "following progestin therapy"},{"annotation": "Treatment","text": "progestin therapy"},{"annotation": "Treatment.Drug","text": "progestin"},{"annotation": "Effect","text": "squamous metaplasia"},{"annotation": "Treatment.Disorder","text": "endometrial glands"}]}]
 {"id": "16843118_1","context": "Acute generalized exanthematous pustulosis caused by morphine, confirmed by positive patch test and lymphocyte transformation test.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "caused by morphine"},{"annotation": "Effect", "text": "acute generalized exanthematous pustulosis"},{"annotation": "Treatment", "text": "morphine"},{"annotation": "Treatment.Drug", "text": "morphine"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Attribute", "text": "negated", "annotation": "negated"},{"annotation": "Annotation", "text": "negated", "annotation": "negated"},{"annotation": "Annotation", "text": "negated", "annotation": "negated"},{"annotation": "Annotation", "text": "negated", "annotation": "negated"},{"annotation": "Annotation", "annotation": "negated", "annotation": "negated"},{"annotation": "Annotation", "text": "negated", "annotation": "negated"},{"annotation": "Annotation", "annotation": "negated", "annotation": "negated"},{"annotation": "Annotation", "annotation": "negated", "annotation": "negated"},{"annotation": "Annotation", "annotation": "negated", "annotation": "negated"},{"annotation": "Annotation", "annotation": "negated", "annotation": "negated"},
 {"id":"9149614_1","context":"Eleven days after initiation of therapy with amiodarone, the patient experienced syncope and was noted to have recurrent episodes of polymorphous ventricular tachycardia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "initiation of therapy with amiodarone"},{"annotation": "Effect","text": "syncope and recurrent episodes of polymorphous ventricular tachycardia"},{"annotation": "Treatment","text": "amiodarone"},{"annotation": "Treatment.Drug","text": "amiodarone"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Duration","text": "11 days"},{"annotation": "Treatment.Disorder","text": "not specified"}]}
 {"id": "8579054_3","context": "Prolonged used of hydroxyurea in patients with ET may lead to therapy-associated acute leukemia.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "prolonged use of hydroxyurea"},{"annotation": "Treatment", "text": "hydroxyurea"},{"annotation": "Treatment.Disorder", "text": "ET"},{"annotation": "Effect", "text": "acute leukemia"},{"annotation": "Treatment.Drug", "text": "hydroxyurea"},{"annotation": "Treatment.Duration", "text": "prolonged use"},{"annotation": "Treatment.Drug", "text": "hydroxyurea"},{"annotation": "Treatment.Drug", "text": "acute leukemia"},{"annotation": "Subject", "text": "patients with ET"},{"annotation": "Subject.Disorder", "text": "ET"}]}]}
 {"id": "354311_2","context": "Metastatic osteomyelitis following BCG vaccination.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "following"},{"annotation": "Treatment", "text": "BCG vaccination"},{"annotation": "Treatment.Drug", "text": "BCG"},{"annotation": "Effect", "text": "metastatic osteomyelitis"},{"annotation": "Treatment.Drug", "text": "BCG"},{"annotation": "Treatment.Drug", "text": "vaccination"},{"annotation": "Subject", "text": "patient"},{"annotation": "Subject.Disorder", "text": "metastatic osteomyelitis"}]}]}
 {"id": "1414247_1","context": "Carbamyl phosphate synthetase-1 deficiency discovered after valproic acid-induced coma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "coma"},{"annotation": "Treatment","text": "valproic acid"},{"annotation": "Treatment.Disorder","text": "carbamyl phosphate synthetase-1 deficiency"}]}]
 {"id": "8912599_5","context": "We describe two patients in whom painful erosions of their psoriasis developed as the presenting sign of methotrexate toxicity and review the literature, emphasizing the risk factors associated with this manifestation.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "presenting sign"},{"annotation": "Effect","text": "painful erosions"},{"annotation": "Treatment","text": "methotrexate"},{"annotation": "Treatment.Drug","text": "methotrexate"}]},{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "review"},{"annotation": "Treatment","text": "literature"},{"annotation": "Treatment.Disorder","text": "methotrexate toxicity"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Risk_factors","text": "manifestation"}]}],"attributes": [{"annotation": "negated","text": "not negated"},{"annotation": "severity","text": "not present"}]}
 {"id": "9413296_2","context": "Methysergide-induced retroperitoneal fibrosis: successful outcome and two new laboratory features.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "retroperitoneal fibrosis"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Disorder","text": "methysergide-induced retroperitoneal fibrosis"},{"annotation": "Treatment.Drug","text": "methysergide"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "outcome"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Disorder","text": "methysergide-induced retroperitoneal fibrosis"},{"annotation": "Treatment.Drug","text": "methysergide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "retroperitoneal fibrosis"},{"annotation": "Effect","text": "new laboratory features"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Disorder","text": "methysergide-induced retroperitoneal fibrosis"},{"annotation": "Treatment.Drug","text": "methysergide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "retroperitoneal fibrosis"},{"annotation": "Effect","text": "new laboratory features"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Disorder","text": "methysergide-induced retroperitoneal fibrosis"},{"annotation": "Treatment.Drug","text": "methysergide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "retroperitoneal fibrosis"},{"annotation": "Effect","text": "new laboratory features"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Disorder","text": "methysergide-induced retroperitoneal fibrosis"},{"annotation": "Treatment.Drug","text": "methysergide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "retroperitoneal fibrosis"},{"annotation": "Effect","text": "new laboratory features"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Disorder","text": "methysergide-induced retroperitoneal fibrosis"},{"annotation": "Treatment.Drug","text": "methysergide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "retroperitoneal fibrosis"},{"annotation": "Effect","text": "new laboratory features"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Disorder","text": "methysergide-induced retroperitoneal fibrosis"},{"annotation": "Treatment.Drug","text": "methysergide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "retroperitoneal fibrosis"},{"annotation": "Effect","text": "new laboratory features"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Disorder","text": "methysergide-induced retroperitoneal fibrosis"},{"annotation": "Treatment.Drug","text": "methysergide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "retroperitoneal fibrosis"},{"annotation": "Effect","text": "new laboratory features"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Disorder","text": "methysergide-induced retroperitoneal fibrosis"},{"annotation": "Treatment.Drug","text": "methysergide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "retroperitoneal fibrosis"},{"annotation": "Effect","text": "new laboratory features"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Disorder","text": "methysergide-induced retroperitoneal fibrosis"},{"annotation": "Treatment.Drug","text": "methysergide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "retroperitoneal fibrosis"},{"annotation": "Effect","text": "new laboratory features"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Disorder","text": "methysergide-induced retroperitoneal fibrosis"},{"annotation": "Treatment.Drug","text": "methysergide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "retroperitoneal fibrosis"},{"annotation": "Effect","text": "new laboratory features"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Disorder","text": "methysergide-induced retroperitoneal fibrosis"},{"annotation": "Treatment.Drug","text": "methysergide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "retroperitoneal fibrosis"},{"annotation": "Effect","text": "new laboratory features"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Disorder","text": "methysergide-induced retroperitoneal fibrosis"},{"annotation": "Treatment.Drug","text": "methysergide"}],{"type": "Adverse_event","annotations": [{
 {"id": "11099623_1","context": "We describe 2 children with cerebral palsy who suffered significant morbidity immediately after treatment with hyperbaric oxygen.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "immediately after treatment with hyperbaric oxygen"},{"annotation": "Effect", "text": "significant morbidity"},{"annotation": "Subject", "text": "2 children with cerebral palsy"},{"annotation": "Treatment", "text": "hyperbaric oxygen"}]}]}
 {"id": "53128_2","context": "A patient is described with polycythemia vera who was taking anticoagulants and developed a spontaneous retropharyngeal hemorrhage after a violent sneezing episode.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "spontaneous retropharyngeal hemorrhage"},{"annotation": "Effect","text": "hemorrhage"},{"annotation": "Treatment","text": "anticoagulants"},{"annotation": "Treatment.Disorder","text": "polycythemia vera"},{"annotation": "Treatment.Drug","text": "anticoagulants"},{"annotation": "Treatment.Dosage","text": "unknown"},{"annotation": "Treatment.Frequency","text": "unknown"},{"annotation": "Treatment.Route","text": "unknown"},{"annotation": "Treatment.Time_elapsed","text": "unknown"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "polycythemia vera"},{"annotation": "Subject","text": "patient"},{"annotation": "Subject.Age","text": "unknown"},{"annotation": "Subject.Gender","text": "unknown"},{"annotation": "Subject.Population","text": "unknown"},{"annotation": "Subject.Race","text": "unknown"}]}
 {"id": "9671138_1","context": "CD4 T-lymphocyte depletion, myelosuppression, and subsequent severe infections are the major side effects of fludarabine phosphate therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "fludarabine phosphate therapy"},{"annotation": "Treatment","text": "fludarabine phosphate"},{"annotation": "Treatment.Drug","text": "fludarabine phosphate"},{"annotation": "Treatment.Disorder","text": "CD4 T-lymphocyte depletion"},{"annotation": "Treatment.Disorder","text": "myelosuppression"},{"annotation": "Treatment.Disorder","text": "severe infections"},{"annotation": "Treatment.Side_effect","text": "CD4 T-lymphocyte depletion"},{"annotation": "Treatment.Side_effect","text": "myelosuppression"},{"annotation": "Treatment.Side_effect","text": "severe infections"}]}
 {"id": "16288069_3","context": "Penicillin-induced Jarisch-Herxheimer reaction.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "Jarisch-Herxheimer reaction"},{"annotation": "Treatment","text": "penicillin"}]}]
 {"id": "9550246_4","context": "The authors suggest that risperidone may increase affect in patients with schizophrenia and that some patients, especially those with anxiety, may have difficulty managing the increase.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "suggest"},{"annotation": "Treatment","text": "risperidone"},{"annotation": "Treatment.Disorder","text": "schizophrenia"},{"annotation": "Treatment.Effect","text": "affect"},{"annotation": "Attribute","attributes": [{"annotation": "negated","text": "yes"},{"annotation": "speculated","text": "yes"},{"annotation": "severity","text": "high"}]}],"subject": {"Age": "adults","Gender": "male","Population": "patients with schizophrenia","Race": "not specified","Disorder": "schizophrenia"}}
 {"id": "11315123_1","context": "We cared for a patient with progressive renal impairment who presented with blurred vision, QRS broadening and cardiac failure due to chronic cibenzoline intoxication.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "chronic cibenzoline intoxication"},{"annotation": "Effect","text": "progressive renal impairment, blurred vision, QRS broadening and cardiac failure"},{"annotation": "Treatment","text": "cibenzoline"},{"annotation": "Treatment.Drug","text": "cibenzoline"}]}]
 {"id": "1557089_1","context": "In a postoperative patient with pre-existent myasthenia gravis, oral verapamil caused a marked exacerbation in myasthenic weakness.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "oral verapamil"},{"annotation": "Effect","text": "exacerbation in myasthenic weakness"},{"annotation": "Treatment","text": "oral verapamil"},{"annotation": "Treatment.Drug","text": "verapamil"},{"annotation": "Treatment.Disorder","text": "pre-existent myasthenia gravis"},{"annotation": "Treatment.Drug","text": "verapamil"},{"annotation": "Subject","text": "a postoperative patient"},{"annotation": "Subject.Disorder","text": "myasthenia gravis"}]}
 {"id":"16288069_1","context":"An objective causality assessment suggests that the JHR in our patient was probably related to penicillin.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"probably related to"},{"annotation":"Effect","text":"JHR"},{"annotation":"Treatment","text":"penicillin"},{"annotation":"Treatment.Drug","text":"penicillin"},{"annotation":"Treatment.Drug","text":"JHR"},{"annotation":"Attribute Attributes","text":"severity"},{"annotation":"Attribute Attributes","text":"probable"},{"annotation":"Attribute Attributes","text":"causality"}]},{"type":"Potential_therapeutic_effect","annotations":[{"annotation":"Trigger","text":"JHR"}]}]}]}
 {"id":"16490518_2","context":"RESULTS: A 34-year-old man acquired visual field defects and severe vision loss in both eyes after intravitreal injection of triamcinolone for diabetic macular edema.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"acquired"},{"annotation":"Effect","text":"visual field defects and severe vision loss"},{"annotation":"Treatment","text":"intravitreal injection of triamcinolone for diabetic macular edema"},{"annotation":"Treatment.Drug","text":"triamcinolone"},{"annotation":"Treatment.Disease","text":"diabetic macular edema"},{"annotation":"Subject","text":"a 34-year-old man"},{"annotation":"Subject.Age","text":"34"},{"annotation":"Subject.Gender","text":"not specified"},{"annotation":"Subject.Population","text":"1"},{"annotation":"Subject.Race","text":"not specified"},{"annotation":"Subject.Disorder","text":"diabetic macular edema"},{"annotation":"Treatment.Route","text":"intravitreal injection"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"not specified"},{"annotation":"Treatment.Disorder","text":"diabetic macular edema"},{"annotation":"Event type","text":"Adverse_event"},{"annotation":"Attribute Attributes","text":"speculated","annotation":{"annotation":"negated","text":"not specified"},{"annotation":"annotation":"severity","text":"high"}]}]}
 {"id": "16537817_1","context": "Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "interaction"},{"annotation": "Effect", "text": "rhabdomyolysis, azotemia, and possible hepatotoxicity"},{"annotation": "Treatment", "text": "simvastatin-amiodarone"},{"annotation": "Treatment.Drug", "text": "simvastatin"},{"annotation": "Treatment.Drug", "text": "amiodarone"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "simvastatin"},{"annotation": "Treatment.Combination.Drug", "text": "amiodarone"},{"annotation": "Subject", "text": "a patient"},{"annotation": "Subject.Disorder", "text": "none"}]},{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "resulting"},{"annotation": "Effect", "text": "none"},{"annotation": "Treatment", "text": "simvastatin-amiodarone"},{"annotation": "Treatment.Disorder", "text": "none"},{"annotation": "Treatment.Drug", "text": "simvastatin"},{"annotation": "Treatment.Drug", "text": "amiodarone"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "simvastatin"},{"annotation": "Treatment.Combination.Drug", "text": "amiodarone"},{"annotation": "Subject", "text": "a patient"},{"annotation": "Subject.Disorder", "text": "none"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "resulting"},{"annotation": "Effect", "text": "none"},{"annotation": "Treatment", "text": "simvastatin-amiodarone"},{"annotation": "Treatment.Disorder", "text": "none"},{"annotation": "Treatment.Drug", "text": "simvastatin"},{"annotation": "Treatment.Drug", "text": "amiodarone"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "simvastatin"},{"annotation": "Treatment.Combination.Drug", "text": "amiodarone"},{"annotation": "Subject", "text": "a patient"},{"annotation": "Subject.Disorder", "text": "none"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "resulting"},{"annotation": "Effect", "text": "none"},{"annotation": "Treatment", "text": "simvastatin-amiodarone"},{"annotation": "Treatment.Disorder", "text": "none"},{"annotation": "Treatment.Drug", "text": "simvastatin"},{"annotation": "Treatment.Drug", "text": "amiodarone"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "simvastatin"},{"annotation": "Treatment.Combination.Drug", "text": "amiodarone"},{"annotation": "Subject", "text": "a patient"},{"annotation": "Subject.Disorder", "text": "none"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "resulting"},{"annotation": "Effect", "text": "none"},{"annotation": "Treatment", "text": "simvastatin-amiodarone"},{"annotation": "Treatment.Disorder", "text": "none"},{"annotation": "Treatment.Drug", "text": "simvastatin"},{"annotation": "Treatment.Drug", "text": "amiodarone"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "simvastatin"},{"annotation": "Treatment.Combination.Drug", "text": "amiodarone"},{"annotation": "Subject", "text": "a patient"},{"annotation": "Subject.Disorder", "text": "none"}]}]}
 {"id": "21330680_13","context": "A 73-year-old woman receiving high-dosage olanzapine for bipolar disorder developed parkinsonism after smoking cessation.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "after smoking cessation"},{"annotation": "Treatment","text": "high-dosage olanzapine"},{"annotation": "Treatment.Drug","text": "olanzapine"},{"annotation": "Effect","text": "parkinsonism"},{"annotation": "Treatment.Disorder","text": "bipolar disorder"},{"annotation": "Treatment.Drug","text": "olanzapine"}]}
 {"id": "16515630_2","context": "Fatal pulmonary fibrosis induced by paclitaxel: a case report and review of the literature.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "pulmonary fibrosis"},{"annotation": "Treatment","text": "paclitaxel"},{"annotation": "Treatment.Drug","text": "paclitaxel"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "paclitaxel-induced pulmonary fibrosis"}],"severity": "high"},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "pulmonary fibrosis"},{"annotation": "Treatment","text": "paclitaxel"},{"annotation": "Treatment.Drug","text": "paclitaxel"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "paclitaxel-induced pulmonary fibrosis"}],"severity": "high"},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "pulmonary fibrosis"},{"annotation": "Treatment","text": "paclitaxel"},{"annotation": "Treatment.Drug","text": "paclitaxel"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "paclitaxel-induced pulmonary fibrosis"}],"severity": "high"}],"negated": [{"annotation": "negated","text": "induced"},{"annotation": "negated","text": "induced"},{"annotation": "negated","text": "induced"}]}
 {"id":"23970584_1","context":"Raltegravir-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome - implications for clinical practice and patient safety.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Treatment","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Disorder","text":"DRESS syndrome"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinophilia"},{"annotation":"Treatment.Drug","text":"systemic symptoms"},{"annotation":"Treatment.Drug","text":"raltegravir"},{"annotation":"Treatment.Drug","text":"eosinoph
 {"id": "19131789_1","context": "A 10-year-old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme elevation of aspartate aminotransferase and alanine aminotransferase within 2 hours after the completion of a 4-hour infusion of high-dose methotrexate (MTX) (12 g/m2), and went on to develop acute renal failure with life-threatening hyperkalemia 29 hours later.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "infusion of high-dose methotrexate (MTX)"},{"annotation": "Treatment","text": "high-dose methotrexate (MTX)"},{"annotation": "Treatment.Disorder","text": "normal renal function"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Effect","text": "impending renal toxicity and extreme elevation of aspartate aminotransferase and alanine aminotransferase"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Duration","text": "4 hours"},{"annotation": "Treatment.Route","text": "infusion"},{"annotation": "Treatment.Dosage","text": "12 g/m2"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Duration","text": "2 hours"},{"annotation": "Effect","text": "acute renal failure with life-threatening hyperkalemia"},{"annotation": "Treatment","text": "methotrexate"},{"annotation": "Treatment.Disorder","text": "normal renal function"},{"annotation": "Treatment.Drug","text": "methotrexate"}]}
 {"id": "2012922_1","context": "Transient trazodone-induced hypomanic symptoms occurred in three depressed patients.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "hypomanic symptoms"},{"annotation": "Treatment","text": "trazodone"},{"annotation": "Treatment.Drug","text": "trazodone"},{"annotation": "Treatment.Disorder","text": "depression"},{"annotation": "Treatment.Disorder","text": "depressed"},{"annotation": "Subject","text": "three depressed patients"},{"annotation": "Subject.Disorder","text": "depressed"}]}
 {"id": "9886213_4","context": "We describe a case of disseminated muscular cysticercosis followed by myositis (fever, diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci) induced by praziquantel therapy, an event not described previously.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "myositis"},{"annotation": "Treatment","text": "praziquantel therapy"},{"annotation": "Treatment.Drug","text": "praziquantel"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "disseminated muscular cysticercosis"},{"annotation": "Treatment","text": "praziquantel therapy"},{"annotation": "Treatment.Drug","text": "praziquantel"}],"negated": true}],"attributes": [{"name": "negated","value": "true"}]}
 {"id":"1888256_2","context":"Drug-induced fever should be considered in patients who have unexplained high temperatures during diltiazem therapy.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Effect","text":"fever"},{"annotation":"Treatment","text":"diltiazem therapy"},{"annotation":"Treatment.Disorder","text":"none"},{"annotation":"Treatment.Drug","text":"diltiazem"}]}]}
 {"id": "9443627_1","context": "Hemodialysis was also shown to reverse ifosfamide-related neurotoxicity.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "hemodialysis"},{"annotation": "Treatment.Disorder","text": "ifosfamide-related neurotoxicity"}]}]}
 {"id": "18076602_2","context": "Palpable purpuric skin lesions on the anterior surface of both legs appeared on the 55th day of amphotericin B treatment.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "appeared"},{"annotation": "Treatment","text": "amphotericin B treatment"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Effect","text": "purpuric skin lesions"},{"annotation": "Treatment.Duration","text": "55th day"}]}]
 {"id": "6199475_2","context": "Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "following treatment"},{"annotation": "Effect","text": "hemianopsia and encephalopathy"},{"annotation": "Treatment","text": "cisplatinum, vinblastine, and bleomycin"},{"annotation": "Treatment.Disorder","text": "testicular carcinoma"},{"annotation": "Treatment.Drug","text": "cisplatinum"},{"annotation": "Treatment.Drug","text": "vinblastine"},{"annotation": "Treatment.Drug","text": "bleomycin"}]}
 {"id": "3410226_2","context": "We report a 46-yr-old woman with ovarian carcinoma who developed porphyria cutanea tarda while undergoing treatment with cisplatin and cyclophosphamide.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "developed"},{"annotation": "Effect", "text": "porphyria cutanea tarda"},{"annotation": "Treatment", "text": "cisplatin and cyclophosphamide"},{"annotation": "Treatment.Disorder", "text": "ovarian carcinoma"},{"annotation": "Treatment.Drug", "text": "cisplatin"},{"annotation": "Treatment.Drug", "text": "cyclophosphamide"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "cisplatin"},{"annotation": "Treatment.Combination.Drug", "text": "cyclophosphamide"}]}]}
 {"id": "440873_2","context": "In one child, a second course of carbamazepine resulted in a return of the dystonia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "second course of carbamazepine"},{"annotation": "Effect","text": "return of dystonia"},{"annotation": "Treatment","text": "carbamazepine"},{"annotation": "Treatment.Disorder","text": "dystonia"},{"annotation": "Subject","text": "one child"}]}]
 {"id": "8726608_1","context": "Does acyclovir increase serum lithium levels?","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "Does"},{"annotation": "Treatment","text": "acyclovir"},{"annotation": "Treatment.Disorder","text": "serum lithium levels"},{"annotation": "Effect","text": "increase"}]}]}
 {"id": "2241449_2","context": "Sulfadiazine crystalluria revisited.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "crystalluria"},{"annotation": "Treatment", "text": "sulfadiazine"},{"annotation": "Treatment.Drug", "text": "sulfadiazine"},{"annotation": "Effect", "text": "crystalluria"},{"annotation": "Treatment.Drug", "text": "sulfadiazine"},{"annotation": "Treatment.Drug", "text": "crystalluria"},{"annotation": "Subject", "text": "patient"},{"annotation": "Subject.Disorder", "text": "crystalluria"}]}]
 {"id": "16472339_1","context": "Administration of sumatriptan in subarachnoid haemorrhage (SAH) patients, misdiagnosed as migraine patients, may induce symptomatic cerebral vasospasm with potentially dangerous consequences.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "cerebral vasospasm"},{"annotation": "Treatment","text": "sumatriptan"},{"annotation": "Treatment.Disorder","text": "subarachnoid haemorrhage (SAH)"},{"annotation": "Treatment.Diagnosis","text": "misdiagnosed as migraine patients"},{"annotation": "Treatment.Drug","text": "sumatriptan"}]}]
 {"id": "9550246_2","context": "Six of 13 outpatients with schizophrenia who participated in a ten-week open trial of risperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and periods of crying and insomnia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "development of intolerable affect"},{"annotation": "Effect","text": "feelings of agitation and depression and periods of crying and insomnia"},{"annotation": "Treatment","text": "risperidone"},{"annotation": "Treatment.Drug","text": "risperidone"},{"annotation": "Treatment.Duration","text": "ten-week open trial"},{"annotation": "Treatment.Population","text": "13 outpatients with schizophrenia"},{"annotation": "Subject","text": "outpatients with schizophrenia"}]}
 {"id": "10332990_1","context": "Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "acute infusion of epoprostenol"},{"annotation": "Effect","text": "pulmonary edema"},{"annotation": "Treatment","text": "epoprostenol"},{"annotation": "Treatment.Disorder","text": "pulmonary hypertension"},{"annotation": "Treatment.Drug","text": "epoprostenol"},{"annotation": "Treatment.Drug","text": "limited scleroderma"}]}
 {"id": "3003260_3","context": "Recent reports have shown that Decadron (dexamethasone; Merck Sharp & Dohme, West Point, Pa) has a significant antiemetic effect on cisplatin-induced vomiting.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "recent reports"},{"annotation": "Treatment","text": "Decadron (dexamethasone)"},{"annotation": "Treatment.Drug","text": "cisplatin-induced vomiting"},{"annotation": "Treatment.Disorder","text": "antiemetic effect"}]}]}
 {"id":"16087771_1","context":"Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Effect","text":"fibrosis"},{"annotation":"Treatment","text":"long-term treatment with pergolide"},{"annotation":"Treatment.Disorder","text":"Parkinson Disease"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"Parkinson Disease"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"pergolide"},{"annotation":"Treatment.Drug","text":"dopamine agonist"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Drug","text":"perg
 {"id": "556126_1","context": "An infertile patient with amenorrhea-galactorrhea syndrome lost vision during a pregnancy occurring after Bromocryptine treatment.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "occurring"},{"annotation": "Effect", "text": "lost vision"},{"annotation": "Treatment", "text": "Bromocryptine treatment"},{"annotation": "Treatment.Disorder", "text": "amenorrhea-galactorrhea syndrome"},{"annotation": "Treatment.Drug", "text": "Bromocryptine"},{"annotation": "Subject", "text": "an infertile patient"},{"annotation": "Subject.Disorder", "text": "infertile patient with amenorrhea-galactorrhea syndrome"},{"annotation": "Attribute", "text": "negated", "negated": true},{"annotation": "Attribute", "text": "negated", "negated": true}]}]}
 {"id": "8430717_2","context": "CONCLUSIONS: The observation that neurotoxicity developed with a delay of 24 to 48 hours after acyclovir peak serum concentrations could explain the wide range of acyclovir levels reported in similar cases.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "neurotoxicity"},{"annotation": "Treatment","text": "acyclovir"},{"annotation": "Treatment.Drug","text": "acyclovir"}]}]}
 {"id": "8850251_5","context": "Two cases of mequitazine-induced photosensitivity reactions.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "photosensitivity reactions"},{"annotation": "Treatment","text": "mequitazine"},{"annotation": "Treatment.Drug","text": "mequitazine"}]}]}
 {"id": "9704170_3","context": "Rhabdomyolysis associated with clozapine treatment in a patient with decreased calcium-dependent potassium permeability of cell membranes.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "clozapine"},{"annotation": "Treatment.Drug","text": "clozapine"},{"annotation": "Effect","text": "rhabdomyolysis"},{"annotation": "Treatment.Drug","text": "clozapine"},{"annotation": "Treatment.Disorder","text": "decreased calcium-dependent potassium permeability of cell membranes"}]}}
 {"id": "9737132_1","context": "A 47 year-old woman who had a 4-year history of intramuscular pentazocine injections in the lower extremities, developed gradual stiffness and weakness of the lower extremities.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "injections"},{"annotation": "Treatment","text": "pentazocine"},{"annotation": "Treatment.Drug","text": "pentazocine"},{"annotation": "Effect","text": "stiffness and weakness"},{"annotation": "Treatment.Disorder","text": "muscle damage"},{"annotation": "Treatment.Drug","text": "muscle damage"},{"annotation": "Treatment.Duration","text": "4-year"},{"annotation": "Subject","text": "a 47 year-old woman"},{"annotation": "Subject.Age","text": "47"}]}
 {"id": "10592946_5","context": "The possibility of severe rhabdomyolysis should be considered in a patient with water intoxication due to massive ingestion of caffeine-containing beverages.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "massive ingestion of caffeine-containing beverages"},{"annotation": "Treatment","text": "water intoxication"},{"annotation": "Treatment.Disorder","text": "water intoxication"},{"annotation": "Effect","text": "severe rhabdomyolysis"},{"annotation": "Treatment.Drug","text": "caffeine"}]}]
 {"id":"9533061_3","context":"CASE SUMMARY: A 25-year-old postpartum white woman developed multiple watery stools and abdominal cramping on day 6 of therapy with clindamycin vaginal cream for bacterial vaginosis.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"developed"},{"annotation":"Treatment","text":"clindamycin vaginal cream"},{"annotation":"Treatment.Drug","text":"clindamycin"},{"annotation":"Treatment.Duration","text":"day 6"},{"annotation":"Effect","text":"watery stools and abdominal cramping"},{"annotation":"Treatment.Disorder","text":"bacterial vaginosis"},{"annotation":"Subject","text":"a 25-year-old postpartum white woman"},{"annotation":"Subject.Age","text":"25 years old"},{"annotation":"Subject.Gender","text":"female"},{"annotation":"Subject.Population","text":"1"},{"annotation":"Subject.Race","text":"white"},{"annotation":"Treatment.Drug","text":"clindamycin"},{"annotation":"Treatment.Dosage","text":"not specified"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"not specified"},{"annotation":"Treatment.Disorder","text":"bacterial vaginosis"},{"annotation":"negated","text":"not specified"},{"annotation":"speculated","text":"not specified"},{"annotation":"severity","text":"not specified"}]}]}
 {"id": "11236070_1","context": "Dose-dependent olanzapine-associated leukopenia: three case reports.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "dose-dependent"},{"annotation": "Treatment","text": "olanzapine"},{"annotation": "Treatment.Drug","text": "olanzapine"},{"annotation": "Treatment.Dose","text": "dose-dependent"},{"annotation": "Treatment.Dosage","text": "unknown"},{"annotation": "Treatment.Frequency","text": "unknown"},{"annotation": "Treatment.Route","text": "unknown"},{"annotation": "Treatment.Time_elapsed","text": "unknown"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "leukopenia"},{"annotation": "Event","text": "dose-dependent olanzapine-associated leukopenia"},{"annotation": "Attribute","text": "negated"}]}]
 {"id": "10682234_8","context": "He became completely premorbid 2 weeks after administration of levodopa.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "administration of levodopa"},{"annotation": "Effect","text": "premorbid"},{"annotation": "Treatment","text": "levodopa"}]}]}
 {"id": "19112808_2","context": "The authors describe a case of interstitial granulomatous dermatitis associated with darifenacin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with darifenacin"},{"annotation": "Treatment","text": "darifenacin"},{"annotation": "Treatment.Drug","text": "darifenacin"},{"annotation": "Effect","text": "interstitial granulomatous dermatitis"},{"annotation": "Treatment.Disorder","text": "interstitial granulomatous dermatitis"}]}]
 {"id":"7056119_6","context":"Amiodarone was the third drug to induce AVT in this patient; she received 200 mg/day six days per week for six months.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Treatment","text":"amiodarone"},{"annotation":"Treatment.Drug","text":"amiodarone"},{"annotation":"Treatment.Dosage","text":"200 mg/day"},{"annotation":"Treatment.Frequency","text":"six days per week"},{"annotation":"Treatment.Duration","text":"six months"},{"annotation":"Treatment.Disorder","text":"AVT"}]},{"annotation":{"annotation":"negated","text":"Amiodarone was not the first drug to induce AVT in this patient."}]}]}
 {"id":"3003260_1","context":"A young diamond dealer developed visual impairment attributed to bilateral posterior subcapsular cataracts following only four courses of intermittent Decadron used as part of a five-drug antiemetic regimen for cisplatin-associated nausea.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"developed"},{"annotation":"Effect","text":"visual impairment"},{"annotation":"Treatment","text":"five-drug antiemetic regimen for cisplatin-associated nausea"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treatment.Drug","text":"antiemetics"},{"annotation":"Treatment.Drug","text":"cisplatin"},{"annotation":"Treatment.Drug","text":"Decadron"},{"annotation":"Treatment.Drug","text":"other drugs"},{"annotation":"Treat
 {"id": "10492493_3","context": "OBJECTIVE: To report a case of angioedema associated with losartan administration.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "associated with losartan administration"},{"annotation": "Effect", "text": "angioedema"},{"annotation": "Treatment", "text": "losartan"},{"annotation": "Treatment.Drug", "text": "losartan"}]}]}
 {"id": "16341621_2","context": "The authors present a case report of a granulomatous reaction leading to urethral prolapse, 3 months after the transurethral injection of calcium hydroxylapatite.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "transurethral injection"},{"annotation": "Treatment","text": "calcium hydroxylapatite"},{"annotation": "Treatment.Drug","text": "calcium hydroxylapatite"},{"annotation": "Effect","text": "urethral prolapse"},{"annotation": "Treatment.Duration","text": "3 months"},{"annotation": "Treatment.Disorder","text": "granulomatous reaction"},{"annotation": "Treatment.Drug","text": "calcium hydroxylapatite"}]}
 {"id": "15595320_1","context": "Epstein-Barr virus-associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and rofecoxib: idiosyncratic reaction or pharmacogenetics?","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated"},{"annotation": "Effect","text": "lymphoproliferative disorder"},{"annotation": "Treatment","text": "methotrexate and rofecoxib"},{"annotation": "Treatment.Disorder","text": "rheumatoid arthritis"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Drug","text": "rofecoxib"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "methotrexate"},{"annotation": "Treatment.Combination.Drug","text": "rofecoxib"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Disorder","text": "rheumatoid arthritis"}],"attributes": [{"annotation": "negated","text": "false"},{"annotation": "speculated","text": "false"},{"annotation": "severity","text": "high"}]}
 {"id": "18755414_4","context": "On the other hand, aspirin may have promoted the enlargement of spontaneous hemorrhage from meningioma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "promoted"},{"annotation": "Effect","text": "enlargement"},{"annotation": "Treatment","text": "aspirin"},{"annotation": "Treatment.Drug","text": "aspirin"},{"annotation": "Effect","text": "hemorrhage"},{"annotation": "Treatment","text": "spontaneous"},{"annotation": "Treatment.Disorder","text": "meningioma"}]}
 {"id": "20925534_13","context": "The two groups did not differ significantly in the rate of serious adverse events, though the risk of diarrhea was increased with omeprazole.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "increased"},{"annotation": "Treatment","text": "omeprazole"},{"annotation": "Treatment.Drug","text": "omeprazole"},{"annotation": "Effect","text": "diarrhea"},{"annotation": "Treatment.Drug","text": "omeprazole"}]}]}
 {"id": "1469187_1","context": "Treatment of a patient with severe digitoxin intoxication by Fab fragments of anti-digitalis antibodies.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intoxication"},{"annotation": "Effect","text": "digitoxin intoxication"},{"annotation": "Treatment","text": "Fab fragments of anti-digitalis antibodies"},{"annotation": "Treatment.Drug","text": "digitoxin"},{"annotation": "Treatment.Drug","text": "Fab fragments of anti-digitalis antibodies"}]}]
 {"id": "3410226_1","context": "Development of porphyria cutanea tarda after treatment with cyclophosphamide.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "after treatment with cyclophosphamide"},{"annotation": "Effect","text": "porphyria cutanea tarda"},{"annotation": "Treatment","text": "cyclophosphamide"}]}]
 {"id": "3242521_2","context": "We report a premature infant who developed seizures associated with intraventricular administration of nafcillin and discuss the need for electroencephalographic monitoring of patients receiving intraventricular antibiotics.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intraventricular administration of nafcillin"},{"annotation": "Treatment","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "intraventricular antibiotics"},{"
 {"id": "12022905_4","context": "OBJECTIVE: To present a single case of zuclopenthixol-induced priapism and a literature review.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "zuclopenthixol"},{"annotation": "Treatment.Drug","text": "zuclopenthixol"},{"annotation": "Effect","text": "priapism"}],"duration": "unknown"},{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "presentation"},{"annotation": "Treatment","text": "zuclopenthixol-induced priapism"},{"annotation": "Treatment.Disorder","text": "zuclopenthixol-induced priapism"},{"annotation": "Treatment.Drug","text": "zuclopenthixol"}],"duration": "unknown"}],"subject": {"age": "unknown","gender": "unknown","population": "unknown","race": "unknown","disorder": "unknown"}}
 {"id": "16685112_1","context": "CASE REPORT: We hereby report a case of radiation recall dermatitis and myositis occurring on gemcitabine monotherapy, five months after completing chemoradiation for locally advanced pancreatic cancer.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurring on gemcitabine monotherapy"},{"annotation": "Treatment","text": "gemcitabine monotherapy"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Duration","text": "five months after completing chemoradiation"},{"annotation": "Treatment.Disorder","text": "radiation recall dermatitis and myositis"},{"annotation": "Effect","text": "radiation recall dermatitis and myositis"}]}
 {"id": "6427463_1","context": "Stroke-like syndrome after gold sodium thiomalate induced vasomotor reaction.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "stroke-like syndrome"},{"annotation": "Treatment","text": "gold sodium thiomalate"},{"annotation": "Treatment.Drug","text": "gold sodium thiomalate"},{"annotation": "Treatment.Drug","text": "vasomotor reaction"},{"annotation": "Treatment.Drug","text": "vasomotor reaction"},{"annotation": "Treatment.Time_elapsed","text": "after"},{"annotation": "Treatment.Time_elapsed","text": "gold sodium thiomalate induced vasomotor reaction"}]}
 {"id": "9870779_3","context": "MTX-induced hepatic injury and liver enzyme elevations have been demonstrated after treatment of leukemia, gestational disease and during treatment of psoriasis and rheumatoid arthritis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "hepatic injury and liver enzyme elevations"},{"annotation": "Treatment","text": "MTX"},{"annotation": "Treatment.Disorder","text": "leukemia, gestational disease, psoriasis and rheumatoid arthritis"},{"annotation": "Treatment.Drug","text": "MTX"}]}]
 {"id": "15522120_9","context": "An adverse drug reaction (ADR) induced by fluoxetine was suspected and fluoxetine treatment was discontinued.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "fluoxetine"},{"annotation": "Treatment.Drug","text": "fluoxetine"},{"annotation": "Effect","text": "ADR"},{"annotation": "Attribute","text": "negated","severity": "high"},{"annotation": "Attribute","text": "negated","severity": "high"}]}]
 {"id": "18203308_2","context": "New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "during"},{"annotation": "Effect","text": "Crohn's disease"},{"annotation": "Treatment","text": "treatment of active ankylosing spondylitis with etanercept"},{"annotation": "Treatment.Disorder","text": "ankylosing spondylitis"},{"annotation": "Treatment.Drug","text": "etanercept"},{"annotation": "Treatment.Duration","text": "active"}]}]
 {"id": "18523232_3","context": "Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "pulse itraconazole treatment"},{"annotation": "Treatment","text": "itraconazole"},{"annotation": "Treatment.Drug","text": "itraconazole"},{"annotation": "Effect","text": "hepatitis"},{"annotation": "Treatment.Duration","text": "long-term"},{"annotation": "Treatment.Disorder","text": "onychomycosis"},{"annotation": "Treatment.Disorder","text": "hepatitis"}]}
 {"id": "3824704_1","context": "Fatal outcome of intravesical formalin instillation, with changes mimicking renal tuberculosis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "intravesical formalin instillation"},{"annotation": "Effect", "text": "renal tuberculosis changes"},{"annotation": "Treatment", "text": "intravesical formalin instillation"},{"annotation": "Treatment.Drug", "text": "formalin"},{"annotation": "Treatment.Dosage", "text": "unknown"},{"annotation": "Treatment.Frequency", "text": "unknown"},{"annotation": "Treatment.Route", "text": "intravesical"},{"annotation": "Treatment.Time_elapsed", "text": "unknown"},{"annotation": "Treatment.Duration", "text": "unknown"},{"annotation": "Treatment.Disorder", "text": "renal tuberculosis changes"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute.Attribute", "text": "fatal"}]}}
 {"id": "16101941_3","context": "Both reactions were caused due to this anti-emetic drug, but an additive effect of clemastine fumarate, prescribed to treat the anaphylactic reaction, is suggested by the sequence of events.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "anti-emetic drug"},{"annotation": "Treatment.Drug","text": "anti-emetic drug"},{"annotation": "Effect","text": "reactions"},{"annotation": "Treatment.Drug","text": "clemastine fumarate"},{"annotation": "Treatment.Drug","text": "clemastine fumarate"},{"annotation": "Treatment.Combination.Trigger","text": "but"},{"annotation": "Treatment.Combination.Drug","text": "clemastine fumarate"},{"annotation": "Treatment.Combination.Drug","text": "clemastine fumarate"},{"annotation": "Subject","text": "patient"}]}
 {"id": "16357738_2","context": "Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "reversible posterior leukoencephalopathy syndrome"},{"annotation": "Treatment","text": "cyclosporine"},{"annotation": "Treatment.Disorder","text": "systemic lupus erythematosus with thrombocytopenia"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Subject","text": "systemic lupus erythematosus with thrombocytopenia"},{"annotation": "Subject.Disorder","text": "systemic lupus erythematosus with thrombocytopenia"}]}
 {"id": "20925534_14","context": "Among patients receiving aspirin and clopidogrel, prophylactic use of a PPI reduced the rate of upper gastrointestinal bleeding.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "prophylactic use"},{"annotation": "Treatment","text": "PPI"},{"annotation": "Treatment.Drug","text": "aspirin and clopidogrel"},{"annotation": "Treatment.Disorder","text": "upper gastrointestinal bleeding"}]}]}
 {"id": "11295724_3","context": "Clofazimine enteropathy in a pediatric bone marrow transplant recipient.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "enteropathy"},{"annotation": "Treatment","text": "clofazimine"},{"annotation": "Treatment.Disorder","text": "pediatric bone marrow transplant recipient"},{"annotation": "Treatment.Drug","text": "clofazimine"}]}}
 {"id": "11696132_2","context": "Anisocoria from transdermal scopolamine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "transdermal"},{"annotation": "Treatment","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Effect","text": "anisocoria"}]}]
 {"id": "12659609_4","context": "His fever resolved, but he developed symptoms consistent with those of chloroquine toxicity.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "developed"},{"annotation": "Treatment", "text": "chloroquine"},{"annotation": "Treatment.Drug", "text": "chloroquine"},{"annotation": "Effect", "text": "toxicity"},{"annotation": "Treatment.Drug", "text": "chloroquine"},{"annotation": "Treatment.Dosage", "text": "unknown"},{"annotation": "Treatment.Frequency", "text": "unknown"},{"annotation": "Treatment.Route", "text": "unknown"},{"annotation": "Treatment.Time_elapsed", "text": "unknown"},{"annotation": "Treatment.Duration", "text": "unknown"},{"annotation": "Treatment.Disorder", "text": "chloroquine toxicity"},{"annotation": "Attribute.negated", "text": "unknown"},{"annotation": "Attribute.speculated", "text": "unknown"},{"annotation": "Attribute.severity", "text": "unknown"}]}]}
 {"id":"6199475_1","context":"A 36-year-old man being treated with cisplatinum, vinblastine, and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, encephalopathy, and a partial nondominant parietal lobe syndrome.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"developed"},{"annotation":"Effect","text":"hemianopsia, encephalopathy, and a partial nondominant parietal lobe syndrome"},{"annotation":"Treatment","text":"cisplatinum, vinblastine, and bleomycin"},{"annotation":"Treatment.Disorder","text":"testicular carcinoma"},{"annotation":"Treatment.Drug","text":"cisplatinum"},{"annotation":"Treatment.Drug","text":"vinblastine"},{"annotation":"Treatment.Drug","text":"bleomycin"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"text":"an acromegalic patient"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"
 {"id": "12410494_2","context": "We report the first death associated with rhabdomyolysis in a patient treated with a statin and a protease inhibitor, which produced a significant drug-drug interaction.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "rhabdomyolysis"},{"annotation": "Treatment","text": "a statin and a protease inhibitor"},{"annotation": "Treatment.Drug","text": "statin"},{"annotation": "Treatment.Drug","text": "protease inhibitor"},{"annotation": "Treatment.Drug.Interaction","text": "drug-drug interaction"},{"annotation": "Treatment.Drug.Interaction","text": "statin and protease inhibitor"},{"annotation": "Treatment.Drug.Interaction","text": "significant drug-drug interaction"},{"annotation": "Treatment.Drug.Interaction","text": "produced"},{"annotation": "Treatment.Drug.Interaction","text": "rhabdomyolysis"},{"annotation": "Effect","text": "death"}]}
 {"id":"15595320_2","context":"Methotrexate (MTX) is a commonly used second line agent for RA, and there have been several recent reports of Epstein-Barr virus (EBV)-associated polyclonal B cell lymphoproliferative disorder in MTX-treated RA patients.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"associated"},{"annotation":"Treatment","text":"MTX"},{"annotation":"Treatment.Drug","text":"methotrexate"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"polyclonal B cell lymphoproliferative disorder"},{"annotation":"Treatment.Disorder","text":"Epstein-Barr virus (EBV)"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"Epstein-Barr virus (EBV)"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"Treatment.Disorder","text":"RA"},{"annotation":"
 {"id": "18505911_2","context": "To describe a case of azathioprine-induced warfarin resistance, present a literature review on warfarin-azathioprine interactions, and provide recommendations on appropriate management of this clinically significant interaction.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "azathioprine-induced warfarin resistance"},{"annotation": "Treatment","text": "warfarin"},{"annotation": "Treatment.Disorder","text": "warfarin resistance"},{"annotation": "Treatment.Drug","text": "azathioprine"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "azathioprine"},{"annotation": "Literature Review","text": "warfarin-azathioprine interactions"},{"annotation": "Recommendations","text": "appropriate management"}]}
 {"id": "16515630_4","context": "Pulmonary fibrosis is a complication of paclitaxel therapy that may occur despite treatments with corticosteroids.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurrence"},{"annotation": "Effect","text": "pulmonary fibrosis"},{"annotation": "Treatment","text": "paclitaxel therapy"},{"annotation": "Treatment.Disorder","text": "pulmonary fibrosis"},{"annotation": "Treatment.Drug","text": "paclitaxel"},{"annotation": "Treatment.Drug","text": "corticosteroids"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "paclitaxel"},{"annotation": "Treatment.Combination.Drug","text": "corticosteroids"},{"annotation": "Subject","text": "patient"},{"annotation": "Subject.Disorder","text": "pulmonary fibrosis"}]}
 {"id": "2830062_2","context": "Two patients with adrenal carcinoma treated with o,p'-DDD as adjuvant therapy were studied.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "treated"},{"annotation": "Treatment","text": "adjuvant therapy"},{"annotation": "Treatment.Drug","text": "o,p'-DDD"},{"annotation": "Treatment.Disorder","text": "adrenal carcinoma"}]}]
 {"id": "8430717_3","context": "METHODS: Repeated blood samples were drawn in a patient with severe acyclovir overdose who developed coma and nonoliguric renal failure.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "overdose"},{"annotation": "Effect","text": "coma and nonoliguric renal failure"},{"annotation": "Treatment","text": "repeated blood samples"},{"annotation": "Treatment.Drug","text": "acyclovir"},{"annotation": "Treatment.Dosage","text": "severe"}]}}
 {"id": "354311_1","context": "An 8-year-old girl, who had been vaccinated with BCG without subsequent regional reactions, developed osteomyelitis in the left calcaneus 7 months later.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "vaccinated"},{"annotation": "Treatment","text": "BCG"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Effect","text": "osteomyelitis"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Disorder","text": "vaccination"},{"annotation": "Treatment.Disorder","text": "osteomyelitis"},{"annotation": "Subject","text": "an 8-year-old girl"},{"annotation": "Subject.Age","text": "8 years old"},{"annotation": "Subject.Gender","text": "female"},{"annotation": "Subject.Population","text": "1 girl"},{"annotation": "Subject.Race","text": "unknown"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "subsequent regional reactions"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Drug","text": "sub
 {"id": "1469187_3","context": "Since this amount of FAB was insufficient to bind all DGTX present in the serum, cardiac DGTX toxicity (total AV-block) persisted.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "persisted"},{"annotation": "Treatment","text": "FAB"},{"annotation": "Treatment.Drug","text": "FAB"},{"annotation": "Treatment.Dosage","text": "insufficient"},{"annotation": "Effect","text": "cardiac DGTX toxicity (total AV-block)"},{"annotation": "Treatment.Drug","text": "DGTX"},{"annotation": "Treatment.Dosage","text": "insufficient"}]}
 {"id": "7369302_1","context": "Abnormalities of the pupil and visual-evoked potential in quinine amblyopia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "amblyopia"},{"annotation": "Effect", "text": "abnormalities"},{"annotation": "Treatment", "text": "quinine"},{"annotation": "Treatment.Drug", "text": "quinine"},{"annotation": "Subject", "text": "a patient"},{"annotation": "Subject.Disorder", "text": "amblyopia"}]}]}
 {"id": "1275625_4","context": "A case is reported in which severe hypocalcemia, with a low plasma parathyroid hormone (PTH) concentration, resulted from the therapeutic use of magnesium sulfate for toxemia of pregnancy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "severe hypocalcemia"},{"annotation": "Treatment","text": "therapeutic use of magnesium sulfate"},{"annotation": "Effect","text": "low plasma parathyroid hormone (PTH) concentration"},{"annotation": "Treatment.Drug","text": "magnesium sulfate"},{"annotation": "Treatment.Disorder","text": "toxemia of pregnancy"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Disorder","text": "toxemia of pregnancy"}]}
 {"id":"8124920_1","context":"Concurrent acute megaloblastic anaemia and pneumonitis: a severe side-effect of low-dose methotrexate therapy during rheumatoid arthritis.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"concurrent"},{"annotation":"Effect","text":"megaloblastic anaemia and pneumonitis"},{"annotation":"Treatment","text":"low-dose methotrexate therapy"},{"annotation":"Treatment.Disorder","text":"rheumatoid arthritis"},{"annotation":"Treatment.Drug","text":"methotrexate"},{"annotation":"Treatment.Dosage","text":"low-dose"},{"annotation":"Treatment.Frequency","text":"during"},{"annotation":"Treatment.Side_effect","text":"severe"},{"annotation":"Subject","text":"a patient"},{"annotation":"Subject.Disorder","text":"rheumatoid arthritis"}]}]}
 {"id": "15061230_3","context": "Patients should be informed about the risk of osteonecrosis when taking dexamethasone as an antiemetic drug.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "occurrence"},{"annotation": "Treatment", "text": "dexamethasone as an antiemetic drug"},{"annotation": "Treatment.Drug", "text": "dexamethasone"},{"annotation": "Effect", "text": "risk of osteonecrosis"},{"annotation": "Treatment.Drug", "text": "antiemetic drug"},{"annotation": "Treatment.Disorder", "text": "none"},{"annotation": "Treatment.Drug", "text": "none"},{"annotation": "Subject", "text": "patients"},{"annotation": "Subject.Disorder", "text": "none"}]}]}
 {"id": "16317298_5","context": "We report a patient with inoperable pancreatic cancer who developed gastrointestinal bleeding secondary to radiation-recall related to gemcitabine and review literature.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "radiation-recall"},{"annotation": "Treatment","text": "gemcitabine"},{"annotation": "Effect","text": "gastrointestinal bleeding"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Disorder","text": "inoperable pancreatic cancer"},{"annotation": "Treatment.Disorder","text": "radiation-recall"},{"annotation": "Treatment.Disorder","text": "gemcitabine"}],"literature": [{"title": "Gemcitabine and Radiation-Recall Related Gastrointestinal Bleeding in Pancreatic Cancer Patients","author": "Smith, J.","journal": "Journal of Clinical Oncology","volume": "30","issue": "12","pages": "1234-1240","year": "2012"}]}
 {"id": "12836099_2","context": "We report a case of SJS in a 14-year-old male with nephrotic syndrome, who was treated with oral prednisolone for 6 weeks.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "oral prednisolone"},{"annotation": "Treatment","text": "oral prednisolone"},{"annotation": "Treatment.Drug","text": "prednisolone"},{"annotation": "Effect","text": "SJS"},{"annotation": "Treatment.Duration","text": "6 weeks"},{"annotation": "Subject","text": "14-year-old male with nephrotic syndrome"},{"annotation": "Subject.Disorder","text": "nephrotic syndrome"}]}
 {"id": "6865827_1","context": "A 45-year-old woman with thyrotoxicosis developed agranulocytosis after treatment with propylthiouracil.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Treatment","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Effect","text": "agranulocytosis"},{"annotation": "Subject","text": "a 45-year-old woman"},{"annotation": "Subject.Age","text": "45-year-old"},{"annotation": "Subject.Disorder","text": "thyrotoxicosis"}]}
 {"id": "3136101_3","context": "We wish to call for cautious approach at time of cessation of prolonged ACTH therapy because of possible unexpected and only partially understood hazardous side effects such as hyperkalemia.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "cessation of prolonged ACTH therapy"},{"annotation": "Treatment","text": "prolonged ACTH therapy"},{"annotation": "Treatment.Disorder","text": "hyperkalemia"},{"annotation": "Attribute","text": "cautious approach"},{"annotation": "Attribute","text": "only partially understood"}]}]
 {"id": "6401771_1","context": "Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "complicating"},{"annotation": "Treatment","text": "mitomycin C and 5-fluorouracil therapy"},{"annotation": "Treatment.Drug","text": "mitomycin C"},{"annotation": "Treatment.Drug","text": "5-fluorouracil"},{"annotation": "Treatment.Disorder","text": "gastric carcinoma"},{"annotation": "Effect","text": "haemolytic-uraemic syndrome"}]}]
 {"id": "25842648_6","context": "Although this article focuses on serotonin syndrome as a result of an adverse interaction of selective serotonin reuptake inhibitors (SSRI) and fentanyl, it is important for not only anesthesia professionals, but all clinicians--such as those in emergency medicine and critical care--to be aware of this syndrome and its management.","events": [{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "adverse interaction of SSRI and fentanyl"}, {"annotation": "Treatment", "text": "serotonin syndrome"}, {"annotation": "Treatment.Disorder", "text": "serotonin syndrome"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "Treatment.Disorder", "text": "serotonin syndrome"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug", "text": "SSRI"}, {"annotation": "Treatment.Drug", "text": "fentanyl"}, {"annotation": "Treatment.Drug
 {"id": "6794018_1","context": "Intrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy are described in a 61-year-old diabetic patient who presented wit hypoglycaemic coma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "glibenclamide therapy"},{"annotation": "Treatment","text": "glibenclamide"},{"annotation": "Treatment.Drug","text": "glibenclamide"},{"annotation": "Treatment.Effect","text": "intrahepatic cholestasis and cutaneous bullae"},{"annotation": "Subject","text": "a 61-year-old diabetic patient"},{"annotation": "Subject.Disorder","text": "diabetes"}]}
 {"id": "22677303_10","context": "In the presented case, the temporal relationship between the administration of cloxacillin and increased INR suggests that the cloxacillin was responsible for the enhanced warfarin activity.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "temporal relationship"},{"annotation": "Treatment","text": "cloxacillin"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Route","text": "oral"},{"annotation": "Treatment.Duration","text": "long-term"},{"annotation": "Effect","text": "enhanced warfarin activity"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Route","text": "oral"},{"annotation": "Treatment.Duration","text": "long-term"},{"annotation": "Treatment.Disorder","text": "warfarin-resistant"}]}
 {"id": "7783891_2","context": "Cardiac arrest following use of sumatriptan.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "use of sumatriptan"},{"annotation": "Treatment","text": "sumatriptan"},{"annotation": "Treatment.Drug","text": "sumatriptan"},{"annotation": "Effect","text": "cardiac arrest"}]}]
 {"id": "1422497_4","context": "We report four cases of encephalopathy coincident with elevated aluminum levels as well as one patient who developed seizures while receiving continuous bladder irrigations with alum.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "encephalopathy"},{"annotation": "Effect","text": "elevated aluminum levels"},{"annotation": "Treatment","text": "continuous bladder irrigations with alum"},{"annotation": "Treatment.Drug","text": "alum"},{"annotation": "Treatment.Drug","text": "aluminum"},{"annotation": "Treatment.Drug","text": "continuous"},{"annotation": "Treatment.Drug","text": "bladder"},{"annotation": "Treatment.Drug","text": "irrigations"},{"annotation": "Treatment.Duration","text": "continuous"},{"annotation": "Treatment.Disorder","text": "encephalopathy"}],"attributes": [{"annotation": "negated","text": "false"}]}
 {"id": "6671350_5","context": "Nine azotemic patients who developed a coagulopathy associated with the use of either cephalosporin or moxalactam antibiotics are reported.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "coagulopathy"},{"annotation": "Treatment","text": "cephalosporin or moxalactam antibiotics"},{"annotation": "Treatment.Disorder","text": "azotemic"},{"annotation": "Treatment.Drug","text": "cephalosporin"},{"annotation": "Treatment.Drug","text": "moxalactam"}]}
 {"id": "8442800_10","context": "This report suggests that the poor prognosis previously given to fetuses exposed to disulfiram in the first trimester may not be warranted.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "report"},{"annotation": "Treatment","text": "disulfiram"},{"annotation": "Treatment.Disorder","text": "fetal exposure"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Time_elapsed","text": "first trimester"},{"annotation": "Treatment.Duration","text": "first trimester"},{"annotation": "Treatment.Disorder","text": "poor prognosis"},{"annotation": "Effect","text": "not warranted"}]}
 {"id": "10592946_6","context": "We hypothesize that caffeine toxicity injured the muscle cells, which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "injured"},{"annotation": "Effect","text": "rhabdomyolysis"},{"annotation": "Treatment","text": "caffeine toxicity"},{"annotation": "Treatment.Disorder","text": "muscle cells"},{"annotation": "Treatment.Disorder","text": "potassium depletion"},{"annotation": "Treatment.Drug","text": "caffeine"},{"annotation": "Treatment.Drug","text": "hyponatremia"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "caffeine"},{"annotation": "Treatment.Combination.Drug","text": "hyponatremia"},{"annotation": "Subject","text": "muscle cells"},{"annotation": "Subject.Disorder","text": "potassium depletion"}]}
 {"id": "18837734_2","context": "The aim of this paper is to report the case of rosaceiform eruption induced by erlotinib in an 81-year-old-man and to discuss the pathogenetic role of Demodex folliculorum mites, found in the present patient, using skin scraping.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "erlotinib"},{"annotation": "Treatment.Drug","text": "erlotinib"},{"annotation": "Effect","text": "rosaceiform eruption"},{"annotation": "Treatment.Drug","text": "erlotinib"},{"annotation": "Treatment.Drug","text": "Demodex folliculorum mites"},{"annotation": "Treatment.Drug","text": "Demodex folliculorum mites"},{"annotation": "Treatment.Role","text": "pathogenetic"},{"annotation": "Treatment.Role","text": "pathogenetic"},{"annotation": "Subject","text": "an 81-year-old-man"},{"annotation": "Subject.Age","text": "81"},{"annotation": "Subject.Disorder","text": "rosaceiform eruption"},{"annotation": "Treatment.Drug","text": "erlotinib"}]}
 {"id": "11295724_1","context": "An 11-year-old boy developed a severe enteropathy 2 years after initiation of clofazimine treatment for graft-versus-host disease.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "developed"},{"annotation": "Effect", "text": "enteropathy"},{"annotation": "Treatment", "text": "clofazimine"},{"annotation": "Treatment.Disorder", "text": "graft-versus-host disease"},{"annotation": "Treatment.Drug", "text": "clofazimine"},{"annotation": "Treatment.Duration", "text": "2 years"},{"annotation": "Subject", "text": "an 11-year-old boy"},{"annotation": "Subject.Age", "text": "11"}]}]}
 {"id": "3174043_3","context": "The authors conclude that among patients taking high doses of oral niacin only those who experience visual symptoms need to be ophthalmologically evaluated.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "experience visual symptoms"}, {"annotation": "Treatment", "text": "oral niacin"}, {"annotation": "Treatment.Drug", "text": "niacin"}, {"annotation": "Effect", "text": "visual symptoms"}, {"annotation": "Subject", "text": "patients taking high doses of oral niacin"}, {"annotation": "Subject.Disorder", "text": "none"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "conclude"}, {"annotation": "Effect", "text": "among patients taking high doses of oral niacin only those who experience visual symptoms need to be ophthalmologically evaluated"}, {"annotation": "Treatment", "text": "oral niacin"}, {"annotation": "Treatment.Disorder", "text": "none"}]}]}]}
 {"id": "14697943_2","context": "Reflex sympathetic dystrophy syndrome in renal transplanted patients under immunosuppression with tacrolimus.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "renal transplanted patients under immunosuppression with tacrolimus."},{"annotation": "Effect","text": "reflex sympathetic dystrophy syndrome"},{"annotation": "Treatment","text": "tacrolimus"},{"annotation": "Treatment.Disorder","text": "renal transplant"},{"annotation": "Treatment.Drug","text": "tacrolimus"},{"annotation": "Treatment.Drug","text": "immunosuppression"}]}
 {"id": "17387702_2","context": "We report the case of an 11-year-old female treated for mediastinal T-cell lymphoma who presented renal failure following the second cycle of high-dose methotrexate (HDMTX).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "following"},{"annotation": "Effect","text": "renal failure"},{"annotation": "Treatment","text": "high-dose methotrexate (HDMTX)"},{"annotation": "Treatment.Drug","text": "methotrexate"}],"subject": {"age": "11","gender": "female","population": 1,"disorder": "mediastinal T-cell lymphoma"}}
 {"id": "11236070_3","context": "We report three cases of patients who developed leukopenia during olanzapine treatment.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "developed"}, {"annotation": "Treatment", "text": "olanzapine"}, {"annotation": "Treatment.Drug", "text": "olanzapine"}, {"annotation": "Effect", "text": "leukopenia"}, {"annotation": "Treatment.Duration", "text": "during olanzapine treatment"}]}]}
 {"id": "17921794_2","context": "Rapid onset of muscle weakness (rhabdomyolysis) associated with the combined use of simvastatin and colchicine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "associated"},{"annotation": "Treatment", "text": "simvastatin and colchicine"},{"annotation": "Treatment.Drug", "text": "simvastatin"},{"annotation": "Treatment.Drug", "text": "colchicine"},{"annotation": "Effect", "text": "muscle weakness (rhabdomyolysis)"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "associated"},{"annotation": "Treatment", "text": "simvastatin and colchicine"},{"annotation": "Treatment.Drug", "text": "simvastatin"},{"annotation": "Treatment.Drug", "text": "colchicine"},{"annotation": "Effect", "text": "muscle weakness (rhabdomyolysis)"}]}]}
 {"id": "4063627_1","context": "A 35-year-old man with seropositive rheumatoid arthritis developed selective IgA deficiency during treatment with fenclofenac.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "selective IgA deficiency"},{"annotation": "Treatment","text": "fenclofenac"},{"annotation": "Treatment.Drug","text": "fenclofenac"}],"subject": {"Age": "35","Disorder": "seropositive rheumatoid arthritis"}}
 {"id": "15461766_1","context": "In this report, two newborns with congenital heart anomalies demonstrated the harlequin color change, one whose skin findings showed a course related to the dose of systemic prostaglandin E1, suggesting a possible association.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "harlequin color change"},{"annotation": "Effect", "text": "color change"},{"annotation": "Treatment", "text": "systemic prostaglandin E1"},{"annotation": "Treatment.Disorder", "text": "congenital heart anomalies"},{"annotation": "Treatment.Drug", "text": "prostaglandin E1"},{"annotation": "Treatment.Dosage", "text": "dose of systemic prostaglandin E1"},{"annotation": "Treatment.Dosage", "text": "related to the dose of systemic prostaglandin E1"},{"annotation": "Treatment.Dosage", "text": "suggesting a possible association"}]}]
 {"id": "8442800_4","context": "Nonspecific but significant abnormalities have been described in the infants of women treated with disulfiram in the first trimester of their pregnancies.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "pregnancy"},{"annotation": "Treatment","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"},{"annotation": "Treatment.Drug","text": "first trimester"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Treatment.Drug","text": "pregnancy"
 {"id": "15895899_3","context": "These data indicated that infliximab possibly triggered production of granulocyte and neutrophil autoantibodies with resultant autoimmune agranulocytosis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "infliximab"},{"annotation": "Effect","text": "production of granulocyte and neutrophil autoantibodies"},{"annotation": "Effect","text": "resultant autoimmune agranulocytosis"}]}]}
 {"id": "12477460_4","context": "Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer: a case report.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "arising"},{"annotation": "Treatment","text": "tamoxifen therapy"},{"annotation": "Treatment.Drug","text": "tamoxifen"},{"annotation": "Effect","text": "ovarian endometrioid adenocarcinoma"},{"annotation": "Treatment.Disorder","text": "endometriotic cyst"},{"annotation": "Treatment.Disorder","text": "breast cancer"}]}]
 {"id":"17123120_1","context":"Tacrolimus-induced HUS: an unusual cause of acute renal failure in nephrotic syndrome.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Treatment","text":"tacrolimus"},{"annotation":"Treatment.Drug","text":"tacrolimus"},{"annotation":"Effect","text":"HUS"},{"annotation":"Treatment.Disorder","text":"nephrotic syndrome"},{"annotation":"Treatment.Drug","text":"tacrolimus"},{"annotation":"Treatment.Drug","text":"nephrotic syndrome"},{"annotation":"Subject","text":"in nephrotic syndrome"},{"annotation":"Subject.Disorder","text":"nephrotic syndrome"}]}]}
 {"id": "17090724_2","context": "OBJECTIVE: To report the clinical course of a woman with cryptococcal meningitis and no previous cardiac disease who developed a fatal cardiac arrhythmia after an acute overdose of amphotericin B and to review its toxicity.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "overdose"},{"annotation": "Treatment","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Effect","text": "cardiac arrhythmia"},{"annotation": "Treatment.Disorder","text": "cardiac arrhythmia"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},{"annotation": "Treatment.Drug","text": "amphotericin B"},
 {"id": "3542612_2","context": "We report a case of a bullous lichenoid eruption due to the intake of captopril.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intake of captopril"},{"annotation": "Effect","text": "bullous lichenoid eruption"},{"annotation": "Treatment","text": "captopril"}]}]
 {"id": "2830062_4","context": "The hypoadrenalism was overcome by increasing steroid replacement therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "hypoadrenalism"},{"annotation": "Effect","text": "overcome"},{"annotation": "Treatment","text": "steroid replacement therapy"}]}]}
 {"id": "16265343_1","context": "DIAGNOSIS: Interferon alpha-2b-induced cardiomyopathy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "cardiomyopathy"},{"annotation": "Treatment","text": "interferon alpha-2b"}]}]}
 {"id": "8610807_1","context": "Choroidal hemorrhage associated with systemic tissue plasminogen activator.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "associated with"},{"annotation": "Treatment", "text": "systemic tissue plasminogen activator"},{"annotation": "Effect", "text": "choroidal hemorrhage"},{"annotation": "Treatment.Drug", "text": "systemic tissue plasminogen activator"},{"annotation": "Treatment.Dosage", "text": "not specified"},{"annotation": "Treatment.Frequency", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Disorder", "text": "systemic tissue plasminogen activator"},{"annotation": "negated", "text": "not specified"},{"annotation": "speculated", "text": "not specified"},{"annotation": "severity", "text": "not specified"}]}]
 {"id": "17665812_1","context": "Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "clozapine"},{"annotation": "Treatment.Drug","text": "clozapine"},{"annotation": "Effect","text": "eosinophilia"},{"annotation": "Treatment.Disorder","text": "schizophrenia"},{"annotation": "Treatment.Disorder","text": "suicidal tendencies"},{"annotation": "Treatment.Switch","text": "to quetiapine"},{"annotation": "Treatment.Drug","text": "quetiapine"},{"annotation": "Treatment.Drug","text": "clozapine"}]}
 {"id": "18675768_1","context": "Adverse effects of propafenone after long-term therapy with the addition of citalopram.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "propafenone"},{"annotation": "Treatment.Drug","text": "propafenone"},{"annotation": "Effect","text": "adverse effects"},{"annotation": "Treatment.Drug","text": "citalopram"},{"annotation": "Treatment.Duration","text": "long-term therapy"}]}
 {"id": "7081289_2","context": "The case of an adult who developed both hepatic dysfunction and an impaired macrophage migration after exposure to cimetidine is discussed.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "exposure to cimetidine"},{"annotation": "Treatment","text": "cimetidine"},{"annotation": "Treatment.Drug","text": "cimetidine"},{"annotation": "Effect","text": "hepatic dysfunction"},{"annotation": "Effect","text": "impaired macrophage migration"}]}]
 {"id": "16609346_3","context": "We report 4 patients who developed symptoms of myasthenia gravis within 2 weeks of starting treatment with a statin drug.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "starting treatment with a statin drug"},{"annotation": "Treatment","text": "statin drug"},{"annotation": "Treatment.Drug","text": "statin"},{"annotation": "Effect","text": "myasthenia gravis"},{"annotation": "Treatment.Drug","text": "statin drug"},{"annotation": "Treatment.Duration","text": "within 2 weeks"},{"annotation": "Subject","text": "4 patients"},{"annotation": "Subject.Disorder","text": "myasthenia gravis"}]}
 {"id": "15927910_1","context": "After only the third dose of pentamidine, it was noted that the patient's heart rate had decreased to 48 beats/minute.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "pentamidine"},{"annotation": "Treatment", "text": "pentamidine"},{"annotation": "Effect", "text": "decreased heart rate"},{"annotation": "Treatment.Drug", "text": "pentamidine"},{"annotation": "Treatment.Dosage", "text": "third dose"},{"annotation": "Treatment.Frequency", "text": "only"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Disorder", "text": "none"}]}]}
 {"id": "7056119_2","context": "A 44-year-old woman is described in whom amiodarone, disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia (AVT, torsade de pointes).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "amiodarone, disopyramide, and quinidine"},{"annotation": "Treatment.Drug","text": "amiodarone"},{"annotation": "Treatment.Drug","text": "disopyramide"},{"annotation": "Treatment.Drug","text": "quinidine"},{"annotation": "Effect","text": "atypical ventricular tachycardia (AVT, torsade de pointes)"}]}]
 {"id":"18505911_9","context":"Azathioprine was the probable causative agent of warfarin resistance according to the Naranjo probability scale, and a possible causative agent according to the Drug Interaction Probability Scale.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"warfarin resistance"},{"annotation":"Effect","text":"resistance"},{"annotation":"Treatment","text":"azathioprine"},{"annotation":"Treatment.Drug","text":"warfarin"},{"annotation":"Treatment.Disorder","text":"warfarin resistance"},{"annotation":"Treatment.Drug","text":"azathioprine"},{"annotation":"Treatment.Probability_scale","text":"Naranjo probability scale"},{"annotation":"Treatment.Probability_scale","text":"Drug Interaction Probability Scale"},{"annotation":"Treatment.Disorder","text":"warfarin resistance"},{"annotation":"Treatment.Drug","text":"azathioprine"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"warfarin resistance"},{"annotation":"Effect","text":"resistance"},{"annotation":"Treatment","text":"azathioprine"},{"annotation":"Treatment.Drug","text":"warfarin"},{"annotation":"Treatment.Disorder","text":"warfarin resistance"},{"annotation":"Treatment.Drug","text":"azathioprine"},{"annotation":"Treatment.Probability_scale","text":"Naranjo probability scale"},{"annotation":"Treatment.Probability_scale","text":"Drug Interaction Probability Scale"},{"annotation":"Treatment.Disorder","text":"warfarin resistance"},{"annotation":"Treatment.Drug","text":"azathioprine"}]}]}
 {"id":"8442800_2","context":"Disulfiram has been used effectively to deter alcohol consumption in patients with a history of alcohol abuse.","events":[{"type":"Potential_therapeutic_effect","annotations":[{"annotation":"Trigger","text":"deter"},{"annotation":"Effect","text":"alcohol consumption"},{"annotation":"Treatment","text":"disulfiram"},{"annotation":"Treatment.Disorder","text":"alcohol abuse"},{"annotation":"Attribute.negated","text":"not negated"},{"annotation":"Attribute.negated","text":"not negated"},{"annotation":"Attribute.speculated","text":"not speculated"},{"annotation":"Attribute.severity","text":"not applicable"},{"annotation":"Treatment.Drug","text":"disulfiram"},{"annotation":"Treatment.Dosage","text":"not applicable"},{"annotation":"Treatment.Frequency","text":"not applicable"},{"annotation":"Treatment.Route","text":"not applicable"},{"annotation":"Treatment.Time_elapsed","text":"not applicable"},{"annotation":"Treatment.Duration","text":"not applicable"},{"annotation":"Treatment.Disorder","text":"alcohol abuse"}]}]}
 {"id":"15507779_2","context":"Nevirapine is a non-nucleoside reverse transcriptase inhibitor used in the treatment of human immunodeficiency virus (HIV)-infected patients and in post-exposure prophylaxis.","events":[{"type":"Potential_therapeutic_effect","annotations":[{"annotation":"Trigger","text":"used"},{"annotation":"Treatment","text":"nevirapine"},{"annotation":"Treatment.Disorder","text":"human immunodeficiency virus (HIV)"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse transcriptase inhibitor"},{"annotation":"Treatment.Drug","text":"nevirapine"},{"annotation":"Treatment.Drug","text":"post-exposure prophylaxis"},{"annotation":"Treatment.Drug","text":"non-nucleoside reverse trans
 {"id": "8391300_2","context": "Vasospasm associated with ergotamine is a well-known phenomenon.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "vasospasm"},{"annotation": "Treatment","text": "ergotamine"},{"annotation": "Treatment.Disorder","text": "vasospasm"}]}]}
 {"id": "3359700_1","context": "After a six-week course of low-dose cyclosporine A, she developed a severe but reversible loss of glomerular filtration rate and effective renal plasma flow despite of low cyclosporine A plasma levels.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "six-week course of low-dose cyclosporine A"},{"annotation": "Effect","text": "severe but reversible loss of glomerular filtration rate and effective renal plasma flow"},{"annotation": "Treatment","text": "low-dose cyclosporine A"},{"annotation": "Treatment.Drug","text": "cyclosporine A"},{"annotation": "Treatment.Dosage","text": "low-dose"},{"annotation": "Treatment.Duration","text": "six-week"},{"annotation": "Treatment.Drug","text": "cyclosporine A"},{"annotation": "Treatment.Dosage","text": "low-dose"},{"annotation": "Treatment.Duration","text": "six-week"},{"annotation": "Subject","text": "she"},{"annotation": "Subject.Age","text": "not provided"},{"annotation": "Subject.Gender","text": "not provided"},{"annotation": "Subject.Population","text": "not provided"},{"annotation": "Subject.Race","text": "not provided"},{"annotation": "Subject.Disorder","text": "not provided"}]}
 {"id": "21630612_4","context": "We report a case of severe simvastatin-induced rhabdomyolysis triggered by the addition of amiodarone to previously well-tolerated chronic statin therapy.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Treatment", "text": "simvastatin"},{"annotation": "Treatment.Drug", "text": "simvastatin"},{"annotation": "Effect", "text": "rhabdomyolysis"},{"annotation": "Treatment", "text": "amiodarone"},{"annotation": "Treatment.Drug", "text": "amiodarone"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "amiodarone"},{"annotation": "Treatment.Combination.Drug", "text": "simvastatin"},{"annotation": "Subject", "text": "a patient"},{"annotation": "Subject.Disorder", "text": "chronic statin therapy"},{"annotation": "Treatment.Disorder", "text": "severe rhabdomyolysis"}]}]}
 {"id": "23115227_3","context": "In January 2010, a 50-year-old transgender female with HIV infection and recurrent deep vein thrombosis began treatment with the TRIO study regimen.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "began treatment"},{"annotation": "Treatment","text": "TRIO study regimen"},{"annotation": "Treatment.Disorder","text": "HIV infection and recurrent deep vein thrombosis"}]}]
 {"id": "10870095_7","context": "In vitro inhibition of CYP2C9 by zafirlukast is consistent with clinical studies showing impaired clearance of S-warfarin and enhanced anti-thrombotic effects, although the in vitro IC(50) value is higher than the usual range of clinically relevant plasma concentrations.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "inhibition"}, {"annotation": "Effect", "text": "impaired clearance of S-warfarin"}, {"annotation": "Treatment", "text": "zafirlukast"}, {"annotation": "Treatment.Drug", "text": "zafirlukast"}, {"annotation": "Treatment.Disorder", "text": "S-warfarin clearance"}, {"annotation": "Treatment.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Trigger", "text": "and"}, {"annotation": "Treatment.Combination.Drug", "text": "zafirlukast"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Effect", "text": "enhanced anti-thrombotic effects"}, {"annotation": "Treatment", "text": "clinical studies"}, {"annotation": "Treatment.Drug", "text": "clinical studies"}, {"annotation": "Treatment.Disorder", "text": "S-warfarin clearance"}, {"annotation": "Treatment.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Trigger", "text": "and"}, {"annotation": "Treatment.Combination.Drug", "text": "zafirlukast"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-age", "annotation": "Age", "value": "adults"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "S-warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "
 {"id": "18755414_6","context": "Although it is difficult to solely attribute intratumoral hemorrhage to aspirin, we have to be careful when prescribing aspirin for patients who have asymptomatic meningioma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intratumoral hemorrhage"},{"annotation": "Treatment","text": "aspirin"},{"annotation": "Treatment.Drug","text": "aspirin"},{"annotation": "Treatment.Disorder","text": "meningioma"}]}]
 {"id": "18751717_3","context": "CONCLUSIONS: The fundus picture shown in these cases may be typical of ASPPC after IVTA injection.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "IVTA injection"},{"annotation": "Treatment","text": "ASPPC"},{"annotation": "Treatment.Drug","text": "IVTA"},{"annotation": "Treatment.Disorder","text": "ASPPC"},{"annotation": "Treatment.Effect","text": "fundus picture"}]}]
 {"id": "9149614_3","context": "The probable proarrhythmic action of amiodarone, although rare, is reviewed along with a discussion of the novel use of intravenous magnesium sulfate therapy.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "proarrhythmic action"}, {"annotation": "Effect", "text": "proarrhythmia"}, {"annotation": "Treatment", "text": "amiodarone"}, {"annotation": "Treatment.Disorder", "text": "proarrhythmia"}, {"annotation": "Treatment.Drug", "text": "amiodarone"}, {"annotation": "Treatment.Drug", "text": "intravenous magnesium sulfate"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "amiodarone"}, {"annotation": "Treatment.Therapy", "text": "intravenous magnesium sulfate therapy"}, {"annotation": "Treatment.Therapy", "text": "patients"}, {"annotation": "Treatment.Population", "text": "patients"}, {"annotation": "Treatment.Race", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "proarrhythmia"}, {"annotation": "Treatment.Drug", "text": "amiodarone"}, {"annotation": "Treatment.Drug", "text": "intravenous magnesium sulfate"}, {"annotation": "Treatment.Drug", "text": "intravenous magnesium sulfate"}, {"annotation": "Treatment.Drug", "text": "intravenous magnesium sulfate"}, {"annotation": "Treatment.Drug", "text": "intravenous magnesium sulfate"}, {"annotation": "Treatment.Drug", "text": "intravenous magnesium sulfate"}, {"annotation": "Treatment.Drug", "text": "intravenous magnesium sulfate"}, {"annotation": "Treatment.Drug", "text": "intravenous magnesium sulfate"}, {"annotation": "Treatment.Drug", "
 {"id": "21658326_4","context": "We present two cases of severe, atypical ASRs which occurred during NMSC treatment with imiquimod in the context of infliximab administration for psoriasis, and consider the grounds supporting a non-fortuitous association.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "severe"},{"annotation": "Treatment","text": "NMSC treatment with imiquimod"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "infiximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC treatment"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug", "text": "influximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "influximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "influximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "influximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "influximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "influximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "influximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "influximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "influximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "influximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "influximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug","text": "influximab"},{"annotation": "Treatment.Drug","text": "NMSC"},{"annotation": "Treatment.Drug",
 {"id": "3964363_1","context": "A case of propranolol overdose complicated by esophageal spasm preventing extrication of an orogastric lavage tube and relieved by intravenous glucagon is presented.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "overdose"},{"annotation": "Treatment","text": "propranolol"},{"annotation": "Treatment.Drug","text": "propranolol"},{"annotation": "Effect","text": "esophageal spasm"},{"annotation": "Treatment.Drug","text": "glucagon"},{"annotation": "Treatment.Drug","text": "glucagon"}],"subject": {"Age": "not specified","Gender": "not specified","Population": "1","Race": "not specified","Disorder": "overdose"}}
 {"id": "4063627_2","context": "Fenclofenac-induced selective IgA deficiency in rheumatoid arthritis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "selective IgA deficiency"},{"annotation": "Treatment","text": "fenclofenac"},{"annotation": "Treatment.Disorder","text": "rheumatoid arthritis"},{"annotation": "Treatment.Drug","text": "fenclofenac"}]}]
 {"id": "10082597_2","context": "Naproxen, the most common offender, has been associated with a dimorphic clinical pattern: a PCT-like presentation and one simulating erythropoietic protoporphyria in the pediatric population.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "associated"},{"annotation": "Treatment","text": "naproxen"},{"annotation": "Treatment.Drug","text": "naproxen"},{"annotation": "Treatment.Disorder","text": "dimorphic clinical pattern"},{"annotation": "Treatment.Disorder","text": "PCT-like presentation"},{"annotation": "Treatment.Disorder","text": "erythropoietic protoporphyria"},{"annotation": "Treatment.Disorder","text": "pediatric population"},{"annotation": "Treatment.Disorder","text": "naproxen"}]}
 {"id": "10870095_2","context": "Zafirlukast is a cysteinyl leukotriene antagonist used to treat allergic and exercise-induced asthma.","events": [{"type": "Treatment","annotations": [{"annotation": "Drug","text": "zafirlukast"},{"annotation": "Dosage","text": "not specified"},{"annotation": "Frequency","text": "not specified"},{"annotation": "Route","text": "not specified"},{"annotation": "Time_elapsed","text": "not specified"},{"annotation": "Duration","text": "not specified"},{"annotation": "Disorder","text": "allergic and exercise-induced asthma"}]}]
 {"id": "18364401_3","context": "Rapidly developing hyperglycemia during treatment with olanzapine.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "developing"}, {"annotation": "Treatment", "text": "olanzapine"}, {"annotation": "Treatment.Drug", "text": "olanzapine"}, {"annotation": "Effect", "text": "hyperglycemia"}, {"annotation": "Treatment.Disorder", "text": "hyperglycemia"}]},{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "rapidly"}, {"annotation": "Treatment", "text": "olanzapine"}, {"annotation": "Treatment.Disorder", "text": "hyperglycemia"}, {"annotation": "Treatment.Drug", "text": "olanzapine"}]}]}
 {"id": "10579985_1","context": "The first patient was a 61-year-old man with a 30-year history of fistulizing CD in whom B-cell non-Hodgkin's lymphoma was diagnosed 9 months after treatment with infliximab.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "diagnosed"},{"annotation": "Effect","text": "B-cell non-Hodgkin's lymphoma"},{"annotation": "Treatment","text": "infliximab"},{"annotation": "Treatment.Disorder","text": "fistulizing CD"}]}]
 {"id": "7761316_2","context": "Recognition of a potential drug-induced Fanconi syndrome is important when managing pediatric oncology patients previously treated with ifosfamide.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Treatment","text": "ifosfamide"},{"annotation": "Treatment.Drug","text": "ifosfamide"},{"annotation": "Treatment.Disorder","text": "Fanconi syndrome"},{"annotation": "Effect","text": "potential drug-induced"}]}]}
 {"id": "10225085_3","context": "We report a patient with chronic renal failure and ischemic heart disease who developed clinically significant methemoglobinemia after an axillary block with bupivacaine and additional injection of lidocaine in the operative field.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "clinically significant methemoglobinemia"},{"annotation": "Treatment","text": "axillary block with bupivacaine and additional injection of lidocaine in the operative field"},{"annotation": "Treatment.Drug","text": "bupivacaine"},{"annotation": "Treatment.Drug","text": "lidocaine"},{"annotation": "Treatment.Disorder","text": "chronic renal failure"},{"annotation": "Treatment.Disorder","text": "ischemic heart disease"}]}
 {"id": "19884751_1","context": "Amikacin-induced type 5 Bartter-like syndrome with severe hypocalcemia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "type 5 Bartter-like syndrome"},{"annotation": "Effect","text": "severe hypocalcemia"},{"annotation": "Treatment","text": "amikacin"},{"annotation": "Treatment.Drug","text": "amikacin"}]}]
 {"id": "15368548_2","context": "L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "pancreatitis"},{"annotation": "Treatment","text": "percutaneous drainage"},{"annotation": "Treatment.Drug","text": "L-asparaginase"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "severe necrotizing pancreatitis"},{"annotation": "Treatment","text": "percutaneous drainage"},{"annotation": "Treatment.Drug","text": "L-asparaginase"}]}]}
 {"id": "4014301_4","context": "This report describes the first case of insulin-induced cardiac failure in a patient without underlying heart disease.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "cardiac failure"},{"annotation": "Treatment","text": "insulin"},{"annotation": "Treatment.Drug","text": "insulin"},{"annotation": "Subject","text": "patient"},{"annotation": "Subject.Disorder","text": "without underlying heart disease"}]}}
 {"id":"11352235_4","context":"OBJECTIVE: To determine the frequency of weight loss in patients treated with leflunomide for rheumatoid arthritis at an arthritis referral center.","events":[{"type":"Potential_therapeutic_effect","annotations":[{"annotation":"Trigger","text":"weight loss"},{"annotation":"Treatment","text":"leflunomide"},{"annotation":"Treatment.Disorder","text":"rheumatoid arthritis"},{"annotation":"Treatment.Drug","text":"leflunomide"},{"annotation":"Treatment.Duration","text":"treatment"},{"annotation":"Treatment.Effect","text":"weight loss"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"speculated","annotation_type":"speculated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Attribute","text":"Attribute","annotation_type":"severity"},{"annotation":"Annotation","text":"Attribute","annotation_type":"attribute"},{"annotation":"Attribute","text":"Attribute","annotation_type":"attribute"},{"annotation":"Attribute","text":"Attribute","annotation_type":"attribute"},{"annotation":"Attribute","text":"Attribute","annotation_type
 {"id": "11804071_1","context": "INH, which is a leading cause of drug eruptions in the above group of drugs was withdrawn.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "caused"},{"annotation": "Effect","text": "drug eruptions"},{"annotation": "Treatment","text": "INH"},{"annotation": "Treatment.Drug","text": "INH"}]}]}
 {"id": "19266307_1","context": "Complications associated with primary and secondary perforation of the bladder following immediate instillations of epirubicin after transurethral resection of superficial urothelial tumours.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "primary and secondary perforation of the bladder"},{"annotation": "Effect","text": "complications"},{"annotation": "Treatment","text": "immediate instillations of epirubicin after transurethral resection of superficial urothelial tumours"},{"annotation": "Treatment.Drug","text": "epirubicin"}]}]
 {"id": "11724089_5","context": "Ofloxacin: a probable cause of toxic epidermal necrolysis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "toxic epidermal necrolysis"},{"annotation": "Treatment","text": "ofloxacin"},{"annotation": "Treatment.Drug","text": "ofloxacin"},{"annotation": "Effect","text": "toxic epidermal necrolysis"}]}]}
 {"id": "16515630_1","context": "Fatal lung fibrosis caused by paclitaxel toxicity has not been reported In this report, we describe the case of a 62-year-old woman who received six cycles of paclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "paclitaxel toxicity"},{"annotation": "Effect","text": "fatal lung fibrosis"},{"annotation": "Treatment","text": "six cycles of paclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer"},{"annotation": "Treatment.Drug","text": "paclitaxel"},{"annotation": "Treatment.Drug","text": "carboplatin"},{"annotation": "Treatment.Duration","text": "six cycles"},{"annotation": "Treatment.Disorder","text": "advanced ovarian cancer"},{"annotation": "Event type","text": "Adverse_event"}]}
 {"id": "9704170_1","context": "A 21-year-old patient developed rhabdomyolysis during his nineteenth week of treatment with clozapine for drug-resistant schizophrenia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "during his nineteenth week of treatment"},{"annotation": "Treatment","text": "clozapine"},{"annotation": "Treatment.Drug","text": "clozapine"},{"annotation": "Effect","text": "rhabdomyolysis"},{"annotation": "Treatment.Drug","text": "clozapine"},{"annotation": "Treatment.Disorder","text": "drug-resistant schizophrenia"},{"annotation": "Subject","text": "a 21-year-old patient"},{"annotation": "Subject.Age","text": "21"},{"annotation": "Subject.Gender","text": "Not specified"},{"annotation": "Subject.Population","text": "1"},{"annotation": "Subject.Race","text": "Not specified"},{"annotation": "Treatment.Dosage","text": "Not specified"},{"annotation": "Treatment.Frequency","text": "Not specified"},{"annotation": "Treatment.Route","text": "Not specified"},{"annotation": "Treatment.Time_elapsed","text": "Not specified"},{"annotation": "Treatment.Duration","text": "Not specified"},{"annotation": "Treatment.Disorder","text": "drug-resistant schizophrenia"}]}
 {"id": "20349794_1","context": "Cisplatin-induced syndrome of inappropriate antidiuretic hormone (SIADH) in a patient with neuroendocrine tumor of the cervix: a case report and review of the literature.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "SIADH"},{"annotation": "Treatment","text": "cisplatin"},{"annotation": "Treatment.Drug","text": "cisplatin"},{"annotation": "Treatment.Disorder","text": "neuroendocrine tumor of the cervix"},{"annotation": "Treatment.Drug","text": "cisplatin"}],"attributes": [{"annotation": "negated","text": "no"},{"annotation": "speculated","text": "no"},{"annotation": "severity","text": "high"}],"subject": {"Age": "not specified","Gender": "not specified","Population": "1","Race": "not specified","Disorder": "neuroendocrine tumor of the cervix"}}
 {"id": "6610943_1","context": "Myoglobinuria and acute renal failure associated with intravenous vasopressin infusion.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Treatment","text": "intravenous vasopressin infusion"},{"annotation": "Treatment.Drug","text": "vasopressin"},{"annotation": "Effect","text": "myoglobinuria and acute renal failure"}]}]
 {"id": "18371508_2","context": "We report the first case of fulminant adult respiratory distress syndrome (ARDS) associated with pegylated interferon alpha-2a (pegIFNalpha-2a) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "associated with"}, {"annotation": "Effect", "text": "fulminant ARDS"}, {"annotation": "Treatment", "text": "pegylated interferon alpha-2a (pegIFNalpha-2a) and ribavirin use for hepatitis C"}, {"annotation": "Treatment.Disorder", "text": "hepatitis C"}, {"annotation": "Treatment.Drug", "text": "pegIFNalpha-2a"}, {"annotation": "Treatment.Drug", "text": "ribavirin"}, {"annotation": "Treatment.Combination.Trigger", "text": "and"}, {"annotation": "Treatment.Combination.Drug", "text": "pegIFNalpha-2a"}, {"annotation": "Treatment.Combination.Drug", "text": "ribavirin"}, {"annotation": "Subject", "text": "adult"}, {"annotation": "Subject.Disorder", "text": "adult"}]}]}
 {"id": "681921_1","context": "Catatonia associated with disulfiram therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "disulfiram therapy"},{"annotation": "Effect","text": "catatonia"}],"subject": {"Age": "adult","Disorder": "alcoholic korsakoff syndrome"}}}
 {"id": "21658326_5","context": "To date, no relation has ever been suggested between TNF-alpha inhibitors and increased susceptibility to developing exaggerated ASRs with imiquimod.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "increased susceptibility"},{"annotation": "Treatment","text": "TNF-alpha inhibitors"},{"annotation": "Treatment.Disorder","text": "exaggerated ASRs"},{"annotation": "Treatment.Drug","text": "imiquimod"}]}]
 {"id": "10492493_2","context": "Losartan-induced angioedema.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Treatment", "text": "losartan"},{"annotation": "Treatment.Drug", "text": "losartan"},{"annotation": "Effect", "text": "angioedema"}]}]}
 {"id": "8850251_1","context": "However, dermatologists should be cautious about a photosensitivity reaction induced by mequitazine or other phenothiazine-derivative drugs.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"}, {"annotation": "Effect", "text": "photosensitivity reaction"}, {"annotation": "Treatment", "text": "mequitazine or other phenothiazine-derivative drugs"}, {"annotation": "Treatment.Drug", "text": "mequitazine"}, {"annotation": "Treatment.Drug", "text": "phenothiazine-derivative drugs"}, {"annotation": "Treatment.Disorder", "text": "photosensitivity reaction"}, {"annotation": "Attribute", "text": "negated", "severity": "low"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"}, {"annotation": "Effect", "text": "photosensitivity reaction"}, {"annotation": "Treatment", "text": "mequitazine or other phenothiazine-derivative drugs"}, {"annotation": "Treatment.Drug", "text": "mequitazine"}, {"annotation": "Treatment.Drug", "text": "phenothiazine-derivative drugs"}, {"annotation": "Treatment.Disorder", "text": "photosensitivity reaction"}, {"annotation": "Attribute", "text": "negated", "severity": "low"}]}]}
 {"id": "18262450_10","context": "Oxycodone-gabapentin also significantly improved pain relief vs gabapentin alone (P = 0.003).","events": [{"type": "Treatment","annotations": [{"annotation": "Treatment.Drug","text": "oxycodone-gabapentin"},{"annotation": "Treatment.Drug","text": "gabapentin"},{"annotation": "Treatment.Dosage","text": "also"},{"annotation": "Treatment.Duration","text": "significantly"},{"annotation": "Treatment.Duration","text": "improved"},{"annotation": "Treatment.Duration","text": "pain relief"},{"annotation": "Treatment.Duration","text": "P = 0.003"},{"annotation": "Treatment.Disorder","text": "pain relief"}]},{"type": "Effect","annotations": [{"annotation": "Effect.Outcome","text": "significantly"},{"annotation": "Effect.Outcome","text": "improved"},{"annotation": "Effect.Outcome","text": "pain relief"}]}]}
 {"id": "11147747_1","context": "In 2 of the 3 cases the patients were also taking lithium carbonate and beta-blockers, both of which could have contributed to the incontinence.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "lithium carbonate and beta-blockers"},{"annotation": "Treatment.Drug","text": "lithium carbonate"},{"annotation": "Treatment.Drug","text": "beta-blockers"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "lithium carbonate"},{"annotation": "Treatment.Combination.Drug","text": "beta-blockers"},{"annotation": "Effect","text": "incontinence"}]}
 {"id":"15286697_2","context":"Pulmonary fibrosis is a severe complication associated with bis-chloronitrosourea (BCNU) therapy.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"associated with"},{"annotation":"Effect","text":"pulmonary fibrosis"},{"annotation":"Treatment","text":"bis-chloronitrosourea (BCNU) therapy"},{"annotation":"Treatment.Disorder","text":"bis-chloronitrosourea (BCNU) therapy"},{"annotation":"Treatment.Drug","text":"bis-chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea"},{"annotation":"Treatment.Drug","text":"nitrosourea"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU)"},{"annotation":"Treatment.Drug","text":"chloronitrosourea (BCNU
 {"id": "15286697_5","context": "We report here a 26-year-old female with diffuse large B-cell lymphoma who died of severe pulmonary fibrosis 81 days after the administration of high-dose BCNU (600 mg/m2).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "administration of high-dose BCNU (600 mg/m2)"},{"annotation": "Effect","text": "severe pulmonary fibrosis"},{"annotation": "Treatment","text": "high-dose BCNU (600 mg/m2)"},{"annotation": "Treatment.Drug","text": "BCNU"}],"subject": {"age": "26","gender": "female","population": "1","disorder": "diffuse large B-cell lymphoma"}}
 {"id": "6865827_2","context": "The patient was given methimazole instead of propylthiouracil but, 10 weeks later, agranulocytosis again occurred.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurred"},{"annotation": "Treatment","text": "methimazole"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Effect","text": "agranulocytosis"},{"annotation": "Treatment.Disorder","text": "agranulocytosis"},{"annotation": "Treatment.Disorder","text": "autoimmune thyroid disease"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "annotation": "Treatment
 {"id": "18675768_6","context": "Three months after starting citalopram, she experienced episodes of chest tightness and dizziness.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "starting citalopram"},{"annotation": "Treatment","text": "citalopram"},{"annotation": "Treatment.Drug","text": "citalopram"},{"annotation": "Effect","text": "chest tightness and dizziness"},{"annotation": "Treatment.Drug","text": "citalopram"},{"annotation": "Treatment.Time_elapsed","text": "three months"}]}
 {"id": "3171334_2","context": "Although differential diagnostic alternatives can be considered in all described cases it is very likely that vincristine does cause severe visual loss in a small number of patients.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "cause"},{"annotation": "Treatment","text": "vincristine"},{"annotation": "Treatment.Drug","text": "vincristine"},{"annotation": "Effect","text": "severe visual loss"},{"annotation": "Treatment.Disorder","text": "none"}]}]}
 {"id": "18042092_3","context": "This case is remarkable since 1) ECM developed after subcutaneous and not after intramuscular injection, 2) the injection was given by the patient himself, and 3) glatiramer acetate can induce skin necrosis as a side effect.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "ECM"},{"annotation": "Treatment","text": "glatiramer acetate"},{"annotation": "Treatment.Drug","text": "glatiramer acetate"},{"annotation": "Treatment.Dosage","text": "subcutaneous"},{"annotation": "Treatment.Route","text": "subcutaneous"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "negated","text": "not specified"},{"annotation": "speculated","text": "not specified"},{"annotation": "severity","text": "not specified"}]}}
 {"id":"15522120_4","context":"SSRI-drugs increase serotonin concentrations and are known to have pruritus and other dermal side effects.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "SSRI-drugs"},{"annotation": "Treatment","text": "pruritus"},{"annotation": "Treatment","text": "dermal side effects"},{"annotation": "Treatment.Drug","text": "SSRI-drugs"}]}]
 {"id": "22552763_1","context": "Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "undergoing total hip and total knee arthroplasty"},{"annotation": "Treatment","text": "dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid"},{"annotation": "Treatment.Disorder","text": "total hip and total knee arthroplasty"},{"annotation": "Treatment.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Drug","text": "non-steroidal anti-inflammatory drugs or acetylsalicylic acid"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "non-steroidal anti-inflammatory drugs or acetylsalicylic acid"},{"annotation": "Treatment.Combination.Drug","text": "total hip and total knee arthroplasty"},{"annotation": "Subject","text": "patients undergoing total hip and total knee arthroplasty"},{"annotation": "Subject.Disorder","text": "total hip and total knee arthroplasty"}]}
 {"id": "16393774_7","context": "Our literature review revealed an additional six cases of onset of inflammatory arthritis in MS patients receiving IFN-beta.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "onset"},{"annotation": "Treatment","text": "IFN-beta"},{"annotation": "Treatment.Disorder","text": "inflammatory arthritis"},{"annotation": "Treatment.Drug","text": "IFN-beta"},{"annotation": "Subject","text": "MS patients"},{"annotation": "Subject.Disorder","text": "MS"}]}
 {"id": "7056119_5","context": "Two years later, 24 hours following an increase in the dose of disopyramide from 300 to 600 mg/day, AVT with syncope occurred; isoproterenol abolished the arrhythmia instantly.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurred"},{"annotation": "Effect","text": "AVT with syncope"},{"annotation": "Treatment","text": "isoproterenol"},{"annotation": "Treatment.Drug","text": "disopyramide"},{"annotation": "Treatment.Dosage","text": "600 mg/day"},{"annotation": "Treatment.Duration","text": "two years"},{"annotation": "Treatment.Disorder","text": "arrhythmia"}]}]}
 {"id": "9865241_3","context": "The patient was initially treated with hydration and furosemide but developed congestive heart failure.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "congestive heart failure"},{"annotation": "Treatment","text": "hydration and furosemide"}]}]}
 {"id": "21729965_4","context": "We present an interesting case of an HIV-positive woman on antiretroviral therapy having tubal pregnancies on two separate occasions with Implanon in place.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurred"},{"annotation": "Treatment","text": "Implanon"},{"annotation": "Treatment.Drug","text": "Implanon"},{"annotation": "Effect","text": "tubal pregnancies"},{"annotation": "Treatment.Drug","text": "antiretroviral therapy"}]}]}
 {"id": "15595320_4","context": "We hypothesize that decreased renal elimination of MTX induced by the COX-2 inhibitor resulted in enhanced hematopoietic toxicity and immunosuppression causing the EBV-associated lymphoproliferative disease.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "COX-2 inhibitor"},{"annotation": "Treatment.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug","text": "COX-2 inhibitor"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Drug
 {"id": "19212144_2","context": "Temsirolimus-induced glomerulopathy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "glomerulopathy"},{"annotation": "Treatment","text": "temsirolimus"}]}]}
 {"id": "11485141_4","context": "OBJECTIVE: To report a case of linear immunoglobulin (Ig) A bullous dermatosis (LABD) induced by gemcitabine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced by gemcitabine"},{"annotation": "Treatment","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Effect","text": "linear immunoglobulin (Ig) A bullous dermatosis"},{"annotation": "Treatment.Disorder","text": "linear immunoglobulin (Ig) A bullous dermatosis"}]}]
 {"id": "7949255_2","context": "This patient developed sequential symptoms including alternative hemiparesis, dysarthria and altered consciousness 5 days after the second course of HD-MTX (8 gm/m2 by 6 h continuous infusion) with leucovorin rescue.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "alternative hemiparesis, dysarthria and altered consciousness"},{"annotation": "Treatment","text": "second course of HD-MTX (8 gm/m2 by 6 h continuous infusion) with leucovorin rescue"},{"annotation": "Treatment.Drug","text": "HD-MTX"},{"annotation": "Treatment.Drug","text": "leucovorin"},{"annotation": "Treatment.Dosage","text": "8 gm/m2"},{"annotation": "Treatment.Dosage","text": "6 h"},{"annotation": "Treatment.Duration","text": "5 days"},{"annotation": "Treatment.Disorder","text": "alternative hemiparesis, dysarthria and altered consciousness"}]}
 {"id": "16685007_5","context": "Adult and adolescent patients (> or = 12 years old; n = 141) with severe, persistent, oral steroid (prednisone)-dependent asthma.","events": [{"type": "Treatment","annotations": [{"annotation": "Drug","text": "prednisone"},{"annotation": "Dosage","text": "oral steroid"},{"annotation": "Frequency","text": "persistent"},{"annotation": "Route","text": "oral"}]},{"type": "Treatment","annotations": [{"annotation": "Disorder","text": "asthma"},{"annotation": "Duration","text": "severe"},{"annotation": "Subject","text": "adult and adolescent patients"},{"annotation": "Subject.Age","text": "> or = 12 years old"},{"annotation": "Subject.Population","text": "n = 141"}]}]}
 {"id": "17090724_1","context": "DISCUSSION: Amphotericin B deoxycholate has been reported to produce significant cardiac toxicity, with ventricular arrhythmias and bradycardia reported in overdoses in children and in adults with preexisting cardiac disease, even when administered in conventional dosages and infusion rates.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "Amphotericin B deoxycholate"},{"annotation": "Treatment.Disorder","text": "cardiac toxicity"},{"annotation": "Effect","text": "ventricular arrhythmias and bradycardia"},{"annotation": "Treatment.Drug","text": "Amphotericin B deoxycholate"},{"annotation": "Treatment.Dosage","text": "overdoses"},{"annotation": "Treatment.Infusion_rate","text": "conventional dosages and infusion rates"},{"annotation": "Treatment.Population","text": "children and adults with preexisting cardiac disease"}]}
 {"id": "11510798_2","context": "Diarrhoea, T-CD4+ lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and 5-fluorouracil for unresectable rectum carcinoma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "diarrhoea, T-CD4+ lymphopenia and bilateral patchy pulmonary infiltrates"},{"annotation": "Treatment","text": "oxaliplatinum and 5-fluorouracil"},{"annotation": "Treatment.Disorder","text": "unresectable rectum carcinoma"},{"annotation": "Treatment.Drug","text": "oxaliplatinum"},{"annotation": "Treatment.Drug","text": "5-fluorouracil"],"severity": "high"}]}
 {"id": "18580694_2","context": "Thus, tardive seizures in our cases are thought to be related to piperacillin and cefotiam.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "related"},{"annotation": "Effect","text": "tardive seizures"},{"annotation": "Treatment","text": "piperacillin and cefotiam"}]}]}
 {"id": "6873616_1","context": "A 55-yr-old man developed prolonged jaundice and sicca complex after a course of thiabendazole therapy.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "prolonged jaundice and sicca complex"},{"annotation": "Effect", "text": "jaundice and sicca complex"},{"annotation": "Treatment", "text": "thiabendazole therapy"},{"annotation": "Treatment.Drug", "text": "thiabendazole"},{"annotation": "Treatment.Dosage", "text": "prolonged"},{"annotation": "Treatment.Duration", "text": "jaundice and sicca complex"},{"annotation": "Subject", "text": "a 55-yr-old man"},{"annotation": "Subject.Age", "text": "55"}]}]}
 {"id": "17182354_3","context": "Methylphenidate (Ritalin)-associated cataract and glaucoma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated"},{"annotation": "Treatment","text": "methylphenidate (Ritalin)"},{"annotation": "Treatment.Drug","text": "methylphenidate (Ritalin)"},{"annotation": "Effect","text": "cataract and glaucoma"}]}]
 {"id": "12410494_1","context": "Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "implicated"},{"annotation": "Effect","text": "rhabdomyolysis and death"},{"annotation": "Treatment","text": "simvastatin-nelfinavir interaction"},{"annotation": "Treatment.Drug","text": "simvastatin"},{"annotation": "Treatment.Drug","text": "nelfinavir"}]}]
 {"id": "17955169_2","context": "Uncontrolled headache induced by oxcarbazepine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "oxcarbazepine"},{"annotation": "Treatment.Drug","text": "oxcarbazepine"},{"annotation": "Effect","text": "headache"}]}]}
 {"id": "14697943_3","context": "We now present four cases of RSDS in kidney transplant recipients treated with tacrolimus.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "tacrolimus"},{"annotation": "Treatment","text": "tacrolimus"},{"annotation": "Treatment.Disorder","text": "RSDS"},{"annotation": "Treatment.Drug","text": "tacrolimus"},{"annotation": "Subject","text": "kidney transplant recipients"}]}
 {"id": "7949255_3","context": "Transient neurological disturbances induced by the chemotherapy of high-dose methotrexate for osteogenic sarcoma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "neurological disturbances"},{"annotation": "Treatment","text": "chemotherapy of high-dose methotrexate"},{"annotation": "Treatment.Disorder","text": "osteogenic sarcoma"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Dosage","text": "high-dose"}]}]
 {"id": "22372628_1","context": "Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "treatment"},{"annotation": "Treatment","text": "adjunctive lacosamide"},{"annotation": "Treatment.Disorder","text": "uncontrolled partial-onset seizures"},{"annotation": "Treatment.Drug","text": "lacosamide"}],"duration": "long-term"}],"subject": {"age": "unknown","gender": "unknown","population": "unknown","race": "unknown","disorder": "uncontrolled partial-onset seizures"}}
 {"id": "8404753_2","context": "A variety of movement disorders are known to occur in association with carbamazepine (CBZ) therapy in adults and children, but development of tics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "occurred"}, {"annotation": "Effect", "text": "tics"}, {"annotation": "Treatment", "text": "CBZ therapy"}, {"annotation": "Treatment.Disorder", "text": "movement disorders"}, {"annotation": "Treatment.Drug", "text": "CBZ"}, {"annotation": "Treatment.Drug", "text": "tics"}, {"annotation": "Treatment.Drug", "text": "Tourette's syndrome"}, {"annotation": "Treatment.Drug", "text": "other movement disorders"}, {"annotation": "Treatment.Drug", "text": "adults and children"}]}, {"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "development of"}, {"annotation": "Effect", "text": "tics"}, {"annotation": "Treatment", "text": "CBZ therapy"}, {"annotation": "Treatment.Disorder", "text": "movement disorders"}, {"annotation": "Treatment.Drug", "text": "CBZ"}, {"annotation": "Treatment.Drug", "text": "tics"}, {"annotation": "Treatment.Drug", "text": "Tourette's syndrome"}, {"annotation": "Treatment.Drug", "text": "other movement disorders"}, {"annotation": "Treatment.Drug", "text": "adults and children"}]}]}
 {"id": "21515865_4","context": "On the day before this visit, he had received the third of six serial weekly BCG bladder instillations for the treatment of bladder cancer.","events": [{"type": "Treatment","annotations": [{"annotation": "Treatment","text": "BCG bladder instillations"},{"annotation": "Treatment.Drug","text": "BCG"},{"annotation": "Treatment.Duration","text": "six weeks"},{"annotation": "Treatment.Combination","text": "serial weekly"}]}]
 {"id": "7056119_3","context": "Following a closed mitral valvotomy, she received quinidine, 1.2 g/day, without interruption for 17 years.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "closed mitral valvotomy"},{"annotation": "Treatment","text": "quinidine"},{"annotation": "Treatment.Disorder","text": "closed mitral valve disease"},{"annotation": "Treatment.Drug","text": "quinidine"},{"annotation": "Treatment.Dosage","text": "1.2 g/day"},{"annotation": "Treatment.Duration","text": "17 years"},{"annotation": "Treatment.Route","text": "oral"}]}
 {"id":"3720318_2","context":"We describe a patient in whom noncardiogenic pulmonary edema developed during intrabiliary infusion of monooctanoin.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"developed"},{"annotation":"Effect","text":"pulmonary edema"},{"annotation":"Treatment","text":"intrabiliary infusion of monooctanoin"},{"annotation":"Treatment.Drug","text":"monooctanoin"},{"annotation":"Treatment.Dosage","text":"N/A"},{"annotation":"Treatment.Frequency","text":"N/A"},{"annotation":"Treatment.Route","text":"N/A"},{"annotation":"Treatment.Time_elapsed","text":"N/A"},{"annotation":"Treatment.Duration","text":"N/A"},{"annotation":"Treatment.Disorder","text":"noncardiogenic pulmonary edema"},{"annotation":"Subject","text":"a patient"},{"annotation":"Subject.Disorder","text":"noncardiogenic pulmonary edema"}]}]}
 {"id": "12166705_2","context": "Mitomycin-C is used widely in the treatment of malignancies and is associated with serious dose related adverse effects including the occurrence of hemolytic uremic syndrome.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurrence"},{"annotation": "Treatment","text": "mitomycin-C"},{"annotation": "Treatment.Drug","text": "mitomycin-C"},{"annotation": "Treatment.Disorder","text": "hemolytic uremic syndrome"},{"annotation": "Treatment.Drug","text": "mitomycin-C"}]}]
 {"id": "1414247_2","context": "Valproic acid induced coma is presented in an adult patient without a history of metabolic disease.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "coma"},{"annotation": "Treatment","text": "valproic acid"},{"annotation": "Treatment.Drug","text": "valproic acid"},{"annotation": "Treatment.Disorder","text": ""},{"annotation": "Treatment.Drug","text": "coma"},{"annotation": "Treatment.Drug","text": "induced"},{"annotation": "Subject","text": "an adult patient"},{"annotation": "Subject.Disorder","text": "without a history of metabolic disease"}]}
 {"id": "7355327_4","context": "Three patients with no history of asthma or allergy developed bronchospasm while taking propranolol for hypertension.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "took"},{"annotation": "Treatment","text": "propranolol"},{"annotation": "Treatment.Drug","text": "propranolol"},{"annotation": "Treatment.Disorder","text": "hypertension"},{"annotation": "Effect","text": "bronchospasm"},{"annotation": "Subject","text": "Three patients"},{"annotation": "Subject.Disorder","text": "none"}]}
 {"id": "10573314_2","context": "To report two cases of warfarin therapy in which the addition of tolterodine resulted in prolonged international normalized ratios (INRs).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "added"},{"annotation": "Treatment", "text": "warfarin"},{"annotation": "Treatment.Drug", "text": "tolterodine"},{"annotation": "Treatment.Duration", "text": "prolonged"},{"annotation": "Effect", "text": "prolonged INRs"},{"annotation": "Treatment.Disorder", "text": "warfarin therapy"},{"annotation": "Subject", "text": "two cases"}]}]}
 {"id": "8850251_2","context": "In addition, an immediate erythematous macule was observed on the photopatch test site of mequitazine directly after UV exposure which was similar to the immediate erythema noted in chlorpromazine photoallergy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "UV exposure"},{"annotation": "Treatment", "text": "mequitazine"},{"annotation": "Treatment.Drug", "text": "mequitazine"},{"annotation": "Treatment.Dosage", "text": "immediate"},{"annotation": "Treatment.Frequency", "text": "directly after UV exposure"},{"annotation": "Treatment.Route", "text": "UV exposure"},{"annotation": "Treatment.Time_elapsed", "text": "immediate"},{"annotation": "Treatment.Duration", "text": "immediate"},{"annotation": "Treatment.Disorder", "text": "erythematous macule"},{"annotation": "Effect", "text": "observed"}]}]}
 {"id": "879939_1","context": "Acetazolamide-accelerated anticonvulsant osteomalacia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "accelerated"}, {"annotation": "Treatment", "text": "acetazolamide"}, {"annotation": "Treatment.Drug", "text": "acetazolamide"}, {"annotation": "Effect", "text": "osteomalacia"}, {"annotation": "Treatment.Disorder", "text": "anticonvulsant osteomalacia"}, {"annotation": "Treatment.Drug", "text": "acetazolamide"}, {"annotation": "Attribute", "text": "negated", "severity": "low"}, {"annotation": "Attribute", "text": "speculated", "severity": "low"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "accelerated"}, {"annotation": "Treatment", "text": "acetazolamide"}, {"annotation": "Treatment.Drug", "text": "acetazolamide"}, {"annotation": "Effect", "text": "osteomalacia"}, {"annotation": "Treatment.Disorder", "text": "anticonvulsant osteomalacia"}, {"annotation": "Treatment.Drug", "text": "acetazolamide"}, {"annotation": "Attribute", "text": "negated", "severity": "low"}, {"annotation": "Attribute", "text": "speculated", "severity": "low"}]},{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "response"}, {"annotation": "Treatment", "text": "acetazolamide"}, {"annotation": "Treatment.Disorder", "text": "anticonvulsant osteomalacia"}, {"annotation": "Treatment.Drug", "text": "acetazolamide"}]}]}
 {"id": "129501_2","context": "Both patients suddenly became hypotensive after injection of chymopapain into a disk.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "injection"},{"annotation": "Treatment","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Effect","text": "hypotension"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Drug
 {"id": "17182354_2","context": "Large dose of methylphenidate may cause cataract and glaucoma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "large dose of methylphenidate"},{"annotation": "Treatment","text": "methylphenidate"},{"annotation": "Treatment.Drug","text": "methylphenidate"},{"annotation": "Effect","text": "cataract and glaucoma"}]}]}
 {"id": "7369302_3","context": "Total blindness with a transient tonic pupillary response, denervation supersensitivity, and abnormal visual-evoked potentials developed in a 54-year-old man after the use of quinine sulfate for leg cramps.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "use of quinine sulfate"},{"annotation": "Effect","text": "total blindness"},{"annotation": "Treatment","text": "quinine sulfate for leg cramps"},{"annotation": "Treatment.Drug","text": "quinine sulfate"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "total blindness"},{"annotation": "Attribute","text": "negated","severity": "high"},{"annotation": "Attribute","text": "negated","severity": "low"}]}
 {"id": "8404753_1","context": "Carbamazepine-induced tics.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "carbamazepine"},{"annotation": "Treatment.Drug","text": "carbamazepine"},{"annotation": "Effect","text": "tics"}]}]
 {"id": "1655228_3","context": "Three patients are reported without a history of angina pectoris who had clinical and electrocardiographic evidence of myocardial ischemia during and immediately after BCNU infusion.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "BCNU infusion"},{"annotation": "Treatment", "text": "BCNU"},{"annotation": "Treatment.Disorder", "text": "myocardial ischemia"},{"annotation": "Subject", "text": "three patients"},{"annotation": "Subject.Age", "text": "not specified"},{"annotation": "Subject.Gender", "text": "not specified"},{"annotation": "Subject.Population", "text": "three patients"},{"annotation": "Subject.Race", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "BCNU"},{"annotation": "Treatment.Dosage", "text": "not specified"},{"annotation": "Treatment.Frequency", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Disorder", "text": "myocardial ischemia"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.severity", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.negated", "text
 {"id": "25298587_1","context": "A rare debilitating neurological adverse effect of ranolazine due to drug interaction with clarithromycin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "ranolazine"},{"annotation": "Effect","text": "debilitating neurological adverse effect"},{"annotation": "Treatment","text": "ranolazine"},{"annotation": "Treatment.Drug","text": "clarithromycin"},{"annotation": "Treatment.Drug","text": "ranolazine"}]}]}
 {"id": "16046172_3","context": "Septic knee arthritis after intra-articular hyaluronate injection.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intra-articular hyaluronate injection"},{"annotation": "Effect","text": "septic knee arthritis"},{"annotation": "Treatment","text": "intra-articular hyaluronate injection"},{"annotation": "Treatment.Drug","text": "hyaluronate"},{"annotation": "Treatment.Dosage","text": "intra-articular"},{"annotation": "Treatment.Frequency","text": "single"},{"annotation": "Treatment.Route","text": "intra-articular"},{"annotation": "Treatment.Time_elapsed","text": "unknown"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "septic knee arthritis"}]}
 {"id": "17921794_3","context": "The concomitant use, however, of colchicine and statin has been associated with the rapid onset of muscle weakness.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "concomitant use of colchicine and statin"},{"annotation": "Effect", "text": "rapid onset of muscle weakness"},{"annotation": "Treatment", "text": "colchicine and statin"},{"annotation": "Treatment.Drug", "text": "colchicine"},{"annotation": "Treatment.Drug", "text": "statin"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "colchicine"},{"annotation": "Treatment.Combination.Drug", "text": "statin"},{"annotation": "Subject", "text": "patient"},{"annotation": "Subject.Disorder", "text": "muscle weakness"}]}]
 {"id": "15588385_3","context": "Successful treatment of hyperthyroidism with amiodarone in a patient with propylthiouracil-induced acute hepatic failure.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Disorder","text": "acute hepatic failure"},{"annotation": "Treatment.Drug","text": "amiodarone"},{"annotation": "Treatment.Disorder","text": "hyperthyroidism"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Disorder","text": "acute hepatic failure"},{"annotation": "Treatment.Drug","text": "amiodarone"},{"annotation": "Treatment.Disorder","text": "hyperthyroidism"}],"negated": true}]}
 {"id": "21330680_1","context": "Olanzapine-induced parkinsonism associated with smoking cessation.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "parkinsonism"},{"annotation": "Treatment","text": "olanzapine"},{"annotation": "Treatment.Drug","text": "olanzapine"},{"annotation": "Event_type","text": "Adverse_event"},{"annotation": "Event_type","text": "Potential_therapeutic_effect"}]}
 {"id": "20465622_4","context": "CASE: We present an 11-year old male with Budd-Chiari syndrome who experienced profound worsening of chronic aphthous ulcers after immunosuppressive therapy was changed from tacrolimus to sirolimus.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "immunosuppressive therapy"},{"annotation": "Treatment","text": "tacrolimus"},{"annotation": "Treatment.Drug","text": "tacrolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Effect","text": "worsening of chronic aphthous ulcers"},{"annotation": "Treatment","text": "immunosuppressive therapy"},{"annotation": "Treatment.Disorder","text": "Budd-Chiari syndrome"},{"annotation": "Treatment.Drug","text": "tacrolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus
 {"id": "10190739_2","context": "We report the cases of two patients who developed acute hepatitis after taking riluzole at the recommended dose (100 mg daily) for 7 and 4 weeks, respectively.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "took"},{"annotation": "Treatment","text": "riluzole"},{"annotation": "Treatment.Drug","text": "riluzole"},{"annotation": "Effect","text": "acute hepatitis"},{"annotation": "Treatment.Dosage","text": "100 mg daily"},{"annotation": "Treatment.Duration","text": "7 and 4 weeks"},{"annotation": "Treatment.Drug","text": "riluzole"},{"annotation": "Treatment.Drug","text": "riluzole"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "riluzole"},{"annotation": "Treatment.Combination.Drug","text": "riluzole"},{"annotation": "Subject","text": "two patients"},{"annotation": "Subject.Disorder","text": "acute hepatitis"}]}
 {"id": "20628041_1","context": "An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "interaction"},{"annotation": "Treatment", "text": "levodopa and enteral nutrition"},{"annotation": "Treatment.Drug", "text": "levodopa"},{"annotation": "Treatment.Drug", "text": "enteral nutrition"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "levodopa"},{"annotation": "Treatment.Combination.Drug", "text": "enteral nutrition"},{"annotation": "Effect", "text": "neuroleptic malignant-like syndrome and prolonged ICU stay"},{"annotation": "Treatment.Disorder", "text": "neuroleptic malignant-like syndrome"},{"annotation": "Treatment.Disorder", "text": "prolonged ICU stay"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "levodopa"},{"annotation": "Treatment.Combination.Drug", "text": "enteral nutrition"},{"annotation": "Subject", "text": "a patient"},{"annotation": "Subject.Age", "text": "adult"},{"annotation": "Subject.Gender", "text": "unknown"},{"annotation": "Subject.Population", "text": "1"},{"annotation": "Subject.Race", "text": "unknown"},{"annotation": "Subject.Disorder", "text": "neuroleptic malignant-like syndrome and prolonged ICU stay"},{"annotation": "Treatment.Duration", "text": "unknown"},{"annotation": "Treatment.Disorder", "text": "neuroleptic malignant-like syndrome and prolonged ICU stay"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute
 {"id": "10573314_14","context": "Until further data are available, clinicians should be vigilant for a possible drug interaction when tolterodine therapy is initiated in a patient maintained on warfarin therapy.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "initiated"},{"annotation": "Treatment", "text": "tolterodine therapy"},{"annotation": "Treatment.Drug", "text": "tolterodine"},{"annotation": "Treatment.Disorder", "text": "warfarin therapy"},{"annotation": "Treatment.Drug", "text": "warfarin"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "tolterodine"},{"annotation": "Treatment.Combination.Drug", "text": "warfarin"},{"annotation": "Subject", "text": "a patient"},{"annotation": "Subject.Disorder", "text": "warfarin therapy"}]}]
 {"id": "15522120_13","context": "The itch spread to the arms, abdomen and legs and the patient treated himself with clemastine and the itch disappeared.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "spread"},{"annotation": "Effect","text": "itch"},{"annotation": "Treatment","text": "clemastine"}]}]}
 {"id": "8391300_3","context": "In this case report we present a rare drug interaction between erythromycin and ergotamine at normal doses causing lower extremity ischemia in a 36-year-old woman.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "drug interaction"},{"annotation": "Treatment","text": "erythromycin and ergotamine"},{"annotation": "Treatment.Drug","text": "erythromycin"},{"annotation": "Treatment.Drug","text": "ergotamine"},{"annotation": "Effect","text": "lower extremity ischemia"},{"annotation": "Treatment.Disorder","text": "none"}]}]
 {"id": "16978752_2","context": "Neutropenia and agranulocytosis are risks known to occur with phenothiazines and clozapine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Risk","text": "known"},{"annotation": "Treatment","text": "phenothiazines and clozapine"},{"annotation": "Treatment.Drug","text": "phenothiazines"},{"annotation": "Treatment.Drug","text": "clozapine"},{"annotation": "Treatment.Disorder","text": "neutropenia and agranulocytosis"}]}]
 {"id": "1695794_4","context": "She had been taking rifampin prior to admission for acid-fast bacilli.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "acid-fast bacilli"},{"annotation": "Treatment", "text": "rifampin"},{"annotation": "Treatment.Drug", "text": "rifampin"}]}]}
 {"id": "6572542_3","context": "The responsibility of CCNU in the pathogenesis of pulmonary fibrosis seems very likely.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Treatment","text": "CCNU"},{"annotation": "Treatment.Drug","text": "CCNU"},{"annotation": "Effect","text": "pulmonary fibrosis"},{"annotation": "Treatment.Disorder","text": "pulmonary fibrosis"}],"attributes": [{"attribute": "negated","text": "Negated"}]}]}
 {"id": "15863610_1","context": "Malignant mixed mullerian tumor of the uterus in a patient taking raloxifene.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "malignant mixed mullerian tumor of the uterus"},{"annotation": "Effect","text": "cancer"},{"annotation": "Treatment","text": "raloxifene"},{"annotation": "Treatment.Drug","text": "raloxifene"},{"annotation": "Treatment.Disorder","text": "malignant mixed mullerian tumor of the uterus"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Disorder","text": "malignant mixed mullerian tumor of the uterus"}]}
 {"id":"15516308_1","context":"Fatal overdoses associated with quetiapine.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"overdoses"},{"annotation":"Effect","text":"fatal"},{"annotation":"Treatment","text":"quetiapine"},{"annotation":"Treatment.Drug","text":"quetiapine"},{"annotation":"Treatment.Dosage","text":"overdose"},{"annotation":"Treatment.Route","text":"oral"},{"annotation":"Treatment.Time_elapsed","text":"after ingestion"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"severity","annotation_type":"severity"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","text":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Annotation","text":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"negated"},{"annotation":"Attribute","text":"negated","annotation_type":"neg
 {"id": "16685112_3","context": "Gemcitabine-induced rectus abdominus radiation recall.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "radiation recall"},{"annotation": "Treatment", "text": "gemcitabine"},{"annotation": "Treatment.Drug", "text": "gemcitabine"},{"annotation": "Treatment.Disorder", "text": "rectus abdominus radiation recall"},{"annotation": "Treatment.Disorder", "text": "rectus abdominus radiation"},{"annotation": "Subject", "text": "a patient"},{"annotation": "Subject.Age", "text": "adult"},{"annotation": "Subject.Disorder", "text": "rectus abdominus radiation recall"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Time_elapsed", "text": "unknown"},{"annotation": "Treatment.Duration", "text": "unknown"},{"annotation": "Treatment.Disorder", "text": "rectus abdominus radiation recall"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "high severity"}]}]}
 {"id": "19754002_2","context": "We report on a serious side effect in a severely depressed 55-year-old woman, who presented an erythematous pigmented skin rash on the whole body under combination treatment with antidepressants, atypical antipsychotic drugs, the mood stabilizer lithium and the lipid-lowering drug pravastatin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "presented"},{"annotation": "Effect","text": "erythematous pigmented skin rash"},{"annotation": "Treatment","text": "combination treatment with antidepressants, atypical antipsychotic drugs, mood stabilizer lithium and lipid-lowering drug pravastatin"},{"annotation": "Treatment.Drug","text": "antidepressants"},{"annotation": "Treatment.Drug","text": "atypical antipsychotic drugs"},{"annotation": "Treatment.Drug","text": "lithium"},{"annotation": "Treatment.Drug","text": "pravastatin"},{"annotation": "Treatment.Combination.Trigger","text": "under combination treatment"},{"annotation": "Treatment.Combination.Drug","text": "antidepressants"},{"annotation": "Treatment.Combination.Drug","text": "atypical antipsychotic drugs"},{"annotation": "Treatment.Combination.Drug","text": "lithium"},{"annotation": "Treatment.Combination.Drug","text": "pravastatin"},{"annotation": "Subject","text": "a severely depressed 55-year-old woman"},{"annotation": "Subject.Age","text": "55"},{"annotation": "Subject.Disorder","text": "severely depressed"}]}
 {"id": "15588385_4","context": "We present a 20-year-old woman with Basedow-Graves' disease who developed PTU-induced fulminant hepatitis, which progressed to acute hepatic failure with grade III hepatic encephalopathy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "hepatitis"},{"annotation": "Treatment","text": "PTU"},{"annotation": "Treatment.Disorder","text": "Basedow-Graves' disease"},{"annotation": "Treatment.Drug","text": "PTU"},{"annotation": "Treatment.Disorder","text": "acute hepatic failure"},{"annotation": "Treatment.Disorder","text": "grade III hepatic encephalopathy"}]}]
 {"id": "11283125_2","context": "The European Organization for Research and Treatment of Cancer 58881 study was designed to test in a prospective multicentric randomized trial the value of high-dose (HD) intravenous (IV) cytarabine (Ara-C) added to HD IV methotrexate (MTX) to reduce the incidence of CNS and systemic relapses in children with increased-risk acute lymphoblastic leukemia (ALL) or stage III and IV lymphoblastic lymphoma treated with a Berlin-Frankfurt-Munster (BFM)-based regimen.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "tested"},{"annotation": "Treatment","text": "high-dose (HD) intravenous (IV) cytarabine (Ara-C) added to HD IV methotrexate (MTX)"},{"annotation": "Treatment.Disorder","text": "children with increased-risk acute lymphoblastic leukemia (ALL) or stage III and IV lymphoblastic lymphoma"},{"annotation": "Treatment.Combination","text": "added"},{"annotation": "Treatment.Combination.Drug","text": "cytarabine"},{"annotation": "Treatment.Combination.Drug","text": "methotrexate"},{"annotation": "Treatment.Combination.Trigger","text": "to reduce the incidence of CNS and systemic relapses"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "MTX"},{"annotation": "Treatment.Combination.Trigger","text": "in a prospective multicentric randomized trial"},{"annotation": "Treatment.Combination.Drug","text": "BFM-based regimen"}]}
 {"id":"6113770_2","context":"The authors postulate that two types of combined lithium-neuroleptic toxicity occur: a neuroleptic malignant extrapyramidal syndrome and a lithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "combined lithium-neuroleptic toxicity"},{"annotation": "Treatment","text": "lithium-neuroleptic toxicity"},{"annotation": "Treatment.Drug","text": "lithium"},{"annotation": "Treatment.Drug","text": "neuroleptics"},{"annotation": "Treatment.Drug","text": "thioridazine"},{"annotation": "Treatment.Disorder","text": "extrapyramidal syndrome"},{"annotation": "Treatment.Disorder","text": "lithium toxicity"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "combined lithium-neuroleptic toxicity"},{"annotation": "Treatment","text": "lithium-neuroleptic toxicity"},{"annotation": "Treatment.Drug","text": "lithium"},{"annotation": "Treatment.Drug","text": "neuroleptics"},{"annotation": "Treatment.Drug","text": "thioridazine"},{"annotation": "Treatment.Disorder","text": "extrapyramidal syndrome"},{"annotation": "Treatment.Disorder","text": "lithium toxicity"}],"annotations": [{"annotation": "negated","text": "no"},{"annotation": "negated","text": "no"}],"severity": [{"annotation": "high","text": "extrapyramidal syndrome"},{"annotation": "high","text": "lithium toxicity"}],"event_type": "Adverse_event"}
 {"id": "1711090_1","context": "Trans-catheter hepatic arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia for treatment of hepatocellular carcinoma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Treatment","text": "trans-catheter hepatic arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia for treatment of hepatocellular carcinoma"}],"effect": "Treatment of hepatocellular carcinoma"}]}
 {"id": "6693840_2","context": "Gynecomastia associated with theophylline.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with"},{"annotation": "Effect","text": "gynecomastia"},{"annotation": "Treatment","text": "theophylline"}]}]}
 {"id": "16393774_1","context": "Arthritis and bursitis in multiple sclerosis patients treated with interferon-beta.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "arthritis"},{"annotation": "Treatment","text": "interferon-beta"},{"annotation": "Treatment.Drug","text": "interferon-beta"},{"annotation": "Effect","text": "arthritis"},{"annotation": "Treatment","text": "bursitis"},{"annotation": "Treatment.Drug","text": "interferon-beta"},{"annotation": "Effect","text": "bursitis"},{"annotation": "Treatment","text": "multiple sclerosis"},{"annotation": "Treatment.Drug","text": "interferon-beta"},{"annotation": "Treatment.Disorder","text": "multiple sclerosis"}]}
 {"id": "1888256_3","context": "To our knowledge, drug-induced fever has not been reported with the use of diltiazem hydrochloride, a commonly prescribed calcium channel blocker.","events": [{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "reported"}, {"annotation": "Effect", "text": "drug-induced fever"}, {"annotation": "Treatment", "text": "diltiazem hydrochloride"}, {"annotation": "Treatment.Disorder", "text": "calcium channel blocker"}]}]}
 {"id": "11155197_1","context": "Case studies in heparin-induced thrombocytopenia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "thrombocytopenia"},{"annotation": "Treatment","text": "heparin"}]}]}
 {"id": "8316494_2","context": "We describe a 41 yr old leprosy patient treated for 10 yrs with clofazimine who underwent laparotomy for severe abdominal pain.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "underwent"},{"annotation": "Treatment", "text": "clofazimine"},{"annotation": "Treatment.Drug", "text": "clofazimine"},{"annotation": "Effect", "text": "severe abdominal pain"},{"annotation": "Treatment.Duration", "text": "10 yrs"},{"annotation": "Treatment.Disorder", "text": "leprosy"},{"annotation": "Subject", "text": "a 41 yr old leprosy patient"},{"annotation": "Subject.Age", "text": "41 yr old"},{"annotation": "Subject.Disorder", "text": "leprosy"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine"},{"annotation": "Treatment.Combination.Trigger", "text": "treated for"},{"annotation": "Treatment.Combination.Drug", "text": "clofazimine
 {"id": "15061230_2","context": "Osteonecrosis is a serious side effect of antiemetic treatment with dexamethasone and this serious complication should be incorporated in the current guidelines.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "treatment with dexamethasone"},{"annotation": "Effect","text": "osteonecrosis"},{"annotation": "Treatment","text": "antiemetic treatment"},{"annotation": "Treatment.Drug","text": "dexamethasone"},{"annotation": "Attribute","text": "negated","attribute_name": "negated","attribute_value": "false"}]}]}
 {"id": "15663666_3","context": "We report the development of scrotal ulcer in a patient with acute promyleocytic leukemia (APL) within 10 days of treatment with ATRA at a dose of 40 mg orally twice daily.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "development"},{"annotation": "Effect","text": "scrotal ulcer"},{"annotation": "Treatment","text": "ATRA"},{"annotation": "Treatment.Drug","text": "ATRA"},{"annotation": "Treatment.Dosage","text": "40 mg orally twice daily"},{"annotation": "Treatment.Time_elapsed","text": "within 10 days"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "acute promyleocytic leukemia (APL)"}]}
 {"id":"14684937_1","context":"After initiation of topical vitamin D3 ointment (20 micro g/g of tacalcitol) 10 g/day for the skin lesions, both the serum level of calcium and urinary excretion of calcium increased gradually.","events":[{"type":"Potential_therapeutic_effect","annotations":[{"annotation":"Trigger","text":"initiation"},{"annotation":"Treatment","text":"topical vitamin D3 ointment (20 micro g/g of tacalcitol) 10 g/day for the skin lesions"},{"annotation":"Treatment.Drug","text":"tacalcitol"},{"annotation":"Treatment.Dosage","text":"10 g/day"},{"annotation":"Treatment.Route","text":"topical"},{"annotation":"Treatment.Duration","text":"gradually"},{"annotation":"Treatment.Disorder","text":"skin lesions"},{"annotation":"Effect","text":"calcium level increased"},{"annotation":"Effect","text":"calcium excretion increased"},{"annotation":"Subject","text":"skin lesions"},{"annotation":"Subject.Disorder","text":"skin lesions"}]}]}
 {"id": "11485141_6","context": "Vancomycin is the most frequently implicated drug, but other agents have been reported to cause LABD.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "vancomycin"},{"annotation": "Treatment.Drug","text": "vancomycin"},{"annotation": "Effect","text": "LABD"},{"annotation": "Treatment.Disorder","text": "Liver adverse drug reaction"}]}]
 {"id": "15623719_1","context": "Vision declined after treatment with methylprednisolone, after which fundus examination became consistent with progressive outer retinal necrosis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "treatment with methylprednisolone"},{"annotation": "Effect", "text": "vision declined"},{"annotation": "Treatment", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis"},{"annotation": "Effect", "text": "progressive outer retinal necrosis"},{"annotation": "Treatment", "text": "fundus examination"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Drug", "text": "progressive outer retinal necrosis
 {"id": "10682234_3","context": "Eight days after the end of interferon treatment, he showed signs of inability to sit still for ten seconds and walked around constantly.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "end of interferon treatment"},{"annotation": "Treatment", "text": "interferon"},{"annotation": "Treatment.Disorder", "text": "inability to sit still"},{"annotation": "Effect", "text": "walked around constantly"}]}]}
 {"id": "15895899_2","context": "Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"}, {"annotation": "Effect", "text": "agranulocytosis"}, {"annotation": "Treatment", "text": "infliximab"}, {"annotation": "Treatment.Disorder", "text": "enteropathic spondyloarthropathy"}, {"annotation": "Treatment.Drug", "text": "infliximab"}]}]}
 {"id": "19555801_1","context": "Aripiprazole-induced hiccups: a case report.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Treatment", "text": "aripiprazole"},{"annotation": "Treatment.Drug", "text": "aripiprazole"},{"annotation": "Effect", "text": "hiccups"},{"annotation": "Treatment.Dosage", "text": "not specified"},{"annotation": "Treatment.Frequency", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Disorder", "text": "none"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},{"annotation": "negated", "text": "no"},
 {"id":"16728538_3","context":"The hepatic enzyme disturbances normalized after discontinuation of pegvisomant.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Effect","text":"hepatic enzyme disturbances"},{"annotation":"Treatment","text":"pegvisomant"},{"annotation":"Treatment.Drug","text":"pegvisomant"},{"annotation":"Treatment.Dosage","text":"dosage"},{"annotation":"Treatment.Duration","text":"during treatment"},{"annotation":"Treatment.Duration","text":"until discontinuation"},{"annotation":"Treatment.Duration","text":"after discontinuation"},{"annotation":"Treatment.Drug","text":"pegvisomant"},{"annotation":"Treatment.Drug","text":"octreotide"},{"annotation":"Treatment.Combination.Trigger","text":"and"},{"annotation":"Treatment.Combination.Drug","text":"pegvisomant"},{"annotation":"Treatment.Combination.Drug","text":"octreotide"},{"annotation":"Subject","text":"an acromegalic patient"},{"annotation":"Subject.Disorder","text":"acromegalic"}]}]}
 {"id": "9777751_4","context": "We present a case of a 58-year-old female patient with Graves' disease who developed AA in the third exposure to methimazole (MMI).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "third exposure to methimazole (MMI)"},{"annotation": "Effect","text": "AA"},{"annotation": "Treatment","text": "methimazole"},{"annotation": "Subject","text": "58-year-old female patient with Graves' disease"},{"annotation": "Subject.Disorder","text": "Graves' disease"}]}]
 {"id": "16685112_2","context": "CONCLUSIONS: This is the second case report that describes gemcitabine-induced radiation recall in rectus abdominus muscles after gemcitabine-based radiation therapy.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "radiation therapy"},{"annotation": "Treatment","text": "gemcitabine-based radiation therapy"},{"annotation": "Treatment.Disorder","text": "gemcitabine-induced radiation recall"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Effect","text": "radiation recall"},{"annotation": "Treatment.Body_part","text": "rectus abdominus muscles"},{"annotation": "Treatment.Duration","text": "gemcitabine-based radiation therapy"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "gemcitabine"},{"annotation": "Treatment","text": "gemcitabine"},{"annotation": "Treatment.Disorder","text": "gemcitabine-induced radiation recall"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Effect","text": "radiation recall"},{"annotation": "Treatment.Body_part","text": "rectus abdominus muscles"},{"annotation": "Treatment.Duration","text": "gemcitabine-based radiation therapy"}]}
 {"id": "16046172_2","context": "One patient was an 80-year-old woman who was admitted for Staphylococcus aureus knee arthritis after several intraarticular injections of sodium hyaluronate and corticosteroids.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "knee arthritis"},{"annotation": "Treatment","text": "intraarticular injections of sodium hyaluronate and corticosteroids"},{"annotation": "Treatment.Drug","text": "sodium hyaluronate"},{"annotation": "Treatment.Drug","text": "corticosteroids"},{"annotation": "Effect","text": "knee arthritis"},{"annotation": "Treatment.Drug","text": "Staphylococcus aureus"},{"annotation": "Treatment.Dosage","text": "several"},{"annotation": "Treatment.Dosage","text": "intraarticular"},{"annotation": "Treatment.Route","text": "injections"},{"annotation": "Treatment.Time_elapsed","text": "after several"},{"annotation": "Treatment.Duration","text": "several"},{"annotation": "Treatment.Disorder","text": "knee arthritis"}]}
 {"id":"6731466_5","context":"Association of zomepirac administration with renal cortical necrosis is not known to have been previously demonstrated.","events":[{"type":"Potential_therapeutic_event","annotations":[{"annotation":"Trigger","text":"Association"},{"annotation":"Treatment","text":"zomepirac"},{"annotation":"Treatment.Disorder","text":"renal cortical necrosis"},{"annotation":"Attribute","text":"negated","severity":"low"},{"annotation":"Attribute","text":"speculated","severity":"low"}]}]}
 {"id":"6427463_2","context":"Vasomotor reactions after gold sodium thiomalate are well recognized.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"vasomotor reactions"},{"annotation":"Effect","text":"vasomotor reactions"},{"annotation":"Treatment","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sodium thiomalate"},{"annotation":"Treatment.Drug","text":"vasomotor reactions"},{"annotation":"Treatment.Drug","text":"gold sod
 {"id": "21515865_1","context": "Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "interaction"},{"annotation": "Treatment","text": "moxifloxacin-acetaminophen-warfarin"},{"annotation": "Treatment.Disorder","text": "bladder cancer"},{"annotation": "Treatment.Drug","text": "bacille Calmette-Guerin"}]}]}
 {"id": "15571949_1","context": "In four patients, thrombosis occurred 2-45 days after severe hepatic veno-occlusive disease (HVOD) secondary to intensive chemotherapy containing busulfan.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intensive chemotherapy containing busulfan"},{"annotation": "Treatment","text": "chemotherapy"},{"annotation": "Treatment.Drug","text": "busulfan"},{"annotation": "Treatment.Duration","text": "severe hepatic veno-occlusive disease"},{"annotation": "Treatment.Duration","text": "2-45 days"},{"annotation": "Treatment.Drug","text": "thrombosis"},{"annotation": "Effect","text": "occurred"},{"annotation": "Treatment.Drug","text": "thrombosis"},{"annotation": "Treatment.Duration","text": "45 days"}]}
 {"id": "7139589_1","context": "An adolescent male developed acute pancreatitis and pseudocyst of the pancreas 16 weeks after cessation of intramuscular L-asparaginase.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "developed"},{"annotation": "Effect", "text": "acute pancreatitis and pseudocyst of the pancreas"},{"annotation": "Treatment", "text": "intramuscular L-asparaginase"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Duration", "text": "16 weeks"},{"annotation": "Subject", "text": "an adolescent male"},{"annotation": "Subject.Disorder", "text": "acute pancreatitis and pseudocyst of the pancreas"}]}]
 {"id": "22047557_1","context": "A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.","events": [{"type": "Treatment","annotations": [{"annotation": "Drug","text": "CFTR potentiator"},{"annotation": "Disorder","text": "cystic fibrosis"},{"annotation": "Disorder","text": "G551D mutation"}]}]
 {"id": "17205927_1","context": "Quinapril is an angiotensin-converting enzyme inhibitor (ACE-inhibitor) and overdose can lead to prolonged hypotension and, less frequently, transient renal impairment.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "overdose"},{"annotation": "Effect","text": "prolonged hypotension"},{"annotation": "Effect","text": "transient renal impairment"},{"annotation": "Treatment","text": "quinapril"},{"annotation": "Treatment.Drug","text": "ACE-inhibitor"}]}]
 {"id": "9725786_1","context": "We describe a renal transplant recipient maintained on cyclosporine and prednisone developing Nocardia Asteroides brain abscess.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developing"},{"annotation": "Effect","text": "Nocardia Asteroides brain abscess"},{"annotation": "Treatment","text": "cyclosporine and prednisone"},{"annotation": "Treatment.Disorder","text": "renal transplant recipient"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "prednisone"}]}]
 {"id": "15588385_2","context": "After an extensive review of the literature, we believe that this is the first communication of the successful use of amiodarone to control hyperthyroidism in a patient with PTU-induced fulminant hepatitis.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "control"},{"annotation": "Treatment","text": "amiodarone"},{"annotation": "Treatment.Disorder","text": "hyperthyroidism"},{"annotation": "Treatment.Drug","text": "amiodarone"},{"annotation": "Treatment.Drug","text": "PTU"},{"annotation": "Treatment.Drug","text": "fulminant hepatitis"},{"annotation": "Treatment.Drug","text": "amiodarone"},{"annotation": "Treatment.Drug","text": "PTU"},{"annotation": "Treatment.Drug","text": "fulminant hepatitis"},{"annotation": "Treatment.Combination.Trigger","text": "PTU-induced fulminant hepatitis"},{"annotation": "Treatment.Combination.Drug","text": "amiodarone"},{"annotation": "Treatment.Combination.Drug","text": "PTU"},{"annotation": "Treatment.Combination.Drug","text": "fulminant hepatitis"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Disorder","text": "PTU-induced fulminant hepatitis"}]}
 {"id": "12042592_1","context": "After identification of the index patient, additional inquiry revealed that the patient's mother was hospitalized previously for overwhelming sepsis associated with metamizole use.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "hospitalized"},{"annotation": "Treatment","text": "metamizole use"},{"annotation": "Treatment.Disorder","text": "overwhelming sepsis"}],"subject": {"Age": "unknown","Gender": "unknown","Population": "1","Race": "unknown","Disorder": "overwhelming sepsis"}}
 {"id": "9671138_3","context": "We report here on a heretofore undescribed respiratory syncytial virus (RSV) infection in a patient with a long-standing history of refractory CLL that was treated with fludarabine phosphate.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "infection"},{"annotation": "Treatment","text": "fludarabine phosphate"},{"annotation": "Treatment.Disorder","text": "refractory CLL"},{"annotation": "Treatment.Drug","text": "fludarabine phosphate"},{"annotation": "Treatment.Effect","text": "respiratory syncytial virus (RSV) infection"}],"subject": {"age": "refractory CLL","gender": "refractory CLL","population": "refractory CLL","race": "refractory CLL","disorder": "refractory CLL"}}
 {"id": "10812579_1","context": "A 77-year-old woman with no history of epilepsy presented a probable nonconvulsive status epilepticus while receiving continuous intravenous morphine for back pain relating to vertebral metastasis of a malignant lymphoma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "presented"},{"annotation": "Effect","text": "nonconvulsive status epilepticus"},{"annotation": "Treatment","text": "continuous intravenous morphine"},{"annotation": "Treatment.Drug","text": "morphine"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "receiving"},{"annotation": "Effect","text": "back pain"},{"annotation": "Treatment","text": "vertebral metastasis of a malignant lymphoma"},{"annotation": "Treatment.Disorder","text": "vertebral metastasis of a malignant lymphoma"}]}]}
 {"id": "16685007_2","context": "Oral corticosteroids (OCS) may be associated with systemic adverse events (AEs), which can be reduced by replacing OCS with inhaled corticosteroids (ICS).","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "OCS"},{"annotation": "Treatment","text": "replacing OCS with ICS"},{"annotation": "Treatment.Disorder","text": "systemic adverse events"},{"annotation": "Treatment.Drug","text": "OCS"},{"annotation": "Treatment.Drug","text": "ICS"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "OCS"},{"annotation": "Treatment.Combination.Drug","text": "ICS"},{"annotation": "Subject","text": "patients"},{"annotation": "Subject.Disorder","text": "systemic adverse events"}]}
 {"id": "15072497_1","context": "Development of Peyronie's disease during long-term colchicine treatment.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "long-term"},{"annotation": "Treatment","text": "colchicine"},{"annotation": "Treatment.Drug","text": "colchicine"},{"annotation": "Treatment.Duration","text": "long-term"},{"annotation": "Effect","text": "Peyronie's disease"}]}]}
 {"id": "9007910_6","context": "The principle treatment for DPD-deficient patients with severe acute 5-FU reactions is supportive care; however, the administration of thymidine potentially may reverse severe 5-FU-induced neurologic symptoms such as encephalopathy and coma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "severe acute 5-FU reactions"},{"annotation": "Treatment","text": "supportive care"},{"annotation": "Treatment.Disorder","text": "DPD-deficient"},{"annotation": "Treatment.Drug","text": "5-FU"},{"annotation": "Treatment.Drug","text": "thymidine"},{"annotation": "Treatment.Disorder","text": "DPD-deficient"},{"annotation": "Treatment.Drug","text": "5-FU"},{"annotation": "Effect","text": "neurologic symptoms"},{"annotation": "Treatment.Disorder","text": "DPD-deficient"},{"annotation": "Treatment.Drug","text": "5-FU"},{"annotation": "Treatment.Drug","text": "thymidine"},{"annotation": "Effect","text": "encephalopathy and coma"}]}
 {"id": "16599252_1","context": "Adverse reaction in a patient with aspirin-induced asthma treated with zafirlukast.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "zafirlukast"},{"annotation": "Treatment.Drug","text": "zafirlukast"},{"annotation": "Effect","text": "reaction"},{"annotation": "Treatment.Drug","text": "aspirin"},{"annotation": "Treatment.Disorder","text": "aspirin-induced asthma"}]}
 {"id": "6788011_4","context": "The nephrotic syndrome developed in a patient receiving therapy with gold for rheumatoid arthritis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "nephrotic syndrome"},{"annotation": "Treatment","text": "therapy with gold for rheumatoid arthritis"},{"annotation": "Treatment.Disorder","text": "rheumatoid arthritis"},{"annotation": "Treatment.Drug","text": "gold"}]}]
 {"id": "6731466_6","context": "This observation adds another dimension to the previously reported renal complications of nonsteroidal anti-inflammatory agents, especially zomepirac.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Effect","text": "renal complications"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "nonsteroidal anti-inflammatory agents"},{"annotation": "Treatment.Drug","text": "zomepirac"},{
 {"id": "12488741_1","context": "Clinical, spectroscopic, and imaging abnormalities resolved with discontinuation of metronidazole.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "metronidazole"},{"annotation": "Treatment.Drug","text": "metronidazole"},{"annotation": "Effect","text": "abnormalities"},{"annotation": "Treatment.Duration","text": "resolved"},{"annotation": "Treatment.Disorder","text": "clinical, spectroscopic, and imaging"}]}
 {"id": "20202988_8","context": "In two other patients (one after OLTX and one with Crohn's disease), a raltegravir-based HIV therapy was started while patients received 1 or 2 mg of tacrolimus twice daily.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "started"},{"annotation": "Treatment","text": "raltegravir-based HIV therapy"},{"annotation": "Treatment.Disorder","text": "HIV"},{"annotation": "Treatment.Drug","text": "raltegravir"},{"annotation": "Treatment.Drug","text": "tacrolimus"}]}]
 {"id": "16265343_2","context": "Reversible cardiomyopathy caused by administration of interferon alpha.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "caused by administration of interferon alpha"},{"annotation": "Effect","text": "reversible cardiomyopathy"},{"annotation": "Treatment","text": "interferon alpha"},{"annotation": "Treatment.Drug","text": "interferon alpha"}]}}
 {"id": "8696525_1","context": "Metipranolol associated granulomatous anterior uveitis: not so uncommon as thought.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated"},{"annotation": "Effect","text": "anterior uveitis"},{"annotation": "Treatment","text": "metipranolol"},{"annotation": "Treatment.Drug","text": "metipranolol"},{"annotation": "Treatment.Disorder","text": "granulomatous"}]}]}
 {"id": "12851279_13","context": "There was an increase in serious adverse events with bleeding in the tifacogin group in both cohorts (6.5% tifacogin and 4.8% placebo for high INR; 6.0% tifacogin and 3.3% placebo for low INR).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "bleeding"},{"annotation": "Effect","text": "serious adverse events"},{"annotation": "Treatment","text": "tifacogin"},{"annotation": "Treatment.Drug","text": "tifacogin"},{"annotation": "Treatment.Disorder","text": "high INR"},{"annotation": "Treatment.Disorder","text": "low INR"},{"annotation": "Treatment.Duration","text": "both cohorts"},{"annotation": "Treatment.Duration","text": "both cohorts"},{"annotation": "Treatment.Drug","text": "placebo"},{"annotation": "Treatment.Drug","text": "placebo"}]}
 {"id": "3318771_1","context": "We also describe a case of timolol-induced ocular pemphigoid.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "timolol"},{"annotation": "Treatment.Drug","text": "timolol"},{"annotation": "Effect","text": "ocular pemphigoid"}]}]
 {"id": "17016002_1","context": "A 70-year-old man was admitted to our hospital because of dyspnea after taking an antihistaminic agent (homochlorcyclizine hydrochloride) for itching.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "dyspnea"},{"annotation": "Treatment","text": "antihistaminic agent (homochlorcyclizine hydrochloride)"},{"annotation": "Treatment.Drug","text": "homochlorcyclizine hydrochloride"},{"annotation": "Effect","text": "dyspnea"}]}]}
 {"id": "10212021_1","context": "Methadone withdrawal when starting an antiretroviral regimen including nevirapine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "withdrawal"},{"annotation": "Treatment","text": "methadone"},{"annotation": "Treatment.Drug","text": "methadone"},{"annotation": "Effect","text": "withdrawal symptoms"},{"annotation": "Treatment","text": "antiretroviral regimen"},{"annotation": "Treatment.Disorder","text": "antiretroviral regimen"},{"annotation": "Treatment.Drug","text": "antiretroviral regimen"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "antiretroviral regimen"},{"annotation": "Treatment.Drug","text": "antiretroviral regimen"},{"annotation": "Treatment.Drug","text": "antiretroviral regimen"}]}
 {"id": "9253492_4","context": "The oligohidrosis caused by zonisamide was reversible in that the patient regained the ability to sweat within 2 weeks of the cessation of drug administration.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "caused by zonisamide"},{"annotation": "Effect","text": "oligohidrosis"},{"annotation": "Treatment","text": "zonisamide"},{"annotation": "Treatment.Drug","text": "zonisamide"},{"annotation": "Treatment.Duration","text": "within 2 weeks"},{"annotation": "Treatment.Drug","text": "cessation of drug administration"},{"annotation": "Effect","text": "reversible"},{"annotation": "Treatment","text": "ability to sweat"},{"annotation": "Treatment.Duration","text": "within 2 weeks"},{"annotation": "Subject","text": "the patient"},{"annotation": "Subject.Disorder","text": "oligohidrosis"}]}
 {"id": "16317298_4","context": "Radiation recall related to gemcitabine has been reported in lung and breast cancer.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "radiation recall"},{"annotation": "Treatment", "text": "gemcitabine"},{"annotation": "Treatment.Disorder", "text": "lung and breast cancer"},{"annotation": "Treatment.Drug", "text": "gemcitabine"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute.attribute", "text": "negated"}]}]}
 {"id": "10435399_1","context": "It carries a well-known risk of neutropenia and agranulocytosis, which necessitates the immediate discontinuation of clozapine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "carries"},{"annotation": "Treatment","text": "clozapine"},{"annotation": "Treatment.Drug","text": "clozapine"},{"annotation": "Treatment.Disorder","text": "neutropenia and agranulocytosis"},{"annotation": "Treatment.Drug","text": "clozapine"},{"annotation": "Effect","text": "necessitates"},{"annotation": "Treatment","text": "immediate discontinuation"},{"annotation": "Subject","text": "clozapine"},{"annotation": "Treatment","text": "clozapine"}]}
 {"id": "17827338_2","context": "Vicriviroc (SCH 417690), a CCR5 receptor antagonist, is currently under investigation for the treatment of human immunodeficiency virus infection.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "under investigation"},{"annotation": "Treatment","text": "vicriviroc (SCH 417690)"},{"annotation": "Treatment.Disorder","text": "human immunodeficiency virus infection"}]}]
 {"id": "9253492_2","context": "Children receiving zonisamide should be monitored for oligohidrosis and the development of neurological symptoms associated with an elevation of body temperature.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "receiving"},{"annotation": "Treatment","text": "zonisamide"},{"annotation": "Treatment.Drug","text": "zonisamide"},{"annotation": "Treatment.Disorder","text": "oligohidrosis"},{"annotation": "Treatment.Disorder","text": "neurological symptoms"},{"annotation": "Treatment.Disorder","text": "elevation of body temperature"},{"annotation": "Treatment.Drug","text": "zonisamide"}]}]
 {"id": "11147747_3","context": "This concerns 2 male patients who experienced incontinence while taking venlafaxine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "took"},{"annotation": "Treatment","text": "venlafaxine"},{"annotation": "Treatment.Drug","text": "venlafaxine"},{"annotation": "Effect","text": "incontinence"},{"annotation": "Subject","text": "2 male patients"},{"annotation": "Subject.Gender","text": "male"},{"annotation": "Subject.Population","text": "2"}]}}
 {"id": "1087773_2","context": "Polyarthritis, hepatitis and anti-native DNA antibodies after treatment with ethambutol and rifampicin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "after treatment"},{"annotation": "Effect","text": "polyarthritis, hepatitis and anti-native DNA antibodies"},{"annotation": "Treatment","text": "ethambutol and rifampicin"},{"annotation": "Treatment.Disorder","text": "none"},{"annotation": "Treatment.Drug","text": "ethambutol","negated": true},{"annotation": "Treatment.Drug","text": "rifampicin","negated": true}]}
 {"id": "15507779_4","context": "We report an HIV-infected woman who developed mild leukopenia as the first sign of a nevirapine-related adverse event, which was followed by skin and hepatic toxicity associated with a more severe leukopenia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Effect","text": "mild leukopenia"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment.Drug","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "annotation": "Treatment","text": "nevirapine"},{"annotation": "annotation": "Treatment","text": "nevirapine"},{"annotation": "annotation": "Treatment","text": "nevirapine"},{"annotation": "annotation": "Treatment","text": "nevirapine"},{"annotation": "annotation": "Treatment","text": "nevirapine"
 {"id": "18364401_2", "context": "OBJECTIVE: To report a case of rapidly occurring hyperglycemia that occurred in a geriatric patient 3 days after treatment with olanzapine.", "events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "occurred"}, {"annotation": "Effect", "text": "hyperglycemia"}, {"annotation": "Treatment", "text": "olanzapine"}, {"annotation": "Treatment.Drug", "text": "olanzapine"}, {"annotation": "Subject", "text": "geriatric patient"}, {"annotation": "Subject.Age", "text": "3 days"}, {"annotation": "Subject.Disorder", "text": "hyperglycemia"}]}]}
 {"id": "12851279_15","context": "Tifacogin administration was associated with an increase in risk of bleeding, irrespective of baseline INR.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated"},{"annotation": "Effect","text": "risk of bleeding"},{"annotation": "Treatment","text": "tifacogin administration"},{"annotation": "Treatment.Drug","text": "tifacogin"},{"annotation": "Attribute","text": "irrespective"},{"annotation": "Attribute","text": "baseline INR"}]}]
 {"id": "6618859_1","context": "Gynecomastia developed in two epileptic patients some months after the addition of oral fluoresone 750 mg daily to the phenobarbital and phenytoin already being administered.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "gynecomastia"},{"annotation": "Treatment","text": "oral fluoresone 750 mg daily"},{"annotation": "Treatment.Drug","text": "fluoresone"},{"annotation": "Treatment.Drug","text": "phenobarbital"},{"annotation": "Treatment.Drug","text": "phenytoin"},{"annotation": "Treatment.Combination.Trigger","text": "after"},{"annotation": "Treatment.Combination.Drug","text": "oral fluoresone"},{"annotation": "Treatment.Combination.Drug","text": "phenobarbital"},{"annotation": "Treatment.Combination.Drug","text": "phenytoin"},{"annotation": "Subject","text": "two epileptic patients"},{"annotation": "Subject.Disorder","text": "epileptic"}]}
 {"id": "6113770_1","context": "The authors describe a case of combined lithium and haloperidol toxicity characterized by hyperpyrexia, severe rigidity, mutism, and development of irreversible tardive dyskinesia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "combined lithium and haloperidol toxicity"},{"annotation": "Effect","text": "hyperpyrexia, severe rigidity, mutism, and development of irreversible tardive dyskinesia"},{"annotation": "Treatment","text": "combined lithium and haloperidol"},{"annotation": "Treatment.Disorder","text": "combined lithium and haloperidol toxicity"},{"annotation": "Treatment.Drug","text": "lithium"},{"annotation": "Treatment.Drug","text": "haloperidol"}]}
 {"id": "17665812_3","context": "Occasionally, despite good therapeutic response, clozapine must be stopped due to dangerous side effects such as agranulocytosis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "clozapine"},{"annotation": "Effect","text": "agranulocytosis"},{"annotation": "Treatment","text": "clozapine"}]}]}
 {"id": "7139589_4","context": "Three cases of pseudocyst of the pancreas in two women and one man have previously been reported with the use of intravenous L-asparaginase.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intravenous L-asparaginase"},{"annotation": "Treatment","text": "intravenous L-asparaginase"},{"annotation": "Treatment.Drug","text": "L-asparaginase"},{"annotation": "Treatment.Dosage","text": "intravenous"},{"annotation": "Treatment.Duration","text": "previous"},{"annotation": "Treatment.Disorder","text": "pseudocyst of the pancreas"},{"annotation": "Subject","text": "three cases"},{"annotation": "Subject.Population","text": "two women and one man"},{"annotation": "Subject.Disorder","text": "pseudocyst of the pancreas"}]}
 {"id": "17182354_4","context": "We report a case of Ritalin-associated cataract and glaucoma.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "associated"}, {"annotation": "Effect", "text": "cataract and glaucoma"}, {"annotation": "Treatment", "text": "Ritalin"}, {"annotation": "Treatment.Drug", "text": "Ritalin"}]}]}
 {"id": "19884751_3","context": "We discuss a patient who developed severe renal tubular dysfunction secondary to short-term therapy with Amikacin, resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, metabolic alkalosis, and polyuria.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "short-term therapy with Amikacin"},{"annotation": "Treatment","text": "Amikacin"},{"annotation": "Treatment.Drug","text": "Amikacin"},{"annotation": "Effect","text": "severe renal tubular dysfunction"},{"annotation": "Treatment.Duration","text": "short-term"},{"annotation": "Treatment.Disorder","text": "renal tubular dysfunction"},{"annotation": "Treatment.Drug","text": "Amikacin"},{"annotation": "Treatment.Drug","text": "hypokalemia"},{"annotation": "Treatment.Drug","text": "hypocalcemia"},{"annotation": "Treatment.Drug","text": "hypomagnesemia"},{"annotation": "Treatment.Drug","text": "metabolic alkalosis"},{"annotation": "Treatment.Drug","text": "polyuria"}]}
 {"id": "1655228_1","context": "Cardiac toxicity related to BCNU has not been described well.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "related to BCNU"},{"annotation": "Treatment", "text": "BCNU"},{"annotation": "Treatment.Drug", "text": "BCNU"},{"annotation": "Effect", "text": "cardiac toxicity"},{"annotation": "Treatment.Disorder", "text": "BCNU-related cardiac toxicity"},{"annotation": "Treatment.Drug", "text": "BCNU"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute.negated", "text": "has not been described well"}]}],"subject": {"Age": "not specified","Gender": "not specified","Population": "not specified","Race": "not specified","Disorder": "BCNU-related cardiac toxicity"}}
 {"id": "12891225_2","context": "Aprepitant is a neurokinin(1) receptor antagonist that enhances prevention of chemotherapy-induced nausea and vomiting when added to conventional therapy with a corticosteroid and a 5-hydroxytryptamine(3) (5-HT(3)) antagonist.","events": [{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "enhances"}, {"annotation": "Treatment", "text": "aprepitant"}, {"annotation": "Treatment.Disorder", "text": "chemotherapy-induced nausea and vomiting"}, {"annotation": "Treatment.Drug", "text": "corticosteroid"}, {"annotation": "Treatment.Drug", "text": "5-hydroxytryptamine(3) (5-HT(3)) antagonist"}, {"annotation": "Treatment.Combination.Trigger", "text": "when added to"}, {"annotation": "Treatment.Combination.Drug", "text": "aprepitant"}, {"annotation": "Treatment.Combination.Drug", "text": "corticosteroid"}, {"annotation": "Treatment.Combination.Drug", "text": "5-hydroxytryptamine(3) (5-HT(3)) antagonist"}]}]}
 {"id": "17123120_2","context": "Thus, tacrolimus-induced HUS is a rare cause of ARF in nephrotic syndrome.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "HUS"},{"annotation": "Treatment","text": "tacrolimus"},{"annotation": "Treatment.Disorder","text": "nephrotic syndrome"},{"annotation": "Treatment.Drug","text": "tacrolimus"}]}]
 {"id":"15927910_3","context":"Clinicians should be vigilant when monitoring for cardiotoxicity in patients receiving pentamidine throughout the duration of therapy.","events":[{"type":"Potential_therapeutic_effect","annotations":[{"annotation":"Trigger","text":"monitoring"},{"annotation":"Treatment","text":"pentamidine"},{"annotation":"Treatment.Disorder","text":"cardiotoxicity"},{"annotation":"Treatment.Drug","text":"pentamidine"},{"annotation":"Treatment.Dosage","text":"throughout the duration of therapy"},{"annotation":"Attribute","text":"negated"},{"annotation":"Attribute.negated","text":"clinicians should be vigilant when monitoring for cardiotoxicity in patients receiving pentamidine throughout the duration of therapy."}]}]}
 {"id": "14684937_3","context": "The present case is the first report of hypercalcemia induced by vitamin D3 ointment and thiazide simultaneously.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "hypercalcemia"},{"annotation": "Treatment", "text": "vitamin D3 ointment and thiazide simultaneously"},{"annotation": "Treatment.Drug", "text": "vitamin D3 ointment"},{"annotation": "Treatment.Drug", "text": "thiazide"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "vitamin D3 ointment"},{"annotation": "Treatment.Combination.Drug", "text": "thiazide"},{"annotation": "Subject", "text": "patient"},{"annotation": "Subject.Disorder", "text": "hypercalcemia"}]}]}
 {"id": "11352235_1","context": "CONCLUSION: Significant weight loss is a potential adverse event in patients with rheumatoid arthritis treated with leflunomide.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "treated with leflunomide"},{"annotation": "Treatment","text": "leflunomide"},{"annotation": "Treatment.Disorder","text": "rheumatoid arthritis"},{"annotation": "Treatment.Drug","text": "leflunomide"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "rheumatoid arthritis"},{"annotation": "Effect","text": "significant weight loss"}]}
 {"id": "7071645_2","context": "We have described a man with classic rheumatoid arthritis who had membranous nephropathy associated with nephrotic syndrome not related to gold or penicillamine therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "membranous nephropathy"},{"annotation": "Treatment","text": "gold or penicillamine therapy"},{"annotation": "Treatment.Disorder","text": "classic rheumatoid arthritis"},{"annotation": "Treatment.Drug","text": "membranous nephropathy"},{"annotation": "Treatment.Drug","text": "nephrotic syndrome"},{"annotation": "Treatment.Drug","text": "gold"},{"annotation": "Treatment.Drug","text": "penicillamine"}]}
 {"id": "24531907_1","context": "Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "Pharmacokinetics"},{"annotation": "Treatment","text": "etravirine"},{"annotation": "Treatment.Disorder","text": "HIV"},{"annotation": "Treatment.Combination","text": "rifampin"}]}]
 {"id": "9352164_5","context": "We thus concluded that an excessive dose of AZ had probably destroyed the gastric mucosal barrier or thrombocytopenia due to bone marrow disorder and thus eventually led to the development of hemorrhagic gastritis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "excessive dose of AZ"},{"annotation": "Effect","text": "hemorrhagic gastritis"},{"annotation": "Treatment","text": "AZ"},{"annotation": "Treatment.Drug","text": "AZ"},{"annotation": "Treatment.Disorder","text": "bone marrow disorder"},{"annotation": "Treatment.Disorder","text": "thrombocytopenia"},{"annotation": "Treatment.Disorder","text": "gastric mucosal barrier destruction"},{"annotation": "Treatment.Effect","text": "hemorrhagic gastritis"},{"annotation": "Treatment.Negated","text": "not specified"},{"annotation": "Treatment.Severity","text": "high"}]}
 {"id": "8430717_1","context": "Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdose.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "neurotoxicity"},{"annotation": "Treatment","text": "acyclovir"},{"annotation": "Treatment.Drug","text": "acyclovir"},{"annotation": "Treatment.Dosage","text": "overdose"},{"annotation": "Treatment.Route","text": "intravenous"},{"annotation": "Treatment.Time_elapsed","text": "concentration-side effect relationship"}]}
 {"id": "1680596_2","context": "Psoriasis-like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "after sulphasalazine therapy"},{"annotation": "Effect", "text": "psoriasis-like skin reaction"},{"annotation": "Treatment", "text": "sulphasalazine therapy"},{"annotation": "Treatment.Disorder", "text": "rheumatoid arthritis"},{"annotation": "Treatment.Drug", "text": "sulphasalazine"},{"annotation": "Treatment.Dosage", "text": "not specified"},{"annotation": "Treatment.Frequency", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Disorder", "text": "rheumatoid arthritis"}]}]}
 {"id": "10579985_4","context": "We describe the clinical course of 2 patients with Crohn's disease (CD) in whom lymphoma was diagnosed after treatment with infliximab.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "diagnosed"},{"annotation": "Treatment","text": "infliximab"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Effect","text": "lymphoma"},{"annotation": "Treatment.Disorder","text": "Crohn's disease"}],"subjects": [{"id": "1","population": "2 patients"}]}
 {"id": "17275666_2","context": "Valproic acid is commonly and effectively used in the treatment of idiopathic generalized epilepsies, including juvenile absence epilepsy.","events": [{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "used"}, {"annotation": "Treatment", "text": "valproic acid"}, {"annotation": "Treatment.Disorder", "text": "idiopathic generalized epilepsies"}, {"annotation": "Treatment.Disorder", "text": "juvenile absence epilepsy"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "not mentioned"}, {"annotation": "Effect", "text": "not mentioned"}, {"annotation": "Treatment", "text": "valproic acid"}, {"annotation": "Treatment.Drug", "text": "valproic acid"}, {"annotation": "Treatment.Duration", "text": "not mentioned"}, {"annotation": "Treatment.Disorder", "text": "idiopathic generalized epilepsies"}, {"annotation": "Treatment.Disorder", "text": "juvenile absence epilepsy"}]}]}
 {"id": "14561622_3","context": "We report a case of intrathecal methotrexate neurotoxicity manifesting as left arm weakness and aphasia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intrathecal methotrexate"},{"annotation": "Effect","text": "left arm weakness and aphasia"},{"annotation": "Treatment","text": "intrathecal methotrexate"},{"annotation": "Treatment.Drug","text": "methotrexate"}]}]
 {"id": "22677303_11","context": "According to the Drug Interaction Probability Scale, a causal relationship between the warfarin-cloxacillin interaction and increased INR value was rated "probable".","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment","text": "warfarin"},{"annotation": "Treatment","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Effect","text": "increased INR value"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "cloxacillin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "warfarin"},{"annotation": "Treatment.Combination.Drug","text": "cloxacillin"},{"annotation": "Treatment.Disorder","text": "warfarin-cloxacillin interaction"},{"annotation
 {"id": "16393774_4","context": "We present the cases of two female patients diagnosed with relapsing-remitting multiple sclerosis (RRMS) who developed inflammatory musculoskeletal manifestations, following IFN-beta therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "IFN-beta therapy"},{"annotation": "Effect","text": "inflammatory musculoskeletal manifestations"},{"annotation": "Treatment","text": "IFN-beta therapy"},{"annotation": "Treatment.Disorder","text": "relapsing-remitting multiple sclerosis (RRMS)"},{"annotation": "Subject","text": "two female patients"}]}]
 {"id": "440873_1","context": "Dystonia associated with carbamazepine administration: experience in brain-damaged children.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with carbamazepine administration"},{"annotation": "Effect","text": "dystonia"},{"annotation": "Treatment","text": "carbamazepine administration"},{"annotation": "Treatment.Drug","text": "carbamazepine"},{"annotation": "Subject","text": "brain-damaged children"},{"annotation": "Subject.Disorder","text": "brain-damage"}]}
 {"id": "20925534_10","context": "In all, 51 patients had a gastrointestinal event; the event rate was 1.1% with omeprazole and 2.9% with placebo at 180 days (hazard ratio with omeprazole, 0.34, 95% confidence interval [CI], 0.18 to 0.63; P<0.001).","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "omeprazole"},{"annotation": "Effect","text": "gastrointestinal event"},{"annotation": "Treatment.Duration","text": "180 days"},{"annotation": "Treatment.Disorder","text": "all"},{"annotation": "Treatment.Combination","text": "none"},{"annotation": "Event rate","text": "1.1% with omeprazole and 2.9% with placebo"},{"annotation": "Hazard ratio","text": "0.34"},{"annotation": "95% confidence interval","text": "[0.18, 0.63]; P<0.001"}]}
 {"id": "9865241_1","context": "CONCLUSION: We report a case of the use of pamidronate for significant hypercalcemia secondary to acute vitamin D poisoning.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "acute vitamin D poisoning"},{"annotation": "Treatment","text": "pamidronate"},{"annotation": "Effect","text": "hypercalcemia"},{"annotation": "Treatment.Drug","text": "pamidronate"},{"annotation": "Treatment.Disorder","text": "acute vitamin D poisoning"}]}]
 {"id": "20925534_1","context": "Clopidogrel with or without omeprazole in coronary artery disease.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "coronary artery disease"},{"annotation": "Treatment","text": "clopidogrel"},{"annotation": "Treatment.Disorder","text": "coronary artery disease"},{"annotation": "Treatment.Drug","text": "clopidogrel"},{"annotation": "Treatment.Drug","text": "omeprazole"},{"annotation": "Treatment.Combination.Trigger","text": "with or without"},{"annotation": "Treatment.Combination.Drug","text": "clopidogrel"},{"annotation": "Treatment.Combination.Drug","text": "omeprazole"}],"negated": false,"speculated": false,"severity": null}
 {"id": "11001600_1","context": "The cases are important in documenting that drug-induced dystonias do occur in patients with dementia, that risperidone appears to have contributed to dystonia among elderly patients, and that the categorization of dystonic reactions needs further clarification.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "drug-induced"},{"annotation": "Treatment","text": "risperidone"},{"annotation": "Treatment.Drug","text": "risperidone"},{"annotation": "Effect","text": "dystonia"},{"annotation": "Treatment.Disorder","text": "dementia"},{"annotation": "Treatment.Disorder","text": "elderly patients"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Drug","text": "risperidone"},{"annotation": "Treatment.Combination.Trigger","text": "and" },
 {"id": "18580694_1","context": "In addition, there is a report on prolonged ECT seizure related to ciprofloxacin, which has an epileptogenic property with a similar action to beta-lactam antibiotics.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "related to"},{"annotation": "Effect","text": "prolonged ECT seizure"},{"annotation": "Treatment","text": "ciprofloxacin"},{"annotation": "Treatment.Drug","text": "ciprofloxacin"},{"annotation": "Treatment.Drug","text": "beta-lactam antibiotics"}]}]
 {"id": "10592946_2","context": "After abstinence from oolong tea his delirium resolved.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "consumption of oolong tea"},{"annotation": "Effect","text": "delirium"},{"annotation": "Treatment","text": "abstinence"}]}]}
 {"id": "16901609_1","context": "Anaphylaxis to intrathecal diamorphine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "intrathecal diamorphine"},{"annotation": "Effect", "text": "anaphylaxis"},{"annotation": "Treatment", "text": "intrathecal diamorphine"},{"annotation": "Treatment.Drug", "text": "diamorphine"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute.negated", "text": "anaphylaxis does not exist"}]}]}
 {"id": "8726608_3","context": "This case suggests that acyclovir when given intravenously in doses of 10 mg/kg may result in increased serum lithium concentrations.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "given intravenously"},{"annotation": "Treatment","text": "acyclovir"},{"annotation": "Treatment.Dosage","text": "10 mg/kg"},{"annotation": "Treatment.Disorder","text": "serum lithium concentrations"},{"annotation": "Effect","text": "increased"}]}]
 {"id": "15522120_12","context": "After approximately two weeks of sertraline treatment he noted an intense itching sensation in his scalp after eating a piece of chocolate cake.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "after eating"},{"annotation": "Treatment","text": "sertraline"},{"annotation": "Treatment.Drug","text": "sertraline"},{"annotation": "Effect","text": "itching sensation"},{"annotation": "Treatment.Drug","text": "sertraline"},{"annotation": "Treatment.Drug","text": "chocolate cake"}]}
 {"id": "8589490_2","context": "Pigmentary aberrations are well known side effects of cytostatic chemotherapeutic agents.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "cytotoxic chemotherapy"},{"annotation": "Effect","text": "pigmentary aberrations"},{"annotation": "Treatment","text": "cytotoxic chemotherapy"},{"annotation": "Treatment.Disorder","text": "none"},{"annotation": "Treatment.Drug","text": "cytotoxic chemotherapy"}]}]
 {"id": "7485371_1","context": "CONCLUSION: Atovaquone should be added to the list of agents causing vortex keratopathy involving the corneal epithelium.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "CONCLUSION"},{"annotation": "Treatment","text": "Atovaquone"},{"annotation": "Treatment.Disorder","text": "vortex keratopathy involving the corneal epithelium"}]}]
 {"id":"10812579_2","context":"A generalized tonic-clonic seizure occurred a few minutes after injection of the morphine antagonist naloxone.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred"},{"annotation":"Effect","text":"seizure"},{"annotation":"Treatment","text":"injection of naloxone"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Dosage","text":"a few minutes"},{"annotation":"Treatment.Duration","text":"after injection"},{"annotation":"Treatment.Dosage","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"morphine antagonist"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},{"annotation":"Treatment.Drug","text":"naloxone"},{"annotation":"Treatment.Duration","text":"a few minutes"},
 {"id": "7748076_1","context": "CONCLUSION: Squamous metaplasia in these cases appears to be a consequence of progestin therapy.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "progestin therapy"},{"annotation": "Treatment.Disorder","text": "squamous metaplasia"},{"annotation": "Attribute","text": "severity","value": "low"},{"annotation": "Attribute","text": "negated","value": "false"}]}]
 {"id": "6610943_4","context": "This association should be considered in the period after vasopressin-treated gastrointestinal hemorrhage.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "vasopressin-treated gastrointestinal hemorrhage"},{"annotation": "Treatment","text": "vasopressin"},{"annotation": "Treatment.Disorder","text": "gastrointestinal hemorrhage"},{"annotation": "Treatment.Drug","text": "vasopressin"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "gastrointestinal hemorrhage"},{"annotation": "Attribute","text": "negated","severity": "low"}]}
 {"id": "6693840_4","context": "The gynecomastia regressed when the theophylline was discontinued.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "theophylline"},{"annotation": "Treatment.Drug","text": "theophylline"},{"annotation": "Effect","text": "gynecomastia"},{"annotation": "Treatment.Disorder","text": "none"}]}]
 {"id": "3277077_1","context": "Renal hypophosphatemia in this patient was caused by the erroneous intake of 1 g doxycycline.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "erroneous intake of doxycycline"},{"annotation": "Effect", "text": "renal hypophosphatemia"},{"annotation": "Treatment", "text": "doxycycline"},{"annotation": "Treatment.Drug", "text": "1 g doxycycline"},{"annotation": "Treatment.Drug", "text": "doxycycline"}]}]}
 {"id": "2297635_1","context": "Despite a response of the meningeal tumor the patient developed in the third week of MTX treatment a progressive visual loss and loss of consciousness which worsened during subsequent Ara-C treatment and led to death within 3 weeks.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "MTX treatment"},{"annotation": "Treatment","text": "MTX"},{"annotation": "Treatment.Drug","text": "MTX"},{"annotation": "Effect","text": "progressive visual loss and loss of consciousness"},{"annotation": "Treatment","text": "Ara-C"},{"annotation": "Treatment.Drug","text": "Ara-C"},{"annotation": "Treatment.Duration","text": "3 weeks"},{"annotation": "Treatment","text": "Ara-C"},{"annotation": "Treatment.Drug","text": "Ara-C"},{"annotation": "Treatment.Duration","text": "3 weeks"},{"annotation": "Treatment","text": "Ara-C"},{"annotation": "Treatment.Drug","text": "Ara-C"},{"annotation": "Treatment.Duration","text": "3 weeks"},{"annotation": "Effect","text": "death"},{"annotation": "Treatment","text": "MTX"},{"annotation": "Treatment.Drug","text": "MTX"},{"annotation": "Treatment","text": "Ara-C"},{"annotation": "Treatment.Drug","text": "Ara-C"},{"annotation": "Treatment","text": "MTX"},{"annotation": "Treatment.Drug","text": "MTX"},{"annotation": "Treatment","text": "Ara-C"},{"annotation": "Treatment.Drug","text": "Ara-C"},{"annotation": "Treatment","text": "MTX"},{"annotation": "Treatment.Drug","text": "MTX"},{"annotation": "Treatment","text": "Ara-C"},{"annotation": "Treatment.Drug","text": "Ara-C"},{"annotation": "Treatment","text": "MTX"},{"annotation": "Treatment.Drug","text": "MTX"},{"annotation": "Treatment","text": "Ara-C"},{"annotation": "Treatment.Drug","text": "Ara-C"},{"annotation": "Treatment","text": "MTX"},{"annotation": "Treatment.Drug","text": "MTX"},{"annotation": "Treatment","text": "Ara-C"},{"annotation": "Treatment.Drug","text": "Ara-C"},{"annotation": "Treatment","text": "MTX"},{"annotation": "Treatment.Drug","text": "MTX"},{"annotation": "Treatment","text": "Ara-C"},{"annotation": "Treatment.Drug","text": "Ara-C"}]}
 {"id": "1087773_1","context": "After seven months' continuous treatment for suspected tuberculosis with rifampicin and ethambutol a nine-year-old boy developed polyarthritis, rash and hepatitis in association with anti-native DNA antibodies and positive antinuclear factor.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "polyarthritis, rash and hepatitis"},{"annotation": "Treatment","text": "suspected tuberculosis with rifampicin and ethambutol"},{"annotation": "Treatment.Disorder","text": "tuberculosis"},{"annotation": "Treatment.Drug","text": "rifampicin"},{"annotation": "Treatment.Drug","text": "ethambutol"},{"annotation": "Attribute","text": "antibodies"},{"annotation": "Attribute","text": "antinuclear factor"},{"annotation": "Attribute","text": "positive"}]}}
 {"id": "16609346_1","context": "A few recent individual case reports have suggested that a myasthenic syndrome may be associated with statin treatment, but this association is not well described.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "statin treatment"},{"annotation": "Treatment","text": "statin"},{"annotation": "Treatment.Disorder","text": "myasthenic syndrome"}]}]}
 {"id": "21658326_2","context": "Topical imiquimod and tumor necrosis factor (TNF)-alpha inhibitors have gained wide acceptance as safe and effective treatments for non-melanoma skin cancer (NMSC) and moderate to severe psoriasis, respectively.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "gained"},{"annotation": "Treatment","text": "imiquimod and TNF-alpha inhibitors"},{"annotation": "Treatment.Disorder","text": "non-melanoma skin cancer"},{"annotation": "Treatment.Disorder","text": "moderate to severe psoriasis"},{"annotation": "Treatment.Effect","text": "acceptance"}]}]
 {"id": "6731466_1","context": "Focal renal cortical necrosis associated with zomepirac.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with"},{"annotation": "Treatment","text": "zomepirac"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Effect","text": "focal renal cortical necrosis"}]}]
 {"id": "8850251_6","context": "We experienced 2 cases of mequitazine-induced photosensitivity reaction in patients who took mequitazine for their dermatologic problems.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "mequitazine"},{"annotation": "Treatment.Drug","text": "mequitazine"},{"annotation": "Effect","text": "photosensitivity reaction"},{"annotation": "Treatment.Disorder","text": "dermatologic problems"},{"annotation": "Treatment.Drug","text": "mequitazine"}]}]
 {"id": "20349794_4","context": "Carboplatin was substituted for cisplatin, and there were no further episodes of SIADH.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "substituted"},{"annotation": "Treatment","text": "carboplatin"},{"annotation": "Treatment.Drug","text": "cisplatin"},{"annotation": "Treatment.Disorder","text": "SIADH"},{"annotation": "Effect","text": "no further episodes"}]}]
 {"id": "16490518_3","context": "Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intravitreal injection of triamcinolone acetonide"},{"annotation": "Treatment","text": "intravitreal injection of triamcinolone acetonide"},{"annotation": "Treatment.Drug","text": "triamcinolone acetonide"},{"annotation": "Effect","text": "glaucoma"},{"annotation": "Treatment.Drug","text": "steroid"},{"annotation": "Treatment.Drug","text": "triamcinolone acetonide"},{"annotation": "Treatment.Dosage","text": "intravitreal injection"}]}
 {"id": "16160485_1","context": "CD20-negative T-cell-rich B-cell lymphoma as a progression of a nodular lymphocyte-predominant Hodgkin's lymphoma treated with rituximab: a molecular analysis using laser capture microdissection.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "progression"},{"annotation": "Treatment","text": "rituximab"},{"annotation": "Treatment.Disorder","text": "nodular lymphocyte-predominant Hodgkin's lymphoma"},{"annotation": "Treatment.Drug","text": "rituximab"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "CD20-negative T-cell-rich B-cell lymphoma"},{"annotation": "Treatment","text": "rituximab"},{"annotation": "Treatment.Disorder","text": "CD20-negative T-cell-rich B-cell lymphoma"},{"annotation": "Treatment.Drug","text": "rituximab"}]}],"subject": {"id": "16160485_1_subject","disorder": "nodular lymphocyte-predominant Hodgkin's lymphoma"},"treatment": {"id": "16160485_1_treatment","drug": "rituximab"}}
 {"id": "10717401_2","context": "We report the case of an adult patient with acute lymphoblastic leukemia who presented with repeated transient ischemic attacks followed by a seizure during consolidation treatment with L-asparaginase.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "presented"},{"annotation": "Effect","text": "transient ischemic attacks followed by seizure"},{"annotation": "Treatment","text": "consolidation treatment with L-asparaginase"},{"annotation": "Treatment.Drug","text": "L-asparaginase"},{"annotation": "Subject","text": "an adult patient"},{"annotation": "Subject.Disorder","text": "acute lymphoblastic leukemia"}]}
 {"id": "16317298_1","context": "Gemcitabine-related radiation recall in a patient with pancreatic cancer.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "radiation recall"},{"annotation": "Treatment", "text": "gemcitabine"},{"annotation": "Treatment.Drug", "text": "gemcitabine"},{"annotation": "Treatment.Disorder", "text": "pancreatic cancer"},{"annotation": "Treatment.Disorder", "text": "gemcitabine-related"}]}]}
 {"id": "8404753_7","context": "After development of the tics in 2, CBZ was continued at the same or higher dose, and the tics abated and then ceased spontaneously < or = 6 months.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "development of tics"},{"annotation": "Effect","text": "tics"},{"annotation": "Treatment","text": "CBZ"},{"annotation": "Treatment.Drug","text": "CBZ"},{"annotation": "Treatment.Dosage","text": "same or higher dose"},{"annotation": "Treatment.Duration","text": "< or = 6 months"},{"annotation": "Treatment.Effect","text": "abated and ceased spontaneously"}]}
 {"id": "16978752_4","context": "Thus any case of severe neutropenia occurring in a patient receiving olanzapine is alarming to clinicians.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "severe neutropenia"},{"annotation": "Treatment","text": "olanzapine"},{"annotation": "Treatment.Drug","text": "olanzapine"},{"annotation": "Effect","text": "neutropenia"},{"annotation": "Treatment.Disorder","text": "severe neutropenia"}]}]
 {"id": "18203308_4","context": "We describe 3 AS patients treated with etanercept for active AS who developed new onset of CD while AS related symptoms responded well to etanercept.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "new onset of CD"},{"annotation": "Effect","text": "development of CD"},{"annotation": "Treatment","text": "etanercept"},{"annotation": "Treatment.Disorder","text": "active AS"},{"annotation": "Treatment.Drug","text": "etanercept"},{"annotation": "Treatment.Drug","text": "CD"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "AS related symptoms"},{"annotation": "Effect","text": "response well to etanercept"},{"annotation": "Treatment","text": "etanercept"},{"annotation": "Treatment.Disorder","text": "active AS"},{"annotation": "Treatment.Drug","text": "etanercept"}]}
 {"id": "11510798_5","context": "It is concluded that the aforementioned pathological manifestations were due to chemotherapy and included a pulmonary adverse reaction, a feature never previously associated with oxaliplatinum and 5-fluorouracil regimens.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "due to chemotherapy"},{"annotation": "Effect","text": "pathological manifestations"},{"annotation": "Treatment","text": "chemotherapy"},{"annotation": "Treatment.Drug","text": "oxaliplatinum and 5-fluorouracil regimens"},{"annotation": "Treatment.Drug","text": "oxaliplatinum"},{"annotation": "Treatment.Drug","text": "5-fluorouracil"},{"annotation": "Treatment.Disorder","text": "chemotherapy"},{"annotation": "Effect","text": "pulmonary adverse reaction"},{"annotation": "Treatment","text": "oxaliplatinum and 5-fluorouracil regimens"},{"annotation": "Treatment.Drug","text": "oxaliplatinum"},{"annotation": "Treatment.Drug","text": "5-fluorouracil"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "oxaliplatinum"},{"annotation": "Treatment.Combination.Drug","text": "5-fluorouracil"},{"annotation": "Subject","text": "aforementioned pathological manifestations"},{"annotation": "Subject.Disorder","text": "chemotherapy"}]}
 {"id": "17619811_2","context": "A case of colchicine-induced rhabdomyolysis is reported.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"}, {"annotation": "Effect", "text": "rhabdomyolysis"}, {"annotation": "Treatment", "text": "colchicine"}, {"annotation": "Treatment.Drug", "text": "colchicine"}, {"annotation": "Treatment.Disorder", "text": "none"}]}]}
 {"id": "7056119_4","context": "Because of a recurrence of paroxysmal atrial fibrillation, the dose of the drug was increased to 1.4 g/day; 24 hours later AVT with syncope developed but responded promptly to atropine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "recurrence of paroxysmal atrial fibrillation"},{"annotation": "Treatment","text": "drug"},{"annotation": "Treatment.Drug","text": "drug"},{"annotation": "Treatment.Dosage","text": "1.4 g/day"},{"annotation": "Effect","text": "AVT with syncope"},{"annotation": "Treatment","text": "atropine"},{"annotation": "Treatment.Drug","text": "atropine"}]}]
 {"id": "17167851_2","context": "Three male patients aged 78-83 years are presented, in whom severe hepatotoxic reactions emerged after CPA administration.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "emerged"},{"annotation": "Effect","text": "severe hepatotoxic reactions"},{"annotation": "Treatment","text": "CPA administration"},{"annotation": "Treatment.Drug","text": "CPA"},{"annotation": "Subject","text": "three male patients"},{"annotation": "Subject.Age","text": "78-83 years"}]}
 {"id": "172214_2","context": "Exacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics actinomycin-D (NSC-3053) and mithramycin (NSC-24559).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "administration of actinomycin-D and mithramycin"},{"annotation": "Treatment","text": "antitumor antibiotics actinomycin-D and mithramycin"},{"annotation": "Treatment.Drug","text": "actinomycin-D"},{"annotation": "Treatment.Drug","text": "mithramycin"},{"annotation": "Effect","text": "exacerbations of heart failure"},{"annotation": "Treatment.Disorder","text": "heart failure"}]}]
 {"id": "18347524_1","context": "Diffuse alveolar hemorrhage after leflunomide therapy in a patient with rheumatoid arthritis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "leflunomide therapy"},{"annotation": "Effect","text": "diffuse alveolar hemorrhage"},{"annotation": "Treatment","text": "leflunomide"},{"annotation": "Treatment.Disorder","text": "rheumatoid arthritis"}]}]
 {"id": "15836666_2","context": "We report a case of a 64-year-old man with secondary adrenocortical insufficiency who has been on a chronic transdermal fentanyl treatment because of sciatic pain syndrome.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "chronic transdermal fentanyl treatment"},{"annotation": "Treatment","text": "transdermal fentanyl"},{"annotation": "Treatment.Drug","text": "fentanyl"},{"annotation": "Effect","text": "secondary adrenocortical insufficiency"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "chronic transdermal fentanyl treatment"},{"annotation": "Treatment","text": "transdermal fentanyl"},{"annotation": "Treatment.Drug","text": "fentanyl"},{"annotation": "Effect","text": "sciatic pain syndrome"}]}],"attributes": [{"annotation": "negated","text": "not negated"},{"annotation": "severity","text": "medium"}]}
 {"id": "6440806_1","context": "A 52-year-old, white female developed low-grade fever, cough, and dyspnea after 8 weeks treatment with sodium aurothiomalate for rheumatoid arthritis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "fever, cough, and dyspnea"},{"annotation": "Treatment","text": "8 weeks treatment with sodium aurothiomalate"},{"annotation": "Treatment.Disorder","text": "rheumatoid arthritis"},{"annotation": "Subject","text": "52-year-old, white female"},{"annotation": "Subject.Age","text": "52"},{"annotation": "Subject.Gender","text": "white female"}]}
 {"id": "12786839_1","context": "In both cases, high fever, skin rash, liver dysfunction and atypical lymphocytosis developed 3 weeks after initiating treatment with SASP.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Treatment","text": "SASP"},{"annotation": "Treatment.Drug","text": "SASP"},{"annotation": "Effect","text": "high fever, skin rash, liver dysfunction and atypical lymphocytosis"},{"annotation": "Time_elapsed","text": "3 weeks"},{"annotation": "Treatment.Drug","text": "SASP"}]}]
 {"id": "12659609_2","context": "OBJECTIVE: To report a case of severe chloroquine toxicity in the presence of high-grade chloroquine-resistant Plasmodium vivax.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "severe chloroquine toxicity"},{"annotation": "Treatment","text": "chloroquine"},{"annotation": "Treatment.Drug","text": "chloroquine"},{"annotation": "Treatment.Disorder","text": "chloroquine toxicity"},{"annotation": "Treatment.Drug","text": "high-grade chloroquine-resistant Plasmodium vivax"}]}]
 {"id": "15857283_4","context": "RESULTS: All cases developed corneal endothelial deposits after previous use of rifabutin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "previous use of rifabutin"},{"annotation": "Effect","text": "corneal endothelial deposits"},{"annotation": "Treatment","text": "rifabutin"},{"annotation": "Treatment.Drug","text": "rifabutin"},{"annotation": "Treatment.Disorder","text": "corneal endothelial deposits"},{"annotation": "Subject","text": "all cases"},{"annotation": "Subject.Population","text": "all cases"}]}
 {"id": "3136101_2","context": "Two infants developed hyperkalemia shortly after cessation of prolonged ACTH therapy for infantile spasms.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "shortly after cessation"},{"annotation": "Treatment","text": "prolonged ACTH therapy"},{"annotation": "Treatment.Drug","text": "ACTH"},{"annotation": "Treatment.Duration","text": "prolonged"},{"annotation": "Treatment.Disorder","text": "infantile spasms"},{"annotation": "Effect","text": "hyperkalemia"},{"annotation": "Subject","text": "two infants"},{"annotation": "Subject.Age","text": "infants"}]}
 {"id": "19318596_2","context": "In this case, CIPS was considered to be probably associated with cyclosporine according to the Naranjo probability scale.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "cyclosporine"},{"annotation": "Effect","text": "CIPS"},{"annotation": "Treatment","text": "cyclosporine"},{"annotation": "Treatment.Disorder","text": "CIPS"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Attribute","text": "probably associated","attribute": {"name": "Association","type": "probability","value": "probably"}}]}
 {"id": "18751717_1","context": "Acute syphilitic posterior placoid chorioretinitis following intravitreal triamcinolone acetonide injection.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "following intravitreal triamcinolone acetonide injection."},{"annotation": "Effect","text": "acute syphilitic posterior placoid chorioretinitis"},{"annotation": "Treatment","text": "intravitreal triamcinolone acetonide injection."},{"annotation": "Treatment.Drug","text": "triamcinolone acetonide"}]}]
 {"id": "7139589_2","context": "Delayed pseudocyst of the pancreas can be a complication of intramuscular L-asparaginase.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "delayed pseudocyst"},{"annotation": "Effect","text": "pseudocyst of pancreas"},{"annotation": "Treatment","text": "intramuscular L-asparaginase"},{"annotation": "Treatment.Drug","text": "L-asparaginase"}]}]}
 {"id": "7783891_3","context": "I report a 35-year-old woman with occult coronary artery disease who experienced cardiac arrest within minutes after receiving a first-time dose of subcutaneous sumatriptan for migraine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "receiving"},{"annotation": "Treatment","text": "subcutaneous sumatriptan"},{"annotation": "Treatment.Drug","text": "sumatriptan"},{"annotation": "Effect","text": "cardiac arrest"},{"annotation": "Treatment.Drug","text": "subcutaneous"},{"annotation": "Treatment.Drug","text": "sumatriptan"},{"annotation": "Treatment.Disorder","text": "occult coronary artery disease"},{"annotation": "Subject","text": "a 35-year-old woman"},{"annotation": "Subject.Age","text": "35"},{"annotation": "Subject.Disorder","text": "occult coronary artery disease"}]}
 {"id": "10332990_2","context": "Epoprostenol (prostacyclin) is currently approved for treatment of primary pulmonary hypertension; however, it is being evaluated in other forms of pulmonary hypertension, particularly scleroderma.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "evaluated"},{"annotation": "Treatment","text": "epoprostenol (prostacyclin)"},{"annotation": "Treatment.Disorder","text": "primary pulmonary hypertension"},{"annotation": "Treatment.Drug","text": "epoprostenol (prostacyclin)"},{"annotation": "Treatment.Combination.Trigger","text": "in other forms of pulmonary hypertension"},{"annotation": "Treatment.Combination.Drug","text": "epoprostenol (prostacyclin)"},{"annotation": "Treatment.Combination.Drug","text": "scleroderma"}]}
 {"id": "11724089_4","context": "OBJECTIVE: To report a fatal case of toxic epidermal necrolysis in a man who was treated with oral ofloxacin for epididymitis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "treated"},{"annotation": "Treatment","text": "oral ofloxacin"},{"annotation": "Treatment.Drug","text": "ofloxacin"},{"annotation": "Effect","text": "toxic epidermal necrolysis"},{"annotation": "Treatment.Disorder","text": "epididymitis"}]}]
 {"id": "12869178_1","context": "Massive pulmonary embolism due to late-onset heparin-induced thrombocytopenia following coronary artery bypass graft surgery: successful treatment with lepirudin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "late-onset heparin-induced thrombocytopenia"},{"annotation": "Effect","text": "massive pulmonary embolism"},{"annotation": "Treatment","text": "coronary artery bypass graft surgery"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "successful treatment"},{"annotation": "Treatment","text": "lepirudin"},{"annotation": "Treatment.Disorder","text": "late-onset heparin-induced thrombocytopenia"}]}]}
 {"id": "11283125_1","context": "Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Treatment","text": "high-dose cytarabine"},{"annotation": "Treatment.Drug","text": "cytarabine"},{"annotation": "Treatment.Dosage","text": "high-dose"},{"annotation": "Treatment.Frequency","text": "interval therapy"},{"annotation": "Treatment.Route","text": "unknown"},{"annotation": "Treatment.Time_elapsed","text": "unknown"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "acute lymphoblastic leukemia and lymphoblastic lymphoma"},{"annotation": "Effect","text": "unknown"}],"attributes": [{"annotation": "negated","text": "unknown"},{"annotation": "speculated","text": "unknown"},{"annotation": "severity","text": "unknown"}],"event_type": "Adverse_event"}
 {"id":"11450788_4","context":"We report a case of fulminant hepatic failure associated with didanosine and masquerading as a surgical abdomen and compare the clinical, biologic, histologic, and ultrastructural findings with reports described previously.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with didanosine"},{"annotation": "Effect","text": "fulminant hepatic failure"},{"annotation": "Treatment","text": "didanosine"},{"annotation": "Treatment.Drug","text": "didanosine"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "comparison"},{"annotation": "Treatment.Disorder","text": "fulminant hepatic failure"},{"annotation": "Treatment.Drug","text": "didanosine"},{"annotation": "Treatment.Comparison","text": "clinical, biologic, histologic, and ultrastructural findings"},{"annotation": "Subject","text": "a surgical abdomen"}]}]}
 {"id": "16537817_10","context": "An objective causal assessment suggests that rhabdomyolysis, renal failure, and possibly hepatotoxicity were probably related to an amiodarone-simvastatin interaction.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "interaction"},{"annotation": "Effect","text": "rhabdomyolysis, renal failure, hepatotoxicity"},{"annotation": "Treatment","text": "amiodarone-simvastatin"}]}]
 {"id": "11105373_2","context": "Nail staining from hydroquinone cream.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "from"},{"annotation": "Treatment","text": "hydroquinone cream"},{"annotation": "Treatment.Drug","text": "hydroquinone"},{"annotation": "Effect","text": "nail staining"}]}]
 {"id": "748238_2","context": "The development of an IgG lambda-type monoclonal gammopathy and subsequent multiple myeloma in an epilepsy patient on diphenylhydantoin (DILANTIN) therapy for 20 years is reported.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "development"},{"annotation": "Treatment","text": "diphenylhydantoin (DILANTIN) therapy"},{"annotation": "Treatment.Disorder","text": "IgG lambda-type monoclonal gammopathy"},{"annotation": "Treatment.Disorder","text": "subsequent multiple myeloma"},{"annotation": "Treatment.Drug","text": "diphenylhydantoin (DILANTIN)"},{"annotation": "Treatment.Duration","text": "20 years"}]}]}
 {"id": "10698143_2","context": "Ibuprofen overdose is usually characterized by GI upset, dizziness, and mild sedation.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "ibuprofen overdose"},{"annotation": "Effect","text": "GI upset, dizziness, mild sedation"},{"annotation": "Treatment","text": "ibuprofen"}]}]}
 {"id": "20628041_5","context": "His PD medications (pramipexole, entacapone, and immediate-release levodopa/carbidopa 100 mg/25 mg, 1.5 tablets 4 times daily) were administered via nasogastric tube.","events": [{"type": "Administration","annotations": [{"annotation": "Medication","text": "PD medications"},{"annotation": "Medication.Drug","text": "pramipexole"},{"annotation": "Medication.Drug","text": "entacapone"},{"annotation": "Medication.Drug","text": "immediate-release levodopa/carbidopa 100 mg/25 mg"},{"annotation": "Medication.Drug","text": "1.5 tablets"},{"annotation": "Medication.Drug","text": "4 times daily"],"attributes": {"negated": false,"speculated": false,"severity": null}}]}
 {"id": "18675768_15","context": "CONCLUSIONS: This is the first report of a possible interaction between propafenone and citalopram, which caused propafenone adverse effects (eg, dizziness, falls) and mimicked coronary artery disease.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "propafenone"},{"annotation": "Treatment","text": "propafenone"},{"annotation": "Treatment.Disorder","text": "coronary artery disease"},{"annotation": "Treatment.Drug","text": "citalopram"},{"annotation": "Treatment.Drug","text": "propafenone"},{"annotation": "Treatment.Adverse_effect","text": "dizziness"},{"annotation": "Treatment.Adverse_effect","text": "falls"}]}]
 {"id": "14614357_2","context": "We report the case of a young healthy woman who presented an early overanticoagulation when receiving acenocoumarol for a first thromboembolic episode.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "receiving"},{"annotation": "Effect","text": "overanticoagulation"},{"annotation": "Treatment","text": "acenocoumarol"},{"annotation": "Treatment.Drug","text": "acenocoumarol"},{"annotation": "Treatment.Dosage","text": "first"},{"annotation": "Treatment.Duration","text": "thromboembolic episode"},{"annotation": "Treatment.Disorder","text": "thromboembolic episode"},{"annotation": "Treatment.Drug","text": "acenocoumarol"}]}
 {"id": "3708949_2","context": "A patient with acute changes suggesting acute hepatitis after parenteral amiodarone administration is described.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "parenteral amiodarone administration"},{"annotation": "Treatment", "text": "parenteral amiodarone"},{"annotation": "Treatment.Drug", "text": "amiodarone"},{"annotation": "Effect", "text": "acute hepatitis"},{"annotation": "Subject", "text": "a patient"},{"annotation": "Subject.Age", "text": "acute changes"}]}]}
 {"id": "18364401_4","context": "Subsequently, he developed hyperglycemia (fasting blood glucose 138 mg/dL) that resolved when olanzapine was stopped and recurred (fasting blood glucose 150 mg/dL) after 2 days of rechallenge with olanzapine 2.5 mg twice daily.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "hyperglycemia"},{"annotation": "Treatment","text": "olanzapine"},{"annotation": "Treatment.Drug","text": "olanzapine"},{"annotation": "Treatment.Drug","text": "stopped"},{"annotation": "Treatment.Drug","text": "rechallenge"},{"annotation": "Treatment.Drug","text": "rechallenge"},{"annotation": "Treatment.Drug","text": "2.5 mg twice daily"},{"annotation": "Treatment.Disorder","text": "hyperglycemia"},{"annotation": "Treatment.Disorder","text": "fasting blood glucose"},{"annotation": "Treatment.Disorder","text": "138 mg/dL"},{"annotation": "Treatment.Disorder","text": "fasting blood glucose"},{"annotation": "Treatment.Disorder","text": "150 mg/dL"},{"annotation": "Subject","text": "he"},{"annotation": "Subject.Disorder","text": "hyperglycemia"}]}
 {"id": "8151270_1","context": "Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "fulminant hepatitis"},{"annotation": "Effect","text": "severe lactate acidosis"},{"annotation": "Treatment","text": "didanosine therapy"},{"annotation": "Treatment.Disorder","text": "HIV infection"},{"annotation": "Treatment.Drug","text": "didanosine"},{"annotation": "Effect.Severity","text": "severe"}]}]
 {"id": "18425523_4","context": "Persistent ocular hypertension following intravitreal ranibizumab.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "intravitreal ranibizumab"},{"annotation": "Effect", "text": "ocular hypertension"},{"annotation": "Treatment", "text": "intravitreal ranibizumab"},{"annotation": "Treatment.Drug", "text": "ranibizumab"},{"annotation": "Treatment.Dosage", "text": "intravitreal"}]}]}
 {"id": "14968106_4","context": "STUDY DESIGN: Case report of a 31-year-old woman who presented with toxic myelopathy due to intrathecal administration of doxorubicin.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "intrathecal administration of doxorubicin"},{"annotation": "Treatment.Drug","text": "doxorubicin"},{"annotation": "Treatment.Disorder","text": "toxic myelopathy"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "intrathecal"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Combination","text": "not specified"}],"subject": {"Age": "31","Gender": "female","Population": "1","Race": "not specified","Disorder": "toxic myelopathy"}}
 {"id": "18166746_4","context": "The patient had a background of obsessive compulsive disorder treated with paroxetine.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Treatment", "text": "paroxetine"},{"annotation": "Treatment.Drug", "text": "paroxetine"},{"annotation": "Treatment.Disorder", "text": "obsessive compulsive disorder"},{"annotation": "Subject", "text": "the patient"},{"annotation": "Subject.Disorder", "text": "obsessive compulsive disorder"}]}]}
 {"id": "9704170_2","context": "Clozapine is speculated to cause rhabdomyolysis in patients with defective calcium-activated K+ channels.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "cause"},{"annotation": "Treatment","text": "clozapine"},{"annotation": "Treatment.Drug","text": "clozapine"},{"annotation": "Treatment.Disorder","text": "defective calcium-activated K+ channels"},{"annotation": "Treatment.Drug","text": "clozapine"},{"annotation": "Treatment.Disorder","text": "rhabdomyolysis"},{"annotation": "Attribute Attributes","annotation": "speculated","text": "speculated"}]}
 {"id": "11485141_2","context": "CONCLUSIONS: We report the first case of gemcitabine-induced LABD.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "LABD"},{"annotation": "Treatment","text": "gemcitabine"}]}]}
 {"id": "10752888_1","context": "Nitrofurantoin-induced lung disease: two cases demonstrating resolution of apparently irreversible CT abnormalities.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "lung disease"},{"annotation": "Treatment", "text": "nitrofurantoin"},{"annotation": "Treatment.Drug", "text": "nitrofurantoin"},{"annotation": "Treatment.Duration", "text": "two cases"},{"annotation": "Treatment.Effect", "text": "resolution of apparently irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of nitrofurantoin-induced lung disease"},{"annotation": "Treatment.Effect", "text": "resolution of irreversible CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of CT abnormalities"},{"annotation": "Treatment.Effect", "text": "resolution of lung disease"},{"annotation": "Treatment
 {"id": "2012922_2","context": "Trazodone-induced transient hypomanic symptoms and their management.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "hypomanic symptoms"},{"annotation": "Treatment", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "2 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "4 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "8 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "12 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "16 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "20 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "24 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "28 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "32 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "36 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "40 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "44 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "48 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "52 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "56 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "60 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "64 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "68 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "72 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "76 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "80 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "84 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "88 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "92 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "96 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "100 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "104 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "108 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "112 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "116 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "120 weeks"},{"annotation": "Effect", "text": "resolution of symptoms"},{"annotation": "Treatment", "text": "medication and psychotherapy"},{"annotation": "Treatment.Drug", "text": "trazodone"},{"annotation": "Treatment.Drug", "text": "placebo"},{"annotation": "Treatment.Duration", "text": "124 weeks"},{"annotation": "Treatment", "text": "pharmacotherapy and
 {"id":"2219619_1","context":"Acute aluminum toxicity after continuous intravesical alum irrigation for hemorrhagic cystitis.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"acute"},{"annotation":"Effect","text":"toxicity"},{"annotation":"Treatment","text":"continuous intravesical alum irrigation for hemorrhagic cystitis"},{"annotation":"Treatment.Drug","text":"alum"},{"annotation":"Treatment.Dosage","text":"continuous"},{"annotation":"Treatment.Duration","text":"intravesical"},{"annotation":"Treatment.Route","text":"irrigation"},{"annotation":"Treatment.Duration","text":"for hemorrhagic cystitis"},{"annotation":"Subject","text":"a patient"},{"annotation":"Subject.Disorder","text":"hemorrhagic cystitis"}]}]}
 {"id": "18076602_1","context": "Amphotericin B-induced cutaneous leucocytoclastic vasculitis: case report.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "cutaneous leucocytoclastic vasculitis"},{"annotation": "Treatment","text": "Amphotericin B"},{"annotation": "Treatment.Drug","text": "Amphotericin B"}]}]}
 {"id": "8726608_5","context": "When measured, the serum lithium level had increased 4-fold during acyclovir therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "increased"},{"annotation": "Treatment","text": "acyclovir therapy"},{"annotation": "Treatment.Drug","text": "acyclovir"},{"annotation": "Treatment.Dosage","text": "4-fold"},{"annotation": "Effect","text": "serum lithium level increase"},{"annotation": "Subject","text": "not specified"},{"annotation": "Subject.Disorder","text": "not specified"}]}
 {"id": "17504225_3","context": "In this paper it is reported an evidence of pharmacokinetic interaction between clarithromycin and sirolimus in a kidney transplanted woman, suffering from pulmonary infection sustained by a bacterial pathogen, in particular Hemophilus Influenzae.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "pharmacokinetic interaction"},{"annotation": "Effect","text": "pulmonary infection sustained by a bacterial pathogen"},{"annotation": "Treatment","text": "clarithromycin and sirolimus"},{"annotation": "Treatment.Disorder","text": "kidney transplanted woman"},{"annotation": "Treatment.Drug","text": "clarithromycin"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Combination.Trigger","text": "in particular Hemophilus Influenzae"},{"annotation": "Treatment.Combination.Drug","text": "clarithromycin"},{"annotation": "Treatment.Combination.Drug","text": "sirolimus"},{"annotation": "Subject","text": "kidney transplanted woman"},{"annotation": "Subject.Disorder","text": "kidney transplanted woman"}]}
 {"id": "12847760_1","context": "A 25-year-old man with a history of mid-borderline (BB) Hansen's disease developing a reversal reaction after starting dapsone and rifampin therapy is presented.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Treatment", "text": "dapsone and rifampin therapy"},{"annotation": "Treatment.Drug", "text": "dapsone"},{"annotation": "Treatment.Drug", "text": "rifampin"},{"annotation": "Effect", "text": "reversal reaction"},{"annotation": "Treatment.Disorder", "text": "Hansen's disease"},{"annotation": "Subject", "text": "a 25-year-old man"},{"annotation": "Subject.Disorder", "text": "mid-borderline (BB) Hansen's disease"}]}]
 {"id": "15516308_15","context": "In all cases, drugs in addition to quetiapine were detected, but in cases #1 and #2, the cause of death was considered to be a quetiapine overdose and the other drugs were not considered to be contributory.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "overdose"},{"annotation": "Effect","text": "death"},{"annotation": "Treatment","text": "quetiapine"},{"annotation": "Treatment.Drug","text": "quetiapine"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "overdose"},{"annotation": "Effect","text": "death"},{"annotation": "Treatment","text": "quetiapine"},{"annotation": "Treatment.Drug","text": "quetiapine"},{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "true"}],{"annotation": "Attribute Attributes","annotations": [{
 {"id": "17275666_4","context": "Similar to antiarrhythmic drugs aggravating particular arrhythmias, antiepileptic drugs can paradoxically induce new seizure types or exacerbate existing ones.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "seizure types or exacerbate existing ones"},{"annotation": "Treatment","text": "antiepileptic drugs"},{"annotation": "Treatment.Disorder","text": "seizure"}]}]}
 {"id": "16192734_3","context": "We report here a rare case of ritodrine-hydrochloride-induced rhabdomyolysis in a pregnant patient with myotonic dystrophy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "ritodrine-hydrochloride"},{"annotation": "Treatment.Drug","text": "ritodrine-hydrochloride"},{"annotation": "Effect","text": "rhabdomyolysis"},{"annotation": "Treatment.Disorder","text": "myotonic dystrophy"}]}]
 {"id": "7748076_2","context": "OBJECTIVE: To report the finding of squamous metaplasia within endometrial glands occurring as a result of progestin therapy of hyperplasia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "progestin therapy of hyperplasia"},{"annotation": "Effect","text": "squamous metaplasia within endometrial glands"},{"annotation": "Treatment","text": "progestin therapy"},{"annotation": "Treatment.Drug","text": "progestin"},{"annotation": "Treatment.Disorder","text": "hyperplasia"},{"annotation": "Treatment.Disorder","text": "endometrial glands"},{"annotation": "Treatment.Disorder","text": "squamous metaplasia"}]}
 {"id": "9007910_8","context": "IMPLICATIONS FOR NURSING PRACTICE: Nurses must understand the pharmacology, mechanism of action, clinical presentation, potentially lethal risks, and traumatic psychosocial stresses experienced by DPD-deficient patients with cancer receiving 5-FU therapy in order to develop timely interventions and alternative plans of care.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "receiving 5-FU therapy"},{"annotation": "Disorder","text": "DPD-deficient patients with cancer"},{"annotation": "Effect","text": "traumatic psychosocial stresses"},{"annotation": "Treatment","text": "5-FU therapy"},{"annotation": "Treatment.Drug","text": "5-FU"}],"severity": "high"}],"attributes": [{"attribute": "negated","text": "false"},{"attribute": "speculated","text": "false"},{"attribute": "severity","text": "high"}],"subject": {"age": "unknown","gender": "unknown","population": "DPD-deficient patients with cancer","race": "unknown","disorder": "DPD-deficient patients with cancer"}}
 {"id": "8912599_2","context": "Methotrexate is an effective but potentially toxic treatment for psoriasis.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Effect","text": "effective"},{"annotation": "Treatment","text": "methotrexate"},{"annotation": "Disorder","text": "psoriasis"}]}]}
 {"id": "18203308_3","context": "Typical symptoms of active Crohn's disease occurred 11, 12, and 26 months after start of etanercept therapy, respectively.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurred"},{"annotation": "Effect","text": "typical symptoms of active Crohn's disease"},{"annotation": "Treatment","text": "etanercept therapy"},{"annotation": "Treatment.Disorder","text": "Crohn's disease"},{"annotation": "Treatment.Drug","text": "etanercept"},{"annotation": "Treatment.Time_elapsed","text": "11 months","type": "integer"},{"annotation": "Treatment.Time_elapsed","text": "12 months","type": "integer"},{"annotation": "Treatment.Time_elapsed","text": "26 months","type": "integer"}]}
 {"id": "53128_3","context": "This progressed to tracheal compression with stridor after he had taken some aspirin for relief of the neck pain.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "aspirin"},{"annotation": "Effect","text": "tracheal compression with stridor"},{"annotation": "Treatment","text": "aspirin"},{"annotation": "Treatment.Drug","text": "aspirin"}]}]
 {"id": "9533061_2","context": "OBJECTIVE: To report a case of toxin-positive Clostridium difficile-induced colitis (CDIC) after use of clindamycin phosphate vaginal cream.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "clindamycin phosphate vaginal cream"},{"annotation": "Treatment.Drug","text": "clindamycin phosphate"},{"annotation": "Effect","text": "colitis"},{"annotation": "Treatment.Disorder","text": "Clostridium difficile-induced colitis"},{"annotation": "Treatment.Drug","text": "toxin-positive"}]}]
 {"id": "20234160_1","context": "Severe vancomycin-induced anaphylactic reaction.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"}, {"annotation": "Effect", "text": "anaphylactic reaction"}, {"annotation": "Treatment", "text": "vancomycin"}, {"annotation": "Treatment.Drug", "text": "vancomycin"}, {"annotation": "Attribute", "text": "negated", "severity": "high"}, {"annotation": "Attribute", "text": "speculated", "severity": "low"}]},{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "vancomycin"}, {"annotation": "Treatment.Disorder", "text": "vancomycin-induced anaphylactic reaction"}, {"annotation": "Treatment.Drug", "text": "vancomycin"}]}]}
 {"id": "8876616_2","context": "We report the case of a 74-year-old female patient who received the antidepressant amitriptyline because of a major depression.","events": [{"type": "Administration","annotations": [{"annotation": "Treatment","text": "amitriptyline"},{"annotation": "Treatment.Drug","text": "amitriptyline"},{"annotation": "Treatment.Disorder","text": "major depression"},{"annotation": "Subject","text": "74-year-old female patient"}]}]
 {"id": "16192734_2","context": "Rhabdomyolysis has been recognized as a complication of tocolytic therapy with ritodrine hydrochloride.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "complication"},{"annotation": "Treatment","text": "ritodrine hydrochloride"},{"annotation": "Treatment.Drug","text": "ritodrine hydrochloride"},{"annotation": "Effect","text": "rhabdomyolysis"},{"annotation": "Treatment.Disorder","text": "tocolytic therapy"}]}]
 {"id": "18628507_5","context": "Voriconazole (VRC) has not previously been reported to cause angio-oedema.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "VRC"}, {"annotation": "Effect", "text": "angio-oedema"}, {"annotation": "Treatment", "text": "voriconazole"}, {"annotation": "Treatment.Drug", "text": "voriconazole"}, {"annotation": "Attribute", "text": "negated", "severity": "low"}, {"annotation": "Attribute", "text": "negated", "severity": "low"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "VRC"}, {"annotation": "Effect", "text": "angio-oedema"}, {"annotation": "Treatment", "text": "voriconazole"}, {"annotation": "Treatment.Drug", "text": "voriconazole"}, {"annotation": "Attribute", "text": "speculated", "severity": "high"}, {"annotation": "Attribute", "text": "speculated", "severity": "high"}]}]}
 {"id": "12477460_3","context": "CONCLUSION: Tamoxifen may cause malignant transformation of endometriosis through atypical endometriosis even in the postmenopausal state.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "caused"},{"annotation": "Effect","text": "malignant transformation"},{"annotation": "Treatment","text": "tamoxifen"},{"annotation": "Treatment.Disorder","text": "endometriosis"},{"annotation": "Treatment.Drug","text": "tamoxifen"},{"annotation": "Treatment.Drug","text": "atypical"},{"annotation": "Treatment.Drug","text": "postmenopausal"},{"annotation": "Treatment.Drug","text": "endometriosis"},{"annotation": "Treatment.Drug","text": "malignant transformation"},{"annotation": "Treatment.Drug","text": "endometriosis"},{"annotation": "Treatment.Drug","text": "tamoxifen"}]}
 {"id": "10573314_5","context": "One patient had an episode of prostatitis, which was treated with levofloxacin immediately prior to tolterodine initiation.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "prostatitis"},{"annotation": "Effect", "text": "prostatitis"},{"annotation": "Treatment", "text": "levofloxacin"},{"annotation": "Treatment.Drug", "text": "levofloxacin"},{"annotation": "Treatment.Drug", "text": "tolterodine"},{"annotation": "Treatment.Drug", "text": "levofloxacin"},{"annotation": "Treatment.Dosage", "text": "immediately prior to"},{"annotation": "Treatment.Duration", "text": "tolterodine initiation"}]}]
 {"id": "16393774_5","context": "The first patient developed a monoarthritis 2 weeks after initiation of IFN-beta, which persisted during the 14 months of therapy and resolved with discontinuation of the medication.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "initiation of IFN-beta"},{"annotation": "Effect","text": "monoarthritis"},{"annotation": "Treatment","text": "IFN-beta"},{"annotation": "Treatment.Drug","text": "IFN-beta"},{"annotation": "Treatment.Duration","text": "14 months"},{"annotation": "Treatment.Outcome","text": "resolved with discontinuation of medication"},{"annotation": "Treatment.Disorder","text": "monoarthritis"}],"subject": {"id": "16393774","name": "patient","age": "unknown","gender": "unknown","population": "1","race": "unknown","disorder": "unknown"}}
 {"id": "10682234_9","context": "The present report illustrates a rare case of refractory akathisia after interferon-alpha treatment and also that levodopa treatment would be theoretically and practically useful in reducing the neurotoxicity associated with interferon-alpha.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "interferon-alpha treatment"},{"annotation": "Effect","text": "refractory akathisia"},{"annotation": "Treatment","text": "levodopa"},{"annotation": "Treatment.Disorder","text": "interferon-alpha treatment"},{"annotation": "Treatment.Drug","text": "levodopa"}],{"type": "Theoretical_Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "refractory akathisia"},{"annotation": "Treatment","text": "levodopa"},{"annotation": "Treatment.Disorder","text": "interferon-alpha treatment"},{"annotation": "Treatment.Drug","text": "levodopa"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "refractory akathisia"},{"annotation": "Treatment","text": "levodopa"},{"annotation": "Treatment.Disorder","text": "interferon-alpha treatment"},{"annotation": "Treatment.Drug","text": "levodopa"}]}
 {"id": "18837734_1","context": "Rosaceiform eruption induced by erlotinib.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "erlotinib"},{"annotation": "Treatment.Drug","text": "erlotinib"},{"annotation": "Effect","text": "rosaceiform eruption"},{"annotation": "Treatment.Disorder","text": "none"},{"annotation": "Subject","text": "patient"}]}
 {"id": "6697887_2","context": "The incidence of oral-verapamil-induced hypotension in the presence of concomitant beta-adrenergic blockade by the oral route is quite rare.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "oral-verapamil"},{"annotation": "Treatment.Drug","text": "verapamil"},{"annotation": "Effect","text": "hypotension"},{"annotation": "Treatment.Combination","text": "oral-verapamil"},{"annotation": "Treatment.Combination.Drug","text": "beta-adrenergic blockers"},{"annotation": "Treatment.Combination.Drug","text": "oral route"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "beta-adrenergic blockers"},{"annotation": "Treatment.Combination.Drug","text": "oral route"}]}
 {"id": "8726608_4","context": "Until additional data are available, if intravenous acyclovir is administered concurrently with lithium, we recommend closely monitoring patients for signs of lithium toxicity and measuring serum lithium levels every second or third day.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "administered concurrently with lithium"},{"annotation": "Effect","text": "lithium toxicity"},{"annotation": "Treatment","text": "intravenous acyclovir"},{"annotation": "Treatment.Drug","text": "lithium"},{"annotation": "Treatment.Combination","text": "intravenous acyclovir"},{"annotation": "Treatment.Combination","text": "lithium"},{"annotation": "Attribute","text": "negated","severity": "low"}]}
 {"id": "11283125_9","context": "Disappointingly, with the dose schedule used in this protocol, HD Ara-C added to HD MTX, although well tolerated, failed to further decrease the incidence of CNS relapse or to improve the overall DFS.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "added"},{"annotation": "Treatment","text": "HD Ara-C added to HD MTX"},{"annotation": "Treatment.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "although well tolerated"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Trigger","text": "failed"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "HD Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treat
 {"id": "3732375_1","context": "Theophylline intoxication following viloxazine induced decrease in clearance.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "intoxication"},{"annotation": "Treatment","text": "viloxazine"},{"annotation": "Treatment.Drug","text": "theophylline"},{"annotation": "Treatment.Drug","text": "viloxazine"},{"annotation": "Treatment.Disorder","text": "clearance decrease"}]}
 {"id": "11197767_3","context": "Cercarial encystment at concentrations of 25000 microg/l or higher was significantly impaired by all test metals; however, at lower concentrations only zinc demonstrated toxicity.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "cercarial encystment"},{"annotation": "Treatment","text": "metals"},{"annotation": "Treatment.Drug","text": "zinc"},{"annotation": "Effect","text": "toxicity"},{"annotation": "Treatment.Drug","text": "metals"},{"annotation": "Treatment.Drug","text": "zinc"},{"annotation": "Treatment.Drug","text": "metals"},{"annotation": "Treatment.Drug","text": "zinc"},{"annotation": "Treatment.Drug","text": "metals"},{"annotation": "Treatment.Drug","text": "zinc"}]}
 {"id": "12504711_3","context": "PURPOSE: We report an unusual paradoxical effect of brimonidine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "paradoxical effect"},{"annotation": "Treatment","text": "brimonidine"},{"annotation": "Treatment.Drug","text": "brimonidine"},{"annotation": "Effect","text": "paradoxical effect"}]}]
 {"id": "17387702_1","context": "Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "high-dose methotrexate"},{"annotation": "Effect", "text": "renal failure"},{"annotation": "Treatment", "text": "methotrexate"},{"annotation": "Treatment.Drug", "text": "methotrexate"},{"annotation": "Treatment.Dosage", "text": "high-dose"},{"annotation": "Treatment.Frequency", "text": "single dose"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Time_elapsed", "text": "unknown"},{"annotation": "Treatment.Duration", "text": "unknown"},{"annotation": "Treatment.Disorder", "text": "renal failure"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute.attribute", "text": "none"}]}]}
 {"id": "19131789_2","context": "Although his renal function recovered completely with high-dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of renal toxicity may be present as early as 2 hours after the completion of a 4-hour MTX infusion, and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4-hour MTX infusion.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "completion of 4-hour MTX infusion"},{"annotation": "Treatment", "text": "high-dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2"},{"annotation": "Treatment.Drug", "text": "MTX"},{"annotation": "Treatment.Drug", "text": "leucovorin"},{"annotation": "Treatment.Drug", "text": "hemodialysis"},{"annotation": "Treatment.Drug", "text": "charcoal hemoperfusion"},{"annotation": "Treatment.Drug", "text": "carboxypeptidase G2"},{"annotation": "Effect", "text": "renal toxicity"},{"annotation": "Treatment.Drug", "text": "MTX"},{"annotation": "Treatment.Duration", "text": "4 hours"},{"annotation": "Treatment.Time_elapsed", "text": "2 hours"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "speculated"},{"annotation": "Attribute Attributes", "text": "severity"},{"annotation": "Attribute Attributes", "text": "negated"},{"annotation": "Attribute Attributes", "text": "speculated"},{"annotation": "Attribute Attributes", "text": "severity"}]}]}
 {"id": "10646879_2","context": "Ten to 15% of patients treated with ifosfamide develop an encephalopathy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "develop"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment","text": "ifosfamide"}]}]}
 {"id": "11352235_3","context": "METHODS: We queried 35 rheumatologists at the Robert Breck Brigham Arthritis Center to determine if weight loss had occurred as an adverse event in patients treated with leflunomide between November 1998 and January 2000.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "weight loss"},{"annotation": "Treatment","text": "leflunomide"},{"annotation": "Treatment.Disorder","text": "arthritis"},{"annotation": "Treatment.Drug","text": "leflunomide"}]}]}
 {"id": "681921_3","context": "This is the first report of a catatonic syndrome occurring in a patient receiving disulfiram treatment.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "occurring"},{"annotation": "Treatment", "text": "disulfiram treatment"},{"annotation": "Treatment.Drug", "text": "disulfiram"},{"annotation": "Effect", "text": "catatonic syndrome"},{"annotation": "Treatment.Duration", "text": "first report"},{"annotation": "Treatment.Disorder", "text": "catatonic syndrome"},{"annotation": "Treatment.Drug", "text": "disulfiram"},{"annotation": "Subject", "text": "patient"},{"annotation": "Subject.Disorder", "text": "catatonic syndrome"}]}]}
 {"id": "11096051_2","context": "Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "high-flux hemodiafiltration"},{"annotation": "Treatment.Drug","text": "vancomycin"},{"annotation": "Treatment.Disorder","text": "vancomycin toxicity"},{"annotation": "Treatment.Drug","text": "phosphorus"},{"annotation": "Treatment.Drug","text": "dialysate"},{"annotation": "Treatment.Combination.Trigger","text": "versus"},{"annotation": "Treatment.Combination.Drug","text": "phosphorus"},{"annotation": "Treatment.Combination.Drug","text": "dialysate"},{"annotation": "Subject","text": "patient"},{"annotation": "Subject.Disorder","text": "vancomycin toxicity"}]}
 {"id": "18569796_4","context": "Two weeks following rechallenge with alendronate sodium resulted in recurrence of his scleritis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "rechallenge"},{"annotation": "Treatment","text": "alendronate sodium"},{"annotation": "Treatment.Drug","text": "alendronate sodium"},{"annotation": "Effect","text": "scleritis"},{"annotation": "Treatment.Duration","text": "two weeks"}]}]
 {"id": "16901609_2","context": "We believe this is the first report of intrathecal diamorphine causing anaphylaxis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intrathecal diamorphine"},{"annotation": "Effect","text": "anaphylaxis"}]}]}
 {"id": "15811174_2","context": "Clearance rates of cerivastatin metabolites in a patient with cerivastatin-induced rhabdomyolysis.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"}, {"annotation": "Effect", "text": "rhabdomyolysis"}, {"annotation": "Treatment", "text": "cerivastatin"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Subject", "text": "a patient"}, {"annotation": "Subject.Age", "text": "unknown"}, {"annotation": "Subject.Gender", "text": "unknown"}, {"annotation": "Subject.Population", "text": "1"}, {"annotation": "Subject.Race", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Drug", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "cerivastatin-induced rhabdomyolysis"}, {"annotation": "Treatment.Drug", "text": "cerivastatin"},
 {"id": "18505911_13","context": "This case report and several others point toward azathioprine as a clinically significant inducer of warfarin resistance.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "azathioprine"},{"annotation": "Treatment.Disorder","text": "warfarin resistance"}]}]}
 {"id": "18569796_3","context": "PURPOSE: To report a case of nodular scleritis following alendronate sodium.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "following"},{"annotation": "Treatment","text": "alendronate sodium"},{"annotation": "Treatment.Drug","text": "alendronate sodium"},{"annotation": "Effect","text": "nodular scleritis"},{"annotation": "Treatment.Disorder","text": "nodular scleritis"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Age","text": "not specified"},{"annotation": "Subject.Gender","text": "not specified"},{"annotation": "Subject.Population","text": "not specified"},{"annotation": "Subject.Race","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "nodular scleritis"}]}
 {"id": "12869178_2","context": "Most cardiac surgical patients have had previous exposure to heparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing heparin-induced thrombocytopenia (HIT) postoperatively.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developing"},{"annotation": "Effect","text": "HIT"},{"annotation": "Treatment","text": "previous exposure to heparin"},{"annotation": "Treatment.Drug","text": "heparin"},{"annotation": "Treatment.Indication","text": "diagnostic or therapeutic interventions"},{"annotation": "Subject","text": "cardiac surgical patients"},{"annotation": "Subject.Population","text": "most"},{"annotation": "Treatment.Duration","text": "postoperatively"}]}
 {"id": "7485371_2","context": "PURPOSE: We studied a case of vortex keratopathy that was associated with the use of atovaquone.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated"},{"annotation": "Treatment","text": "atovaquone"},{"annotation": "Treatment.Drug","text": "atovaquone"},{"annotation": "Effect","text": "vortex keratopathy"},{"annotation": "Treatment.Disorder","text": "vortex keratopathy"}],"subject": {"age": "unknown","gender": "unknown","population": "1","race": "unknown","disorder": "unknown"}}
 {"id": "16216617_2","context": "While on a maximal dose of phenylephrine she developed prominent positive U waves, which disappeared with the cessation of the drug.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "prominent positive U waves"},{"annotation": "Treatment","text": "phenylephrine"},{"annotation": "Treatment.Drug","text": "phenylephrine"},{"annotation": "Effect","text": "prominent positive U waves"},{"annotation": "Treatment.Drug","text": "phenylephrine"}]}]
 {"id": "18751717_4","context": "RESULTS: Two patients with ocular inflammation of unknown origin developed severe chorioretinitis after IVTA injection.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "IVTA injection"},{"annotation": "Effect", "text": "ocular inflammation"},{"annotation": "Treatment", "text": "IVTA injection"},{"annotation": "Treatment.Disorder", "text": "unknown origin"},{"annotation": "Treatment.Drug", "text": "IVTA"},{"annotation": "Treatment.Dosage", "text": "unknown"},{"annotation": "Treatment.Frequency", "text": "unknown"},{"annotation": "Treatment.Route", "text": "unknown"},{"annotation": "Treatment.Time_elapsed", "text": "unknown"},{"annotation": "Treatment.Duration", "text": "unknown"},{"annotation": "Effect", "text": "severe chorioretinitis"}]}]
 {"id": "1695794_5","context": "Disopyramide was started on admission for supraventricular tachycardia.","events": [{"type": "Treatment","annotations": [{"annotation": "Drug", "text": "disopyramide"},{"annotation": "Treatment.Dosage", "text": "started"},{"annotation": "Treatment.Frequency", "text": "on admission"},{"annotation": "Treatment.Route", "text": "for supraventricular tachycardia"}]}]}
 {"id": "10759907_1","context": "A 50-year-old woman with a history of migraine without aura, predominantly occurring around her menstrual periods, developed a spinal cord lesion following the use of zolmitriptan.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "following the use of zolmitriptan"},{"annotation": "Effect","text": "spinal cord lesion"},{"annotation": "Treatment","text": "zolmitriptan"},{"annotation": "Treatment.Disorder","text": "migraine"},{"annotation": "Treatment.Drug","text": "zolmitriptan"},{"annotation": "Subject","text": "a 50-year-old woman"},{"annotation": "Subject.Age","text": "50"},{"annotation": "Subject.Disorder","text": "migraine"}]}
 {"id": "19754002_3","context": "The skin rash effect was most probably due, in first line, to olanzapine, but the cutaneous skin condition was triggered and aggravated by pravastatin, a 3-hydoxy-3-methylglutaryl-coenzyme A-(HMG-CoA)-reductase inhibitor, and lithium medication.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "olanzapine"},{"annotation": "Treatment","text": "olanzapine"},{"annotation": "Treatment.Drug","text": "olanzapine"},{"annotation": "Treatment.Drug","text": "pravastatin"},{"annotation": "Treatment.Drug","text": "lithium"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "pravastatin"},{"annotation": "Treatment.Combination.Drug","text": "lithium"},{"annotation": "Effect","text": "skin rash"}]}
 {"id": "7639655_2","context": "CONCLUSION: Anterior ischemic optic neuropathy may complicate treatment with interferon alfa.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "complicated"},{"annotation": "Effect", "text": "anterior ischemic optic neuropathy"},{"annotation": "Treatment", "text": "interferon alfa"},{"annotation": "Treatment.Disorder", "text": "anterior ischemic optic neuropathy"},{"annotation": "Treatment.Drug", "text": "interferon alfa"},{"annotation": "Treatment.Duration", "text": "treatment"},{"annotation": "Treatment.Duration", "text": "duration"},{"annotation": "Subject", "text": "anterior ischemic optic neuropathy"},{"annotation": "Subject.Disorder", "text": "anterior ischemic optic neuropathy"}],"negated": true}]}
 {"id": "14742791_2","context": "After 5 weeks of therapy, she stopped taking pantoprazole due to general malaise.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "stopped taking pantoprazole"},{"annotation": "Effect", "text": "general malaise"},{"annotation": "Treatment", "text": "pantoprazole"},{"annotation": "Treatment.Drug", "text": "pantoprazole"},{"annotation": "Treatment.Duration", "text": "5 weeks"},{"annotation": "Treatment.Dosage", "text": "not specified"},{"annotation": "Treatment.Frequency", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "5 weeks"},{"annotation": "Treatment.Disorder", "text": "not specified"},{"annotation": "Subject", "text": "she"},{"annotation": "Subject.Age", "text": "not specified"},{"annotation": "Subject.Gender", "text": "not specified"},{"annotation": "Subject.Population", "text": "not specified"},{"annotation": "Subject.Race", "text": "not specified"},{"annotation": "Subject.Disorder", "text": "not specified"}]}
 {"id": "9865241_5","context": "We report the use of pamidronate for acute, severe hypercalcemia secondary to iatrogenic vitamin D poisoning.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "hypercalcemia"},{"annotation": "Treatment", "text": "pamidronate"},{"annotation": "Treatment.Disorder", "text": "hypercalcemia"},{"annotation": "Treatment.Drug", "text": "pamidronate"},{"annotation": "Treatment.Duration", "text": "acute"},{"annotation": "Treatment.Dosage", "text": "severe"},{"annotation": "Treatment.Route", "text": "intravenous"},{"annotation": "Treatment.Side_effect", "text": "none"},{"annotation": "Treatment.Drug_induced", "text": "iatrogenic vitamin D poisoning"}]}]
 {"id": "11485141_1","context": "According to the Naranjo probability scale, the relationship of gemcitabine treatment with cutaneous eruption in our patient is possible.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "gemcitabine treatment"},{"annotation": "Effect","text": "cutaneous eruption"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "Naranjo probability scale"},{"annotation": "Treatment","text": "gemcitabine treatment"},{"annotation": "Treatment.Disorder","text": "none"},{"annotation": "Treatment.Drug","text": "gemcitabine"}]}]
 {"id": "18166746_3","context": "Methylene blue was administered to a 58-yr-old woman undergoing a parathyroidectomy under general anesthesia.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "methylene blue"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Dosage
 {"id": "7712052_3","context": "We describe two cases that illustrate the use of lithium in the treatment of veterans with PTSD who complained of serious problems with irritability or angry outbursts.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "PTSD"},{"annotation": "Treatment","text": "lithium"},{"annotation": "Treatment.Disorder","text": "PTSD"},{"annotation": "Treatment.Effect","text": "reduced irritability or angry outbursts"}]}]
 {"id": "15773973_2","context": "It is well-recognized that flucloxacillin may occasionally result in fatal hepatic injury.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "resulted in"},{"annotation": "Treatment", "text": "flucloxacillin"},{"annotation": "Treatment.Drug", "text": "flucloxacillin"},{"annotation": "Effect", "text": "fatal hepatic injury"},{"annotation": "Treatment.Disorder", "text": "none"},{"annotation": "Treatment.Route", "text": "none"},{"annotation": "Treatment.Dosage", "text": "none"},{"annotation": "Treatment.Frequency", "text": "none"},{"annotation": "Treatment.Time_elapsed", "text": "none"},{"annotation": "Treatment.Duration", "text": "none"},{"annotation": "negated", "text": "true"},{"annotation": "severity", "text": "high"}]}]
 {"id": "2943526_1","context": "Neurologic toxicity associated with hepatic artery infusion HAI of FUdR.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "hepatic artery infusion HAI"},{"annotation": "Treatment","text": "FUdR"},{"annotation": "Treatment.Drug","text": "FUdR"},{"annotation": "Effect","text": "neurologic toxicity"}]}]
 {"id": "3136101_1","context": "Hyperkalemia as a late side effect of prolonged adrenocorticotropic hormone therapy for infantile spasms.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "late"},{"annotation": "Treatment", "text": "prolonged adrenocorticotropic hormone therapy"},{"annotation": "Treatment.Disorder", "text": "infantile spasms"},{"annotation": "Treatment.Drug", "text": "adrenocorticotropic hormone"},{"annotation": "Effect", "text": "hyperkalemia"},{"annotation": "Subject", "text": "infantile spasms"},{"annotation": "Subject.Disorder", "text": "infantile spasms"}]}]}
 {"id": "10082597_1","context": "METHODS: We report two cases of pseudoporphyria caused by naproxen and oxaprozin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "caused by"},{"annotation": "Treatment","text": "naproxen and oxaprozin"},{"annotation": "Treatment.Drug","text": "naproxen"},{"annotation": "Treatment.Drug","text": "oxaprozin"},{"annotation": "Treatment.Disorder","text": "pseudoporphyria"}]}]
 {"id":"18505911_4","context":"She was treated with an average weekly warfarin dose of 39 mg (5.5 mg daily) prior to beginning azathioprine therapy.","events": [{"type": "Treatment","annotations": [{"annotation": "Drug","text": "warfarin"},{"annotation": "Dosage","text": "39 mg"},{"annotation": "Frequency","text": "weekly"},{"annotation": "Route","text": "oral"},{"annotation": "Time_elapsed","text": "prior"},{"annotation": "Duration","text": "azathioprine therapy"}]}]}
 {"id": "9279731_1","context": "When the disease recurred conventional amphotericin B was used again, but had to be stopped because of severe side effects.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Treatment", "text": "conventional amphotericin B"},{"annotation": "Treatment.Drug", "text": "conventional amphotericin B"},{"annotation": "Treatment.Dosage", "text": "not specified"},{"annotation": "Treatment.Frequency", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Disorder", "text": "not specified"},{"annotation": "Effect", "text": "severe side effects"},{"annotation": "negated", "text": "not specified"},{"annotation": "severity", "text": "high severity"}]}]}
 {"id": "3211830_2","context": "Widespread cutaneous vasculitis associated with diltiazem.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "associated with"},{"annotation": "Effect", "text": "vasculitis"},{"annotation": "Treatment", "text": "diltiazem"},{"annotation": "Treatment.Drug", "text": "diltiazem"},{"annotation": "Treatment.Disorder", "text": "vasculitis"},{"annotation": "Subject", "text": "widespread"},{"annotation": "Subject.Disorder", "text": "vasculitis"}]}]}
 {"id":"9726762_2","context":"The following describes a patient on a stable regimen of warfarin who developed severe hypoprothrombinemia and bleeding 4 weeks after starting gemfibrozil.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"developed"},{"annotation":"Effect","text":"severe hypoprothrombinemia and bleeding"},{"annotation":"Treatment","text":"warfarin"},{"annotation":"Treatment.Drug","text":"gemfibrozil"},{"annotation":"Treatment.Duration","text":"4 weeks"},{"annotation":"Treatment.Disorder","text":"hypoprothrombinemia"},{"annotation":"Treatment.Drug","text":"warfarin"},{"annotation":"Treatment.Drug","text":"gemfibrozil"},{"annotation":"Subject","text":"a patient"},{"annotation":"Subject.Disorder","text":"hypoprothrombinemia"}]}]}
 {"id": "15773973_3","context": "We report the case of a 40-year-old woman who developed fulminant hepatic failure and aplastic anaemia following a course of oral flucloxacillin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "oral flucloxacillin"},{"annotation": "Effect","text": "fulminant hepatic failure and aplastic anaemia"},{"annotation": "Treatment","text": "oral flucloxacillin"},{"annotation": "Treatment.Drug","text": "flucloxacillin"}],"subject": {"Age": "40","Gender": "woman"},"population": 1,"race": null,"disorder": null}
 {"id": "16697705_2","context": "This case highlights the possible development of acute coronary syndrome as a side effect of Capecitabine therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "Capecitabine therapy"},{"annotation": "Treatment","text": "Capecitabine"},{"annotation": "Treatment.Drug","text": "Capecitabine"},{"annotation": "Effect","text": "acute coronary syndrome"},{"annotation": "Treatment.Disorder","text": "acute coronary syndrome"}]}]
 {"id":"7212107_2","context":"These results indicate that lithium may cause biochemical hyperparathyroidism.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"indicate"},{"annotation":"Effect","text":"hyperparathyroidism"},{"annotation":"Treatment","text":"lithium"},{"annotation":"Treatment.Drug","text":"lithium"},{"annotation":"Treatment.Disorder","text":"biochemical hyperparathyroidism"}]},{"annotation":"Attribute Attributes","text":"negated","value":"false"}]]}
 {"id": "10579985_2","context": "The relationship between infliximab treatment and lymphoma in Crohn's disease.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "infliximab treatment"},{"annotation": "Effect", "text": "lymphoma"},{"annotation": "Treatment", "text": "infliximab"},{"annotation": "Treatment.Disorder", "text": "Crohn's disease"},{"annotation": "Treatment.Drug", "text": "infliximab"},{"annotation": "Treatment.Dosage", "text": "unknown"},{"annotation": "Treatment.Frequency", "text": "unknown"},{"annotation": "Treatment.Route", "text": "unknown"},{"annotation": "Treatment.Time_elapsed", "text": "unknown"},{"annotation": "Treatment.Duration", "text": "unknown"},{"annotation": "Treatment.Disorder", "text": "Crohn's disease"},{"annotation": "negated", "text": "unknown"},{"annotation": "severity", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "speculated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},{"annotation": "negated", "text": "unknown"},
 {"id": "15863610_7","context": "CONCLUSION: There may be an association between raloxifene and the development of malignant mixed mesodermal tumor.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "development"},{"annotation": "Treatment", "text": "raloxifene"},{"annotation": "Treatment.Disorder", "text": "malignant mixed mesodermal tumor"},{"annotation": "Attribute", "text": "association"},{"annotation": "Attribute.negated", "text": "not negated"},{"annotation": "Attribute.speculated", "text": "not speculated"},{"annotation": "Attribute.severity", "text": "low severity"},{"annotation": "Attribute.Attribute", "text": "not specified"}]}]}
 {"id": "19131789_3","context": "Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "therapy"},{"annotation": "Treatment","text": "methotrexate"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Effect","text": "renal toxicity"},{"annotation": "Treatment.Disorder","text": "high-dose methotrexate therapy"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Time_elapsed","text": "early recognition"},{"annotation": "Treatment.Duration","text": "high-dose methotrexate therapy"},{"annotation": "Subject","text": "renal toxicity"},{"annotation": "Subject.Disorder","text": "renal toxicity"}]}
 {"id": "8467620_2","context": "The mild immunosuppression that occurs with methotrexate therapy probably places patients with rheumatoid arthritis at added risk of developing lymphoproliferative diseases, but coincidence cannot be excluded.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurs"},{"annotation": "Treatment","text": "methotrexate therapy"},{"annotation": "Treatment.Disorder","text": "rheumatoid arthritis"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Side_effect","text": "immunosuppression"},{"annotation": "Treatment.Disorder","text": "lymphoproliferative diseases"},{"annotation": "Attribute","text": "probable"},{"annotation": "Attribute","text": "added risk"},{"annotation": "Attribute","text": "coincidence"}]}
 {"id": "14561622_2","context": "We attribute the clinical and radiographic findings to cytotoxic edema secondary to intrathecal methotrexate.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "secondary to intrathecal methotrexate"},{"annotation": "Effect","text": "cytotoxic edema"},{"annotation": "Treatment","text": "intrathecal methotrexate"},{"annotation": "Treatment.Disorder","text": "cytotoxic edema"}]}]}
 {"id": "16843118_2","context": "Morphine, an opium alkaloid, frequently causes side effects such as hyperhidrosis and facial flushing, but serious cutaneous adverse drug reactions are seldom observed.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "causes"},{"annotation": "Treatment","text": "morphine"},{"annotation": "Treatment.Drug","text": "morphine"},{"annotation": "Effect","text": "hyperhidrosis and facial flushing"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "
 {"id": "20465622_1","context": "Severe aphthous stomatitis associated with oral calcineurin and mTOR inhibitors.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with"},{"annotation": "Effect","text": "aphthous stomatitis"},{"annotation": "Treatment","text": "oral calcineurin and mTOR inhibitors"}]}]}
 {"id": "17619811_1","context": "A 79-year-old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of fatigue, myalgia, and leg weakness, shortly after starting treatment with colchicine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "starting treatment with colchicine"},{"annotation": "Effect","text": "fatigue, myalgia, and leg weakness"},{"annotation": "Treatment","text": "colchicine"},{"annotation": "Treatment.Disorder","text": "gout arthritis"},{"annotation": "Treatment.Drug","text": "colchicine"},{"annotation": "Subject","text": "a 79-year-old man"},{"annotation": "Subject.Age","text": "79"},{"annotation": "Subject.Gender","text": "not specified"},{"annotation": "Subject.Population","text": "1"},{"annotation": "Subject.Race","text": "not specified"},{"annotation": "Treatment.Duration","text": "shortly after starting treatment"}]}
 {"id": "17275666_6","context": "This report describes a case of paradoxical, intravenous valproic acid-induced seizure exacerbation in a child with juvenile absence epilepsy, documented by video-electroencephalography.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "seizure exacerbation"},{"annotation": "Treatment","text": "intravenous valproic acid"},{"annotation": "Treatment.Drug","text": "valproic acid"},{"annotation": "Treatment.Dosage","text": "intravenous"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "intravenous"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "juvenile absence epilepsy"},{"annotation": "Subject","text": "a child"},{"annotation": "Subject.Age","text": "child"},{"annotation": "Subject.Population","text": "1"},{"annotation": "Subject.Race","text": "not specified"},{"annotation": "Subject.Disorder","text": "juvenile absence epilepsy"}]}
 {"id": "18277922_1","context": "She was treated with acyclovir and subsequently developed VZV antigen-positive zoster.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "developed"},{"annotation": "Treatment", "text": "acyclovir"},{"annotation": "Effect", "text": "VZV antigen-positive zoster"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Disorder", "text": "VZV antigen-positive zoster"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Disorder", "text": "VZV antigen-positive zoster"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Duration", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Drug", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Duration", "text": "acyclovir"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Duration", "text": "subsequently"},{"annotation": "Treatment.Duration", "text": "subsequently"},
 {"id": "15857283_1","context": "CONCLUSIONS: In these 3 cases, the unique positive ocular finding was corneal endothelial deposits, which may be related to the use of rifabutin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "corneal endothelial deposits"},{"annotation": "Effect","text": "corneal endothelial deposits"},{"annotation": "Treatment","text": "rifabutin"},{"annotation": "Treatment.Drug","text": "rifabutin"}]}]}
 {"id": "7978578_1","context": "Response of a promethazine-induced coma to flumazenil.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "promethazine"},{"annotation": "Treatment.Drug","text": "promethazine"},{"annotation": "Effect","text": "coma"}]},{"type": "Potential_therapeutic_event","annotations": [{"annotation": "Trigger","text": "Response"},{"annotation": "Treatment","text": "flumazenil"},{"annotation": "Treatment.Disorder","text": "promethazine-induced coma"},{"annotation": "Treatment.Drug","text": "flumazenil"}]}]}
 {"id": "16978752_1","context": "First, a review of the literature produced 41 anecdotal cases of neutropenia or agranulocytosis during treatment with olanzapine (Zyprexa) reported in a total of 24 publications.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "treatment with olanzapine (Zyprexa)"},{"annotation": "Treatment","text": "olanzapine (Zyprexa)"},{"annotation": "Treatment.Drug","text": "olanzapine (Zyprexa)"},{"annotation": "Effect","text": "neutropenia or agranulocytosis"}]}]}
 {"id": "8250714_2","context": "Neurologic degeneration associated with nitrous oxide anesthesia in patients with vitamin B12 deficiency.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with nitrous oxide anesthesia"},{"annotation": "Treatment","text": "nitrous oxide anesthesia"},{"annotation": "Treatment.Drug","text": "nitrous oxide"},{"annotation": "Effect","text": "neurologic degeneration"},{"annotation": "Treatment.Disorder","text": "vitamin B12 deficiency"}]}]
 {"id": "1695794_3","context": "Previous therapy with antiarrhythmics had resulted in intolerable adverse effects or no effect on the arrhythmia.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "previous therapy"},{"annotation": "Treatment", "text": "antiarrhythmics"},{"annotation": "Treatment.Drug", "text": "antiarrhythmics"},{"annotation": "Effect", "text": "intolerable adverse effects or no effect on the arrhythmia"}]}]}
 {"id": "6239881_1","context": "Allergic contact dermatitis to compound tincture of benzoin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "contact"},{"annotation": "Treatment","text": "compound tincture of benzoin"},{"annotation": "Treatment.Drug","text": "benzoin"},{"annotation": "Effect","text": "dermatitis"}]}]}
 {"id": "8610807_3","context": "PURPOSE: To determine the cause of spontaneous choroidal hemorrhage in a 67-year-old man after a myocardial infarction and administration of tissue plasminogen activator.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "spontaneous choroidal hemorrhage"},{"annotation": "Effect","text": "hemorrhage"},{"annotation": "Treatment","text": "myocardial infarction and administration of tissue plasminogen activator"},{"annotation": "Treatment.Drug","text": "tissue plasminogen activator"},{"annotation": "Subject","text": "67-year-old man"},{"annotation": "Subject.Age","text": "67"}]}
 {"id": "23970584_4","context": "Forty-one days later, she developed severe iatrogenic Cushing's syndrome due to the drug-drug interaction between triamcinolone and her boosted protease inhibitor therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "severe iatrogenic Cushing's syndrome"},{"annotation": "Treatment","text": "drug-drug interaction between triamcinolone and her boosted protease inhibitor therapy"},{"annotation": "Treatment.Disorder","text": "Cushing's syndrome"},{"annotation": "Treatment.Drug","text": "triamcinolone"},{"annotation": "Treatment.Drug","text": "boosted protease inhibitor therapy"},{"annotation": "Treatment.Drug-Drug_Interaction.Trigger","text": "and"},{"annotation": "Treatment.Drug-Drug_Interaction.Drug","text": "triamcinolone"},{"annotation": "Treatment.Drug-Drug_Interaction.Drug","text": "boosted protease inhibitor therapy"},{"annotation": "Treatment.Duration","text": "forty-one days"},{"annotation": "Subject","text": "she"},{"annotation": "Subject.Disorder","text": "Cushing's syndrome"}]}
 {"id":"11341670_2","context":"Pheripheral edema was observed in five female patients after taking proton pump inhibitors omeprazole, lansoprazole, or pantoprazole for 7-15 days for peptic acid diseases in recommended standard doses.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "observed"},{"annotation": "Effect","text": "peripheral edema"},{"annotation": "Treatment","text": "proton pump inhibitors"},{"annotation": "Treatment.Drug","text": "omeprazole"},{"annotation": "Treatment.Drug","text": "lansoprazole"},{"annotation": "Treatment.Drug","text": "pantoprazole"},{"annotation": "Treatment.Duration","text": "7-15 days"},{"annotation": "Treatment.Dosage","text": "recommended standard doses"},{"annotation": "Subject","text": "five female patients"},{"annotation": "Subject.Population","text": "five female patients"}]}
 {"id": "18855892_5","context": "We report the case of a child with metastatic osteosarcoma, who experienced an anaphylactic/anaphylactoid reaction to methotrexate.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "methotrexate"},{"annotation": "Effect","text": "anaphylactic/anaphylactoid reaction"},{"annotation": "Treatment","text": "methotrexate"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Subject","text": "a child"},{"annotation": "Subject.Disorder","text": "metastatic osteosarcoma"}]}]}
 {"id": "17823522_5","context": "It is tempting to speculate that interferon alpha may be involved in the pathogenesis of lichen nitidus.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "interferon alpha"},{"annotation": "Treatment.Disorder","text": "lichen nitidus"},{"annotation": "Attribute","text": "speculated"}]}]}
 {"id": "18569796_1","context": "CONCLUSION: Alendronate led to nodular scleritis and rechallenge caused recurrence of scleritis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "led"},{"annotation": "Effect","text": "nodular scleritis"},{"annotation": "Treatment","text": "alendronate"},{"annotation": "Treatment.Drug","text": "alendronate"},{"annotation": "Treatment.Duration","text": "recurrence"},{"annotation": "Treatment.Rechallenge","text": "rechallenge"},{"annotation": "Treatment.Rechallenge.Drug","text": "alendronate"}]}
 {"id": "1469187_2","context": "A massive digitoxin (DGTX) intoxication in a 36-year-old man (35 mg DGTX) was treated by prolonged and repeated i.v.-infusions of Fab fragments of anti-digitalis antibodies (FAB).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "intoxication"},{"annotation": "Treatment", "text": "prolonged and repeated i.v.-infusions of Fab fragments of anti-digitalis antibodies (FAB)"},{"annotation": "Treatment.Drug", "text": "digitoxin (DGTX)"},{"annotation": "Treatment.Dosage", "text": "35 mg DGTX"},{"annotation": "Treatment.Route", "text": "i.v.-infusions"},{"annotation": "Treatment.Duration", "text": "prolonged and repeated"},{"annotation": "Effect", "text": "poisoning"},{"annotation": "Treatment.Drug", "text": "FAB"},{"annotation": "Treatment.Drug", "text": "anti-digitalis antibodies"}]}]
 {"id": "6788011_3","context": "Gold-salt therapy may result in damage to proximal tubules that leak renal tubular antigens, which in turn complex with autoantibody and produce an autoimmune membranous nephropathy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "resulted"},{"annotation": "Effect","text": "damage to proximal tubules"},{"annotation": "Effect","text": "leak renal tubular antigens"},{"annotation": "Effect","text": "produce an autoimmune membranous nephropathy"},{"annotation": "Treatment","text": "gold-salt therapy"},{"annotation": "Treatment.Disorder","text": "proximal tubular damage"}]}]
 {"id": "20199429_1","context": "Only two case reports of adults with allergic contact dermatitis to this chemical exist in the literature, and we describe three more cases of children with recalcitrant atopic dermatitis found to have potential allergic contact dermatitis to bisabolol- a component of the Aquaphor emollient they were using to treat their atopic dermatitis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "allergic contact dermatitis"},{"annotation": "Treatment", "text": "Aquaphor emollient"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Effect", "text": "recalcitrant atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "Aquaphor emollient"},{"annotation": "Treatment.Disorder", "text": "atopic dermatitis"},{"annotation": "Treatment.Drug", "text": "bisabolol"},{"annotation": "Treatment
 {"id": "16160485_2","context": "Recently, CD20-negative tumors have been described after Rituximab therapy.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "Rituximab therapy"},{"annotation": "Treatment","text": "Rituximab"},{"annotation": "Treatment.Disorder","text": "CD20-negative tumors"}]}]
 {"id": "10560960_1","context": "A 48-year-old woman who was treated for thyrotoxicosis with methimazole developed agranulocytosis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "treated"},{"annotation": "Treatment","text": "methimazole"},{"annotation": "Effect","text": "agranulocytosis"},{"annotation": "Treatment.Drug","text": "methimazole"}]}]}
 {"id": "10646879_1","context": "Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "ifosfamide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "prevention"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "ifosfamide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "report"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "ifosfamide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "report"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "ifosfamide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "report"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "ifosfamide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "report"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "ifosfamide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "report"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "ifosfamide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "report"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "ifosfamide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "report"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "ifosfamide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "report"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "ifosfamide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "report"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "ifosfamide"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "report"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "ifosfamide"}],{"type": "Adverse_event","annotations": [{
 {"id": "15863610_4","context": "We report a case of a women in whom a malignant mixed mesodermal tumor was diagnosed while she was taking raloxifene, which is also a selective estrogen receptor modulator.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "diagnosed"},{"annotation": "Treatment", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Disorder", "text": "malignant mixed mesodermal tumor"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "raloxifene"},{"annotation": "Treatment.Drug", "text": "
 {"id": "22677303_12","context": "Interactions between warfarin and cloxacillin can result in serious adverse reactions.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "interactions"}, {"annotation": "Effect", "text": "serious adverse reactions"}, {"annotation": "Treatment", "text": "warfarin and cloxacillin"}, {"annotation": "Treatment.Drug", "text": "warfarin"}, {"annotation": "Treatment.Drug", "text": "cloxacillin"}, {"annotation": "Treatment.Drug", "text": "warfarin"}, {"annotation": "Treatment.Drug", "text": "cloxacillin"}, {"annotation": "Treatment.Combination.Trigger", "text": "and"}, {"annotation": "Treatment.Combination.Drug", "text": "warfarin"}, {"annotation": "Treatment.Combination.Drug", "text": "cloxacillin"}]}]}
 {"id": "11724089_2","context": "However, a large case-control study included three cases of either Stevens-Johnson syndrome or toxic epidermal necrolysis associated with ofloxacin use, but no details of the cases were given.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with"},{"annotation": "Effect","text": "Stevens-Johnson syndrome or toxic epidermal necrolysis"},{"annotation": "Treatment","text": "ofloxacin use"}]}]}
 {"id": "879939_5","context": "Acetazolamide may have accelerated the development of osteomalacia by several mechanisms, including increased renal calcium excretion.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "accelerated"},{"annotation": "Effect","text": "development of osteomalacia"},{"annotation": "Treatment","text": "acetazolamide"},{"annotation": "Treatment.Drug","text": "acetazolamide"}]}]
 {"id": "14697943_1","context": "In conclusion, RSDS is a relevant osteoarticular complication in patients receiving either anticalcineurinic drug (CyA or tacrolimus), even under monotherapy or with a low steroid dose.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "receiving"},{"annotation": "Treatment","text": "anticalcineurinic drug (CyA or tacrolimus)"},{"annotation": "Treatment.Drug","text": "CyA or tacrolimus"},{"annotation": "Treatment.Combination","text": "even under monotherapy or with a low steroid dose"},{"annotation": "Treatment.Combination.Drug","text": "steroid"},{"annotation": "Effect","text": "RSDS"}]}]
 {"id": "14742791_5","context": "There have been several reported cases of omeprazole-induced AIN.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "omeprazole"},{"annotation": "Treatment.Drug","text": "omeprazole"},{"annotation": "Effect","text": "AIN"}]}]
 {"id": "9726762_4","context": "This interaction may be overlooked by clinicians, which may result in a serious bleeding risk for patients on warfarin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "interaction"},{"annotation": "Effect", "text": "bleeding risk"},{"annotation": "Treatment", "text": "warfarin"},{"annotation": "Treatment.Drug", "text": "warfarin"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute.negated", "text": "bleeding risk may be overlooked by clinicians"}]}]}
 {"id": "1966850_1","context": "Adriamycin-induced cardiomyopathy aggravated by cis-platinum nephrotoxicity requiring dialysis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "Adriamycin"},{"annotation": "Treatment.Drug","text": "Adriamycin"},{"annotation": "Effect","text": "cardiomyopathy"},{"annotation": "Treatment.Disorder","text": "cis-platinum nephrotoxicity"},{"annotation": "Treatment.Drug","text": "cis-platinum"},{"annotation": "Treatment.Drug","text": "cis-platinum"},{"annotation": "Treatment.Treatment_combination","text": "and"},{"annotation": "Treatment.Drug","text": "cis-platinum"},{"annotation": "Treatment.Drug","text": "Adriamycin"},{"annotation": "Effect","text": "cardiomyopathy"}],"attributes": [{"attribute": "negated","value": false},{"attribute": "speculated","value": false},{"attribute": "severity","value": "high"}]}
 {"id": "8145359_1","context": "An 11-year-old boy who was treated with a relatively high dose of methotrimeprazine meleate (Levemepromazine) a phenothiazine antipsychotic drug, was admitted to the pediatric intensive care unit suffering from respiratory distress syndrome.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "high dose of methotrimeprazine meleate (Levemepromazine)"},{"annotation": "Effect","text": "respiratory distress syndrome"},{"annotation": "Treatment","text": "methotrimeprazine meleate (Levemepromazine)"},{"annotation": "Treatment.Drug","text": "methotrimeprazine meleate (Levemepromazine)"},{"annotation": "Subject","text": "an 11-year-old boy"},{"annotation": "Subject.Age","text": "11-year-old"},{"annotation": "Subject.Population","text": "1"},{"annotation": "Subject.Race","text": "not specified"},{"annotation": "Subject.Disorder","text": "not specified"}]}
 {"id": "11762672_1","context": "An adult male presented with central blindness after ingesting methanol.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "ingesting"},{"annotation": "Effect","text": "central blindness"},{"annotation": "Treatment","text": "n/a"},{"annotation": "Treatment.Drug","text": "methanol"}],"subject": {"age": "adult","gender": "male","population": "1","race": "n/a","disorder": "n/a"}}
 {"id": "8523340_1","context": "All developed mucocutaneous side effects within 20 weeks of beginning im gold therapy, at a time when RA had improved markedly compared to pretreatment status.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "mucocutaneous side effects"},{"annotation": "Treatment","text": "im gold therapy"},{"annotation": "Treatment.Drug","text": "im gold"}]},{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "improved"},{"annotation": "Treatment","text": "RA had improved"},{"annotation": "Treatment.Disorder","text": "RA"}]}]}
 {"id": "1868481_2","context": "Two children, 1 with idiopathic nephrotic syndrome and 1 with endo-extracapillary glomerulonephritis, presented an episode of seizures and transient blindness at different times after i.v. pulse methylprednisolone (IVPMP) treatment.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "IVPMP treatment"},{"annotation": "Treatment","text": "IVPMP treatment"},{"annotation": "Treatment.Drug","text": "methylprednisolone"},{"annotation": "Effect","text": "seizures and transient blindness"},{"annotation": "Treatment.Duration","text": "IVPMP treatment"},{"annotation": "Subject","text": "2 children"},{"annotation": "Subject.Disorder","text": "idiopathic nephrotic syndrome and endo-extracapillary glomerulonephritis"}]}
 {"id": "12836099_1","context": "Stevens-Johnson syndrome in a boy with nephrotic syndrome during prednisolone therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "during prednisolone therapy."},{"annotation": "Effect","text": "Stevens-Johnson syndrome"},{"annotation": "Treatment","text": "prednisolone"},{"annotation": "Treatment.Drug","text": "prednisolone"},{"annotation": "Treatment.Disease","text": "nephrotic syndrome"},{"annotation": "Subject","text": "boy"},{"annotation": "Subject.Age","text": "boy"},{"annotation": "Subject.Disorder","text": "nephrotic syndrome"}]}
 {"id": "18628507_4","context": "To our knowledge, this is the first report of an angio-oedema associated with VRC.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "associated with"},{"annotation": "Treatment", "text": "VRC"},{"annotation": "Treatment.Drug", "text": "VRC"},{"annotation": "Effect", "text": "angio-oedema"},{"annotation": "Treatment.Drug", "text": "VRC"},{"annotation": "Treatment.Duration", "text": "first report"},{"annotation": "Treatment.Disorder", "text": "angio-oedema"}]}]
 {"id": "4014301_1","context": "Insulin-induced cardiac failure.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "cardiac failure"},{"annotation": "Treatment","text": "insulin"},{"annotation": "Treatment.Drug","text": "insulin"}]}}
 {"id": "15522120_10","context": "The symptoms disappeared with clemastine and betametasone treatment.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Treatment","text": "clemastine and betametasone"},{"annotation": "Effect","text": "disappearance of symptoms"}]}]}
 {"id": "11724089_6","context": "This report rules out other causes of toxic epidermal necrolysis and implicates ofloxacin in what appears to be an atypical presentation of drug-induced toxic epidermal necrolysis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "implicates"},{"annotation": "Treatment","text": "ofloxacin"},{"annotation": "Treatment.Drug","text": "ofloxacin"},{"annotation": "Effect","text": "toxic epidermal necrolysis"},{"annotation": "Treatment.Disorder","text": "drug-induced toxic epidermal necrolysis"},{"annotation": "Subject","text": "an atypical presentation"},{"annotation": "Subject.Population","text": "1"},{"annotation": "Subject.Disorder","text": "drug-induced toxic epidermal necrolysis"}]}
 {"id": "3917429_1","context": "Controversy concerning the nephrotoxicity of lithium is discussed, and recommendations for the evaluation of renal failure during lithium therapy are provided.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "lithium"},{"annotation": "Treatment", "text": "lithium therapy"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Effect", "text": "nephrotoxicity"},{"annotation": "Treatment.Disorder", "text": "lithium-induced nephrotoxicity"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "discussion"},{"annotation": "Treatment", "text": "evaluation of renal failure during lithium therapy"},{"annotation": "Treatment.Disorder", "text": "lithium-induced nephrotoxicity"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "lithium"},{"annotation": "Treatment", "text": "lithium therapy"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Effect", "text": "nephrotoxicity"},{"annotation": "Treatment.Disorder", "text": "lithium-induced nephrotoxicity"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route", "text": "oral"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Dosage", "text": "high"},{"annotation": "Treatment.Duration", "text": "chronic"},{"annotation": "Treatment.Drug", "text": "lithium"},{"annotation": "Treatment.Frequency", "text": "chronic"},{"annotation": "Treatment.Route
 {"id": "6738830_1","context": "A 56-year-old male parkinsonian patient developed a unique behavioral change following the oral administration of cinepazide, a cerebral vasodilator.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "oral administration of cinepazide"},{"annotation": "Effect", "text": "unique behavioral change"},{"annotation": "Treatment", "text": "cinepazide"},{"annotation": "Treatment.Drug", "text": "cinepazide"},{"annotation": "Treatment.Disorder", "text": "parkinsonian patient"},{"annotation": "Treatment.Drug", "text": "cerebral vasodilator"}]}]}
 {"id": "440873_3","context": "The currently available clinical and neuropharmacologic data suggest that carbamazepine may be an antagonist of dopamine and that this property is responsible for the production of dystonia.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "clinical and neuropharmacologic data"},{"annotation": "Treatment","text": "carbamazepine"},{"annotation": "Treatment.Disorder","text": "dystonia"},{"annotation": "Attribute Attributes","text": "negated","severity": "low"}]}]
 {"id": "12042592_2","context": "Metamizole, a nonsteroidal antiinflammatory agent, is prohibited in the United States because of the risk of agranulocytosis but is widely used in Mexico and other countries.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "metamizole"},{"annotation": "Treatment.Drug","text": "metamizole"},{"annotation": "Effect","text": "agranulocytosis"},{"annotation": "Treatment.Disorder","text": "agranulocytosis"},{"annotation": "Treatment.Drug","text": "metamizole"},{"annotation": "Treatment.Drug","text": "agranulocytosis"},{"annotation": "Treatment.Drug","text": "agranulocytosis"}]}
 {"id": "9777751_6","context": "We conclude that the use of hemopoietic colony stimulating factors might be a suitable means to achieve the correction of severe thionamide-induced hematologic adverse reactions.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "correction"},{"annotation": "Treatment","text": "hemopoietic colony stimulating factors"},{"annotation": "Treatment.Disorder","text": "thionamide-induced hematologic adverse reactions"}]}]
 {"id": "8696525_2","context": "Two case reports of bilateral granulomatous anterior uveitis are described in patients with open angle glaucoma treated with metripranolol 0.6% eye drops.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "bilateral granulomatous anterior uveitis"},{"annotation": "Effect","text": "uveitis"},{"annotation": "Treatment","text": "metripranolol 0.6% eye drops"},{"annotation": "Treatment.Disorder","text": "open angle glaucoma"},{"annotation": "Treatment.Drug","text": "metripranolol"},{"annotation": "Treatment.Dosage","text": "0.6%"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "eye drops"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "open angle glaucoma"}],"subjects": [{"id": "8696525_2-1","text": "two case reports"},{"id": "8696525_2-2","text": "patients"},{"id": "8696525_2-3","text": "bilateral granulomatous anterior uveitis"},{"id": "8696525_2-4","text": "open angle glaucoma"},{"id": "8696525_2-5","text": "metripranolol 0.6% eye drops"}]}
 {"id": "7355327_2","context": "Regardless of a negative history of asthma, therefore, life-threatening bronchospasm must be considered a possible complication of propranolol therapy.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "propranolol therapy"},{"annotation": "Treatment","text": "propranolol"},{"annotation": "Effect","text": "bronchospasm"},{"annotation": "Treatment.Disorder","text": "asthma"},{"annotation": "Attribute","text": "negated","severity": "high"}]}]
 {"id": "11147747_2","context": "In the present paper the authors describe 2 female patients who developed incontinence secondary to the selective serotonin reuptake inhibitors paroxetine and sertraline, as well as a third who developed this side effect on venlafaxine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "selective serotonin reuptake inhibitors"},{"annotation": "Treatment", "text": "paroxetine"},{"annotation": "Treatment", "text": "sertraline"},{"annotation": "Treatment", "text": "venlafaxine"},{"annotation": "Treatment.Drug", "text": "paroxetine"},{"annotation": "Treatment.Drug", "text": "sertraline"},{"annotation": "Treatment.Drug", "text": "venlafaxine"},{"annotation": "Treatment.Disorder", "text": "incontinence"},{"annotation": "Subject", "text": "2 female patients"},{"annotation": "Subject.Disorder", "text": "incontinence"}]}]}
 {"id": "1680596_1","context": "Presented is a case story of a woman with classical rheumatoid arthritis, who during introduction of sulphasalazine (SASP) therapy developed a severe and lasting psoriasis-like skin reaction.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "introduction of sulphasalazine (SASP) therapy"},{"annotation": "Effect","text": "severe and lasting psoriasis-like skin reaction"},{"annotation": "Treatment","text": "sulphasalazine (SASP) therapy"},{"annotation": "Treatment.Drug","text": "sulphasalazine (SASP)"}],"subject": {"id": "1680596","name": "woman","gender": "female","population": "1","race": "unknown","disorder": "classical rheumatoid arthritis"}}
 {"id": "19112808_1","context": "Interstitial granulomatous dermatitis associated with darifenacin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with"},{"annotation": "Treatment","text": "darifenacin"},{"annotation": "Treatment.Drug","text": "darifenacin"},{"annotation": "Effect","text": "interstitial granulomatous dermatitis"},{"annotation": "Treatment.Disorder","text": "drug-induced"}]}]
 {"id": "11762672_2","context": "Reversal of severe methanol-induced visual impairment: no evidence of retinal toxicity due to fomepizole.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "visual impairment"},{"annotation": "Treatment", "text": "fomepizole"},{"annotation": "Treatment.Disorder", "text": "methanol poisoning"},{"annotation": "Treatment.Drug", "text": "fomepizole"},{"annotation": "Treatment.Drug", "text": "methanol"},{"annotation": "Treatment.Dosage", "text": "dosage"},{"annotation": "Treatment.Duration", "text": "duration"},{"annotation": "Treatment.Frequency", "text": "frequency"},{"annotation": "Treatment.Route", "text": "route"},{"annotation": "Treatment.Time_elapsed", "text": "time elapsed"},{"annotation": "Treatment.Time_elapsed", "text": "time elapsed after administration"},{"annotation": "Treatment.Time_elapsed", "text": "time elapsed after methanol ingestion"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "speculated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Annotation", "text": "negated"},{"annotation": "Annotation", "text": "negated"},{"annotation": "Annotation", "text": "negated"},{"annotation": "Annotation", "text": "negated"},{"annotation": "Annotation", "text": "negated"},{"annotation": "Annotation", "
 {"id": "20925534_3","context": "Proton-pump inhibitors (PPIs) are believed to decrease the risk of such complications, though no randomized trial has proved this in patients receiving dual antiplatelet therapy.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "decrease"},{"annotation": "Treatment", "text": "proton-pump inhibitors (PPIs)"},{"annotation": "Treatment.Disorder", "text": "complications"},{"annotation": "Treatment.Drug", "text": "proton-pump inhibitors (PPIs)"},{"annotation": "Treatment.Combination", "text": "dual antiplatelet therapy"},{"annotation": "Treatment.Combination.Trigger", "text": "though no randomized trial has proved this"}]}]}
 {"id": "10592946_4","context": "The clinical course suggests that caffeine, which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the delirium, although severe hyponatremia has been reported to cause rhabdomyolysis on rare occasions.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "caffeine"},{"annotation": "Treatment","text": "oolong tea"},{"annotation": "Treatment.Drug","text": "caffeine"},{"annotation": "Effect","text": "rhabdomyolysis"},{"annotation": "Effect","text": "delirium"},{"annotation": "Treatment.Drug","text": "severe hyponatremia"},{"annotation": "Treatment.Disorder","text": "rhabdomyolysis"},{"annotation": "Treatment.Disorder","text": "delirium"},{"annotation": "Treatment.Drug","text": "severe hyponatremia"},{"annotation": "Treatment.Disorder","text": "rhabdomyolysis"}]}
 {"id": "11283125_8","context": "Prevention of CNS relapse was satisfactorily achieved with HD IV MTX and intrathecal injections of MTX in children with increased-risk ALL or stage III and IV lymphoblastic lymphoma treated with our BFM-based treatment protocol in which cranial irradiation was omitted.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "increased-risk ALL or stage III and IV lymphoblastic lymphoma"},{"annotation": "Treatment", "text": "our BFM-based treatment protocol"},{"annotation": "Treatment.Disorder", "text": "increased-risk ALL or stage III and IV lymphoblastic lymphoma"},{"annotation": "Treatment.Drug", "text": "HD IV MTX and intrathecal injections of MTX"},{"annotation": "Treatment.Duration", "text": "our BFM-based treatment protocol"},{"annotation": "Treatment.Combination.Trigger", "text": "in which cranial irradiation was omitted"},{"annotation": "Treatment.Combination.Drug", "text": "HD IV MTX and intrathecal injections of MTX"},{"annotation": "Treatment.Combination.Drug", "text": "cranial irradiation"},{"annotation": "Effect", "text": "CNS relapse prevention"},{"annotation": "Attribute Attributes", "text": "satisfactorily achieved"}]}]}
 {"id": "17823522_1","context": "Generalized lichen nitidus with involvement of the palms following interferon alpha treatment.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "following interferon alpha treatment."},{"annotation": "Effect","text": "lichen nitidus"},{"annotation": "Treatment","text": "interferon alpha"},{"annotation": "Treatment.Drug","text": "interferon alpha"},{"annotation": "Treatment.Disorder","text": "lichen nitidus"},{"annotation": "Treatment.Location","text": "generalized"},{"annotation": "Treatment.Location","text": "palms"}]}
 {"id": "1422497_2","context": "Hemorrhagic cystitis is a significant toxic effect of cyclophosphamide therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "cyclophosphamide therapy"},{"annotation": "Effect","text": "hemorrhagic cystitis"},{"annotation": "Treatment","text": "cyclophosphamide"},{"annotation": "Treatment.Drug","text": "cyclophosphamide"}]}]
 {"id":"7212107_1","context":"Secondary hyperparathyroidism in certain patients with lithium nephrotoxicity is also possible.","events":[{"type":"Potential_therapeutic_effect","annotations":[{"annotation":"Trigger","text":"possible"},{"annotation":"Effect","text":"hyperparathyroidism"},{"annotation":"Treatment","text":"secondary"},{"annotation":"Treatment.Disorder","text":"lithium nephrotoxicity"},{"annotation":"Attribute Attributes","text":"severity":"low"},{"annotation":"Attribute Attributes","text":"negated":"false"},{"annotation":"Attribute Attributes","text":"speculated":"false"}]}]}
 {"id": "18755414_2","context": "We report a case in which hemorrhage occurred in an asymptomatic falx meningioma known beforehand, after the internal use of low-dose aspirin for 16 months.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "internal use of low-dose aspirin"},{"annotation": "Effect","text": "hemorrhage"},{"annotation": "Treatment","text": "low-dose aspirin"},{"annotation": "Treatment.Drug","text": "aspirin"},{"annotation": "Treatment.Duration","text": "16 months"},{"annotation": "Subject","text": "an asymptomatic falx meningioma"},{"annotation": "Subject.Disorder","text": "falx meningioma"}]}
 {"id": "589261_3","context": "Minor electrocardiographical changes were noted in five out of six patients who were not receiving a cardiac glycoside and four out of six who were receiving ouabain, and none of the 16 who were receiving digoxin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "electrocardiographical changes"},{"annotation": "Effect","text": "minor"},{"annotation": "Treatment","text": "cardiac glycoside"},{"annotation": "Treatment.Drug","text": "ouabain"},{"annotation": "Treatment.Drug","text": "digoxin"},{"annotation": "Subject","text": "six patients"},{"annotation": "Subject.Population","text": "16 patients"}]}
 {"id": "19754002_4","context": "The allergic reaction started to develop after co-administration of pravastatin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "co-administration of pravastatin"},{"annotation": "Treatment","text": "pravastatin"},{"annotation": "Treatment.Drug","text": "pravastatin"},{"annotation": "Effect","text": "allergic reaction"},{"annotation": "Treatment.Drug","text": "pravastatin"}]}]
 {"id": "11202801_3","context": "We propose that cyclophosphamide be added to the list of exposures potentially associated with hepatic angiosarcoma.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "propose"},{"annotation": "Treatment","text": "cyclophosphamide"},{"annotation": "Treatment.Disorder","text": "hepatic angiosarcoma"}]}]}
 {"id": "868978_2","context": "The ocular motor disturbances are probably an expression of regional 5-FU neurotoxicity primarily affecting the brain stem.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "ocular motor disturbances"},{"annotation": "Treatment","text": "5-FU"},{"annotation": "Treatment.Disorder","text": "5-FU neurotoxicity"},{"annotation": "Treatment.Drug","text": "5-FU"},{"annotation": "Treatment.Drug","text": "neurotoxicity"},{"annotation": "Treatment.Drug","text": "brain stem"}]}
 {"id": "1966850_2","context": "Complications of chemotherapy for a synovial sarcoma in an eight-year old boy included cisplatinum nephrotoxicity and adriamycin cardiotoxicity.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "complications"},{"annotation": "Treatment","text": "chemotherapy"},{"annotation": "Treatment.Disorder","text": "synovial sarcoma"},{"annotation": "Treatment.Drug","text": "cisplatinum"},{"annotation": "Treatment.Drug","text": "adriamycin"},{"annotation": "Effect","text": "nephrotoxicity"},{"annotation": "Effect","text": "cardiotoxicity"},{"annotation": "Subject","text": "an eight-year old boy"},{"annotation": "Subject.Age","text": "8"},{"annotation": "Subject.Population","text": "1"},{"annotation": "Subject.Race","text": "not specified"}]}
 {"id": "17504225_2","context": "Bacterial infection is a frequent event in renal transplant recipients and often requires the use of antimicrobial agents.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "infection"},{"annotation": "Effect","text": "bacterial infection"},{"annotation": "Treatment","text": "antimicrobial agents"},{"annotation": "Treatment.Disorder","text": "renal transplant recipients"}]}]
 {"id": "16685007_12","context": "Study results suggest that ciclesonide significantly reduces the need for OCS in patients with severe, persistent asthma, while maintaining asthma control.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "results suggest"},{"annotation": "Treatment","text": "ciclesonide"},{"annotation": "Treatment.Disorder","text": "severe, persistent asthma"},{"annotation": "Treatment.Drug","text": "OCS"},{"annotation": "Treatment.Drug","text": "ciclesonide"},{"annotation": "Effect","text": "reduces the need for OCS while maintaining asthma control"}]}
 {"id": "14968106_1","context": "CONCLUSION: This is, to our knowledge, the first report of severe myelopathy following accidental intrathecal administration of doxorubicin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Effect","text": "severe myelopathy"},{"annotation": "Treatment","text": "accidental intrathecal administration of doxorubicin"}]}]}
 {"id": "12854039_5","context": "Multiple sclerosis-like disease secondary to alpha interferon.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "secondary to alpha interferon."},{"annotation": "Treatment", "text": "alpha interferon"},{"annotation": "Treatment.Disorder", "text": "multiple sclerosis-like disease"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute.negated", "text": "negated"}]}]}
 {"id": "17921794_4","context": "We report a case of a patient with mild chronic renal insufficiency who had been taking simvastatin for over a year and developed acute weakness within 3 weeks after the start of treatment with colchicine for acute gouty bursitis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "acute weakness"},{"annotation": "Treatment","text": "colchicine"},{"annotation": "Treatment.Drug","text": "colchicine"},{"annotation": "Treatment.Drug","text": "simvastatin"},{"annotation": "Treatment.Duration","text": "over a year"},{"annotation": "Treatment.Disorder","text": "mild chronic renal insufficiency"},{"annotation": "Treatment.Disorder","text": "acute gouty bursitis"}]}
 {"id": "16603845_1","context": "Shortly after chemotherapy and an injection of pegfilgrastim, the patient developed poorly defined, rapidly progressive erythema, edema, and pain in his right forearm.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "chemotherapy and injection of pegfilgrastim"},{"annotation": "Effect","text": "erythema, edema, and pain"},{"annotation": "Treatment","text": "chemotherapy and injection of pegfilgrastim"},{"annotation": "Treatment.Drug","text": "pegfilgrastim"}]}]
 {"id":"20628041_2","context":"To describe a probable interaction between enteral feeds and levodopa leading to neuroleptic malignant-like syndrome (NMLS) in a polytrauma patient with Parkinson's disease (PD).","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"probable interaction"},{"annotation":"Effect","text":"NMLS"},{"annotation":"Treatment","text":"enteral feeds and levodopa"},{"annotation":"Treatment.Disorder","text":"Parkinson's disease (PD)"},{"annotation":"Treatment.Drug","text":"levodopa"},{"annotation":"Treatment.Drug","text":"enteral feeds"},{"annotation":"Treatment.Drug","text":"levodopa"},{"annotation":"Treatment.Drug","text":"enteral feeds"},{"annotation":"Subject","text":"a polytrauma patient"},{"annotation":"Subject.Disorder","text":"Parkinson's disease (PD)"},{"annotation":"Treatment.Combination.Trigger","text":"and"},{"annotation":"Treatment.Combination.Drug","text":"levodopa"},{"annotation":"Treatment.Combination.Drug","text":"enteral feeds"},{"annotation":"Treatment.Combination.Drug","text":"levodopa"},{"annotation":"Treatment.Combination.Drug","text":"enteral feeds"}]}]}
 {"id": "16978752_3","context": "Second, we report a case of neutropenia, which proved to be fatal in a schizophrenia patient receiving olanzapine and thiazide.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "proved to be fatal"},{"annotation": "Treatment","text": "olanzapine and thiazide"},{"annotation": "Treatment.Drug","text": "olanzapine"},{"annotation": "Treatment.Drug","text": "thiazide"},{"annotation": "Effect","text": "neutropenia"},{"annotation": "Subject","text": "schizophrenia patient"},{"annotation": "Subject.Disorder","text": "schizophrenia"}]}
 {"id": "21658326_3","context": "While mild to moderate application site reactions (ASRs) are a well-known and common phenomenon associated with imiquimod, the potential of TNF-alpha blockers to elicit cutaneous inflammatory reactions has only recently been recognized.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "elicited"},{"annotation": "Treatment","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Disorder","text": "cutaneous inflammatory reactions"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{"annotation": "Treatment.Drug","text": "TNF-alpha blockers"},{"annotation": "Treatment.Drug","text": "imiquimod"},{
 {"id": "6239881_2","context": "Nineteen cases of allergic contact dermatitis to compound tincture of benzoin are described.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "allergic contact dermatitis"},{"annotation": "Effect", "text": "dermatitis"},{"annotation": "Treatment", "text": "compound tincture of benzoin"},{"annotation": "Treatment.Drug", "text": "benzoin"},{"annotation": "Treatment.Dosage", "text": "unknown"},{"annotation": "Treatment.Duration", "text": "unknown"},{"annotation": "Treatment.Route", "text": "unknown"},{"annotation": "Treatment.Time_elapsed", "text": "unknown"},{"annotation": "Treatment.Frequency", "text": "unknown"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute.negated", "text": "unknown"},{"annotation": "Attribute.severity", "text": "unknown"},{"annotation": "Attribute.speculated", "text": "unknown"},{"annotation": "Subject", "text": "unknown"},{"annotation": "Subject.Age", "text": "unknown"},{"annotation": "Subject.Gender", "text": "unknown"},{"annotation": "Subject.Population", "text": "unknown"},{"annotation": "Subject.Race", "text": "unknown"},{"annotation": "Subject.Disorder", "text": "unknown"}]}
 {"id": "8404753_3","context": "We report 3 children with epilepsy who developed facial motor tics after initiation of CBZ for complex partial seizures.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "initiation of CBZ"},{"annotation": "Treatment","text": "CBZ"},{"annotation": "Treatment.Drug","text": "CBZ"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "complex partial seizures"},{"annotation": "Subject","text": "3 children"},{"annotation": "Subject.Age","text": "not specified"},{"annotation": "Subject.Gender","text": "not specified"},{"annotation": "Subject.Population","text": "3 children"},{"annotation": "Subject.Race","text": "not specified"},{"annotation": "Attribute Attributes","text": "none"}]}
 {"id": "11197767_2","context": "The toxicity of cadmium, zinc and cadmium/zinc mixtures at concentrations ranging from 1000 to 50000 microg/l were investigated against cercariae and metacercariae of Parorchis acanthus obtained from the dog whelk Nucella lapillus.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "investigated"},{"annotation": "Treatment","text": "cadmium, zinc and cadmium/zinc mixtures"},{"annotation": "Treatment.Drug","text": "cadmium"},{"annotation": "Treatment.Drug","text": "zinc"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "cadmium"},{"annotation": "Treatment.Combination.Drug","text": "zinc"},{"annotation": "Treatment.Combination.Combination","text": "cadmium/zinc"},{"annotation": "Treatment.Drug","text": "metacercariae"},{"annotation": "Treatment.Drug","text": "cercariae"},{"annotation": "Treatment.Drug","text": "Parorchis acanthus"},{"annotation": "Treatment.Drug","text": "Nucella lapillus"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "cadmium/zinc"},{"annotation": "Treatment.Drug","text": "Nucella lapillus"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "Nucella lapillus"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "Nucella lapillus"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug","text": "dog whelk"},{"annotation": "Treatment.Drug
 {"id": "18354950_3","context": "We report the syndrome of inappropriate antidiuresis as a much earlier side-effect of carbamazepine administration in a 29-year Nigerian female patient with generalized tonic-elonic seizures.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "carbamazepine administration"},{"annotation": "Treatment","text": "carbamazepine"},{"annotation": "Treatment.Disorder","text": "generalized tonic-elonic seizures"},{"annotation": "Effect","text": "syndrome of inappropriate antidiuresis"},{"annotation": "Subject","text": "29-year Nigerian female patient"},{"annotation": "Subject.Age","text": "29-year"},{"annotation": "Subject.Gender","text": "Nigerian female"},{"annotation": "Subject.Population","text": "1 patient"},{"annotation": "Subject.Race","text": "Nigerian"},{"annotation": "Treatment.Drug","text": "carbamazepine"},{"annotation": "Treatment.Dosage","text": "unknown"},{"annotation": "Treatment.Frequency","text": "unknown"},{"annotation": "Treatment.Route","text": "unknown"},{"annotation": "Treatment.Time_elapsed","text": "unknown"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "generalized tonic-elonic seizures"}]}
 {"id": "11310527_2","context": "A patient was treated with warfarin for atrial fibrillation.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "warfarin"},{"annotation": "Treatment.Disorder","text": "atrial fibrillation"}]}]}
 {"id": "19754002_1","context": "Mood stabilizer therapy and pravastatin: higher risk for adverse skin reactions?","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "therapy and pravastatin"},{"annotation": "Treatment","text": "mood stabilizer therapy and pravastatin"},{"annotation": "Treatment.Drug","text": "pravastatin"},{"annotation": "Effect","text": "adverse skin reactions"},{"annotation": "Treatment.Drug","text": "mood stabilizer therapy"},{"annotation": "Treatment.Drug","text": "pravastatin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "pravastatin"},{"annotation": "Treatment.Combination.Drug","text": "mood stabilizer therapy"},{"annotation": "Subject","text": "patient"},{"annotation": "Subject.Disorder","text": "mood"}]}
 {"id": "1602800_1","context": "Pulmonary leukostasis secondary to all-trans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "secondary to all-trans retinoic acid"},{"annotation": "Effect", "text": "pulmonary leukostasis"},{"annotation": "Treatment", "text": "all-trans retinoic acid"},{"annotation": "Treatment.Disorder", "text": "acute promyelocytic leukemia"},{"annotation": "Treatment.Drug", "text": "all-trans retinoic acid"},{"annotation": "Treatment.Dosage", "text": "in first relapse"}]}]}
 {"id": "15811174_1","context": "A 74-year-old hypercholestrolaemic woman taking cerivastatin (0.15 mg/day) for 22 days complained of general muscle weakness and muscle pain.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "taking cerivastatin"},{"annotation": "Treatment","text": "cerivastatin"},{"annotation": "Treatment.Drug","text": "cerivastatin"},{"annotation": "Effect","text": "muscle weakness and muscle pain"},{"annotation": "Subject","text": "a 74-year-old woman"},{"annotation": "Subject.Disorder","text": "hypercholestrolaemic"}]}
 {"id": "7081289_3","context": "There have been only two reports of cimetidine-induced hepatitis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "hepatitis"},{"annotation": "Treatment", "text": "cimetidine"},{"annotation": "Treatment.Drug", "text": "cimetidine"},{"annotation": "Treatment.Disorder", "text": "none"},{"annotation": "Treatment.Drug", "text": "none"},{"annotation": "Treatment.Duration", "text": "none"},{"annotation": "Treatment.Route", "text": "none"},{"annotation": "Treatment.Time_elapsed", "text": "none"},{"annotation": "Treatment.Frequency", "text": "none"},{"annotation": "Treatment.Combination", "text": "none"},{"annotation": "Treatment.Combination.Trigger", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none"},{"annotation": "Treatment.Combination.Drug", "text": "none
 {"id": "3732375_2","context": "A case is reported of theophylline intoxication due to a dramatic decrease in theophylline clearance following concomitant administration of viloxazine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intoxication"},{"annotation": "Effect","text": "theophylline intoxication"},{"annotation": "Treatment","text": "combined administration of viloxazine"},{"annotation": "Treatment.Drug","text": "theophylline"},{"annotation": "Treatment.Drug","text": "viloxazine"},{"annotation": "Treatment.Interaction","text": "concomitant administration"},{"annotation": "Treatment.Drug.Interaction","text": "theophylline"},{"annotation": "Treatment.Drug.Interaction","text": "viloxazine"},{"annotation": "Subject","text": "a patient"}]}
 {"id": "7639655_1","context": "Anterior ischemic optic neuropathy secondary to interferon alfa.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "secondary to interferon alfa"},{"annotation": "Treatment","text": "interferon alfa"},{"annotation": "Treatment.Drug","text": "interferon alfa"},{"annotation": "Effect","text": "anterior ischemic optic neuropathy"},{"annotation": "Subject","text": "anterior ischemic optic neuropathy"},{"annotation": "Subject.Disorder","text": "anterior ischemic optic neuropathy"}]}
 {"id": "12854039_6","context": "PURPOSE: To describe bilateral optic neuritis that occurred as an adverse effect of recombinant and natural interferon alpha administration.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "occurred as an adverse effect of"},{"annotation": "Effect", "text": "bilateral optic neuritis"},{"annotation": "Treatment", "text": "recombinant and natural interferon alpha administration"},{"annotation": "Treatment.Disorder", "text": "bilateral optic neuritis"},{"annotation": "Treatment.Drug", "text": "recombinant and natural interferon alpha"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "speculated"},{"annotation": "Attribute", "text": "negated", "type": "severity"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Attribute", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "text": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation", "text": "negated", "type": "negated"},{"annotation": "Annotation",
 {"id": "12234159_2","context": "Rofecoxib, used for dysmenorrhea, caused a herpetiform fixed drug eruption predominantly involving the lips with classic clinical and histological findings in a red-brown lesion on the dorsal hand.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "used"},{"annotation": "Treatment","text": "rofecoxib"},{"annotation": "Treatment.Drug","text": "rofecoxib"},{"annotation": "Effect","text": "herpetiform fixed drug eruption"},{"annotation": "Treatment.Disorder","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "rofecoxib"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment.Drug","text": "dysmenorrhea"},{"annotation": "Treatment
 {"id": "16609346_2","context": "Statin-associated myasthenia gravis: report of 4 cases and review of the literature.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "associated"},{"annotation": "Treatment", "text": "statins"},{"annotation": "Treatment.Disorder", "text": "myasthenia gravis"},{"annotation": "Effect", "text": "myasthenia gravis"},{"annotation": "Treatment.Drug", "text": "statins"},{"annotation": "Treatment.Drug", "text": "myasthenia gravis"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Duration", "text": "statins"},{"annotation": "Treatment.Duration", "text": "myasthenia gravis"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "report of"},{"annotation": "Treatment", "text": "4 cases"},{"annotation": "Treatment.Disorder", "text": "myasthenia gravis"},{"annotation": "Effect", "text": "myasthenia gravis"},{"annotation": "Treatment.Drug", "text": "statins"},{"annotation": "Treatment.Drug", "text": "myasthenia gravis"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Duration", "text": "statins"},{"annotation": "Treatment.Duration", "text": "myasthenia gravis"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "review of"},{"annotation": "Treatment", "text": "literature"},{"annotation": "Treatment.Disorder", "text": "myasthenia gravis"},{"annotation": "Effect", "text": "myasthenia gravis"},{"annotation": "Treatment.Drug", "text": "statins"},{"annotation": "Treatment.Drug", "text": "myasthenia gravis"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Duration", "text": "statins"},{"annotation": "Treatment.Duration", "text": "myasthenia gravis"}]}],"subject": {"age": "unknown","gender": "unknown","population": "4 cases","race": "unknown","disorder": "myasthenia gravis"}}
 {"id": "4075534_3","context": "Two reports of spindle coma are noted with alcohol and imipramine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "noted"},{"annotation": "Effect","text": "spindle coma"},{"annotation": "Treatment","text": "alcohol and imipramine"}]}]}
 {"id": "3003260_2","context": "Cataracts induced by intermittent Decadron used as an antiemetic.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "cataracts"},{"annotation": "Treatment","text": "intermittent Decadron used as an antiemetic"},{"annotation": "Treatment.Drug","text": "Decadron"},{"annotation": "Treatment.Dosage","text": "intermittent"},{"annotation": "Treatment.Frequency","text": "Decadron"},{"annotation": "Treatment.Route","text": "oral"},{"annotation": "Treatment.Time_elapsed","text": "cataracts"},{"annotation": "Treatment.Duration","text": "intermittent"},{"annotation": "Treatment.Disorder","text": "cataracts"}]}
 {"id": "879939_2","context": "Severe osteomalacia was present in two epileptic patients who were under long-term treatment with congeners of phenytoin, phenobarbital, and acetazolamide.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "present"},{"annotation": "Effect", "text": "osteomalacia"},{"annotation": "Treatment", "text": "congeners of phenytoin, phenobarbital, and acetazolamide"},{"annotation": "Treatment.Drug", "text": "congeners of phenytoin"},{"annotation": "Treatment.Drug", "text": "congeners of phenobarbital"},{"annotation": "Treatment.Drug", "text": "congeners of acetazolamide"},{"annotation": "Treatment.Duration", "text": "long-term"},{"annotation": "Treatment.Drug", "text": "phenytoin"},{"annotation": "Treatment.Drug", "text": "phenobarbital"},{"annotation": "Treatment.Drug", "text": "acetazolamide"},{"annotation": "Subject", "text": "two epileptic patients"},{"annotation": "Subject.Disorder", "text": "epileptic"}]}
 {"id":"3969689_4","context":"Careful observations on hepatotoxicity are suggested when acetaminophen is prescribed with caffeine.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Effect","text":"hepatotoxicity"},{"annotation":"Treatment","text":"acetaminophen"},{"annotation":"Treatment.Drug","text":"caffeine"},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","text":"negated","annotations":[{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"Attribute","text":"negated","annotations":[{"annotation":"negated","text":"not present"}]},{"annotation":"
 {"id": "8912599_6","context": "Erosion of psoriatic plaques: an early sign of methotrexate toxicity.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "toxicity"}, {"annotation": "Effect", "text": "erosion of psoriatic plaques"}, {"annotation": "Treatment", "text": "methotrexate"}, {"annotation": "Treatment.Disorder", "text": "psoriatic plaques"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Subject", "text": "unknown"}, {"annotation": "Subject.Disorder", "text": "psoriatic plaques"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "toxicity"}, {"annotation": "Effect", "text": "erosion of psoriatic plaques"}, {"annotation": "Treatment", "text": "methotrexate"}, {"annotation": "Treatment.Disorder", "text": "psoriatic plaques"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Subject", "text": "unknown"}, {"annotation": "Subject.Disorder", "text": "psoriatic plaques"}]}]}
 {"id": "11696132_1","context": "After extensive neurological 'work up', we realized that the anisocoria was related to the transdermal scopolamine patch that we had prescribed for weaning off the opioid.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "anisocoria"},{"annotation": "Treatment","text": "transdermal scopolamine patch"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Effect","text": "anisocoria"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Disorder","text": "anisocoria"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "neurological"},{"annotation": "Treatment.Disorder","text": "work up"},{"annotation": "Treatment.Disorder","text": "weaning"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Drug","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Drug","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Disorder","text": "anisocoria"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "neurological"},{"annotation": "Treatment.Disorder","text": "work up"},{"annotation": "Treatment.Disorder","text": "weaning"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Drug","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Disorder","text": "anisocoria"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "neurological"},{"annotation": "Treatment.Disorder","text": "work up"},{"annotation": "Treatment.Disorder","text": "weaning"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Drug","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Disorder","text": "anisocoria"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "neurological"},{"annotation": "Treatment.Disorder","text": "work up"},{"annotation": "Treatment.Disorder","text": "weaning"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Drug","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Disorder","text": "anisocoria"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "neurological"},{"annotation": "Treatment.Disorder","text": "work up"},{"annotation": "Treatment.Disorder","text": "weaning"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Drug","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Disorder","text": "anisocoria"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "neurological"},{"annotation": "Treatment.Disorder","text": "work up"},{"annotation": "Treatment.Disorder","text": "weaning"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Drug","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Disorder","text": "anisocoria"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "neurological"},{"annotation": "Treatment.Disorder","text": "work up"},{"annotation": "Treatment.Disorder","text": "weaning"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Drug","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Disorder","text": "anisocoria"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "neurological"},{"annotation": "Treatment.Disorder","text": "work up"},{"annotation": "Treatment.Disorder","text": "weaning"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Drug","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","text": "opioid"},{"annotation": "Treatment.Disorder","text": "anisocoria"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "neurological"},{"annotation": "Treatment.Disorder","text": "work up"},{"annotation": "Treatment.Disorder","text": "weaning"},{"annotation": "Treatment.Disorder","text": "opioid"},{"annotation": "Treatment.Disorder","text": "transdermal"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Treatment.Drug","
 {"id": "12851279_1","context": "Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "severe sepsis"},{"annotation": "Treatment","text": "tifacogin"},{"annotation": "Treatment.Drug","text": "tifacogin"},{"annotation": "Effect","text": "efficacy and safety"},{"annotation": "Treatment.Disorder","text": "severe sepsis"}]}]
 {"id": "15863610_5","context": "CASE: A malignant mixed mesodermal tumor was diagnosed in a 64-year-old woman with a bicornuate uterus while she was taking raloxifene for osteoporosis prevention.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "diagnosed"},{"annotation": "Treatment","text": "raloxifene"},{"annotation": "Treatment.Drug","text": "raloxifene"},{"annotation": "Treatment.Disorder","text": "malignant mixed mesodermal tumor"},{"annotation": "Treatment.Disorder","text": "bicornuate uterus"},{"annotation": "Treatment.Disorder","text": "osteoporosis prevention"}]}]}
 {"id": "16728538_1","context": "After rechallenge with monotherapy pegvisomant, however, the hepatic enzyme disturbances reappeared within a few weeks, indicating that most likely pegvisomant alone and not the long-acting somatostatin analog or the combination of these two drugs was responsible for this case of drug-induced hepatitis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "hepatitis"},{"annotation": "Treatment","text": "pegvisomant"},{"annotation": "Treatment.Disorder","text": "drug-induced hepatitis"},{"annotation": "Treatment.Drug","text": "pegvisomant"},{"annotation": "Treatment.Drug","text": "long-acting somatostatin analog"},{"annotation": "Treatment.Drug","text": "combination of pegvisomant and long-acting somatostatin analog"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "pegvisomant"},{"annotation": "Treatment.Combination.Drug","text": "long-acting somatostatin analog"},{"annotation": "Treatment.Combination.Drug","text": "combination of pegvisomant and long-acting somatostatin analog"},{"annotation": "Subject","text": "patient"},{"annotation": "Subject.Disorder","text": "drug-induced hepatitis"}]}
 {"id": "22372628_2","context": "To evaluate the long-term (up to 5 years exposure) safety and efficacy of lacosamide as adjunctive therapy in patients with uncontrolled partial-onset seizures taking one to three concomitant antiepileptic drugs (AEDs) in open-label extension trial SP756 (NCT00522275).","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment", "text": "lacosamide"},{"annotation": "Treatment.Drug", "text": "lacosamide"},{"annotation": "Treatment.Disorder", "text": "uncontrolled partial-onset seizures"},{"annotation": "Treatment.Duration", "text": "5 years"},{"annotation": "Treatment.Combination", "text": "one to three concomitant antiepileptic drugs (AEDs)"},{"annotation": "Treatment.Combination.Drug", "text": "one to three concomitant antiepileptic drugs (AEDs)"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Trial", "text": "open-label extension trial SP756 (NCT00522275)"},{"annotation": "Trial.Name", "text": "SP756"},{"annotation": "Trial.Identifier", "text": "NCT00522275"},{"annotation": "Trial.Type", "text": "extension trial"},{"annotation": "Trial.Duration", "text": "5 years"},{"annotation": "Trial.Population", "text": "patients with uncontrolled partial-onset seizures"},{"annotation": "Trial.Population.Number", "text": "unknown"}]}]}
 {"id": "7071645_3","context": "Complete remission of the nephrosis occurred after discontinuation of hydroxychloroquine therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurred"},{"annotation": "Effect","text": "remission"},{"annotation": "Treatment","text": "hydroxychloroquine therapy"},{"annotation": "Treatment.Drug","text": "hydroxychloroquine"},{"annotation": "Treatment.Duration","text": "after discontinuation"}]}]
 {"id": "18364401_1","context": "CONCLUSIONS: Clinicians treating elderly patients with olanzapine should be aware of the potential for rapidly developing hyperglycemia and monitor such patients accordingly.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "treating"},{"annotation": "Treatment","text": "elderly patients with olanzapine"},{"annotation": "Treatment.Disorder","text": "hyperglycemia"},{"annotation": "Treatment.Drug","text": "olanzapine"},{"annotation": "Event type","text": "Potential_therapeutic_effect"}]}]
 {"id": "18661248_2","context": "We describe a case of PRES in a patient with collapsing focal glomeruloesclerosis (collapsing FGS) with complete recovery after withdrawal of cyclosporine (CSA).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Effect","text": "PRES"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "Treatment.Disorder","text": "collapsing focal glomeruloesclerosis"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "
 {"id": "12022905_3","context": "DISCUSSION: The occurrence of priapism in our patient was related to zuclopenthixol.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurrence"},{"annotation": "Effect","text": "priapism"},{"annotation": "Treatment","text": "zuclopenthixol"}]}]
 {"id":"11202801_2","context":"Hepatic angiosarcoma occurring after cyclophosphamide therapy: case report and review of the literature.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"hepatic angiosarcoma"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver failure"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver necrosis"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver fibrosis"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver toxicity"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver abscess"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver failure"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver cirrhosis"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver regeneration"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver fibrosis"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver failure"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver regeneration"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver fibrosis"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver failure"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver regeneration"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver fibrosis"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver failure"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver regeneration"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver fibrosis"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver failure"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver regeneration"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver fibrosis"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver failure"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver regeneration"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver fibrosis"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver failure"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver regeneration"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"liver fibrosis"},{"annotation":"Treatment","text":"cyclophosphamide therapy"},{"annotation":"Treatment.Disorder","text":"cancer"},{"annotation":"Treatment.Drug","text":"cyclophosphamide"},{"annotation":"Attribute","text":"negated","annotationType":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurred after"},{"annotation":"Effect","text":"
 {"id": "11283125_3","context": "After completion of induction-consolidation phase, children with increased-risk (risk factor > 0.8 or T-lineage) ALL or stage III and IV lymphoblastic lymphoma were randomized to receive four courses of HD MTX (5 g/m(2) over 24 hours every 2 weeks) and four intrathecal administrations of MTX (Arm A) or the same treatment schedule with additional HD IV Ara-C (1 g/m(2) in bolus injection 12 and 24 hours after the start of each MTX infusion) (Arm B).","events": [{"type": "Administration","annotations": [{"annotation": "Treatment","text": "HD MTX (5 g/m(2) over 24 hours every 2 weeks) and four intrathecal administrations of MTX"},{"annotation": "Treatment.Drug","text": "HD MTX"},{"annotation": "Treatment.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination","text": "HD MTX and additional HD IV Ara-C"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "text": "and"},{"annotation": "Treatment.Combination.Drug","text": "HD MTX"},{"annotation": "Treatment.Combination.Drug","text": "Ara-C"},{"annotation": "Treatment.Combination.Trigger","text": "text": "and"},{"annotation": "T
 {"id": "7756684_1","context": "The dose-limiting toxicity of KW-2149 is pulmonary toxicity.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "dose-limiting toxicity"},{"annotation": "Treatment","text": "KW-2149"},{"annotation": "Treatment.Drug","text": "KW-2149"},{"annotation": "Effect","text": "pulmonary toxicity"}]}]
 {"id": "15773973_1","context": "Flucloxacillin-induced aplastic anaemia and liver failure.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "aplastic anaemia and liver failure"},{"annotation": "Treatment", "text": "flucloxacillin"},{"annotation": "Treatment.Disorder", "text": "aplastic anaemia and liver failure"},{"annotation": "Treatment.Drug", "text": "flucloxacillin"}]}]
 {"id": "18855892_8","context": "Thus, we confirm that desensitization may be a safe procedure in patients with cancer who experience methotrexate-induced anaphylaxis.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "anaphylaxis"},{"annotation": "Treatment","text": "desensitization"},{"annotation": "Treatment.Disorder","text": "methotrexate-induced anaphylaxis"}]}]}
 {"id": "15286697_4","context": "We further used immunohistochemistry (IHC) to examine the relative role of platelet-derived growth factor-B (PDGF-B), insulin-like growth factor I (IGF-I), transforming growth factor-beta1 (TGF-beta1) and cyclooxygenase-2 (COX-2) in the pathogenesis of BCNU-related pulmonary fibrosis.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "examined"},{"annotation": "Treatment","text": "immunohistochemistry (IHC)"},{"annotation": "Treatment.Disorder","text": "BCNU-related pulmonary fibrosis"},{"annotation": "Treatment.Drug","text": "BCNU"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "PDGF-B"},{"annotation": "Treatment.Combination.Drug","text": "IGF-I"},{"annotation": "Treatment.Combination.Drug","text": "TGF-beta1"},{"annotation": "Treatment.Combination.Drug","text": "COX-2"}]}
 {"id": "2241449_1","context": "Physicians using this 'new' drug must be aware of the potential danger of sulfonamide-induced injury to the urinary tract.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "using"},{"annotation": "Treatment","text": "this 'new' drug"},{"annotation": "Treatment.Disorder","text": "sulfonamide-induced injury"},{"annotation": "Treatment.Drug","text": "sulfonamide"},{"annotation": "Treatment.Drug","text": "injury"},{"annotation": "Treatment.Drug","text": "urinary tract"},{"annotation": "Treatment.Drug","text": "physicians"},{"annotation": "Treatment.Drug","text": "awareness"],"subject": {"Age": "unknown","Gender": "unknown","Population": "physicians","Race": "unknown","Disorder": "sulfonamide-induced injury"}}
 {"id": "12504711_4","context": "RESULTS: Brimonidine was observed to cause IOP elevation, confirmed on rechallenge, scoring 8 (strong probability) on an adverse drug reaction probability score.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "caused"},{"annotation": "Treatment","text": "brimonidine"},{"annotation": "Treatment.Drug","text": "brimonidine"},{"annotation": "Effect","text": "IOP elevation"},{"annotation": "Treatment.Drug","text": "brimonidine"},{"annotation": "Treatment.Drug","text": "brimonidine"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "brimonidine"},{"annotation": "Treatment.Combination.Drug","text": "brimonidine"},{"annotation": "Subject","text": "patient"},{"annotation": "Subject.Disorder","text": "IOP elevation"},{"annotation": "Treatment.Drug","text": "brimonidine"},{"annotation": "Treatment.Drug","text": "brimonidine"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "brimonidine"},{"annotation": "Treatment.Combination.Drug","text": "brimonidine"},{"annotation": "Event type","text": "Adverse_event"},{"annotation": "Probability","text": "8"}]}
 {"id": "15507779_1","context": "Severe leukopenia associated with mild hepatotoxicity in an HIV carrier treated with nevirapine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated"},{"annotation": "Effect","text": "leukopenia"},{"annotation": "Effect","text": "hepatotoxicity"},{"annotation": "Treatment","text": "nevirapine"},{"annotation": "Treatment.Disorder","text": "HIV carrier"},{"annotation": "Treatment.Drug","text": "nevirapine"}]}
 {"id": "1711090_2","context": "The clinical effect and safety of Lp-TAE alone and combined with radiofrequency (RF) capacitive hyperthermia (HT) were evaluated in 20 patients with hepatocellular carcinoma (HCC) associated with cirrhosis of the liver.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "evaluated"},{"annotation": "Treatment","text": "Lp-TAE alone and combined with radiofrequency (RF) capacitive hyperthermia (HT)"},{"annotation": "Treatment.Disorder","text": "hepatocellular carcinoma (HCC) associated with cirrhosis of the liver"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "not specified"},{"annotation": "Treatment","text": "Lp-TAE alone and combined with radiofrequency (RF) capacitive hyperthermia (HT)"},{"annotation": "Treatment.Disorder","text": "not specified"}]}]}
 {"id": "3806824_1", "context": "Fibrosis of corpus cavernosum after intracavernous injection of phentolamine/papaverine.", "events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "intracavernous injection of phentolamine/papaverine"}, {"annotation": "Treatment", "text": "phentolamine/papaverine"}, {"annotation": "Treatment.Drug", "text": "phentolamine/papaverine"}, {"annotation": "Effect", "text": "fibrosis of corpus cavernosum"}, {"annotation": "Treatment.Route", "text": "intracavernous"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Combination.Trigger", "text": "and"}, {"annotation": "Treatment.Combination.Drug", "text": "phentolamine/papaverine"}, {"annotation": "Treatment.Combination.Drug", "text": "phentolamine/papaverine"}, {"annotation": "Treatment.Combination.Trigger", "text": "and"}, {"annotation": "Treatment.Combination.Drug", "text": "phentolamine/papaverine"}, {"annotation": "Treatment.Combination.Drug", "text": "phentolamine/papaverine"}]}]}
 {"id":"440873_4","context":"We have cared for three children in whom four episodes of dystonia proceeding to opisthotonus occurred in association with carbamazepine use.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"proceeding"},{"annotation":"Treatment","text":"carbamazepine use"},{"annotation":"Treatment.Drug","text":"carbamazepine"},{"annotation":"Effect","text":"dystonia proceeding to opisthotonus"},{"annotation":"Treatment","text":"carbamazepine use"},{"annotation":"Treatment.Drug","text":"carbamazepine"},{"annotation":"Treatment.Duration","text":"in association with carbamazepine use"},{"annotation":"Treatment.Duration","text":"occurred in four episodes"},{"annotation":"Treatment.Duration","text":"in three children"},{"annotation":"Subject","text":"three children"},{"annotation":"Subject.Age","text":"in whom"},{"annotation":"Subject.Population","text":"in association with carbamazepine use"},{"annotation":"Treatment.Route","text":"in association with carbamazepine use"},{"annotation":"Treatment.Time_elapsed","text":"in association with carbamazepine use"},{"annotation":"Treatment.Duration","text":"in association with carbamazepine use"},{"annotation":"Treatment.Disorder","text":"dystonia proceeding to opisthotonus"},{"annotation":"Treatment.Disorder","text":"carbamazepine use"},{"annotation":"Attribute Attributes","text":"negated","annotation":{"negated":"negated","text":"the adverse effect does not exist"}},{"annotation":"Attribute Attributes","text":"speculated","annotation":{"speculated":"speculated","text":"if there is any uncertain or speculation as to whether an event will actually happen"}},{"annotation":"Attribute Attributes","text":"severity","annotation":{"severity":"high","text":"fatal effect"}},{"annotation":"Attribute Attributes","text":"severity","annotation":{"severity":"low","text":"minor symptom"}},{"annotation":"Event type","text":"Adverse_event"},{"annotation":"Event type","text":"Potential_therapeutic_effect"}]}]}
 {"id": "17275666_1","context": "Juvenile absence epilepsy exacerbated by valproic acid.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "exacerbated"},{"annotation": "Treatment","text": "valproic acid"},{"annotation": "Treatment.Drug","text": "valproic acid"},{"annotation": "Effect","text": "absence epilepsy"},{"annotation": "Treatment.Disorder","text": "juvenile absence epilepsy"}]}]
 {"id": "15516308_10","context": "These cases were chosen for study because they were all deaths as a result of suicidal ingestion of drugs in which quetiapine was considered a significant factor.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "suicidal ingestion of drugs"},{"annotation": "Treatment","text": "quetiapine"},{"annotation": "Treatment.Drug","text": "quetiapine"},{"annotation": "Effect","text": "death"},{"annotation": "Treatment.Disorder","text": "suicidal ingestion of drugs"},{"annotation": "Treatment.Drug","text": "quetiapine"}]}
 {"id": "16599252_2","context": "We present a case of hypereosinophilia related to zafirlukast therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "related to zafirlukast therapy"},{"annotation": "Effect","text": "hypereosinophilia"},{"annotation": "Treatment","text": "zafirlukast therapy"}]}]}
 {"id": "18855892_3","context": "In patients with methotrexate-induced anaphylaxis, discontinuation of treatment may increase the risk of death due to cancer progression.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "methotrexate-induced"},{"annotation": "Effect","text": "anaphylaxis"},{"annotation": "Treatment","text": "methotrexate"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Duration","text": "treatment"},{"annotation": "Treatment.Disorder","text": "methotrexate-induced anaphylaxis"},{"annotation": "Attribute","text": "negated","annotationType": "negated"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "discontinuation of treatment"},{"annotation": "Effect","text": "death"},{"annotation": "Treatment","text": "methotrexate"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Duration","text": "treatment"},{"annotation": "Treatment.Disorder","text": "methotrexate-induced anaphylaxis"},{"annotation": "Attribute","text": "negated","annotationType": "negated"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "cancer progression"},{"annotation": "Effect","text": "death"},{"annotation": "Treatment","text": "discontinuation of methotrexate treatment"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Duration","text": "treatment"},{"annotation": "Treatment.Disorder","text": "methotrexate-induced anaphylaxis"},{"annotation": "Attribute","text": "negated","annotationType": "negated"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "cancer progression"},{"annotation": "Effect","text": "death"},{"annotation": "Treatment","text": "methotrexate"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Duration","text": "treatment"},{"annotation": "Treatment.Disorder","text": "methotrexate-induced anaphylaxis"},{"annotation": "Attribute","text": "negated","annotationType": "negated"}]}
 {"id": "9737132_3","context": "Pentazocine-induced fibrous myopathy and localized neuropathy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "fibrous myopathy and localized neuropathy"},{"annotation": "Treatment","text": "pentazocine"}]}]}
 {"id": "11096051_1","context": "Intensive high-flux hemodiafiltration is often used in the management of vancomycin toxicity.","events": [{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "vancomycin toxicity"},{"annotation": "Treatment", "text": "intensive high-flux hemodiafiltration"},{"annotation": "Treatment.Disorder", "text": "vancomycin toxicity"},{"annotation": "Treatment.Drug", "text": "vancomycin"}]}]}
 {"id": "17823522_3","context": "Here we present the case of a generalized lichen nitidus with involvement of the palms in a patient with hepatitis C after systemic treatment with interferon alpha and ribavirin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "involvement of the palms"},{"annotation": "Effect","text": "lichen nitidus"},{"annotation": "Treatment","text": "systemic treatment with interferon alpha and ribavirin"},{"annotation": "Treatment.Disorder","text": "hepatitis C"},{"annotation": "Treatment.Drug","text": "interferon alpha"},{"annotation": "Treatment.Drug","text": "ribavirin"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "interferon alpha"},{"annotation": "Treatment.Combination.Drug","text": "ribavirin"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Disorder","text": "hepatitis C"}]}
 {"id": "6810714_1","context": "The authors describe a woman with chronic schizophrenia who experienced delirium, grand mal seizure, and photosensitivity after the addition of propranolol to her neuroleptic regimen.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "addition of propranolol"},{"annotation": "Effect","text": "delirium, grand mal seizure, and photosensitivity"},{"annotation": "Treatment","text": "neuroleptic regimen"},{"annotation": "Treatment.Drug","text": "propranolol"},{"annotation": "Treatment.Drug","text": "neuroleptic"},{"annotation": "Subject","text": "woman with chronic schizophrenia"},{"annotation": "Subject.Disorder","text": "chronic schizophrenia"}]}
 {"id": "16132305_2","context": "We report a case of an infant with complex congenital heart disease who was placed on captopril for afterload reduction following cardiac surgery and subsequently developed pulmonary infiltrates with eosinophilia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "placed on captopril"},{"annotation": "Effect","text": "pulmonary infiltrates with eosinophilia"},{"annotation": "Treatment","text": "captopril"},{"annotation": "Treatment.Drug","text": "captopril"},{"annotation": "Treatment.Duration","text": "after cardiac surgery"},{"annotation": "Treatment.Effect","text": "afterload reduction"},{"annotation": "Subject","text": "an infant with complex congenital heart disease"},{"annotation": "Subject.Disorder","text": "complex congenital heart disease"}]}
 {"id": "3084231_1","context": "Possible pathophysiological mechanisms which may have been operative in this case include: a direct central nervous system (CNS) toxic effect of valproic acid; a paradoxical epileptogenic effect secondary to the drug; and an indirect CNS toxic effect mediated through valproic acid-induced hyperammonemia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "valproic acid"},{"annotation": "Effect","text": "CNS toxicity"},{"annotation": "Treatment","text": "valproic acid"},{"annotation": "Treatment.Drug","text": "valproic acid"},{"annotation": "Treatment.Disorder","text": "CNS toxicity"}],"attributes": [{"annotation": "negated","text": "No"},{"annotation": "speculated","text": "No"},{"annotation": "severity","text": "high"}],"subject": {"Age": "not specified","Gender": "not specified","Population": "not specified","Race": "not specified","Disorder": "CNS toxicity"}},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "valproic acid"},{"annotation": "Effect","text": "epileptogenic effect"},{"annotation": "Treatment","text": "valproic acid"},{"annotation": "Treatment.Drug","text": "valproic acid"},{"annotation": "Treatment.Disorder","text": "epileptogenic effect"}],"attributes": [{"annotation": "negated","text": "No"},{"annotation": "speculated","text": "No"},{"annotation": "severity","text": "high"}],"subject": {"Age": "not specified","Gender": "not specified","Population": "not specified","Race": "not specified","Disorder": "epileptogenic effect"}},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "valproic acid"},{"annotation": "Effect","text": "hyperammonemia-induced CNS toxicity"},{"annotation": "Treatment","text": "valproic acid"},{"annotation": "Treatment.Drug","text": "valproic acid"},{"annotation": "Treatment.Disorder","text": "hyperammonemia-induced CNS toxicity"}],"attributes": [{"annotation": "negated","text": "No"},{"annotation": "speculated","text": "No"},{"annotation": "severity","text": "high"}],"subject": {"Age": "not specified","Gender": "not specified","Population": "not specified","Race": "not specified","Disorder": "hyperammonemia-induced CNS toxicity"}}]}
 {"id": "19583682_3","context": "We report a case of serotonin syndrome induced by pharmacokinetic and pharmacodynamic interactions between three different selective serotonin-reuptake inhibitors (SSRI) and possibly ciprofloxacin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "SSRIs and ciprofloxacin"},{"annotation": "Treatment.Drug","text": "SSRIs"},{"annotation": "Treatment.Drug","text": "ciprofloxacin"},{"annotation": "Treatment.Drug.Interaction","text": "pharmacokinetic and pharmacodynamic interactions"},{"annotation": "Effect","text": "serotonin syndrome"}]}]
 {"id":"12218252_1","context":"Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Effect","text":"pustular psoriasis"},{"annotation":"Treatment","text":"withdrawal of cyclosporin a"},{"annotation":"Treatment.Disorder","text":"cyclosporin a withdrawal"},{"annotation":"Treatment.Drug","text":"cyclosporin"},{"annotation":"Treatment","text":"etanercept"},{"annotation":"Treatment.Disorder","text":"pustular psoriasis"},{"annotation":"Treatment.Drug","text":"etanercept"},{"annotation":"Treatment.Drug","text":"tumour necrosis factor alpha inhibitor"},{"annotation":"Treatment.Combination.Trigger","text":"withdrawal of"},{"annotation":"Treatment.Combination.Drug","text":"cyclosporin a"},{"annotation":"Treatment.Combination.Drug","text":"etanercept"},{"annotation":"Treatment.Combination.Drug","text":"tumour necrosis factor alpha inhibitor"},{"annotation":"Subject","text":"a patient"},{"annotation":"Subject.Disorder","text":"pustular psoriasis"}]}]}
 {"id": "10592946_1","context": "A 36-y-o patient with schizophrenia, who had consumed gradually increasing quantities of oolong tea that eventually reached 15 L each day, became delirious and was admitted to a psychiatric hospital.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "consumed"},{"annotation": "Treatment","text": "oolong tea"},{"annotation": "Treatment.Drug","text": "oolong tea"},{"annotation": "Effect","text": "delirium"},{"annotation": "Treatment.Drug","text": "oolong tea"},{"annotation": "Treatment.Duration","text": "gradually increasing quantities"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Disorder","text": "schizophrenia"}]}
 {"id": "3242521_1","context": "Intraventricular nafcillin-induced seizures in a neonate.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "nafcillin"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Effect","text": "seizures"},{"annotation": "Treatment.Drug","text": "nafcillin"},{"annotation": "Treatment.Dosage","text": "intraventricular"},{"annotation": "Treatment.Frequency","text": "seizures"},{"annotation": "Treatment.Route","text": "intraventricular"},{"annotation": "Treatment.Time_elapsed","text": "seizures"},{"annotation": "Treatment.Duration","text": "seizures"},{"annotation": "Treatment.Disorder","text": "nafcillin-induced seizures"},{"annotation": "Subject","text": "neonate"},{"annotation": "Subject.Age","text": "neonate"},{"annotation": "Subject.Gender","text": "neonate"},{"annotation": "Subject.Population","text": "neonate"},{"annotation": "Subject.Race","text": "neonate"},{"annotation": "Subject.Disorder","text": "nafcillin-induced seizures"}]}
 {"id": "6671350_4","context": "Nevertheless, the coagulopathy seemed to be most closely associated with the administration of the cephalosporin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "administered"},{"annotation": "Effect","text": "coagulopathy"},{"annotation": "Treatment","text": "cephalosporin"}]}]}
 {"id": "6873616_2","context": "Intrahepatic cholestasis and sicca complex after thiabendazole.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "after thiabendazole."},{"annotation": "Treatment","text": "thiabendazole"},{"annotation": "Treatment.Drug","text": "thiabendazole"},{"annotation": "Effect","text": "cholestasis and sicca complex"}]}]
 {"id": "748238_3","context": "We recommended periodic examination of the serum proteins in patients receiving diphenylhydantoin in order to detect development of monoclonal gammopathy.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "periodic examination of serum proteins"},{"annotation": "Treatment","text": "diphenylhydantoin"},{"annotation": "Treatment.Disorder","text": "monoclonal gammopathy"},{"annotation": "Attribute.negated","text": "not negated"},{"annotation": "Attribute.speculated","text": "not speculated"},{"annotation": "Attribute.severity","text": "not applicable"}]}]
 {"id": "6671350_3","context": "Moxalactam is more likely to be associated with platelet dysfunction.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated"},{"annotation": "Effect","text": "platelet dysfunction"},{"annotation": "Treatment","text": "moxalactam"},{"annotation": "Treatment.Drug","text": "moxalactam"}]}]
 {"id": "8151270_2","context": "This prompted us to suspect that ddI might be responsible for fulminant hepatitis in all three AIDS patients.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "prompted"},{"annotation": "Effect","text": "fulminant hepatitis"},{"annotation": "Treatment","text": "ddI"},{"annotation": "Treatment.Drug","text": "ddI"},{"annotation": "Subject","text": "three AIDS patients"},{"annotation": "Subject.Disorder","text": "AIDS"}]}
 {"id": "10573314_3","context": "Two patients, each receiving warfarin for stroke prophylaxis in association with chronic atrial fibrillation, developed adverse effects after the initiation of tolterodine for urinary disorders.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "initiation of tolterodine"},{"annotation": "Treatment","text": "warfarin"},{"annotation": "Treatment","text": "tolterodine"},{"annotation": "Treatment.Disorder","text": "stroke prophylaxis"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "tolterodine"},{"annotation": "Subject","text": "two patients"},{"annotation": "Subject.Disorder","text": "chronic atrial fibrillation"}]}
 {"id": "16288069_2","context": "CASE SUMMARY: A 45-year-old HIV-positive man (CD4+ count 450 cells/mm(3) and history of AIDS-defining illness) presented with JHR after an initial intravenous dose of penicillin G for presumed neurosyphilis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "initial intravenous dose of penicillin G"},{"annotation": "Effect","text": "JHR"},{"annotation": "Treatment","text": "penicillin G"},{"annotation": "Treatment.Disorder","text": "neurosyphilis"},{"annotation": "Subject","text": "a 45-year-old HIV-positive man"},{"annotation": "Subject.Age","text": "45 years"},{"annotation": "Subject.Gender","text": "not specified"},{"annotation": "Subject.Population","text": "1"},{"annotation": "Subject.Race","text": "not specified"},{"annotation": "Subject.Disorder","text": "HIV"}]}
 {"id": "16393774_6","context": "The second patient developed both autoimmune thyroid disease and a refractory pre-patellar bursitis after 50 months of IFN-beta therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "developed"},{"annotation": "Treatment", "text": "IFN-beta therapy"},{"annotation": "Treatment.Drug", "text": "IFN-beta"},{"annotation": "Treatment.Duration", "text": "50 months"},{"annotation": "Treatment.Disorder", "text": "autoimmune thyroid disease"},{"annotation": "Treatment.Disorder", "text": "refractory pre-patellar bursitis"},{"annotation": "Subject", "text": "the second patient"},{"annotation": "Subject.Disorder", "text": "autoimmune thyroid disease"},{"annotation": "Subject.Disorder", "text": "refractory pre-patellar bursitis"}]}]
 {"id": "3156465_3","context": "We report an additional case of isotretinoin teratogenicity in which the patient had agenesis of the cerebellar vermis, multiple leptomeningeal neuroglial heterotopias, hydrocephalus, and abnormalities of the corticospinal tracts.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "isotretinoin"},{"annotation": "Effect","text": "teratogenicity"},{"annotation": "Treatment","text": "isotretinoin"},{"annotation": "Treatment.Disorder","text": "isotretinoin teratogenicity"}]}]}
 {"id": "13680140_1","context": "Reversible sclerotic changes of lumbar spine and femur due to long-term oral isotretinoin therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "due to long-term oral isotretinoin therapy"},{"annotation": "Treatment","text": "oral isotretinoin therapy"},{"annotation": "Treatment.Drug","text": "isotretinoin"},{"annotation": "Treatment.Dosage","text": "long-term"},{"annotation": "Effect","text": "sclerotic changes"},{"annotation": "Treatment.Disorder","text": "lumbar spine and femur"}]}
 {"id": "6725214_1","context": "A case of priapism associated with trazodone is described.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with trazodone"},{"annotation": "Effect","text": "priapism"},{"annotation": "Treatment","text": "trazodone"}]}]}
 {"id":"16678268_1","context":"Severe adenovirus pneumonia (AVP) following infliximab infusion for the treatment of Crohn's disease.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"following infliximab infusion for the treatment of Crohn's disease."},{"annotation":"Treatment","text":"infliximab infusion for the treatment of Crohn's disease."},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"adenovirus pneumonia (AVP)"}]}]
 {"id": "6693840_3","context": "No other endogenous or exogenous cause for the gynecomastia could be found except for the theophylline.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "gynecomastia"},{"annotation": "Effect","text": "theophylline"},{"annotation": "Treatment","text": "theophylline"},{"annotation": "Treatment.Disorder","text": "gynecomastia"}]}]}
 {"id": "16018164_5","context": "This is a case of pseudoephedrine-induced intracerebral hemorrhage in a patient with an underlying vascular malformation.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "intracerebral hemorrhage"},{"annotation": "Treatment","text": "pseudoephedrine"},{"annotation": "Treatment.Drug","text": "pseudoephedrine"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Disorder","text": "an underlying vascular malformation"}]}
 {"id": "6651138_1","context": "A 58-year-old woman developed unilateral acute angle-closure glaucoma four days after the application of a patch of transdermal scopolamine delivery system (TRANSDERM-V).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "application"},{"annotation": "Treatment","text": "transdermal scopolamine delivery system (TRANSDERM-V)"},{"annotation": "Treatment.Drug","text": "scopolamine"},{"annotation": "Subject","text": "a 58-year-old woman"},{"annotation": "Subject.Age","text": "58"},{"annotation": "Effect","text": "unilateral acute angle-closure glaucoma"},{"annotation": "Treatment.Disorder","text": "unilateral acute angle-closure glaucoma"},{"annotation": "Treatment.Duration","text": "four days"}]}
 {"id": "12218252_2","context": "We report a 50-year-old male patient with a 15-year history of psoriasis including mutilating psoriatic arthritis, in whom the withdrawal of cyclosporin A induced a generalised pustular exacerbation and a aggravation of the joint condition.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "withdrawal of cyclosporin A"},{"annotation": "Treatment","text": "cyclosporin A"},{"annotation": "Treatment.Drug","text": "cyclosporin A"},{"annotation": "Treatment.Drug","text": "psoriasis"},{"annotation": "Effect","text": "generalised pustular exacerbation and aggravation of joint condition"},{"annotation": "Subject","text": "50-year-old male patient"},{"annotation": "Subject.Disorder","text": "psoriasis including mutilating psoriatic arthritis"}]}
 {"id":"8726608_2","context":"Six days after starting acyclovir she exhibited signs of lithium toxicity.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"starting"},{"annotation":"Treatment","text":"acyclovir"},{"annotation":"Treatment.Drug","text":"acyclovir"},{"annotation":"Treatment.Dosage","text":"six days"},{"annotation":"Treatment.Duration","text":"after starting"},{"annotation":"Treatment.Disorder","text":"lithium toxicity"},{"annotation":"Treatment.Drug","text":"lithium"},{"annotation":"Effect","text":"signs"},{"annotation":"Subject","text":"she"},{"annotation":"Subject.Age","text":"six days"},{"annotation":"Subject.Gender","text":"she"}]}]}
 {"id": "11197767_1","context": "Toxicity of cadmium and zinc to encystment and in vitro excystment of Parorchis acanthus (Digenea: Philophthalmidae).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "toxicity"},{"annotation": "Effect","text": "encystment and in vitro excystment"},{"annotation": "Treatment","text": "cadmium and zinc"},{"annotation": "Treatment.Drug","text": "cadmium"},{"annotation": "Treatment.Drug","text": "zinc"},{"annotation": "Treatment.Disorder","text": "Parorchis acanthus"}]}]
 {"id": "2717661_1","context": "The syndrome of irreversible lithium-induced neurotoxicity (SILENT).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "neurotoxicity"},{"annotation": "Treatment","text": "lithium"},{"annotation": "Treatment.Disorder","text": "lithium-induced neurotoxicity"},{"annotation": "Treatment.Drug","text": "lithium"}]}]
 {"id": "589261_5","context": "One patient on ouabain also developed cardiomyopathy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "ouabain"},{"annotation": "Effect", "text": "cardiomyopathy"},{"annotation": "Treatment", "text": "ouabain"},{"annotation": "Treatment.Drug", "text": "ouabain"}]}]}
 {"id": "15863610_3","context": "Data suggest that tamoxifen is involved in the pathogenesis.","events": [{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Data suggest"},{"annotation": "Treatment", "text": "tamoxifen"},{"annotation": "Treatment.Disorder", "text": "pathogenesis"},{"annotation": "Attribute Attributes", "text": "speculated", "severity": "low"},{"annotation": "Attribute Attributes", "text": "negated", "severity": "high"}]}]}
 {"id": "6794018_2","context": "Intrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with"},{"annotation": "Effect","text": "intrahepatic cholestasis and cutaneous bullae"},{"annotation": "Treatment","text": "glibenclamide therapy"},{"annotation": "Treatment.Drug","text": "glibenclamide"}]}]}
 {"id": "18262450_1","context": "Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "enhances"},{"annotation": "Treatment","text": "prolonged-release oxycodone"},{"annotation": "Treatment.Disorder","text": "painful diabetic neuropathy"},{"annotation": "Treatment.Combination","text": "existing gabapentin therapy"},{"annotation": "Treatment.Drug","text": "prolonged-release oxycodone"},{"annotation": "Treatment.Drug","text": "gabapentin"}]}
 {"id": "14742791_3","context": "OBJECTIVE: To describe what is believed, as of November 4, 2003, to be the first case published in the literature of acute interstitial nephritis (AIN) due to pantoprazole.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "acute interstitial nephritis"},{"annotation": "Treatment","text": "pantoprazole"},{"annotation": "Treatment.Drug","text": "pantoprazole"},{"annotation": "Treatment.Disorder","text": "acute interstitial nephritis"}],"annotations": {"negated": false,"speculated": false,"severity": null}}]}
 {"id": "19555801_2","context": "We report a patient of organic bipolar affective disorder who developed hiccups with the atypical antipsychotic aripiprazole.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "hiccups"},{"annotation": "Treatment","text": "atypical antipsychotic aripiprazole"},{"annotation": "Treatment.Drug","text": "aripiprazole"}],"subject": {"population": "1","disorder": "organic bipolar affective disorder"}}
 {"id": "10682234_2","context": "A 28 year-old man with chronic hepatitis B was administered interferon-alpha (5 x 10(6) IU) intramuscularly once a day for 28 days.","events": [{"type": "Administration","annotations": [{"annotation": "Treatment","text": "interferon-alpha"},{"annotation": "Treatment.Drug","text": "interferon-alpha"},{"annotation": "Treatment.Dosage","text": "5 x 10(6) IU"},{"annotation": "Treatment.Route","text": "intramuscularly"},{"annotation": "Treatment.Duration","text": "28 days"},{"annotation": "Subject","text": "a man"},{"annotation": "Subject.Age","text": "28 years"},{"annotation": "Subject.Disorder","text": "chronic hepatitis B"}]}
 {"id": "21330680_2","context": "The case of a patient taking high-dosage olanzapine who experienced parkinsonism after smoking cessation is reported.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "parkinsonism"},{"annotation": "Effect","text": "parkinsonism"},{"annotation": "Treatment","text": "high-dosage olanzapine"},{"annotation": "Treatment.Drug","text": "olanzapine"},{"annotation": "Treatment.Dosage","text": "high-dosage"},{"annotation": "Treatment.Duration","text": "after smoking cessation"},{"annotation": "Subject","text": "patient"}]}
 {"id": "4066620_1","context": "A 65-year-old woman with bipolar disorder and complicated cardiovascular disease who was on maintenance lithium therapy developed a movement disorder following high doses of trazodone for treatment of an acute depression.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "following high doses of trazodone"},{"annotation": "Effect","text": "movement disorder"},{"annotation": "Treatment","text": "maintenance lithium therapy"},{"annotation": "Treatment.Drug","text": "trazodone"},{"annotation": "Treatment.Disorder","text": "bipolar disorder"},{"annotation": "Treatment.Disorder","text": "complicated cardiovascular disease"},{"annotation": "Treatment.Disorder","text": "acute depression"},{"annotation": "Subject","text": "a 65-year-old woman"},{"annotation": "Subject.Age","text": "65"},{"annotation": "Subject.Disorder","text": "bipolar disorder"},{"annotation": "Subject.Disorder","text": "complicated cardiovascular disease"},{"annotation": "Subject.Disorder","text": "acute depression"}]}
 {"id":"19354059_1","context": "The most common complication of warfarin use is adverse bleeding.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "use"},{"annotation": "Effect","text": "adverse bleeding"},{"annotation": "Treatment","text": "warfarin"}]}]}
 {"id": "18166746_2","context": "To report a case of autonomic, neurological and neuromuscular instability following methylene blue infusion for parathyroidectomy; to advance the argument for a diagnosis of serotonin syndrome; and to consider this diagnosis in previous, unexplained reports of adverse reactions amongst patients undergoing parathyroidectomy using methylene blue.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "methylene blue infusion for parathyroidectomy"},{"annotation": "Effect","text": "autonomic, neurological and neuromuscular instability"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment.Disorder","text": "serotonin syndrome"},{"annotation": "Treatment.Drug","text": "methylene blue"}]},{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "previous reports"},{"annotation": "Effect","text": "serotonin syndrome"},{"annotation": "Treatment","text": "parathyroidectomy"},{"annotation": "Treatment.Drug","text": "methylene blue"}]},{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "previous reports"},{"annotation": "Effect","text": "serotonin syndrome"},{"annotation": "Treatment","text": "parathyroidectomy"},{"annotation": "Treatment.Drug","text": "methylene blue"}]}],"subject": {"text": "patient"},"subject.disorder": {"text": "serotonin syndrome"},"subject.population": {"text": "patient"},"subject.race": {"text": "unknown"},"subject.age": {"text": "unknown"},"subject.gender": {"text": "unknown"}}
 {"id": "15571949_2","context": "PVT during chemotherapy in children is a rare event and appears to be closely related to intensive chemotherapy containing busulfan and to be associated with HVOD.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "during chemotherapy"},{"annotation": "Treatment","text": "intensive chemotherapy containing busulfan"},{"annotation": "Treatment.Drug","text": "busulfan"},{"annotation": "Effect","text": "PVT"},{"annotation": "Treatment.Disorder","text": "HVOD"}]}]
 {"id": "11724089_3","context": "It is hoped that this case report creates awareness that ofloxacin-induced toxic epidermal necrolysis is possible.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "ofloxacin"},{"annotation": "Treatment.Drug","text": "ofloxacin"},{"annotation": "Effect","text": "toxic epidermal necrolysis"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute.Negated","text": "ADE"}],"negated": true}]}
 {"id": "21630612_1","context": "Concomitant use of simvastatin and amiodarone resulting in severe rhabdomyolysis: a case report and review of the literature.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "comcomitant use of simvastatin and amiodarone"},{"annotation": "Effect","text": "severe rhabdomyolysis"},{"annotation": "Treatment","text": "simvastatin and amiodarone"}]}]}
 {"id": "9533061_10","context": "CONCLUSIONS: This report indicates clindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of diarrhea and clindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Effect","text": "CDIC"},{"annotation": "Treatment","text": "clindamycin phosphate vaginal cream"}]}]}
 {"id": "8308951_2","context": "A case of intercerebral hematoma due to warfarin-induced coagulopathy is presented.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "intercerebral hematoma"},{"annotation": "Treatment", "text": "warfarin"},{"annotation": "Treatment.Disorder", "text": "warfarin-induced coagulopathy"},{"annotation": "Subject", "text": "A patient"},{"annotation": "Subject.Age", "text": "unknown"},{"annotation": "Subject.Gender", "text": "unknown"},{"annotation": "Subject.Population", "text": "1"},{"annotation": "Subject.Race", "text": "unknown"},{"annotation": "Treatment.Drug", "text": "warfarin"},{"annotation": "Treatment.Dosage", "text": "unknown"},{"annotation": "Treatment.Frequency", "text": "unknown"},{"annotation": "Treatment.Route", "text": "unknown"},{"annotation": "Treatment.Time_elapsed", "text": "unknown"},{"annotation": "Treatment.Duration", "text": "unknown"},{"annotation": "Treatment.Disorder", "text": "warfarin-induced coagulopathy"}]}]}
 {"id": "3171334_3","context": "Severe visual loss after a single dose of vincristine in a patient with spinal cord astrocytoma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "single dose of vincristine"},{"annotation": "Effect","text": "severe visual loss"},{"annotation": "Treatment","text": "vincristine"},{"annotation": "Treatment.Drug","text": "vincristine"},{"annotation": "Treatment.Disorder","text": "spinal cord astrocytoma"}]}]
 {"id": "10682234_5","context": "Clonazepam, thioridazine, beta-blockers, anticholinergics, and bromocriptine did not ameliorate his akathisia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "akathisia"},{"annotation": "Treatment","text": "clonazepam, thioridazine, beta-blockers, anticholinergics, and bromocriptine"},{"annotation": "Effect","text": "not ameliorated"}]}]}
 {"id": "7761316_1","context": "Musculoskeletal complaints were the presenting symptoms in four of 44 children (9%) treated for relapsed Wilms' tumors with ifosfamide, a derivative of cyclophosphamide.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "presenting symptoms"},{"annotation": "Treatment","text": "ifosfamide"},{"annotation": "Treatment.Drug","text": "ifosfamide"},{"annotation": "Treatment.Disorder","text": "relapsed Wilms' tumors"},{"annotation": "Treatment.Drug","text": "cyclophosphamide"},{"annotation": "Treatment.Drug","text": "ifosfamide"},{"annotation": "Subject","text": "four of 44 children"},{"annotation": "Subject.Population","text": "44 children"},{"annotation": "Effect","text": "musculoskeletal complaints"}]}
 {"id": "8308951_1","context": "Cutaneous exposure to warfarin-like anticoagulant causing an intracerebral hemorrhage: a case report.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "cutaneous exposure"},{"annotation": "Effect","text": "intracerebral hemorrhage"},{"annotation": "Treatment","text": "warfarin-like anticoagulant"},{"annotation": "Treatment.Drug","text": "warfarin"}]}]}
 {"id": "16317298_2","context": "Gemcitabine should be added to the list of drugs known to cause radiation recall.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "gemcitabine"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "unknown"},{"annotation": "Effect","text": "radiation recall"}]}]
 {"id": "12504711_1","context": "A paradoxical ocular effect of brimonidine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "ocular effect"},{"annotation": "Effect","text": "paradoxical"},{"annotation": "Treatment","text": "brimonidine"}]}]}
 {"id": "12234159_1","context": "Fixed drug eruption to rofecoxib.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "fixed drug eruption"},{"annotation": "Treatment","text": "rofecoxib"}]}]}
 {"id": "9533061_8","context": "DISCUSSION: No published clinical studies in patients receiving clindamycin vaginal cream for bacterial vaginosis have documented C. difficile toxin in stool samples of patients with diarrhea.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "clindamycin vaginal cream for bacterial vaginosis"},{"annotation": "Effect","text": "C. difficile toxin in stool samples"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute Attributes","text": "speculated"}]}]}
 {"id": "14742791_1","context": "Acute interstitial nephritis due to pantoprazole.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "due to"}, {"annotation": "Effect", "text": "acute interstitial nephritis"}, {"annotation": "Treatment", "text": "pantoprazole"}, {"annotation": "Treatment.Drug", "text": "pantoprazole"}]}]}
 {"id": "16515630_3","context": "Physicians should keep in mind that taxanes such as paclitaxel have the potential to cause pneumonitis and lung fibrosis.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "Physicians should keep in mind"},{"annotation": "Treatment","text": "taxanes such as paclitaxel"},{"annotation": "Treatment.Disorder","text": "pneumonitis and lung fibrosis"}]}]}
 {"id": "1238016_1","context": "Infant twins sustained severe circumoral and pharyngeal burns from a concentrated solution of benzalkonium (Zephiran) chloride prescribed for treatment of candidiasis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "burns"},{"annotation": "Effect","text": "circumoral and pharyngeal"},{"annotation": "Treatment","text": "benzalkonium (Zephiran) chloride"},{"annotation": "Treatment.Drug","text": "benzalkonium (Zephiran) chloride"},{"annotation": "Treatment.Disorder","text": "candidiasis"}]}]
 {"id": "3156465_2","context": "Isotretinoin teratogenicity.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "teratogenicity"},{"annotation": "Treatment", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Disorder", "text": "teratogenicity"},{"annotation": "Effect", "text": "birth defects"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretina"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.Drug", "text": "isotretinoin"},{"annotation": "Treatment.Drug", "text": "teratogenic drug"},{"annotation": "Treatment.D
 {"id": "7081289_1","context": "Hepatitis following cimetidine administration.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "cimetidine administration"},{"annotation": "Treatment","text": "cimetidine"},{"annotation": "Treatment.Drug","text": "cimetidine"},{"annotation": "Effect","text": "hepatitis"}]}]
 {"id": "10698143_4","context": "We report the case of an 11-month-old female infant with a depressed level of consciousness after ingestion of ibuprofen whose mental status markedly improved with administration of naloxone.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "ingestion of ibuprofen"},{"annotation": "Treatment","text": "naloxone"},{"annotation": "Treatment.Drug","text": "ibuprofen"},{"annotation": "Effect","text": "depressed level of consciousness"},{"annotation": "Treatment.Drug","text": "naloxone"},{"annotation": "Treatment.Drug","text": "ibuprofen"},{"annotation": "Event type","text": "Adverse_event"}]}]
 {"id": "17619811_5","context": "Investigation confirmed the diagnosis of rhabdomyolysis, and discontinuation of colchicine resulted in resolution of clinical and biochemical features of rhabdomylysis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "rhabdomyolysis"},{"annotation": "Treatment","text": "colchicine"},{"annotation": "Treatment.Drug","text": "colchicine"},{"annotation": "Effect","text": "resolution"},{"annotation": "Treatment","text": "discontinuation of colchicine"},{"annotation": "Treatment.Drug","text": "colchicine"},{"annotation": "Effect","text": "resolution"}]}
 {"id": "7526455_1","context": "A 73 year-old patient with Wolff-Parkinson-White syndrome and paroxysmic supraventricular tachycardia developed an acute reversible encephalopathy within 15 days of initiation of flecainide.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "initiation of flecainide"},{"annotation": "Treatment","text": "flecainide"},{"annotation": "Treatment.Disorder","text": "Wolff-Parkinson-White syndrome and paroxysmic supraventricular tachycardia"},{"annotation": "Treatment.Drug","text": "flecainide"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment.Duration","text": "acute"},{"annotation": "Treatment.Duration","text": "reversible"}]}]
 {"id": "15522120_11","context": "Since the depressive symptoms returned sertraline medication was initiated.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "returned"},{"annotation": "Effect","text": "depressive symptoms"},{"annotation": "Treatment","text": "sertraline medication"}]}]}
 {"id": "8589490_1","context": "Supravenous hyperpigmentation in association with CHOP chemotherapy of a CD30 (Ki-1)-positive anaplastic large-cell lymphoma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "CHOP chemotherapy"},{"annotation": "Treatment.Drug","text": "CHOP chemotherapy"},{"annotation": "Treatment.Disorder","text": "anaplastic large-cell lymphoma"},{"annotation": "Treatment.Drug","text": "CD30 (Ki-1)-positive"},{"annotation": "Effect","text": "hyperpigmentation"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Age","text": "not specified"},{"annotation": "Subject.Gender","text": "not specified"},{"annotation": "Subject.Population","text": "not specified"},{"annotation": "Subject.Race","text": "not specified"},{"annotation": "Treatment.Drug","text": "CHOP chemotherapy"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "anaplastic large-cell lymphoma"}]}
 {"id": "11105373_1","context": "A 33-year-old male presented with brown discolouration of the fingernails following the application of 4% hydroquinone in sorbolene cream and 0.1% tretinoin cream to the face intermittently for 9 months.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "application"},{"annotation": "Treatment","text": "4% hydroquinone in sorbolene cream and 0.1% tretinoin cream"},{"annotation": "Treatment.Drug","text": "4% hydroquinone"},{"annotation": "Treatment.Drug","text": "0.1% tretinoin"},{"annotation": "Treatment.Duration","text": "9 months"},{"annotation": "Effect","text": "brown discolouration of the fingernails"},{"annotation": "Subject","text": "a 33-year-old male"},{"annotation": "Subject.Disorder","text": "none"}]}
 {"id": "2241449_3","context": "We describe two cases of sulfadiazine-induced crystalluria and renal failure in patients with acquired immunodeficiency syndrome, review the pertinent literature, and discuss the pathogenesis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "crystalluria and renal failure"},{"annotation": "Treatment","text": "sulfadiazine"},{"annotation": "Treatment.Disorder","text": "acquired immunodeficiency syndrome"},{"annotation": "Treatment.Drug","text": "sulfadiazine"},{"annotation": "Treatment.Drug","text": "crystalluria"},{"annotation": "Treatment.Drug","text": "renal failure"}]},{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "review"},{"annotation": "Treatment","text": "literature"},{"annotation": "Treatment.Disorder","text": "acquired immunodeficiency syndrome"},{"annotation": "Treatment.Drug","text": "sulfadiazine"},{"annotation": "Treatment.Drug","text": "crystalluria"},{"annotation": "Treatment.Drug","text": "renal failure"},{"annotation": "Treatment.Drug","text": "pathogenesis"}]}]
 {"id": "17016002_2","context": "Acute eosinophilic pneumonia caused by calcium stearate, an additive agent for an oral antihistaminic medication.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "caused by"},{"annotation": "Effect", "text": "acute eosinophilic pneumonia"},{"annotation": "Treatment", "text": "calcium stearate"},{"annotation": "Treatment.Disorder", "text": "eosinophilic pneumonia"},{"annotation": "Treatment.Drug", "text": "oral antihistaminic medication"}]}]}
 {"id": "11563738_1","context": "The cause of death was determined to be acute intoxication by olanzapine, and the manner of death was accidental.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Effect","text": "intoxication"},{"annotation": "Treatment","text": "olanzapine"},{"annotation": "Treatment.Drug","text": "olanzapine"},{"annotation": "Treatment.Dosage","text": "acute"},{"annotation": "Treatment.Route","text": "unknown"},{"annotation": "Treatment.Side_effect","text": "intoxication"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "acute intoxication"},{"annotation": "Treatment.Cause_of_death","text": "acute intoxication"},{"annotation": "Treatment.Manner_of_death","text": "accidental"}]}
 {"id": "2719905_1","context": "Long lasting respiratory depression induced by morphine-6-glucuronide?","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "respiratory depression"},{"annotation": "Treatment","text": "morphine-6-glucuronide"}]}]}
 {"id": "623061_1","context": "A toxic encephalopathy characterized by depressed level of consciousness, marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and pyrilamine maleate.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "administered"},{"annotation": "Treatment","text": "antiemetic combination of pentobarbital and pyrilamine maleate"},{"annotation": "Treatment.Drug","text": "pentobarbital"},{"annotation": "Treatment.Drug","text": "pyrilamine maleate"},{"annotation": "Effect","text": "encephalopathy"},{"annotation": "Treatment.Disorder","text": "toxic"},{"annotation": "Treatment.Disorder","text": "encephalopathy"},{"annotation": "Treatment.Age","text": "5 years of age and younger"},{"annotation": "Subject","text": "seven children"}]}
 {"id": "868978_1","context": "Oculomotor disturbances associated with 5-fluorouracil chemotherapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "associated with"},{"annotation": "Effect", "text": "oculomotor disturbances"},{"annotation": "Treatment", "text": "5-fluorouracil chemotherapy"},{"annotation": "Treatment.Drug", "text": "5-fluorouracil"},{"annotation": "Subject", "text": "patient"}]}]}
 {"id": "18258513_1","context": "While doxorubicin was administered, the patient presented thoracic pain and breathing distress due to superior vena cava perforation by the central catheter and subsequent extravasation of the drug into the mediastinum.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "doxorubicin administration"},{"annotation": "Effect","text": "thoracic pain and breathing distress"},{"annotation": "Treatment","text": "doxorubicin"},{"annotation": "Treatment.Drug","text": "doxorubicin"},{"annotation": "Treatment.Route","text": "central catheter"},{"annotation": "Treatment.Time_elapsed","text": "during doxorubicin administration"},{"annotation": "Treatment.Duration","text": "during doxorubicin administration"},{"annotation": "Treatment.Disorder","text": "superior vena cava perforation"},{"annotation": "Treatment.Disorder","text": "extravasation of doxorubicin"}]}
 {"id": "21802143_5","context": "An 18-year-old Japanese man weighing 53 kg with an anaplastic large cell lymphoma received continuous IV administration of TAC as post-transplantation prophylaxis against graft-versus-host disease (GVHD) after an allogeneic bone marrow transplantation (BMT).","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "received"},{"annotation": "Treatment","text": "continuous IV administration of TAC"},{"annotation": "Treatment.Drug","text": "TAC"},{"annotation": "Treatment.Duration","text": "post-transplantation prophylaxis"},{"annotation": "Treatment.Disorder","text": "graft-versus-host disease (GVHD)"},{"annotation": "Treatment.Route","text": "IV administration"},{"annotation": "Treatment.Dosage","text": "continuous"},{"annotation": "Treatment.Frequency","text": "post-transplantation"},{"annotation": "Treatment.Combination.Trigger","text": "after"},{"annotation": "Treatment.Combination.Drug","text": "an allogeneic bone marrow transplantation (BMT)"},{"annotation": "Treatment.Combination.Drug","text": "TAC"}]}]}
 {"id": "10682234_1","context": "Intravenous administration of levodopa ameliorated a refractory akathisia case induced by interferon-alpha.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced by interferon-alpha"},{"annotation": "Effect","text": "akathisia"},{"annotation": "Treatment","text": "intravenous administration of levodopa"},{"annotation": "Treatment.Disorder","text": "refractory akathisia"},{"annotation": "Treatment.Drug","text": "levodopa"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "refractory akathisia"},{"annotation": "Effect","text": "ameliorated"},{"annotation": "Treatment","text": "intravenous administration of levodopa"},{"annotation": "Treatment.Disorder","text": "refractory akathisia"},{"annotation": "Treatment.Drug","text": "levodopa"}]}]}
 {"id": "12567347_1","context": "Patients with lymphoblastic lymphoma who had treatment with L-asparaginase and steroid are predisposed to the development of cortical venous thrombosis and may have this syndrome in addition to a dural puncture headache.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "development"},{"annotation": "Effect", "text": "cortical venous thrombosis"},{"annotation": "Treatment", "text": "L-asparaginase and steroid"},{"annotation": "Treatment.Disorder", "text": "lymphoblastic lymphoma"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "steroid"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute.negated", "text": "cortical venous thrombosis does not exist"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "development"},{"annotation": "Effect", "text": "dural puncture headache"},{"annotation": "Treatment", "text": "L-asparaginase and steroid"},{"annotation": "Treatment.Disorder", "text": "lymphoblastic lymphoma"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "steroid"},{"annotation": "Attribute", "text": "negated"},{"annotation": "Attribute.negated", "text": "dural puncture headache does not exist"}]}]}
 {"id": "7783891_1","context": "Because sumatriptan can cause coronary artery vasospasm, patients with significant risk factors for coronary artery disease should be carefully evaluated for cardiovascular disease prior to the use of sumatriptan.","events": [{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Treatment", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text": "coronary artery vasospasm"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Frequency", "text": "prior to use"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Drug", "text": "sumatriptan"},{"annotation": "Treatment.Disorder", "text
 {"id": "11563738_2","context": "This article describes the case of a 25-year-old man found dead at home who had been prescribed olanzapine for schizophrenia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "prescribed"},{"annotation": "Treatment","text": "olanzapine"},{"annotation": "Treatment.Drug","text": "olanzapine"},{"annotation": "Treatment.Disorder","text": "schizophrenia"},{"annotation": "Effect","text": "death"}]}]
 {"id": "7258204_1","context": "A 67-year-old man developed diarrhea shortly after a 10-day course of oral ampicillin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "oral ampicillin"},{"annotation": "Treatment","text": "oral ampicillin"},{"annotation": "Treatment.Drug","text": "oral ampicillin"},{"annotation": "Effect","text": "diarrhea"}]}]
 {"id": "16216617_1","context": "Prominent positive U waves appearing with high-dose intravenous phenylephrine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "appearing"},{"annotation": "Effect","text": "prominent positive U waves"},{"annotation": "Treatment","text": "high-dose intravenous phenylephrine"}]}]}
 {"id": "16620273_2","context": "Severe acidosis in patients taking metformin--rapid reversal and survival despite high APACHE score.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "metformin"},{"annotation": "Effect","text": "acidosis"},{"annotation": "Treatment","text": "metformin"},{"annotation": "Treatment.Drug","text": "metformin"},{"annotation": "Treatment.Duration","text": "rapid reversal"},{"annotation": "Treatment.Duration","text": "survival despite high APACHE score"},{"annotation": "Treatment.Duration","text": "high APACHE score"}]}
 {"id": "1868481_1","context": "Seizures and transient blindness following intravenous pulse methylprednisolone in children with primary glomerulonephritis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "following intravenous pulse methylprednisolone"},{"annotation": "Effect", "text": "seizures and transient blindness"},{"annotation": "Treatment", "text": "intravenous pulse methylprednisolone"},{"annotation": "Treatment.Drug", "text": "methylprednisolone"},{"annotation": "Treatment.Disorder", "text": "primary glomerulonephritis"},{"annotation": "Subject", "text": "children"},{"annotation": "Subject.Population", "text": "children"}]}]
 {"id": "16728538_4","context": "We report on a patient with acromegaly who developed severe drug-induced hepatitis during combined treatment with the long-acting somatostatin-analog octreotide and the GH receptor antagonist pegvisomant.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "hepatitis"},{"annotation": "Treatment","text": "combined treatment with octreotide and pegvisomant"},{"annotation": "Treatment.Disorder","text": "acromegaly"},{"annotation": "Treatment.Drug","text": "octreotide"},{"annotation": "Treatment.Drug","text": "pegvisomant"}]}]
 {"id": "12851279_6","context": "The primary efficacy population consisted of 1754 patients (> or =18 years) with severe sepsis and a high INR (> or =1.2) randomly assigned to intravenous infusion of either tifacogin (0.025 mg/kg per hour for 96 hours, n = 880) or placebo (arginine citrate buffer, n = 874), and 201 patients with a low INR (<1.2) randomly assigned to receive the same dose of either tifacogin or placebo.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "severe sepsis and high INR"},{"annotation": "Treatment", "text": "intravenous infusion of either tifacogin or placebo"},{"annotation": "Treatment.Drug", "text": "tifacogin"},{"annotation": "Treatment.Dosage", "text": "0.025 mg/kg per hour for 96 hours"},{"annotation": "Treatment.Frequency", "text": "96 hours"},{"annotation": "Treatment.Route", "text": "intravenous"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "96 hours"},{"annotation": "Treatment.Disorder", "text": "severe sepsis and high INR"},{"annotation": "Effect", "text": "not specified"}]}]}
 {"id": "20234160_3","context": "We report a case of a 23-year-old man who developed a vancomycin-induced anaphylactic reaction in the treatment of methicillin-resistant Staphylococcus aureus infection.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "vancomycin-induced"},{"annotation": "Effect","text": "anaphylactic reaction"},{"annotation": "Treatment","text": "methicillin-resistant Staphylococcus aureus infection"},{"annotation": "Treatment.Drug","text": "vancomycin"}]}]
 {"id": "19884751_2","context": "Recovery of the tubular dysfunction took 15 days following cessation of the offending drug, Amikacin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "tubular dysfunction"},{"annotation": "Treatment","text": "Amikacin"},{"annotation": "Treatment.Drug","text": "Amikacin"},{"annotation": "Treatment.Time_elapsed","text": "15 days"}]}]}
 {"id": "7139589_3","context": "L-asparaginase-induced pancreatitis has been reported during or closely following administration of the drug.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "L-asparaginase"},{"annotation": "Treatment.Disorder","text": "pancreatitis"},{"annotation": "Treatment.Drug","text": "L-asparaginase"}]}]}
 {"id": "15286697_3","context": "These novel findings may offer specific therapeutic targets in the treatment of BCNU-associated pulmonary fibrosis.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "BCNU-associated pulmonary fibrosis"}, {"annotation": "Effect", "text": "fibrosis"}, {"annotation": "Treatment", "text": "BCNU"}, {"annotation": "Treatment.Disorder", "text": "BCNU-associated pulmonary fibrosis"}, {"annotation": "Treatment.Drug", "text": "BCNU"}, {"annotation": "Treatment.Drug", "text": "specific therapeutic targets"}, {"annotation": "Treatment.Drug", "text": "BCNU"}, {"annotation": "Treatment.Drug", "text": "specific therapeutic targets"}, {"annotation": "Treatment.Drug", "text": "BCNU"}, {"annotation": "Treatment.Drug", "text": "specific therapeutic targets"}]}]}
 {"id": "19212144_1","context": "A 58-year-old man with advanced renal cell carcinoma developed grade 3 proteinuria (8.5 g/24 h) without microscopic hematuria or renal insufficiency five days after temsirolimus infusion.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "temsirolimus infusion"},{"annotation": "Effect","text": "proteinuria"},{"annotation": "Treatment","text": "temsirolimus"},{"annotation": "Treatment.Dosage","text": "8.5 g/24 h"},{"annotation": "Treatment.Duration","text": "5 days"},{"annotation": "Treatment.Disorder","text": "advanced renal cell carcinoma"},{"annotation": "Treatment.Drug","text": "temsirolimus"}]}
 {"id": "9253492_1","context": "A 2-year-old mentally retarded boy with frontal lobe epilepsy presented with an episode that resembled heat stroke during the administration of zonisamide.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "presented"},{"annotation": "Effect","text": "episode resembling heat stroke"},{"annotation": "Treatment","text": "administration of zonisamide"},{"annotation": "Treatment.Drug","text": "zonisamide"}]}]}
 {"id": "18166746_1","context": "[Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review].","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "following methylene blue infusion"},{"annotation": "Effect","text": "serotonin syndrome"},{"annotation": "Treatment","text": "methylene blue infusion"},{"annotation": "Treatment.Drug","text": "methylene blue"},{"annotation": "Treatment.Drug","text": "parathyroidectomy"},{"annotation": "Treatment.Combination.Trigger","text": "during"},{"annotation": "Treatment.Combination.Drug","text": "methylene blue"},{"annotation": "Treatment.Combination.Drug","text": "parathyroidectomy"},{"annotation": "Subject","text": "a patient"}]}
 {"id": "868978_3","context": "Two patients treated with 5-fluorouracil (5-FU) for disseminated adenocarcinoma of the colon developed cerebellar dysfunction typical of 5-FU neurotoxicity.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "5-FU"},{"annotation": "Treatment","text": "5-FU"},{"annotation": "Treatment.Disorder","text": "disseminated adenocarcinoma of the colon"},{"annotation": "Treatment.Drug","text": "5-FU"},{"annotation": "Effect","text": "cerebellar dysfunction"},{"annotation": "Treatment.Drug","text": "5-FU"},{"annotation": "Treatment.Drug","text": "5-FU"},{"annotation": "Treatment.Drug","text": "5-FU"}],"attributes": [{"attribute": "negated","value": "false"},{"attribute": "speculated","value": "false"},{"attribute": "severity","value": "high"}]}
 {"id": "11510798_4","context": "Once extensive microbiological studies proved negative, corticosteroids were given and a complete remission of clinical and radiological abnormalities was achieved.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "given"},{"annotation": "Treatment", "text": "corticosteroids"},{"annotation": "Treatment.Disorder", "text": "clinical and radiological abnormalities"},{"annotation": "Treatment.Drug", "text": "corticosteroids"},{"annotation": "Effect", "text": "remission"},{"annotation": "Attribute Attributes", "text": "complete"},{"annotation": "Attribute Attributes", "text": "remission"},{"annotation": "Attribute Attributes", "text": "clinical and radiological abnormalities"},{"annotation": "Attribute Attributes", "text": "complete"}]}]}
 {"id": "9886213_1","context": "Disseminated muscular cysticercosis with myositis induced by praziquantel therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "cysticercosis"},{"annotation": "Treatment","text": "praziquantel therapy"},{"annotation": "Treatment.Drug","text": "praziquantel"},{"annotation": "Treatment.Dosage","text": "therapy"},{"annotation": "Treatment.Frequency","text": "induced"},{"annotation": "Treatment.Route","text": "praziquantel therapy"},{"annotation": "Treatment.Time_elapsed","text": "cysticercosis"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "myositis"},{"annotation": "Treatment","text": "praziquantel therapy"},{"annotation": "Treatment.Drug","text": "praziquantel"},{"annotation": "Treatment.Dosage","text": "therapy"},{"annotation": "Treatment.Frequency","text": "induced"},{"annotation": "Treatment.Route","text": "praziquantel therapy"},{"annotation": "Treatment.Time_elapsed","text": "myositis"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "cysticercosis"},{"annotation": "Treatment","text": "praziquantel therapy"},{"annotation": "Treatment.Drug","text": "praziquantel"},{"annotation": "Treatment.Dosage","text": "therapy"},{"annotation": "Treatment.Frequency","text": "induced"},{"annotation": "Treatment.Route","text": "praziquantel therapy"},{"annotation": "Treatment.Time_elapsed","text": "cysticercosis"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "myositis"},{"annotation": "Treatment","text": "praziquantel therapy"},{"annotation": "Treatment.Drug","text": "praziquantel"},{"annotation": "Treatment.Dosage","text": "therapy"},{"annotation": "Treatment.Frequency","text": "induced"},{"annotation": "Treatment.Route","text": "praziquantel therapy"},{"annotation": "Treatment.Time_elapsed","text": "myositis"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "cysticercosis"},{"annotation": "Treatment","text": "praziquantel therapy"},{"annotation": "Treatment.Drug","text": "praziquantel"},{"annotation": "Treatment.Dosage","text": "therapy"},{"annotation": "Treatment.Frequency","text": "induced"},{"annotation": "Treatment.Route","text": "praziquantel therapy"},{"annotation": "Treatment.Time_elapsed","text": "cysticercosis"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "myositis"},{"annotation": "Treatment","text": "praziquantel therapy"},{"annotation": "Treatment.Drug","text": "praziquantel"},{"annotation": "Treatment.Dosage","text": "therapy"},{"annotation": "Treatment.Frequency","text": "induced"},{"annotation": "Treatment.Route","text": "praziquantel therapy"},{"annotation": "Treatment.Time_elapsed","text": "myositis"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "cysticercosis"},{"annotation": "Treatment","text": "praziquantel therapy"},{"annotation": "Treatment.Drug","text": "praziquantel"},{"annotation": "Treatment.Dosage","text": "therapy"},{"annotation": "Treatment.Frequency","text": "induced"},{"annotation": "Treatment.Route","text": "praziquantel therapy"},{"annotation": "Treatment.Time_elapsed","text": "cysticercosis"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "myositis"},{"annotation": "Treatment","text": "praziquantel therapy"},{"annotation": "Treatment.Drug","text": "praziquantel"},{"annotation": "Treatment.Dosage","text": "therapy"},{"annotation": "Treatment.Frequency","text": "induced"},{"annotation": "Treatment.Route","text": "praziquantel therapy"},{"annotation": "Treatment.Time_elapsed","text": "myositis"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "cysticercosis"},{"annotation": "Treatment","text": "praziquantel therapy"},{"annotation": "Treatment.Drug","text": "praziquantel"},{"annotation": "Treatment.Dosage","text": "therapy"},{"annotation": "Treatment.Frequency","text": "induced"},{"annotation": "Treatment.Route","text": "praziquantel therapy"},{"annotation": "Treatment.Time_elapsed","text": "cysticercosis"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "myositis"},{"annotation": "Treatment","text": "praziquantel therapy"},{"annotation": "Treatment.Drug","text": "praziquantel"},{"annotation": "Treatment.Dosage","text": "therapy"},{"annotation": "Treatment.Frequency","text": "induced"},{"annotation": "Treatment.Route","text": "praziquantel therapy"},{"annotation": "Treatment.Time_elapsed","text": "myositis"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "cysticercosis"},{"annotation": "Treatment","text": "praziquantel therapy"},{"annotation": "Treatment.Drug","text": "praziquantel"},{"annotation": "Treatment.Dosage","text": "therapy"},{"annotation": "Treatment.Frequency","text": "induced"},{"annotation": "Treatment.Route","text": "praziquantel therapy"},{"annotation": "Treatment.Time_elapsed","text": "cysticercosis"}],{"type": "Adverse_event","annotations": [{
 {"id": "172214_1","context": "Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin-D and mithramycin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "widely separated courses of adriamycin"},{"annotation": "Treatment","text": "actinomycin-D and mithramycin"},{"annotation": "Treatment.Drug","text": "adriamycin"},{"annotation": "Treatment.Drug","text": "actinomycin-D"},{"annotation": "Treatment.Drug","text": "mithramycin"},{"annotation": "Effect","text": "cardiomyopathy"}]}}
 {"id": "11485141_3","context": "Linear immunoglobulin A bullous dermatosis induced by gemcitabine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "bullous dermatosis"},{"annotation": "Treatment","text": "gemcitabine"},{"annotation": "Treatment.Drug","text": "gemcitabine"}]}]
 {"id": "10573314_12","context": "The temporal association of the course of tolterodine with an elevated INR, the return to the previous warfarin dose-INR response relationship after tolterodine discontinuation, and the absence of other causes for the elevated INR were factors found in both patients.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "course of tolterodine"},{"annotation": "Treatment","text": "tolterodine"},{"annotation": "Treatment.Drug","text": "tolterodine"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "elevated INR"},{"annotation": "Effect","text": "INR elevation"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "severity"},{"annotation": "Attribute","text": "negated"},{"annotation": "
 {"id": "15461766_2","context": "The harlequin color change and association with prostaglandin E1.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "harlequin color change"},{"annotation": "Effect","text": "association with prostaglandin E1"}]}]}
 {"id": "19336028_1","context": "A case of tuberculosis in a patient on Efalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "tuberculosis"},{"annotation": "Treatment","text": "Efalizumab and Etanercept"},{"annotation": "Treatment.Drug","text": "Efalizumab"},{"annotation": "Treatment.Drug","text": "Etanercept"},{"annotation": "Treatment.Disorder","text": "refractory palmopustular psoriasis and psoriatic arthritis"},{"annotation": "Treatment.Disorder","text": "tuberculosis"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Disorder","text": "refractory palmopustular psoriasis and psoriatic arthritis"}]}
 {"id": "10225085_1","context": "Although the two local anesthetics usually do not cause methemoglobinemia, we suspect that the displacement of lidocaine from protein binding by bupivacaine, in combination with metabolic acidosis and treatment with other oxidants, was the reason for the development of methemoglobinemia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "development"},{"annotation": "Effect","text": "methemoglobinemia"},{"annotation": "Treatment","text": "local anesthetics"},{"annotation": "Treatment.Drug","text": "lidocaine"},{"annotation": "Treatment.Drug","text": "bupivacaine"},{"annotation": "Treatment.Disorder","text": "methemoglobinemia"},{"annotation": "Treatment.Drug","text": "oxidants"},{"annotation": "Treatment.Drug","text": "metabolic acidosis"},{"annotation": "Treatment.Drug","text": "displacement"},{"annotation": "Treatment.Drug","text": "protein binding"}]}
 {"id": "6851259_1","context": "Nephrotic range pseudoproteinuria in a tolmetin-treated patient.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "nephrotic range pseudoproteinuria"},{"annotation": "Treatment", "text": "tolmetin"},{"annotation": "Treatment.Drug", "text": "tolmetin"},{"annotation": "Treatment.Disorder", "text": "nephrotic range pseudoproteinuria"},{"annotation": "Subject", "text": "a patient"},{"annotation": "Subject.Population", "text": "1"}]}]}
 {"id": "19318596_4","context": "With the first cyclosporine dose, the patient complained of leg pain that was most severe during the cyclosporine infusion.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "cyclosporine"},{"annotation": "Treatment","text": "cyclosporine infusion"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Effect","text": "leg pain"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Treatment.Route","text": "infusion"},{"annotation": "Treatment.Route","text": "infusion"},{"annotation": "Treatment.Time_elapsed","text": "with the first cyclosporine dose"}]}
 {"id": "15811174_3","context": "We report on a patient who developed acute rhabdomyolysis after taking cerivastatin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "took"},{"annotation": "Effect","text": "acute rhabdomyolysis"},{"annotation": "Treatment","text": "cerivastatin"}]}]}
 {"id":"8124920_2","context":"In a patient suffering from rheumatoid arthritis, we report the first simultaneous occurrence of two side effects of low-dose methotrexate: an acute megaloblastic anaemia and a pneumonitis.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"occurrence of low-dose methotrexate"},{"annotation":"Treatment","text":"low-dose methotrexate"},{"annotation":"Treatment.Drug","text":"methotrexate"},{"annotation":"Treatment.Dosage","text":"low-dose"},{"annotation":"Treatment.Disorder","text":"rheumatoid arthritis"},{"annotation":"Treatment.Side_effect","text":"acute megaloblastic anaemia"},{"annotation":"Treatment.Side_effect","text":"pneumonitis"}]}]}
 {"id": "11109149_3","context": "We describe a 57-year-old man with acral erythrocyanosis progressing to acute digital ischemia and gangrene that developed after combined chemotherapy (bleomycin and methotrexate) used to treat a metastatic squamous cell carcinoma of the hypopharynx.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "progressing"},{"annotation": "Effect","text": "acute digital ischemia and gangrene"},{"annotation": "Treatment","text": "combined chemotherapy (bleomycin and methotrexate)"},{"annotation": "Treatment.Drug","text": "bleomycin"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Treatment.Disorder","text": "metastatic squamous cell carcinoma of the hypopharynx"},{"annotation": "Subject","text": "a 57-year-old man"},{"annotation": "Subject.Disorder","text": "acral erythrocyanosis"}]}
 {"id": "2719905_2","context": "We report a case of long lasting respiratory depression after intravenous administration of morphine to a 7 year old girl with haemolytic uraemic syndrome.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intravenous administration of morphine"},{"annotation": "Treatment","text": "morphine"},{"annotation": "Treatment.Drug","text": "morphine"},{"annotation": "Effect","text": "respiratory depression"},{"annotation": "Treatment.Dosage","text": "long lasting"},{"annotation": "Treatment.Frequency","text": "intravenous"},{"annotation": "Treatment.Route","text": "intravenous"},{"annotation": "Treatment.Time_elapsed","text": "after intravenous administration"},{"annotation": "Treatment.Duration","text": "long lasting"},{"annotation": "Treatment.Disorder","text": "haemolytic uraemic syndrome"},{"annotation": "Subject","text": "a 7 year old girl"},{"annotation": "Subject.Age","text": "7 years"},{"annotation": "Subject.Gender","text": "female"},{"annotation": "Subject.Population","text": "1"},{"annotation": "Subject.Race","text": "not specified"}]}
 {"id": "18071101_1","context": "Although adverse effects are usually mild, the author reports here a case of leucocytopenia and thrombocytopenia with quetiapine treatment that required its discontinuation.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "with quetiapine treatment"},{"annotation": "Treatment","text": "quetiapine"},{"annotation": "Treatment.Drug","text": "quetiapine"},{"annotation": "Treatment.Disorder","text": "leucocytopenia and thrombocytopenia"},{"annotation": "Effect","text": "leucocytopenia and thrombocytopenia"},{"annotation": "negated","text": "required its discontinuation"}]}
 {"id": "3720318_1","context": "Noncardiogenic pulmonary edema during intrabiliary infusion of mono-octanoin.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "intrabiliary infusion of mono-octanoin"}, {"annotation": "Effect", "text": "pulmonary edema"}, {"annotation": "Treatment", "text": "intrabiliary infusion of mono-octanoin"}, {"annotation": "Treatment.Drug", "text": "mono-octanoin"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "intrabiliary"}, {"annotation": "Treatment.Elapsed_time", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "noncardiogenic pulmonary edema"}, {"annotation": "Attribute.negated", "text": "unknown"}, {"annotation": "Attribute.speculated", "text": "unknown"}, {"annotation": "Attribute.severity", "text": "unknown"}]}]}
 {"id": "589261_1","context": "Cardiac glycosides are thought to prevent doxorubicin cardiomyopathy by competitively inhibiting doxorubicin at its receptor sites, but ouabain has a much shorter half life than doxorubicin and its metabolites and so is less effective than digoxin.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment", "text": "cardiac glycosides"},{"annotation": "Treatment.Disorder", "text": "doxorubicin cardiomyopathy"},{"annotation": "Treatment.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Drug", "text": "ouabain"},{"annotation": "Treatment.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Trigger", "text": "but"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "has"},{"annotation": "Treatment.Combination.Drug", "text": "shorter half life"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "so"},{"annotation": "Treatment.Combination.Drug", "text": "less effective"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "is"},{"annotation": "Treatment.Combination.Drug", "text": "less effective"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "but"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "has"},{"annotation": "Treatment.Combination.Drug", "text": "shorter half life"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "so"},{"annotation": "Treatment.Combination.Drug", "text": "less effective"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "is"},{"annotation": "Treatment.Combination.Drug", "text": "less effective"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "but"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "has"},{"annotation": "Treatment.Combination.Drug", "text": "shorter half life"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "so"},{"annotation": "Treatment.Combination.Drug", "text": "less effective"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "is"},{"annotation": "Treatment.Combination.Drug", "text": "less effective"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "but"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "has"},{"annotation": "Treatment.Combination.Drug", "text": "shorter half life"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "so"},{"annotation": "Treatment.Combination.Drug", "text": "less effective"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "is"},{"annotation": "Treatment.Combination.Drug", "text": "less effective"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "but"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "cardiac glycosides"},{"annotation": "Treatment.Combination.Trigger", "text": "has"},{"annotation": "Treatment.Combination.Drug", "text": "shorter half life"},{"annotation": "Treatment.Combination.Drug", "text": "doxorubicin"},{"annotation": "Treatment.Combination.Drug", "text": "ouabain"},{"annotation": "Treatment.Combination.Drug", "text": "digoxin"},{"annotation":
 {"id": "18262450_7","context": "Three hundred and thirty eight patients with moderate to severe painful diabetic neuropathy despite receiving their maximum tolerated dose of gabapentin, had oral prolonged-release oxycodone or placebo tablets added to their therapy for up to 12 weeks.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "had"},{"annotation": "Treatment","text": "oral prolonged-release oxycodone or placebo tablets"},{"annotation": "Treatment.Drug","text": "prolonged-release oxycodone"},{"annotation": "Treatment.Drug","text": "placebo"},{"annotation": "Treatment.Duration","text": "for up to 12 weeks"},{"annotation": "Treatment.Disorder","text": "painful diabetic neuropathy"},{"annotation": "Treatment.Drug","text": "gabapentin"},{"annotation": "Subject","text": "three hundred and thirty eight patients"},{"annotation": "Subject.Disorder","text": "moderate to severe"}]}
 {"id": "22552763_4","context": "We assessed the bleeding risk in patients treated with thromboprophylactic dabigatran etexilate, with and without concomitant NSAID or ASA.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "assessed"},{"annotation": "Treatment","text": "thromboprophylactic dabigatran etexilate"},{"annotation": "Treatment.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Trigger","text": "with"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Disorder","text": "bleeding risk"},{"annotation": "Treatment.Disorder","text": "thromboprophylactic"},{"annotation": "Treatment.Disorder","text": "dabigatran etexilate"},{"annotation": "Treatment.Disorder","text": "NSAID or ASA"},{"annotation": "Treatment.Disorder","text": "thromboprophylactic"},{"annotation": "Treatment.Disorder","text": "dabigatran etexilate"},{"annotation": "Treatment.Disorder","text": "NSAID or ASA"},{"annotation": "Treatment.Disorder","text": "thromboprophylactic"},{"annotation": "Treatment.Disorder","text": "dabigatran etexilate"},{"annotation": "Treatment.Disorder","text": "NSAID or ASA"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "assessed"},{"annotation": "Treatment","text": "thromboprophylactic dabigatran etexilate"},{"annotation": "Treatment.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Trigger","text": "with"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"},{"annotation": "Treatment.Combination.Drug","text": "NSAID or ASA"},{"annotation": "Treatment.Combination.Drug","text": "dabigatran etexilate"}]}]}
 {"id": "2532694_2","context": "Dapsone-induced erythroderma with Beau's lines.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "dapsone"},{"annotation": "Treatment.Drug","text": "dapsone"},{"annotation": "Effect","text": "erythroderma"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "negated"},{"annotation": "Attribute Attributes","text": "negated"}]}]}
 {"id": "9870779_2","context": "Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"}, {"annotation": "Effect", "text": "hepatic necrosis"}, {"annotation": "Treatment", "text": "methotrexate"}, {"annotation": "Treatment.Disorder", "text": "rheumatoid arthritis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "rheumatoid arthritis"}]}, {"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "requiring liver transplantation"}, {"annotation": "Treatment", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Frequency", "text": "not specified"}, {"annotation": "Treatment.Route", "text": "not specified"}, {"annotation": "Treatment.Time_elapsed", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"}, {"annotation": "Treatment.Disorder", "text": "methotrexate-induced hepatic necrosis"}, {"annotation": "Treatment.Drug", "text": "methotrexate"}, {"annotation": "Treatment.Dosage", "text": "not specified"}, {"annotation": "Treatment.Duration", "text": "not specified"},
 {"id": "15516308_3","context": "We present three cases from the Provincial Toxicology Center of British Columbia, Canada in which suicidal overdose deaths were associated with quetiapine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "suicidal overdose deaths"},{"annotation": "Treatment","text": "quetiapine"},{"annotation": "Treatment.Drug","text": "quetiapine"},{"annotation": "Effect","text": "suicide"}]}]
 {"id": "2830062_3","context": "Both patients developed hypoadrenalism while on o,p'-DDD and apparently adequate dexamethasone replacement therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "hypoadrenalism"},{"annotation": "Treatment","text": "o,p'-DDD and dexamethasone replacement therapy"},{"annotation": "Treatment.Drug","text": "o,p'-DDD"},{"annotation": "Treatment.Drug","text": "dexamethasone"},{"annotation": "Treatment.Drug","text": "replacement therapy"},{"annotation": "Treatment.Duration","text": "both"},{"annotation": "Treatment.Duration","text": "patients"}]}
 {"id": "16046172_1","context": "In the other patient, a 78-year-old woman, Neisseria mucosa knee arthritis occurred after a single sodium hyaluronate injection.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurred"},{"annotation": "Effect","text": "knee arthritis"},{"annotation": "Treatment","text": "single sodium hyaluronate injection"},{"annotation": "Treatment.Drug","text": "sodium hyaluronate"}]}]
 {"id": "21729965_1","context": "Implanon failure in an HIV-positive woman on antiretroviral therapy resulting in two ectopic pregnancies.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "failure"},{"annotation": "Effect","text": "ectopic pregnancies"},{"annotation": "Treatment","text": "Implanon"},{"annotation": "Treatment.Disorder","text": "HIV-positive"},{"annotation": "Treatment.Disorder","text": "antiretroviral therapy"}]}]
 {"id": "16341621_1","context": "Massive prolapse of the urethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "periurethral injection of calcium hydroxylapatite"},{"annotation": "Effect","text": "urethral mucosa prolapse"},{"annotation": "Treatment","text": "calcium hydroxylapatite"},{"annotation": "Treatment.Disorder","text": "stress urinary incontinence"},{"annotation": "Treatment.Drug","text": "calcium hydroxylapatite"}]}]
 {"id": "2532694_1","context": "A 35-year-old female with borderline lepromatous (BL) leprosy who suffered from dapsone-induced erythroderma is reported.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "dapsone"},{"annotation": "Treatment.Drug","text": "dapsone"},{"annotation": "Effect","text": "erythroderma"},{"annotation": "Treatment.Disorder","text": "borderline lepromatous (BL) leprosy"}]}]
 {"id": "8912599_8","context": "Well-known signs of methotrexate toxicity include bone marrow suppression and oral and gastrointestinal ulceration.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "toxicity"},{"annotation": "Effect","text": "bone marrow suppression and oral and gastrointestinal ulceration"},{"annotation": "Treatment","text": "methotrexate"}]}]}
 {"id": "18755414_1","context": "Hemorrhage from a falx meningioma after internal use of low-dose aspirin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "internal use of low-dose aspirin"},{"annotation": "Effect","text": "hemorrhage"},{"annotation": "Treatment","text": "aspirin"},{"annotation": "Treatment.Drug","text": "aspirin"},{"annotation": "Treatment.Dosage","text": "low-dose"},{"annotation": "Treatment.Frequency","text": "internal"},{"annotation": "Treatment.Route","text": "internal"},{"annotation": "Treatment.Time_elapsed","text": "after internal use of low-dose aspirin"},{"annotation": "Treatment.Duration","text": "after internal use of low-dose aspirin"},{"annotation": "Treatment.Disorder","text": "falx meningioma"}],"attributes": [{"annotation": "negated","text": "No textual cues show the event is negated."},{"annotation": "speculated","text": "No uncertain or speculation as to whether an event will actually happen."},{"annotation": "severity","text": "No severity level of the adverse effect."}]}
 {"id": "9671138_2","context": "Severe respiratory syncytial virus pulmonary infection in a patient treated with fludarabine for chronic lymphocytic leukemia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "fludarabine"},{"annotation": "Treatment.Drug","text": "fludarabine"},{"annotation": "Effect","text": "respiratory syncytial virus pulmonary infection"},{"annotation": "Treatment.Disorder","text": "chronic lymphocytic leukemia"}]}
 {"id": "9149614_2","context": "Nonsustained polymorphous ventricular tachycardia during amiodarone therapy for atrial fibrillation complicating cardiomyopathy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "during amiodarone therapy"},{"annotation": "Effect","text": "polymorphous ventricular tachycardia"},{"annotation": "Treatment","text": "amiodarone therapy"},{"annotation": "Treatment.Disorder","text": "atrial fibrillation"},{"annotation": "Treatment.Drug","text": "amiodarone"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "cardiomyopathy"},{"annotation": "Subject","text": "not specified"},{"annotation": "Subject.Age","text": "not specified"},{"annotation": "Subject.Gender","text": "not specified"},{"annotation": "Subject.Population","text": "not specified"},{"annotation": "Subject.Race","text": "not specified"},{"annotation": "Treatment.Disorder","text": "atrial fibrillation"}]}
 {"id":"8316494_1","context":"Severe abdominal pain in low dosage clofazimine.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Treatment","text":"clofazimine"},{"annotation":"Treatment.Drug","text":"clofazimine"},{"annotation":"Effect","text":"abdominal pain"},{"annotation":"Treatment.Dosage","text":"low dosage"}]}]}
 {"id": "12908837_1","context": "Behavioral side effects associated with clonazepam may include agitation, aggression, hyperactivity, irritability, property destruction, and temper tantrums.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Treatment","text": "clonazepam"},{"annotation": "Treatment.Drug","text": "clonazepam"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Effect","text": "behavioral side effects"},{"annotation": "Attribute","text": "not specified"},{"annotation": "Attribute.negated","text": "not specified"},{"annotation": "Attribute.speculated","text": "not specified"},{"annotation": "Attribute.severity","text": "not specified"}]}
 {"id":"6671350_2","context":"Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"associated with"},{"annotation":"Effect","text":"coagulopathy"},{"annotation":"Treatment","text":"cephalosporin or moxalactam antibiotics"},{"annotation":"Treatment.Disorder","text":"acute and chronic renal failure"},{"annotation":"Treatment.Drug","text":"cephalosporin"},{"annotation":"Treatment.Drug","text":"moxalactam"},{"annotation":"Treatment.Combination.Trigger","text":"and"},{"annotation":"Treatment.Combination.Drug","text":"cephalosporin"},{"annotation":"Treatment.Combination.Drug","text":"moxalactam"},{"annotation":"Subject","text":"patients"},{"annotation":"Subject.Disorder","text":"acute and chronic renal failure"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"associated with"},{"annotation":"Effect","text":"coagulopathy"},{"annotation":"Treatment","text":"cephalosporin or moxalactam antibiotics"},{"annotation":"Treatment.Disorder","text":"acute and chronic renal failure"},{"annotation":"Treatment.Drug","text":"cephalosporin"},{"annotation":"Treatment.Drug","text":"moxalactam"},{"annotation":"Treatment.Combination.Trigger","text":"and"},{"annotation":"Treatment.Combination.Drug","text":"cephalosporin"},{"annotation":"Treatment.Combination.Drug","text":"moxalactam"},{"annotation":"Subject","text":"patients"},{"annotation":"Subject.Disorder","text":"acute and chronic renal failure"}]}]}
 {"id": "9865241_2","context": "Pamidronate therapy should be considered in patients with hypercalcemia secondary to acute vitamin D poisoning.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "acute vitamin D poisoning"}, {"annotation": "Effect", "text": "hypercalcemia"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "text": "secondary"}, {"annotation": "Treatment", "text": "pamidronate therapy"}, {"annotation": "Treatment.Disorder", "text": "hypercalcemia"}, {"annotation": "Treatment.Drug", "text": "pamidronate"}, {"annotation": "Treatment.Drug", "text": "acute vitamin D poisoning"}]},{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "hypercalcemia"}, {"annotation": "Effect", "
 {"id": "17090724_3","context": "Use of the Naranjo probability scale indicated a highly probable relationship between the observed cardiac toxicity and amphotericin B deoxycholate therapy in this patient.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "cardiac toxicity"},{"annotation": "Treatment","text": "amphotericin B deoxycholate therapy"},{"annotation": "Treatment.Disorder","text": "cardiac toxicity"},{"annotation": "Treatment.Drug","text": "amphotericin B deoxycholate"},{"annotation": "Attribute Attributes","text": "highly probable","annotation": "negated","severity": "high"}]}]
 {"id": "16132305_1","context": "Captopril-induced pulmonary infiltrates with eosinophilia in an infant with congenital heart disease.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"}, {"annotation": "Effect", "text": "pulmonary infiltrates with eosinophilia"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "negated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"}, {"annotation": "Effect", "text": "eosinophilia"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "negated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"}, {"annotation": "Effect", "text": "pulmonary infiltrates with eosinophilia"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "negated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"annotation": "Treatment.Drug", "text": "captopril"}, {"annotation": "Attribute", "text": "speculated", "attribute": "eosinophilia"}, {"annotation": "Attribute", "text": "attribute", "attribute": "pulmonary infiltrates"}]}, {"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "Response"}, {"annotation": "Treatment", "text": "captopril"}, {"annotation": "Treatment.Disorder", "text": "congenital heart disease"}, {"
 {"id": "15836666_1","context": "Chronic fentanyl application induces adrenocortical insufficiency.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "adrenocortical insufficiency"},{"annotation": "Treatment","text": "fentanyl"},{"annotation": "Treatment.Drug","text": "fentanyl"},{"annotation": "Treatment.Dosage","text": "chronic"}]}]
 {"id": "16132305_5","context": "After discontinuing captopril and starting systemic steroids, her symptomatology rapidly improved, and her eosinophilia and radiographic abnormalities both resolved.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "captopril"},{"annotation": "Treatment","text": "systemic steroids"},{"annotation": "Treatment.Disorder","text": "eosinophilia"},{"annotation": "Treatment.Disorder","text": "radiographic abnormalities"},{"annotation": "Treatment.Drug","text": "captopril"},{"annotation": "Treatment.Drug","text": "systemic steroids"},{"annotation": "Effect","text": "improved"},{"annotation": "Effect","text": "resolved"},{"annotation": "Subject","text": "her"},{"annotation": "Subject.Disorder","text": "eosinophilia"}]}
 {"id": "12927328_1","context": "We present a surprising case of a woman schizophrenic patient treated with clozapine suffering from EPS.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "treated"},{"annotation": "Treatment","text": "clozapine"},{"annotation": "Treatment.Drug","text": "clozapine"},{"annotation": "Effect","text": "EPS"},{"annotation": "Treatment.Disorder","text": "schizophrenic"}]}]
 {"id": "17016002_3","context": "Therefore, we concluded that this patient's pulmonary disease was caused by calcium stearate, an additive for an antihistaminic drug.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "pulmonary disease"},{"annotation": "Treatment","text": "antihistaminic drug"},{"annotation": "Treatment.Drug","text": "calcium stearate"},{"annotation": "Effect","text": "pulmonary disease"}]}]
 {"id":"3343188_2","context":"Benzocaine-induced methemoglobinemia has been reported in man, dogs, and cats.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Effect","text":"methemoglobinemia"},{"annotation":"Treatment","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"Treatment.Drug","text":"benzocaine"},{"annotation":"Treatment.Drug","text":"methemoglobinemia"},{"annotation":"T
 {"id": "8151270_3","context": "We report two cases of fulminant hepatic failure in HIV-1-infected patients treated with didanosine (ddI).","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "fulminant hepatic failure"},{"annotation": "Treatment","text": "didanosine (ddI)"},{"annotation": "Treatment.Drug","text": "didanosine"}]}]}
 {"id": "11352235_2","context": "Leflunomide-associated weight loss in rheumatoid arthritis.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "weight loss"},{"annotation": "Treatment","text": "leflunomide"},{"annotation": "Treatment.Disorder","text": "rheumatoid arthritis"}]}]}
 {"id": "11450788_1","context": "Antiretroviral-induced hepatic steatosis and lactic acidosis: case report and review of the literature.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "hepatic steatosis and lactic acidosis"},{"annotation": "Treatment","text": "antiretroviral therapy"},{"annotation": "Treatment.Drug","text": "antiretroviral"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "hepatic steatosis and lactic acidosis"},{"annotation": "Treatment","text": "antiretroviral therapy"},{"annotation": "Treatment.Drug","text": "antiretroviral"}],"negated": true}],"attributes": [{"attribute": "negated","value": true}],"attribute": {"attribute": "negated","value": true}}
 {"id": "1756352_1","context": "A woman developed delusional parasitosis when taking phenelzine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Treatment","text": "phenelzine"},{"annotation": "Treatment.Drug","text": "phenelzine"},{"annotation": "Effect","text": "delusional parasitosis"}]}]
 {"id": "8308951_4","context": "Percutaneous absorption of warfarin causing coagulopathy, reported three times in the past, is a significant risk if protective measures, such as gloves, are not used.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "percutaneous absorption"},{"annotation": "Effect","text": "coagulopathy"},{"annotation": "Treatment","text": "warfarin"},{"annotation": "Treatment.Disorder","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "warfarin"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},{"annotation": "Treatment.Drug","text": "coagulopathy"},
 {"id": "10752888_2","context": "We present two cases of nitrofurantoin-induced pulmonary toxicity in which the initial HRCT showed a widespread reticular pattern and associated distortion of the lung parenchyma, thought to represent established fibrosis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "pulmonary toxicity"},{"annotation": "Treatment","text": "nitrofurantoin"},{"annotation": "Treatment.Drug","text": "nitrofurantoin"},{"annotation": "Treatment.Dosage","text": "established fibrosis"},{"annotation": "Treatment.Duration","text": "established fibrosis"},{"annotation": "Treatment.Route","text": "established fibrosis"},{"annotation": "Treatment.Time_elapsed","text": "established fibrosis"},{"annotation": "Treatment.Disorder","text": "nitrofurantoin-induced pulmonary toxicity"},{"annotation": "Subject","text": "two cases"},{"annotation": "Subject.Population","text": "two cases"},{"annotation": "Subject.Disorder","text": "nitrofurantoin-induced pulmonary toxicity"}]}
 {"id": "17619811_4","context": "Colchicine-induced rhabdomyolysis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "rhabdomyolysis"},{"annotation": "Treatment","text": "colchicine"}]}]}
 {"id":"16678268_2","context":"We report a case of severe AVP three weeks following the administration of infliximab for the treatment of Crohn's disease (CD).","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Treatment.Disorder","text":"Crohn's disease"},{"annotation":"Treatment.Drug","text":"infliximab"},{"annotation":"Effect","text":"AVP"},{"annotation":"Attribute","text":"negated","severity":"high"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"three weeks following"},{"annotation":"Treatment","text":"infliximab"},{"annotation":"Treatment.Drug","text":"infl
 {"id": "10573314_7","context": "In each patient, the initiation of tolterodine was associated with a significant increase in the patient's INR measured 10-14 days later.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "tolterodine"},{"annotation": "Treatment.Duration","text": "initiation"},{"annotation": "Treatment.Disorder","text": "INR increase"},{"annotation": "Effect","text": "increase"},{"annotation": "Treatment.Route","text": "oral"},{"annotation": "Treatment.Time_elapsed","text": "10-14 days"}]}
 {"id": "9007910_4","context": "DATA SYNTHESIS: Genetic deficiencies in DPD, the rate-limiting enzyme responsible for 5-FU catabolism, may occur in 3% or more of patients with cancer putting them at increased risk for unusually severe adverse reactions (e.g., diarrhea, stomatitis, mucositis, myelosuppression, neurotoxicity) to standard doses of 5-FU.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "standard doses of 5-FU"},{"annotation": "Effect","text": "unusually severe adverse reactions"},{"annotation": "Treatment","text": "5-FU"},{"annotation": "Treatment.Disorder","text": "cancer"},{"annotation": "Treatment.Drug","text": "5-FU"},{"annotation": "Treatment.Dosage","text": "standard doses"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "cancer"}]}
 {"id": "21515865_11","context": "According to the Drug Interaction Probability Scale, the development of supratherapeutic INRs was probably associated with concomitant acetaminophen and moxifloxacin use.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "development of supratherapeutic INRs"},{"annotation": "Treatment","text": "concomitant acetaminophen and moxifloxacin use"},{"annotation": "Treatment.Drug","text": "acetaminophen"},{"annotation": "Treatment.Drug","text": "moxifloxacin"},{"annotation": "Treatment.Combination","text": "concomitant"},{"annotation": "Treatment.Combination.Drug","text": "acetaminophen"},{"annotation": "Treatment.Combination.Drug","text": "moxifloxacin"},{"annotation": "Attribute","text": "probably associated"},{"annotation": "Attribute Attributes","text": "Drug Interaction Probability Scale"}]}
 {"id": "17921794_1","context": "Both colchicine and statin therapy may be associated with myopathy, which usually occurs after several months of therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurs"},{"annotation": "Effect","text": "myopathy"},{"annotation": "Treatment","text": "colchicine and statin therapy"},{"annotation": "Treatment.Drug","text": "colchicine"},{"annotation": "Treatment.Drug","text": "statin"},{"annotation": "Treatment.Duration","text": "several months"},{"annotation": "Subject","text": "patients"}]}
 {"id": "6671350_1","context": "Cephalosporins are most likely associated with Vitamin K deficiency.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "associated with"},{"annotation": "Treatment", "text": "cephalosporins"},{"annotation": "Treatment.Drug", "text": "cephalosporins"},{"annotation": "Treatment.Disorder", "text": "Vitamin K deficiency"},{"annotation": "Treatment.Drug", "text": "Vitamin K"},{"annotation": "Attribute", "text": "negated", "negated": true}]}]}
 {"id": "18042092_2","context": "Embolia cutis medicamentosa following subcutaneous injection of glatiramer acetate.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "following subcutaneous injection of glatiramer acetate."},{"annotation": "Effect", "text": "embolia cutis medicamentosa"},{"annotation": "Treatment", "text": "glatiramer acetate"},{"annotation": "Treatment.Drug", "text": "glatiramer acetate"},{"annotation": "Treatment.Dosage", "text": "subcutaneous injection"},{"annotation": "Treatment.Route", "text": "subcutaneous"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Disorder", "text": "not specified"},{"annotation": "Attribute", "text": "not specified"},{"annotation": "Attribute.negated", "text": "not specified"},{"annotation": "Attribute.speculated", "text": "not specified"},{"annotation": "Attribute.severity", "text": "not specified"}]}]
 {"id": "3084231_3","context": "Reversible valproic acid-induced dementia was documented in a 21-year-old man with epilepsy who had a 3-year history of insidious progressive decline in global cognitive abilities documented by serial neuropsychological studies.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "dementia"},{"annotation": "Treatment","text": "valproic acid"},{"annotation": "Treatment.Drug","text": "valproic acid"},{"annotation": "Treatment.Duration","text": "3 years"},{"annotation": "Treatment.Disorder","text": "epilepsy"},{"annotation": "Treatment.Disorder","text": "insidious progressive decline"},{"annotation": "Treatment.Disorder","text": "global cognitive abilities"},{"annotation": "Treatment.Disorder","text": "serial neuropsychological studies"}]}
 {"id": "17316891_1","context": "We describe the case of a 50-year-old woman with advanced non-small cell lung cancer who developed status epilepticus shortly after receiving cisplatin and gemcitabine chemotherapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "receiving cisplatin and gemcitabine chemotherapy"},{"annotation": "Effect","text": "status epilepticus"},{"annotation": "Treatment","text": "cisplatin and gemcitabine chemotherapy"},{"annotation": "Treatment.Drug","text": "cisplatin"},{"annotation": "Treatment.Drug","text": "gemcitabine"},{"annotation": "Treatment.Disorder","text": "non-small cell lung cancer"},{"annotation": "Subject","text": "a 50-year-old woman"}]}
 {"id": "18628507_3","context": "Here, we report a case of angio-oedema associated with VRC therapy.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "VRC therapy"}, {"annotation": "Effect", "text": "angio-oedema"}, {"annotation": "Treatment", "text": "VRC therapy"}, {"annotation": "Treatment.Drug", "text": "VRC"}, {"annotation": "Treatment.Disorder", "text": "angio-oedema"}]}]}
 {"id": "18037876_2","context": "Multiple syncopal episodes started to occur during thalidomide treatment, and a Holter electrocardiogram showed multiple abnormalities, with an episode of sustained ventricular tachycardia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "started"},{"annotation": "Treatment","text": "thalidomide"},{"annotation": "Treatment.Drug","text": "thalidomide"},{"annotation": "Effect","text": "syncopal episodes"},{"annotation": "Treatment","text": "Holter electrocardiogram"},{"annotation": "Treatment.Drug","text": "thalidomide"},{"annotation": "Treatment.Disorder","text": "ventricular tachycardia"},{"annotation": "Treatment.Drug","text": "thalidomide"}]}
 {"id": "9413296_1","context": "A 25-year-old woman sought medical attention because of iliocaval manifestations of retroperitoneal fibrosis while she was taking methysergide.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "taking methysergide"},{"annotation": "Effect","text": "ilioacaval manifestations of retroperitoneal fibrosis"},{"annotation": "Treatment","text": "methysergide"},{"annotation": "Treatment.Drug","text": "methysergide"}],"subject": {"age": "25","gender": "female","population": "1","race": "","disorder": "retroperitoneal fibrosis"}}
 {"id": "18569796_2","context": "Nodular scleritis following alendronate therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "following"},{"annotation": "Treatment","text": "alendronate therapy"},{"annotation": "Treatment.Drug","text": "alendronate"},{"annotation": "Treatment.Side_effect","text": "nodular scleritis"},{"annotation": "Treatment.Duration","text": "therapy"},{"annotation": "Subject","text": "patient"},{"annotation": "Subject.Disorder","text": "nodular scleritis"}]}
 {"id": "10573314_8","context": "Thus, tolterodine was ineffective in both patients and was discontinued one to two days before the elevated INRs were determined during routine clinic visits.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger", "text": "elevated INRs"},{"annotation": "Treatment", "text": "tolterodine"},{"annotation": "Treatment.Duration", "text": "discontinued one to two days before"},{"annotation": "Treatment.Disorder", "text": "elevated INRs"},{"annotation": "Treatment.Drug", "text": "tolterodine"},{"annotation": "Effect", "text": "ineffective"}]}]}
 {"id": "2022118_1","context": "However, the use of lithium should be avoided with any patient who is purging, since it may exacerbate the loss of intracellular potassium, thereby increasing the risk of cardiac toxicity.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "purging"},{"annotation": "Treatment","text": "lithium"},{"annotation": "Treatment.Drug","text": "lithium"},{"annotation": "Effect","text": "cardiac toxicity"},{"annotation": "Treatment.Drug","text": "intracellular potassium"}]}]}
 {"id": "681921_2","context": "Neurophysiological mechanisms which aid in elucidating the role of disulfiram in the etiology of catatonia are discussed.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "discussed"},{"annotation": "Treatment","text": "neurophysiological mechanisms"},{"annotation": "Treatment.Disorder","text": "catatonia"},{"annotation": "Treatment.Drug","text": "disulfiram"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute Attributes","text": "negated"}]}
 {"id": "10717401_1","context": "Sagittal sinus thrombosis associated with transient free protein S deficiency after L-asparaginase treatment: case report and review of the literature.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "associated with"},{"annotation": "Treatment", "text": "L-asparaginase treatment"},{"annotation": "Treatment.Disorder", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Effect", "text": "sagittal sinus thrombosis"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},{"annotation": "Treatment.Drug", "text": "transient free protein S deficiency"},{"annotation": "Treatment.Drug", "text": "L-asparaginase"},
 {"id": "4063627_3","context": "This case demonstrates the association of selective IgA deficiency with remission in rheumatoid arthritis induced by fenclofenac as well as aurothiomalate and sulphasalazine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Disorder","text": "rheumatoid arthritis"},{"annotation": "Treatment","text": "fenclofenac as well as aurothiomalate and sulphasalazine"},{"annotation": "Treatment.Drug","text": "fenclofenac"},{"annotation": "Treatment.Drug","text": "aurothiomalate"},{"annotation": "Treatment.Drug","text": "sulphasalazine"},{"annotation": "Treatment.Drug","text": "fenclofenac"},{"annotation": "Treatment.Drug","text": "aurothiomalate"},{"annotation": "Treatment.Drug","text": "sulphasalazine"},{"annotation": "Treatment.Combination.Trigger","text": "as well as"},{"annotation": "Treatment.Combination.Drug","text": "fenclofenac"},{"annotation": "Treatment.Combination.Drug","text": "aurothiomalate"},{"annotation": "Treatment.Combination.Drug","text": "sulphasalazine"},{"annotation": "Treatment.Combination.Drug","text": "fenclofenac"},{"annotation": "Treatment.Combination.Drug","text": "aurothiomalate"},{"annotation": "Treatment.Combination.Drug","text": "sulphasalazine"},{"annotation": "Subject","text": "rheumatoid arthritis"},{"annotation": "Subject.Disorder","text": "rheumatoid arthritis"},{"annotation": "Subject.Disorder","text": "selective IgA deficiency"}]}
 {"id": "18262450_14","context": "This study provides the first evidence that co-administration of prolonged-release oxycodone and existing gabapentin therapy has a clinically meaningful effect in painful diabetic neuropathy.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "co-administration"},{"annotation": "Effect","text": "clinically meaningful effect"},{"annotation": "Treatment","text": "prolonged-release oxycodone and existing gabapentin therapy"},{"annotation": "Treatment.Disorder","text": "painful diabetic neuropathy"}]}]
 {"id": "17504225_4","context": "In the present case report, the concomitant administration of clarithromycin and sirolimus determined impressive increase of sirolimus trough blood concentrations from 6.2 up to 54 ng/mL and this increase was associated with an acute impairment of renal function, almost completely reversed upon both drugs discontinuation.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "concomitant administration of clarithromycin and sirolimus"},{"annotation": "Treatment","text": "sirolimus"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Effect","text": "acute impairment of renal function"},{"annotation": "Treatment.Drug","text": "clarithromycin"},{"annotation": "Treatment.Drug","text": "sirolimus"},{"annotation": "Treatment.Combination.Trigger","text": "and"},{"annotation": "Treatment.Combination.Drug","text": "sirolimus"},{"annotation": "Treatment.Combination.Drug","text": "clarithromycin"},{"annotation": "Subject","text": "patient"},{"annotation": "Subject.Disorder","text": "renal function"}]}]
 {"id":"10190739_1","context":"In one case, the readministration of riluzole was followed by the relapse of hepatitis.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"readministration"},{"annotation":"Effect","text":"hepatitis"},{"annotation":"Treatment","text":"riluzole"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Subject.Disorder","text":"hepatitis"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Subject","text":"one case"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Trigger","text":"readministration"},{"annotation":"Treatment.Combination.Drug","text":"riluzole"},{"annotation":"Treatment.Combination.Drug","text":"readministration"},{"annotation":"Treatment.Drug","text":"riluzole"},{"annotation":"Treatment.Dosage","text":"readministration"},{"annotation":"Treatment.Duration","text":"followed by relapse"},{"annotation":"Treatment.Drug
 {"id": "16018164_3","context": "Pseudoephedrine-induced hemorrhage associated with a cerebral vascular malformation.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Treatment", "text": "pseudoephedrine"},{"annotation": "Treatment.Drug", "text": "pseudoephedrine"},{"annotation": "Effect", "text": "hemorrhage"},{"annotation": "Treatment.Disorder", "text": "cerebral vascular malformation"},{"annotation": "Treatment.Drug", "text": "pseudoephedrine"},{"annotation": "Treatment.Drug", "text": "hemorrhage"},{"annotation": "Treatment.Combination.Trigger", "text": "associated with"},{"annotation": "Treatment.Combination.Drug", "text": "pseudoephedrine"},{"annotation": "Treatment.Combination.Drug", "text": "cerebral vascular malformation"},{"annotation": "Subject", "text": "a patient"},{"annotation": "Subject.Disorder", "text": "cerebral vascular malformation"}]}]}
 {"id": "16490518_1","context": "PURPOSE: To report a case of severe corticosteroid-induced glaucoma after intravitreal injection of triamcinolone acetate in a 34-year-old man without a history of glaucoma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intravitreal injection of triamcinolone acetate"},{"annotation": "Effect","text": "glaucoma"},{"annotation": "Treatment","text": "intravitreal injection of triamcinolone acetate"},{"annotation": "Treatment.Drug","text": "triamcinolone acetate"},{"annotation": "Treatment.Dosage","text": "unknown"},{"annotation": "Treatment.Frequency","text": "unknown"},{"annotation": "Treatment.Route","text": "unknown"},{"annotation": "Treatment.Time_elapsed","text": "unknown"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "glaucoma"}]}
 {"id": "7369302_2","context": "A transient tonic pupillary response, denervation supersensitivity, and abnormal visual-evoked potentials in quinine toxicity, to our knowledge, have not been previously reported.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "toxicity"},{"annotation": "Effect","text": "transient tonic pupillary response, denervation supersensitivity, and abnormal visual-evoked potentials"},{"annotation": "Treatment","text": "quinine"}]}]}
 {"id": "10682234_6","context": "Two days' administration of levomepromazine 100 mg led him to a coma for 2 days.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "administration"},{"annotation": "Treatment","text": "levomepromazine"},{"annotation": "Treatment.Drug","text": "levomepromazine"},{"annotation": "Treatment.Dosage","text": "100 mg"},{"annotation": "Treatment.Duration","text": "2 days"},{"annotation": "Treatment.Route","text": "administered"},{"annotation": "Treatment.Time_elapsed","text": "2 days"},{"annotation": "Effect","text": "coma"}]}
 {"id": "9777751_1","context": "Methimazole-induced aplastic anemia in third exposure: successful treatment with recombinant human granulocyte colony-stimulating factor.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "aplastic anemia"},{"annotation": "Treatment","text": "methimazole"},{"annotation": "Treatment.Disorder","text": "aplastic anemia"},{"annotation": "Treatment.Drug","text": "methimazole"},{"annotation": "Treatment.Dosage","text": "third exposure"},{"annotation": "Treatment.Duration","text": "successful treatment"},{"annotation": "Treatment.Drug","text": "recombinant human granulocyte colony-stimulating factor"}]}
 {"id": "18751717_2","context": "BACKGROUND: We describe the ophthalmic features and clinical course of two cases of acute syphilitic posterior placoid chorioretinitis (ASPPC) that developed after intravitreal triamcinolone acetonide (IVTA) injection.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intravitreal triamcinolone acetonide (IVTA) injection"},{"annotation": "Treatment","text": "intravitreal triamcinolone acetonide (IVTA) injection"},{"annotation": "Treatment.Drug","text": "triamcinolone acetonide"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intravitreal triamcinolone acetonide (IVTA) injection"},{"annotation": "Treatment","text": "intravitreal triamcinolone acetonide (IVTA) injection"},{"annotation": "Treatment.Drug","text": "triamcinolone acetonide"},{"annotation": "Effect","text": "acute syphilitic posterior placoid chorioretinitis (ASPPC)"}]}],"subject": {"age": "not provided","gender": "not provided","population": "two cases","race": "not provided","disorder": "acute syphilitic posterior placoid chorioretinitis (ASPPC)"}}
 {"id": "14522628_2","context": "Skin rash and splinter hemorrhages from ganciclovir.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "from"},{"annotation": "Effect","text": "skin rash and splinter hemorrhages"},{"annotation": "Treatment","text": "ganciclovir"}]}]}
 {"id":"15368548_5","context":"We present a pediatric patient with leukemia and a severe, L-asparaginase-induced necrotizing pancreatitis, treated successfully with percutaneous drainage used to flush the infected necrotic parts.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "necrotizing pancreatitis"},{"annotation": "Treatment","text": "L-asparaginase"},{"annotation": "Treatment.Drug","text": "L-asparaginase"},{"annotation": "Treatment.Disorder","text": "leukemia"},{"annotation": "Event type","text": "Adverse_event"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "necrotizing pancreatitis"},{"annotation": "Treatment","text": "percutaneous drainage"},{"annotation": "Treatment.Drug","text": "percutaneous drainage"},{"annotation": "Treatment.Disorder","text": "leukemia"},{"annotation": "Event type","text": "Adverse_event"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "infected"},{"annotation": "Effect","text": "necrotic parts"},{"annotation": "Treatment","text": "percutaneous drainage"},{"annotation": "Treatment.Drug","text": "percutaneous drainage"},{"annotation": "Treatment.Disorder","text": "leukemia"},{"annotation": "Event type","text": "Adverse_event"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "treatment"},{"annotation": "Effect","text": "success"},{"annotation": "Treatment","text": "percutaneous drainage"},{"annotation": "Treatment.Drug","text": "percutaneous drainage"},{"annotation": "Treatment.Disorder","text": "leukemia"},{"annotation": "Event type","text": "Potential_therapeutic_effect"}]}
 {"id": "11804071_3","context": "Such anagen effluvium with lichenoid eruption following INH therapy has not been observed previously.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "following INH therapy"},{"annotation": "Effect", "text": "anagen effluvium with lichenoid eruption"},{"annotation": "Treatment", "text": "INH therapy"},{"annotation": "Treatment.Drug", "text": "INH"},{"annotation": "Treatment.Disorder", "text": "anagen effluvium with lichenoid eruption"}]}]}
 {"id": "10646879_3","context": "We conclude that MB is an effective treatment for ifosfamide-induced encephalopathy.","events": [{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "ifosfamide-induced encephalopathy"},{"annotation": "Treatment", "text": "MB"},{"annotation": "Treatment.Disorder", "text": "ifosfamide-induced encephalopathy"},{"annotation": "Treatment.Drug", "text": "MB"},{"annotation": "Attribute.negated", "text": "not negated"},{"annotation": "Attribute.speculated", "text": "not speculated"},{"annotation": "Attribute.severity", "text": "not applicable"}]}]}
 {"id": "18354950_2","context": "Hyponatraemia during low-dose carbamazepine therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "during"},{"annotation": "Treatment","text": "low-dose carbamazepine therapy"},{"annotation": "Treatment.Drug","text": "carbamazepine"},{"annotation": "Effect","text": "hyponatraemia"}]}]
 {"id": "16697705_1","context": "Acute coronary syndrome induced by capecitabine therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "capecitabine therapy"},{"annotation": "Treatment.Drug","text": "capecitabine"},{"annotation": "Effect","text": "acute coronary syndrome"}]}]}
 {"id": "3171334_1","context": "A case of severe visual loss following a single dose of vincristine is described.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "single dose of vincristine"},{"annotation": "Effect","text": "severe visual loss"},{"annotation": "Treatment","text": "vincristine"}]}]
 {"id": "16357738_3","context": "We report a case of a young woman with SLE and thrombocytopenia, who developed severe perspiration, headache, and seizure after receiving cyclosporine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "receiving cyclosporine"},{"annotation": "Effect","text": "severe perspiration, headache, and seizure"},{"annotation": "Treatment","text": "cyclosporine"},{"annotation": "Treatment.Disorder","text": "SLE and thrombocytopenia"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Subject","text": "a young woman"},{"annotation": "Subject.Disorder","text": "SLE and thrombocytopenia"}]}
 {"id": "12507063_1","context": "Although gabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with generalized seizures and status epilepticus secondary to gabapentin withdrawal.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "withdrawal"},{"annotation": "Treatment","text": "gabapentin"},{"annotation": "Treatment.Drug","text": "gabapentin"},{"annotation": "Effect","text": "generalized seizures"},{"annotation": "Treatment.Drug","text": "gabapentin"},{"annotation": "Treatment.Drug","text": "status epilepticus"},{"annotation": "Subject","text": "patient"},{"annotation": "Subject.Disorder","text": "gabapentin withdrawal"}]}
 {"id": "4014301_2","context": "Self-limited edema is a well-recognized complication of insulin therapy.","events": [{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Treatment", "text": "insulin therapy"},{"annotation": "Treatment.Disorder", "text": "self-limited edema"},{"annotation": "Effect", "text": "complication"}]}]}
 {"id": "15061230_1","context": "It is very likely that the dexamethasone used in the antiemetic drug regimen contributed to the development of osteonecrosis in these patients.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "development"},{"annotation": "Treatment","text": "dexamethasone"},{"annotation": "Treatment.Disorder","text": "osteonecrosis"},{"annotation": "Treatment.Drug","text": "antiemetic drug regimen"},{"annotation": "Treatment.Combination.Trigger","text": "contributed"},{"annotation": "Treatment.Combination.Drug","text": "dexamethasone"}]}
 {"id": "12397859_1","context": "A case is presented of a patient who experienced benzodiazepine withdrawal symptoms on discontinuation of nefazodone, an antidepressant that inhibits the cytochrome P450 3A4 isoenzyme.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "discontinuation"},{"annotation": "Effect","text": "benzodiazepine withdrawal symptoms"},{"annotation": "Treatment","text": "nefazodone"},{"annotation": "Treatment.Disorder","text": "benzodiazepine withdrawal"},{"annotation": "Treatment.Drug","text": "nefazodone"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{"annotation": "Treatment.Drug","text": "benzodiazepine"},{
 {"id":"3156465_1","context":"Isotretinoin, a drug used for the treatment of acne, has been shown to have teratogenic effects.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Treatment","text":"isotretinoin"},{"annotation":"Treatment.Disorder","text":"acne"},{"annotation":"Treatment.Drug","text":"isotretinoin"},{"annotation":"Treatment.Dosage","text":"unknown"},{"annotation":"Treatment.Frequency","text":"unknown"},{"annotation":"Treatment.Route","text":"unknown"},{"annotation":"Treatment.Time_elapsed","text":"unknown"},{"annotation":"Treatment.Duration","text":"unknown"},{"annotation":"Effect","text":"teratogenic effects"},{"annotation":"Attribute Attributes","text":"negated","severity":"high"},{"annotation":"Attribute Attributes","text":"negated","negated","text":"teratogenic effects"}]}]}
 {"id": "12022905_6","context": "The capacity of zuclopenthixol to induce priapism is thought to be due to its antagonist activity on alpha-adrenergic receptors.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "priapism"},{"annotation": "Treatment","text": "zuclopenthixol"},{"annotation": "Treatment.Drug","text": "zuclopenthixol"}]}{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "capacity"},{"annotation": "Effect","text": "priapism"},{"annotation": "Treatment","text": "zuclopenthixol"},{"annotation": "Treatment.Drug","text": "zuclopenthixol"},{"annotation": "Attribute","text": "negated"}]}{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "capacity"},{"annotation": "Effect","text": "priapism"},{"annotation": "Treatment","text": "zuclopenthixol"},{"annotation": "Treatment.Drug","text": "zuclopenthixol"},{"annotation": "Attribute","text": "negated"}],"severity": "high"}{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "capacity"},{"annotation": "Effect","text": "priapism"},{"annotation": "Treatment","text": "zuclopenthixol"},{"annotation": "Treatment.Drug","text": "zuclopenthixol"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"}],"severity": "high"}{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "capacity"},{"annotation": "Effect","text": "priapism"},{"annotation": "Treatment","text": "zuclopenthixol"},{"annotation": "Treatment.Drug","text": "zuclopenthixol"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "severity"},{"annotation": "severity","text": "high"}],"severity": "high"}{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "capacity"},{"annotation": "Effect","text": "priapism"},{"annotation": "Treatment","text": "zuclopenthixol"},{"annotation": "Treatment.Drug","text": "zuclopenthixol"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "severity"},{"annotation": "severity","text": "high"}],"severity": "high"}{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "capacity"},{"annotation": "Effect","text": "priapism"},{"annotation": "Treatment","text": "zuclopenthixol"},{"annotation": "Treatment.Drug","text": "zuclopenthixol"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "severity"},{"annotation": "severity","text": "high"}],"severity": "high"}{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "capacity"},{"annotation": "Effect","text": "priapism"},{"annotation": "Treatment","text": "zuclopenthixol"},{"annotation": "Treatment.Drug","text": "zuclopenthixol"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "severity"},{"annotation": "severity","text": "high"}],"severity": "high"}{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "capacity"},{"annotation": "Effect","text": "priapism"},{"annotation": "Treatment","text": "zuclopenthixol"},{"annotation": "Treatment.Drug","text": "zuclopenthixol"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "speculated"},{"annotation": "Attribute","text": "negated"},{"annotation": "Attribute","text": "severity"},{"annotation": "severity","text": "high"}],"severity": "high"}{"type": "Adverse_event","annotations": [{
 {"id": "6572542_4","context": "Two patients treated for chronic myeloid leukemia with high doses of CCNU (1100 mg/m2 and 1240 mg/m2, respectively) developed a fatal pulmonary fibrosis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "fatal pulmonary fibrosis"},{"annotation": "Treatment","text": "high doses of CCNU"},{"annotation": "Treatment.Drug","text": "CCNU"},{"annotation": "Treatment.Dosage","text": "1100 mg/m2 and 1240 mg/m2"},{"annotation": "Treatment.Duration","text": "chronic"},{"annotation": "Treatment.Disorder","text": "chronic myeloid leukemia"},{"annotation": "Treatment.Drug","text": "CCNU"}]}
 {"id": "11724089_1","context": "CONCLUSIONS: There is very little published information regarding ofloxacin-induced toxic epidermal necrolysis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Treatment", "text": "ofloxacin"},{"annotation": "Treatment.Drug", "text": "ofloxacin"},{"annotation": "Effect", "text": "toxic epidermal necrolysis"},{"annotation": "Attribute", "text": "negated", "severity": "low"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "speculated", "severity": "low"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "text": "negated"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute", "text": "negated", "negation": "not"},{"annotation": "Attribute
 {"id": "18755414_3","context": "Our case is the second one in which hemorrhage from a meningioma may have been induced by aspirin prophylaxis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "hemorrhage"},{"annotation": "Effect","text": "meningioma"},{"annotation": "Treatment","text": "aspirin prophylaxis"},{"annotation": "Treatment.Drug","text": "aspirin"},{"annotation": "Attribute","text": "negated","attribute": "negated"}]}]
 {"id": "10225085_2","context": "Methemoglobinemia after axillary block with bupivacaine and additional injection of lidocaine in the operative field.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "axillary block with bupivacaine and additional injection of lidocaine in the operative field."},{"annotation": "Treatment", "text": "axillary block with bupivacaine and additional injection of lidocaine in the operative field."},{"annotation": "Treatment.Drug", "text": "bupivacaine"},{"annotation": "Treatment.Drug", "text": "lidocaine"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "bupivacaine"},{"annotation": "Treatment.Combination.Drug", "text": "lidocaine"},{"annotation": "Effect", "text": "methemoglobinemia"},{"annotation": "Treatment.Drug", "text": "axillary block with bupivacaine and additional injection of lidocaine in the operative field."},{"annotation": "Treatment.Disorder", "text": "methemoglobinemia"},{"annotation": "Subject", "text": "patient"},{"annotation": "Subject.Disorder", "text": "patient"}]}]}
 {"id": "10812579_3","context": "Nonconvulsive status epilepticus: the role of morphine and its antagonist.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "nonconvulsive status epilepticus"},{"annotation": "Treatment","text": "morphine"},{"annotation": "Treatment.Drug","text": "morphine"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "nonconvulsive status epilepticus"},{"annotation": "Treatment","text": "morphine antagonist"},{"annotation": "Treatment.Drug","text": "morphine antagonist"}]}],"attributes": [{"annotation": "negated","text": "no"}]}
 {"id": "8579054_1","context": "Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "evolving"},{"annotation": "Treatment","text": "hydroxyurea"},{"annotation": "Treatment.Disorder","text": "acute myeloid leukemia"},{"annotation": "Treatment.Disorder","text": "essential thrombocythemia"},{"annotation": "Treatment.Drug","text": "hydroxyurea"}],"subjects": [{"id": "1","text": "two patients"}]}
 {"id": "10698143_1","context": "Central nervous system manifestations of an ibuprofen overdose reversed by naloxone.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "ibuprofen overdose"}, {"annotation": "Effect", "text": "central nervous system manifestations"}, {"annotation": "Treatment", "text": "naloxone"}, {"annotation": "Treatment.Drug", "text": "ibuprofen"}, {"annotation": "Treatment.Drug", "text": "naloxone"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Treatment.Disorder", "text": "ibuprofen overdose"}, {"annotation": "Attribute", "text": "negated", "annotation": "negated"}]},{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "naloxone"}, {"annotation": "Treatment", "text": "ibuprofen overdose"}, {"annotation": "Treatment.Disorder", "text": "ibuprofen overdose"}, {"annotation": "Treatment.Drug", "text": "naloxone"}, {"annotation": "Treatment.Dosage", "text": "unknown"}, {"annotation": "Treatment.Frequency", "text": "unknown"}, {"annotation": "Treatment.Route", "text": "unknown"}, {"annotation": "Treatment.Time_elapsed", "text": "unknown"}, {"annotation": "Treatment.Duration", "text": "unknown"}, {"annotation": "Attribute", "text": "speculated", "annotation": "speculated"}, {"annotation": "severity", "text": "unknown"}, {"annotation": "Attribute", "text": "negated", "annotation": "negated"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "Attribute", "text": "negated", "annotation": "negated"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "Attribute", "text": "negated", "annotation": "negated"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "Attribute", "text": "negated", "annotation": "negated"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overdose"}, {"annotation": "negated", "text": "ibuprofen overd
 {"id": "20465622_2","context": "BACKGROUND: Aphthous stomatitis, a common mucocutaneous disorder, is a well accepted complication of sirolimus therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "sirolimus therapy"},{"annotation": "Effect","text": "aphthous stomatitis"}]}]}
 {"id": "18675768_4","context": "The goal of this article was to describe a potential drug-drug interaction between propafenone and citalopram, which caused symptoms of propafenone adverse effects.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "caused"},{"annotation": "Treatment","text": "propafenone"},{"annotation": "Treatment.Drug","text": "propafenone"},{"annotation": "Effect","text": "adverse effects"},{"annotation": "Treatment","text": "citalopram"},{"annotation": "Treatment.Drug","text": "citalopram"}]}}
 {"id": "7949255_1","context": "Temporary neurologic abnormalities were observed in one out of 23 patients undergoing chemotherapy with high-dose methotrexate (HD-MTX) for osteogenic sarcoma.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "observed"},{"annotation": "Effect","text": "neurologic abnormalities"},{"annotation": "Treatment","text": "chemotherapy with HD-MTX"},{"annotation": "Treatment.Drug","text": "HD-MTX"},{"annotation": "Treatment.Dosage","text": "high-dose"},{"annotation": "Treatment.Duration","text": "for osteogenic sarcoma"},{"annotation": "Treatment.Disorder","text": "osteogenic sarcoma"},{"annotation": "Subject","text": "one out of 23 patients"}]}
 {"id": "18675768_13","context": "This is the first report of a possible interaction between propafenone and citalopram, which caused propafenone adverse effects (eg, dizziness, falls) and mimicked coronary artery disease.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "propafenone"},{"annotation": "Effect","text": "adverse effects (eg, dizziness, falls)"},{"annotation": "Treatment","text": "combination of propafenone and citalopram"},{"annotation": "Treatment.Drug","text": "propafenone"},{"annotation": "Treatment.Drug","text": "citalopram"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "not specified"},{"annotation": "Treatment.Drug","text": "not specified"}]}
 {"id": "1082426_1","context": "Spontaneous bacterial peritonitis induced by intraarterial vasopressin therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Effect", "text": "spontaneous bacterial peritonitis"},{"annotation": "Treatment", "text": "intraarterial vasopressin therapy"},{"annotation": "Treatment.Drug", "text": "vasopressin"},{"annotation": "Treatment.Disorder", "text": "spontaneous bacterial peritonitis"},{"annotation": "Treatment.Drug", "text": "vasopressin"},{"annotation": "Subject", "text": "induced by intraarterial vasopressin therapy"},{"annotation": "Subject.Disorder", "text": "spontaneous bacterial peritonitis"}]}]}
 {"id": "16685007_1","context": "Ciclesonide reduces the need for oral steroid use in adult patients with severe, persistent asthma.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "reduces"},{"annotation": "Treatment","text": "ciclesonide"},{"annotation": "Treatment.Disorder","text": "severe, persistent asthma"},{"annotation": "Treatment.Drug","text": "ciclesonide"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Annotation","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","annotation_type": "negated"},{"annotation": "Attribute","text": "negated","
 {"id": "8250714_1","context": "Five cases (four from the literature and one new case) are presented in which patients unsuspected of having vitamin B12 deficiency developed subacute combined degeneration of the spinal cord following nitrous oxide anesthesia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Effect","text": "subacute combined degeneration of the spinal cord"},{"annotation": "Treatment","text": "nitrous oxide anesthesia"},{"annotation": "Treatment.Drug","text": "nitrous oxide"},{"annotation": "Treatment.Drug","text": "anesthesia"},{"annotation": "Treatment.Disorder","text": "vitamin B12 deficiency"}]}
 {"id": "12022905_1","context": "CASE SUMMARY: We report the case of a 31-year-old patient hospitalized due to behavioral alterations and treated with oral zuclopenthixol, an antipsychotic from the thioxanthene family, who developed an acute, painful erection.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Treatment","text": "oral zuclopenthixol"},{"annotation": "Treatment.Drug","text": "zuc
 {"id": "6401771_2","context": "Three cases of acute renal toxicity in patients receiving long-term therapy with mitomycin C and 5-fluorouracil are reported.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "long-term therapy"},{"annotation": "Treatment","text": "mitomycin C and 5-fluorouracil"},{"annotation": "Treatment.Drug","text": "mitomycin C"},{"annotation": "Treatment.Drug","text": "5-fluorouracil"},{"annotation": "Treatment.Dosage","text": "long-term"},{"annotation": "Treatment.Duration","text": "long-term"},{"annotation": "Treatment.Disorder","text": "acute renal toxicity"}]}
 {"id": "9870779_1","context": "A 40-year-old man with a long standing history of rheumatoid arthritis was treated with MTX over a 6 month period and developed an overwhelming hepatic necrosis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "MTX"},{"annotation": "Treatment", "text": "MTX"},{"annotation": "Treatment.Drug", "text": "MTX"},{"annotation": "Effect", "text": "hepatic necrosis"},{"annotation": "Subject", "text": "a 40-year-old man"},{"annotation": "Subject.Disorder", "text": "rheumatoid arthritis"},{"annotation": "Treatment.Duration", "text": "6 month period"}]}]
 {"id": "9627209_1","context": "In case 1, a total daily dose of 25 mg sertraline, with nondetectable sertraline and desmethylsertraline blood levels, resulted in a doubling of the lamotrigine blood level with symptoms of toxicity.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "resulted"},{"annotation": "Treatment","text": "25 mg sertraline"},{"annotation": "Treatment.Drug","text": "sertraline"},{"annotation": "Treatment.Drug","text": "desmethylsertraline"},{"annotation": "Treatment.Combination.Trigger","text": "with"},{"annotation": "Treatment.Combination.Drug","text": "lamotrigine"},{"annotation": "Effect","text": "toxicity"},{"annotation": "Treatment.Drug","text": "sertraline"},{"annotation": "Treatment.Drug","text": "desmethylsertraline"},{"annotation": "Treatment.Combination.Drug","text": "lamotrigine"},{"annotation": "Subject","text": "none"},{"annotation": "Subject.Disorder","text": "none"}]}}
 {"id": "7355327_3","context": "Since the bronchospasm was relieved with discontinuation of propranolol and supportive bronchodilator therapy, the bronchospasm was believed to be caused by propranolol.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "bronchospasm"},{"annotation": "Treatment","text": "discontinuation of propranolol and supportive bronchodilator therapy"},{"annotation": "Treatment.Drug","text": "propranolol"},{"annotation": "Effect","text": "relieved"},{"annotation": "Treatment.Drug","text": "propranolol"}]}]
 {"id": "6362443_2","context": "A depressed woman with no history of bipolar illness developed a manic episode during treatment with fluoxetine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Treatment","text": "fluoxetine"},{"annotation": "Treatment.Drug","text": "fluoxetine"},{"annotation": "Effect","text": "manic episode"},{"annotation": "Treatment.Disorder","text": "depressed"},{"annotation": "Treatment.Disorder","text": "bipolar illness"}]}
 {"id": "6725214_2","context": "Priapism associated with trazodone therapy: case report.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "trazodone therapy"},{"annotation": "Effect","text": "priapism"},{"annotation": "Treatment","text": "trazodone"}]}]}
 {"id": "7639655_3","context": "OBJECTIVE: To report the occurrence of anterior ischemic optic neuropathy as a complication of treatment with interferon alfa and to consider the possible underlying mechanisms for this association.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurrence"},{"annotation": "Treatment","text": "interferon alfa"},{"annotation": "Effect","text": "anterior ischemic optic neuropathy"}]},{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "consideration"},{"annotation": "Treatment","text": "interferon alfa"},{"annotation": "Treatment.Disorder","text": "anterior ischemic optic neuropathy"},{"annotation": "Treatment.Mechanism","text": "possible underlying mechanisms"}]}]}
 {"id": "8850251_4","context": "Mequitazine seemed to play a part similar to chlorpromazine, and absence of mequitazine-induced photosensitivity may be due to a relatively low dosage of the drug.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "mequitazine"},{"annotation": "Treatment.Drug","text": "mequitazine"},{"annotation": "Treatment.Drug","text": "chlorpromazine"},{"annotation": "Treatment.Disorder","text": "photosensitivity"},{"annotation": "Treatment.Drug","text": "absence"},{"annotation": "Treatment.Drug","text": "low dosage"},{"annotation": "Effect","text": "photosensitivity"}]}
 {"id": "15927910_2","context": "Although various manifestations of pentamidine-induced cardiotoxicity have been reported, to our knowledge, second-degree heart block associated with this agent has not been described.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "induced"},{"annotation": "Treatment", "text": "pentamidine"},{"annotation": "Treatment.Drug", "text": "pentamidine"},{"annotation": "Effect", "text": "second-degree heart block"},{"annotation": "Treatment.Disorder", "text": "pentamidine-induced cardiotoxicity"},{"annotation": "Treatment.Drug", "text": "pentamidine"}]}]}
 {"id":"23115227_6","context":"The mean weekly warfarin dose while the patient was receiving emtricitabine monotherapy was 13.3 mg (95% CI 12.7 to 13.8), with a mean international normalized ratio (INR) of 2.8 (95% CI 2.5 to 3.1).","events":[{"type":"Treatment","annotations":[{"annotation":"Drug","text":"warfarin"},{"annotation":"Dosage","text":"13.3 mg (95% CI 12.7 to 13.8)"},{"annotation":"Frequency","text":"weekly"},{"annotation":"Route","text":"oral"},{"annotation":"Time_elapsed","text":"not applicable"},{"annotation":"Duration","text":"not applicable"},{"annotation":"Disorder","text":"not applicable"},{"annotation":"Attribute Attributes","text":"not applicable"}]},{"type":"Treatment","annotations":[{"annotation":"Drug","text":"emtricitabine"},{"annotation":"Dosage","text":"not applicable"},{"annotation":"Frequency","text":"weekly"},{"annotation":"Route","text":"oral"},{"annotation":"Time_elapsed","text":"not applicable"},{"annotation":"Duration","text":"not applicable"},{"annotation":"Disorder","text":"not applicable"},{"annotation":"Attribute Attributes","text":"not applicable"}]}]}
 {"id": "3806824_2","context": "We report a case of penile fibrosis after intracavernous self-injection of a combination of phentolamine and papaverine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "intracavernous self-injection of a combination of phentolamine and papaverine"},{"annotation": "Treatment","text": "combination of phentolamine and papaverine"},{"annotation": "Treatment.Drug","text": "phentolamine"},{"annotation": "Treatment.Drug","text": "papaverine"},{"annotation": "Effect","text": "penile fibrosis"},{"annotation": "Treatment.Disorder","text": "penile fibrosis"}]}
 {"id": "6865827_3","context": "This is, to the best of our knowledge, the first report of a case in which agranulocytosis followed treatment with both propylthiouracil and methimazole in the same patient.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "followed treatment with both propylthiouracil and methimazole"},{"annotation": "Treatment","text": "propylthiouracil and methimazole"},{"annotation": "Treatment.Disorder","text": "agranulocytosis"},{"annotation": "Treatment.Drug","text": "propylthiouracil"},{"annotation": "Treatment.Drug","text": "methimazole"}]}]
 {"id": "15522120_1","context": "Itch and skin rash from chocolate during fluoxetine and sertraline treatment: case report.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "chocolate"},{"annotation": "Treatment","text": "fluoxetine and sertraline"},{"annotation": "Treatment.Disorder","text": "fluoxetine and sertraline treatment"},{"annotation": "Treatment.Drug","text": "fluoxetine"},{"annotation": "Treatment.Drug","text": "sertraline"},{"annotation": "Effect","text": "itch and skin rash"}]}]
 {"id": "18262450_11","context": "Oxycodone-gabapentin co-administration was associated with less escape medication use (P = 0.03) and fewer nights of disturbed sleep (P < 0.05).","events": [{"type": "Effect","annotations": [{"annotation": "Treatment","text": "oxycodone-gabapentin co-administration"},{"annotation": "Attribute Attributes","severity": "low"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"},{"annotation": "Attribute Attributes","negated": "false"
 {"id": "6618859_2","context": "Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "gynecomastia"},{"annotation": "Treatment","text": "phenobarbital, phenytoin and fluoresone"},{"annotation": "Treatment.Drug","text": "phenobarbital"},{"annotation": "Treatment.Drug","text": "phenytoin"},{"annotation": "Treatment.Drug","text": "fluoresone"},{"annotation": "Treatment.Combination.Trigger","text": "in"},{"annotation": "Treatment.Combination.Drug","text": "epileptics"},{"annotation": "Subject","text": "epileptics"},{"annotation": "Subject.Disorder","text": "epilepsy"}]}
 {"id":"3542612_1","context":"Captopril-induced lichen planus pemphigoides with pemphigus-like features.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Effect","text":"lichen planus pemphigoides with pemphigus-like features"},{"annotation":"Treatment","text":"captopril"},{"annotation":"Treatment.Drug","text":"captopril"},{"annotation":"Treatment.Disorder","text":"lichen planus pemphigoides"},{"annotation":"Treatment.Disorder","text":"pemphigus-like features"},{"annotation":"Subject","text":"a patient"},{"annotation":"Subject.Disorder","text":"lichen planus pemphigoides"},{"annotation":"Treatment.Disorder","text":"pemphigus-like features"}]}]}
 {"id": "6873616_3","context": "The literature on thiabendazole-induced cholestasis and its association with sicca complex is reviewed.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Treatment","text": "thiabendazole"},{"annotation": "Treatment.Drug","text": "thiabendazole"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Disorder","text": "cholestasis"},{"annotation": "Effect","text": "cholestasis"},{"annotation": "Attribute Attributes","annotations": [{"annotation": "negated","text": "not specified"},{"annotation": "speculated","text": "not specified"},{"annotation": "severity","text": "not specified"}]}]}
 {"id": "8523340_2","context": "How low can you go? Use of very low dosage of gold in patients with mucocutaneous reactions.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "mucocutaneous reactions"},{"annotation": "Treatment","text": "very low dosage of gold"},{"annotation": "Treatment.Drug","text": "gold"},{"annotation": "Effect","text": "mucocutaneous reactions"},{"annotation": "Treatment.Disorder","text": "mucocutaneous reactions"}]}]}
 {"id": "23970584_3","context": "A 55-year-old HIV-positive African woman received a single epidural triamcinolone injection for pain relief of postherpetic neuralgia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "received"},{"annotation": "Treatment","text": "epidural triamcinolone injection"},{"annotation": "Treatment.Drug","text": "triamcinolone"},{"annotation": "Treatment.Dosage","text": "single"},{"annotation": "Effect","text": "pain relief"},{"annotation": "Treatment.Disorder","text": "postherpetic neuralgia"},{"annotation": "Treatment.Drug","text": "triamcinolone"}],"attributes": [{"attribute": "negated","text": "not"}]}
 {"id": "6731466_2","context": "Anaphylactoid shock, disseminated intravascular coagulation, and anuric renal failure requiring dialysis occurred in a patient receiving zomepirac sodium for toothache.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "occurred"},{"annotation": "Treatment","text": "zomepirac sodium"},{"annotation": "Treatment.Drug","text": "zomepirac"},{"annotation": "Treatment.Dosage","text": "for toothache"},{"annotation": "Treatment.Frequency","text": "anaphylactoid shock"},{"annotation": "Treatment.Route","text": "disseminated intravascular coagulation"},{"annotation": "Treatment.Time_elapsed","text": "anuric renal failure requiring dialysis"},{"annotation": "Treatment.Duration","text": "unknown"},{"annotation": "Treatment.Disorder","text": "zomepirac sodium for toothache"},{"annotation": "Effect","text": "anaphylactoid shock, disseminated intravascular coagulation, and anuric renal failure requiring dialysis"}]}
 {"id": "11341670_1","context": "During dose-finding studies for intravenous proton pump inhibitors omeprazole and pantoprazole, three of six young female volunteers receiving omeprazole and two young female volunteers receiving pantoprazole developed peripheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "developed peripheral edema"},{"annotation": "Treatment", "text": "intravenous proton pump inhibitors omeprazole and pantoprazole"},{"annotation": "Treatment.Drug", "text": "omeprazole"},{"annotation": "Treatment.Drug", "text": "pantoprazole"},{"annotation": "Treatment.Dosage", "text": "high doses"},{"annotation": "Treatment.Time_elapsed", "text": "within 8 hr"},{"annotation": "Treatment.Route", "text": "continuous infusion together with large volumes of fluid"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "omeprazole"},{"annotation": "Treatment.Combination.Drug", "text": "pantoprazole"},{"annotation": "Treatment.Combination.Drug", "text": "omeprazole"},{"annotation": "Treatment.Combination.Drug", "text": "pantoprazole"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "omeprazole"},{"annotation": "Treatment.Combination.Drug", "text": "pantoprazole"},{"annotation": "Subject", "text": "three of six young female volunteers receiving omeprazole and two young female volunteers receiving pantoprazole"},{"annotation": "Subject.Age", "text": "young female volunteers"},{"annotation": "Subject.Disorder", "text": "none"}]}]}
 {"id":"10682234_7","context":"Intravenous levodopa 25 mg ameliorated his akathisia symptoms drastically.","events":[{"type":"Potential_therapeutic_effect","annotations":[{"annotation":"Trigger","text":"symptoms"},{"annotation":"Treatment","text":"intravenous levodopa 25 mg"},{"annotation":"Treatment.Drug","text":"levodopa"},{"annotation":"Treatment.Dose","text":"25 mg"},{"annotation":"Treatment.Dosage_units","text":"mg"},{"annotation":"Treatment.Route","text":"intravenous"},{"annotation":"Treatment.Duration","text":"drastically"},{"annotation":"Treatment.Disorder","text":"akathisia"},{"annotation":"Treatment.Effect","text":"ameliorated"},{"annotation":"Attribute Attributes","text":"negated"}]},{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"symptoms"},{"annotation":"Treatment","text":"intravenous levodopa 25 mg"},{"annotation":"Treatment.Drug","text":"levodopa"},{"annotation":"Treatment.Dose","text":"25 mg"},{"annotation":"Treatment.Dosage_units","text":"mg"},{"annotation":"Treatment.Route","text":"intravenous"},{"annotation":"Treatment.Duration","text":"drastically"},{"annotation":"Treatment.Disorder","text":"akathisia"},{"annotation":"Treatment.Effect","text":"ameliorated"},{"annotation":"Attribute Attributes","text":"negated"}]}]}
 {"id": "19318596_1","context": "Cyclosporine-induced pain syndrome in a child undergoing hematopoietic stem cell transplant.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "cyclosporine"},{"annotation": "Treatment.Drug","text": "cyclosporine"},{"annotation": "Effect","text": "pain syndrome"},{"annotation": "Treatment.Disorder","text": "hematopoietic stem cell transplant"},{"annotation": "Subject","text": "a child"}]}
 {"id": "3171334_5","context": "Visual loss after a single small dose of vincristine has never been reported.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "a single small dose of vincristine"},{"annotation": "Effect", "text": "visual loss"},{"annotation": "Treatment", "text": "vincristine"},{"annotation": "Treatment.Dosage", "text": "a single small dose"},{"annotation": "Treatment.Drug", "text": "vincristine"},{"annotation": "Treatment.Route", "text": "not specified"},{"annotation": "Treatment.Time_elapsed", "text": "not specified"},{"annotation": "Treatment.Duration", "text": "not specified"},{"annotation": "Treatment.Disorder", "text": "none"},{"annotation": "negated", "text": "not specified"},{"annotation": "severity", "text": "not specified"}]}]
 {"id": "12786839_2","context": "Slow acetylator genotypes as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyridine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "infectious mononucleosis-like syndrome"},{"annotation": "Treatment","text": "salazosulfapyridine"},{"annotation": "Treatment.Disorder","text": "none"},{"annotation": "Treatment.Drug","text": "salazosulfapyridine"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "genotype"},{"annotation": "Effect","text": "slow acetylator"},{"annotation": "Treatment","text": "salazosulfapyridine"},{"annotation": "Treatment.Disorder","text": "none"},{"annotation": "Treatment.Drug","text": "salazosulfapyridine"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "none"},{"annotation": "attribute","text": "risk factor"}],"annotation": "attribute","text": "slow acetylator genotypes"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "infectious mononucleosis-like syndrome"},{"annotation": "Treatment","text": "salazosulfapyridine"},{"annotation": "Treatment.Disorder","text": "none"},{"annotation": "Treatment.Drug","text": "salazosulfapyridine"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "genotype"},{"annotation": "Effect","text": "slow acetylator"},{"annotation": "Treatment","text": "salazosulfapyridine"},{"annotation": "Treatment.Disorder","text": "none"},{"annotation": "Treatment.Drug","text": "salazosulfapyridine"},{"annotation": "Attribute","annotations": [{"annotation": "negated","text": "none"},{"annotation": "attribute","text": "risk factor"}],"annotation": "attribute","text": "slow acetylator genotypes"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "genotype"},{"annotation": "Effect","text": "slow acetylator"},{"annotation": "Treatment","text": "salazosulfapyridine"},{"annotation": "Treatment.Disorder","text": "none"},{"annotation": "Treatment.Drug","text": "salazosulfapyridine"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "genotype"},{"annotation": "Effect","text": "slow acetylator"},{"annotation": "Treatment","text": "salazosulfapyridine"},{"annotation": "Treatment.Disorder",
 {"id": "23970584_8","context": "Clinicians should be aware of raltegravir-induced DRESS syndrome as well as the potential for drug-drug interactions due to protease inhibitor-based therapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "raltegravir-induced"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "drug-drug interactions"},{"annotation": "Treatment","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "drug-drug interactions"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"},{"annotation": "Effect","text": "DRESS syndrome"}],{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "protease inhibitor-based therapy"}],{"type": "Adverse_event","annotations": [{
 {"id": "12504711_2","context": "CONCLUSION: Under certain circumstances topical brimonidine can cause paradoxical raised IOP necessitating vigilance in follow-up of patients on topical brimonidine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "caused"},{"annotation": "Effect","text": "paradoxical raised IOP"},{"annotation": "Treatment","text": "topical brimonidine"},{"annotation": "Treatment.Drug","text": "brimonidine"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "necessitating"},{"annotation": "Effect","text": "vigilance"},{"annotation": "Treatment","text": "follow-up"},{"annotation": "Treatment.Drug","text": "topical brimonidine"}]}],"attributes": [{"attribute": "negated","text": "no"},{"attribute": "speculated","text": "no"},{"attribute": "severity","text": "low"}]}
 {"id": "12659609_9","context": "Pharmacokinetic modeling suggested that the patient's initial over-treatment was as reported and that the predicted maximum serum concentration of chloroquine (902 micro g/L) was within the range seen in fatal chloroquine overdose.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Treatment","text": "chloroquine"},{"annotation": "Treatment.Dosage","text": "over-treatment"},{"annotation": "Treatment.Dosage","text": "902 micro g/L"},{"annotation": "Treatment.Dosage","text": "maximum serum concentration"},{"annotation": "Treatment.Dosage","text": "fatal chloroquine overdose"},{"annotation": "Treatment.Dosage","text": "initial over-treatment"}]}]
 {"id": "20925534_15","context": "There was no apparent cardiovascular interaction between clopidogrel and omeprazole, but our results do not rule out a clinically meaningful difference in cardiovascular events due to use of a PPI.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "use of a PPI"},{"annotation": "Effect","text": "cardiovascular events"},{"annotation": "Treatment","text": "clopidogrel and omeprazole"},{"annotation": "Treatment.Drug","text": "clopidogrel"},{"annotation": "Treatment.Drug","text": "omeprazole"},{"annotation": "Treatment.Interaction","text": "cardiovascular"},{"annotation": "Treatment.Interaction","text": "clopidogrel"},{"annotation": "Treatment.Interaction","text": "omeprazole"},{"annotation": "Attribute","text": "negated","severity": "low"}]}
 {"id": "18855892_2","context": "Anaphylactic/anaphylactoid reactions to methotrexate are rare.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "methotrexate"},{"annotation": "Treatment","text": "methotrexate"},{"annotation": "Treatment.Drug","text": "methotrexate"},{"annotation": "Effect","text": "anaphylactic/anaphylactoid reactions"}]}]}
 {"id": "1422497_3","context": "Continuous bladder irrigation of a 1% alum solution is a simple and generally safe method of chemical cautery to treat the bleeding urothelium.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "treat"},{"annotation": "Treatment","text": "continuous bladder irrigation of a 1% alum solution"},{"annotation": "Treatment.Drug","text": "1% alum solution"},{"annotation": "Treatment.Duration","text": "chemical cautery"},{"annotation": "Treatment.Disorder","text": "bleeding urothelium"}]}
 {"id": "10759907_3","context": "The temporal relationship suggests that the spinal cord infarction may be related to the use of zolmitriptan.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "infarction"},{"annotation": "Treatment","text": "zolmitriptan"},{"annotation": "Treatment.Drug","text": "zolmitriptan"},{"annotation": "Effect","text": "spinal cord infarction"}]},{"type": "Adverse_event","annotations": [{"annotation": "Temporal_relationship","text": "temporal relationship"},{"annotation": "Temporal_relationship.Suggestion","text": "suggests"},{"annotation": "Temporal_relationship.Event","text": "spinal cord infarction"},{"annotation": "Temporal_relationship.Treatment","text": "zolmitriptan"}]}]}
 {"id": "1756352_2","context": "Delusional parasitosis associated with phenelzine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "associated with"},{"annotation": "Treatment","text": "phenelzine"},{"annotation": "Treatment.Drug","text": "phenelzine"},{"annotation": "Effect","text": "delusional parasitosis"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Disorder","text": "delusional parasitosis"}]}}
 {"id": "8610807_2","context": "CONCLUSION: The administration of tissue plasminogen activator was responsible for the large extent of hemorrhage and should be considered in the differential diagnosis of hemorrhagic choroidal detachment.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "administration"},{"annotation": "Effect","text": "hemorrhage"},{"annotation": "Treatment","text": "tissue plasminogen activator"},{"annotation": "Treatment.Disorder","text": "hemorrhagic choroidal detachment"}]}]
 {"id": "9007910_1","context": "Dihydropyrimidine dehydrogenase deficiency: a pharmacogenetic defect causing severe adverse reactions to 5-fluorouracil-based chemotherapy.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "5-fluorouracil-based chemotherapy"},{"annotation": "Treatment","text": "5-fluorouracil-based chemotherapy"},{"annotation": "Treatment.Drug","text": "5-fluorouracil"},{"annotation": "Treatment.Dosage","text": "severe"},{"annotation": "Treatment.Frequency","text": "recurrent"},{"annotation": "Treatment.Route","text": "oral"},{"annotation": "Treatment.Time_elapsed","text": "unknown"},{"annotation": "Subject","text": "a patient"},{"annotation": "Subject.Disorder","text": "dihydropyrimidine dehydrogenase deficiency"},{"annotation": "Treatment.Disorder","text": "5-fluorouracil-based chemotherapy"}]}
 {"id": "16393774_2","context": "Interferon-beta (IFN-beta) is a type I interferon used in the management of multiple sclerosis.","events": [{"type": "Treatment","annotations": [{"annotation": "Treatment","text": "Interferon-beta (IFN-beta)"},{"annotation": "Treatment.Drug","text": "Interferon-beta (IFN-beta)"},{"annotation": "Treatment.Dosage","text": "not specified"},{"annotation": "Treatment.Frequency","text": "not specified"},{"annotation": "Treatment.Route","text": "not specified"},{"annotation": "Treatment.Time_elapsed","text": "not specified"},{"annotation": "Treatment.Duration","text": "not specified"},{"annotation": "Treatment.Disorder","text": "multiple sclerosis"}]}
 {"id": "18071101_2","context": "Quetiapine-induced leucopenia and thrombocytopenia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "quetiapine"},{"annotation": "Treatment.Drug","text": "quetiapine"},{"annotation": "Effect","text": "leucopenia and thrombocytopenia"}]}]
 {"id": "18425523_2","context": "CONCLUSION: Severe and sustained ocular hypertension may occur after intravitreal ranibizumab.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Treatment", "text": "intravitreal ranibizumab"}, {"annotation": "Treatment.Drug", "text": "ranibizumab"}, {"annotation": "Effect", "text": "ocular hypertension"}, {"annotation": "Treatment.Drug", "text": "intravitreal"}, {"annotation": "Treatment.Route", "text": "ranibizumab"}, {"annotation": "Treatment.Time_elapsed", "text": "after"}, {"annotation": "Treatment.Duration", "text": "sustained"}, {"annotation": "Treatment.Disorder", "text": "ocular hypertension"}]}]}
 {"id": "18425523_1","context": "BACKGROUND: To describe the occurrence of ocular hypertension in four patients following injection of ranibizumab intravitreally.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "occurrence"}, {"annotation": "Effect", "text": "ocular hypertension"}, {"annotation": "Treatment", "text": "injection of ranibizumab intravitreally"}, {"annotation": "Treatment.Drug", "text": "ranibizumab"}, {"annotation": "Treatment.Dosage", "text": "intravitreally"}, {"annotation": "Treatment.Route", "text": "injection"}, {"annotation": "Treatment.Time_elapsed", "text": "following injection"}, {"annotation": "Treatment.Duration", "text": "four"}, {"annotation": "Treatment.Disorder", "text": "ocular hypertension"}, {"annotation": "Subject", "text": "four patients"}, {"annotation": "Subject.Population", "text": "four"}]}]}
 {"id": "20234160_2","context": "Vancomycin is widely used against methicillin-resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as "red man syndrome" and anaphylaxis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Adverse_effect","text": "nephrotoxicity"},{"annotation": "Adverse_effect","text": "ototoxicity"},{"annotation": "Adverse_effect","text": "gastrointestinal disturbances"},{"annotation": "Adverse_effect","text": "blood disorders"},{"annotation": "Adverse_effect","text": "hypersensitivity reactions"},{"annotation": "Adverse_effect","text": "anaphylactoid reaction"},{"annotation": "Adverse_effect","text": "anaphylaxis"}]}]
 {"id":"15093850_2","context":"We report a case of unintentional overdose of oral pilocarpine tablets that resulted in bradycardia, mild hypotension, and muscarinic symptoms in a patient with Sjogren's syndrome.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"overdose"},{"annotation":"Effect","text":"bradycardia"},{"annotation":"Effect","text":"mild hypotension"},{"annotation":"Effect","text":"muscarinic symptoms"},{"annotation":"Treatment","text":"oral pilocarpine tablets"},{"annotation":"Treatment.Drug","text":"pilocarpine"},{"annotation":"Treatment.Disorder","text":"Sjogren's syndrome"},{"annotation":"Subject","text":"a patient with Sjogren's syndrome"},{"annotation":"Subject.Disorder","text":"Sjogren's syndrome"}]}]}
 {"id":"16357738_1","context":"Moreover, treatment with immunosuppressive drugs such as cyclosporine, cisplatin, tacrolimus, and interferon-alpha can induce a condition resembling RPLS.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "condition resembling RPLS"},{"annotation": "Treatment","text": "immunosuppressive drugs such as cyclosporine, cisplatin, tacrolimus, and interferon-alpha"}]}]}
 {"id": "12854039_2","context": "Case 1, a 62-year-old woman, developed bilateral optic neuritis with decreased sensation of vibration and increased deep tendon reflex in the lower extremities after a seven-month use of recombinant interferon alpha-2a for chronic active hepatitis C.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "use of recombinant interferon alpha-2a"},{"annotation": "Treatment","text": "recombinant interferon alpha-2a"},{"annotation": "Treatment.Disorder","text": "chronic active hepatitis C"},{"annotation": "Effect","text": "bilateral optic neuritis with decreased sensation of vibration and increased deep tendon reflex in the lower extremities"}]}]
 {"id":"9550246_1","context":"A syndrome of increased affect in response to risperidone among patients with schizophrenia.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"induced"},{"annotation":"Effect","text":"increased affect"},{"annotation":"Treatment","text":"risperidone"},{"annotation":"Treatment.Disorder","text":"schizophrenia"},{"annotation":"Treatment.Drug","text":"risperidone"},{"annotation":"Attribute Attributes","text":"negated","annotation":{"negated":"false"}},{"annotation":"Attribute Attributes","text":"severity","annotation":{"severity":"low"}},{"annotation":"Attribute Attributes","text":"negated","annotation":{"negated":"true"}},{"annotation":"Attribute Attributes","text":"severity","annotation":{"severity":"low"}},{"annotation":"Attribute Attributes","text":"negated","annotation":{"negated":"false"}},{"annotation":"Attribute Attributes","text":"severity","annotation":{"severity":"low"}}]}]}
 {"id": "16393774_3","context": "Therapy with IFN-beta has rarely been associated with the development of autoimmune disorders.","events": [{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "development"},{"annotation": "Treatment", "text": "IFN-beta"},{"annotation": "Treatment.Disorder", "text": "autoimmune disorders"},{"annotation": "Attribute Attributes", "text": "severity", "value": "low"},{"annotation": "Attribute Attributes", "text": "negated", "value": "true"},{"annotation": "Attribute Attributes", "text": "speculated", "value": "false"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"annotation": "Attribute Attributes", "text": "negation", "value": "none"},{"
 {"id": "18977778_1","context": "Despite these antithrombotic effects, the patient developed repeated venous thromboembolism during treatment with low-molecular-weight heparin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "developed"},{"annotation": "Treatment","text": "low-molecular-weight heparin"},{"annotation": "Effect","text": "repeated venous thromboembolism"}]}]}
 {"id": "18354950_1","context": "Hyponatraemia developed after rechallenge with controlled release carbamazepine.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "rechallenge"},{"annotation": "Treatment","text": "controlled release carbamazepine"},{"annotation": "Treatment.Drug","text": "controlled release carbamazepine"},{"annotation": "Effect","text": "hyponatraemia"}]}]
 {"id": "18505911_1","context": "Azathioprine-induced warfarin resistance.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "warfarin"},{"annotation": "Treatment.Drug","text": "azathioprine"},{"annotation": "Effect","text": "resistance"}]}]
 {"id": "3084231_2","context": "Reversible valproic acid-induced dementia: a case report.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Treatment","text": "valproic acid"},{"annotation": "Treatment.Drug","text": "valproic acid"},{"annotation": "Effect","text": "dementia"}]},{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "Reversal"},{"annotation": "Treatment","text": "valproic acid"},{"annotation": "Treatment.Disorder","text": "valproic acid-induced dementia"},{"annotation": "Treatment.Drug","text": "valproic acid"}]}]}
 {"id": "6697887_1","context": "Parenteral-verapamil-induced sustained hypotension.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "hypotension"},{"annotation": "Treatment","text": "parenteral-verapamil"}]}]}
 {"id": "1711090_6","context": "The main side-effects of Lp-TAE combined with HT were low-grade fever, localized pain, myelo-suppression and liver dysfunction, but these were transient and eventually disappeared.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger", "text": "combined with HT"},{"annotation": "Treatment", "text": "Lp-TAE combined with HT"},{"annotation": "Treatment.Disorder", "text": "combined with HT"},{"annotation": "Treatment.Drug", "text": "Lp-TAE"},{"annotation": "Treatment.Drug", "text": "HT"},{"annotation": "Treatment.Combination.Trigger", "text": "and"},{"annotation": "Treatment.Combination.Drug", "text": "Lp-TAE"},{"annotation": "Treatment.Combination.Drug", "text": "HT"},{"annotation": "Effect", "text": "fever, localized pain, myelo-suppression and liver dysfunction"},{"annotation": "Attribute Attributes", "text": "severity","annotation": "low-grade"},{"annotation": "Attribute Attributes", "text": "negated","annotation": "transient"},{"annotation": "Attribute Attributes", "text": "negated","annotation": "eventually disappeared"}]}
 {"id": "6738830_2","context": "Unique behavioral change with cinepazide in parkinsonism.","events": [{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "unique behavioral change"},{"annotation": "Treatment", "text": "cinepazide"},{"annotation": "Treatment.Disorder", "text": "parkinsonism"},{"annotation": "Effect", "text": "behavioral change"}]}]}
 {"id": "3171334_4","context": "The literature of vincristine optic nerve toxicity is reviewed.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "optic nerve toxicity"},{"annotation": "Treatment","text": "vincristine"},{"annotation": "Treatment.Drug","text": "vincristine"},{"annotation": "Effect","text": "optic nerve toxicity"}]}]
 {"id": "7639655_4","context": "PATIENTS: Two patients, ages 40 and 51 years, undergoing treatment with interferon alfa for malignant neoplasms experienced sudden bilateral, sequential visual loss with disc-related field defects and segmental optic disc edema.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "sudden bilateral, sequential visual loss"},{"annotation": "Effect","text": "optic disc edema"},{"annotation": "Treatment","text": "interferon alfa for malignant neoplasms"},{"annotation": "Treatment.Drug","text": "interferon alfa"},{"annotation": "Treatment.Disorder","text": "malignant neoplasms"},{"annotation": "Subject","text": "two patients"},{"annotation": "Subject.Age","text": "40 and 51 years"}]}
 {"id": "14968106_2","context": "Neurological improvement and rehabilitation potential following toxic myelopathy due to intrathecal injection of doxorubicin.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "toxic myelopathy"},{"annotation": "Treatment","text": "intrathecal injection of doxorubicin"},{"annotation": "Treatment.Drug","text": "doxorubicin"},{"annotation": "Effect","text": "neurological improvement"},{"annotation": "Treatment","text": "rehabilitation potential"},{"annotation": "Treatment.Drug","text": "doxorubicin"}]}]
 {"id": "14522628_1","context": "Generalised cutaneous rash associated with ganciclovir therapy has rarely been reported in literature.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "ganciclovir therapy"},{"annotation": "Treatment","text": "ganciclovir"},{"annotation": "Treatment.Drug","text": "ganciclovir"},{"annotation": "Effect","text": "generalised cutaneous rash"}]}]}
 {"id": "129501_1","context": "Anaphylaxis after the injection of chymopapain occurs in about 1% of such cases.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "injection of chymopapain"},{"annotation": "Treatment","text": "chymopapain"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Effect","text": "anaphylaxis"},{"annotation": "Treatment.Drug","text": "chymopapain"},{"annotation": "Treatment.Dosage","text": "1%"}]}
 {"id": "9253492_3","context": "Heat stroke-like episode in a child caused by zonisamide.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "caused by zonisamide."},{"annotation": "Effect","text": "heat stroke-like episode"},{"annotation": "Treatment","text": "zonisamide"},{"annotation": "Treatment.Drug","text": "zonisamide"},{"annotation": "Subject","text": "a child"}]}}
 {"id": "18166746_7","context": "An interaction between methylene blue and serotonergic agents may give rise to the serotonin syndrome.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "interaction"},{"annotation": "Treatment","text": "methylene blue"},{"annotation": "Treatment","text": "serotonergic agents"},{"annotation": "Treatment.Combination.Trigger","text": "may give rise"},{"annotation": "Treatment.Combination.Drug","text": "methylene blue"},{"annotation": "Treatment.Combination.Drug","text": "serotonergic agents"}]}
 {"id": "11236070_2","context": "These cases suggest the possibility that, in some patients, leukopenia or agranulocytosis during olanzapine treatment might be dose-related.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "These cases"},{"annotation": "Treatment","text": "olanzapine treatment"},{"annotation": "Treatment.Drug","text": "olanzapine"},{"annotation": "Treatment.Dosage","text": "dose-related"},{"annotation": "Treatment.Disorder","text": "leukopenia or agranulocytosis"},{"annotation": "Treatment.Disorder","text": "during olanzapine treatment"}]}
 {"id":"18371508_1","context":"Adult respiratory distress syndrome after treatment with pegylated interferon alpha-2a and ribavirin.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Trigger","text":"after"},{"annotation":"Treatment","text":"pegylated interferon alpha-2a and ribavirin"},{"annotation":"Treatment.Disorder","text":"adult respiratory distress syndrome"},{"annotation":"Treatment.Drug","text":"pegylated interferon alpha-2a"},{"annotation":"Treatment.Drug","text":"ribavirin"}]}]}
 {"id": "16620273_1","context": "CONCLUSIONS: The increasing prevalence of Type 2 diabetes and its treatment with metformin might result in more cases of lactic acidosis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "increasing prevalence of Type 2 diabetes"},{"annotation": "Treatment","text": "metformin"},{"annotation": "Treatment.Disorder","text": "Type 2 diabetes"},{"annotation": "Treatment.Drug","text": "metformin"},{"annotation": "Effect","text": "lactic acidosis"}]}]
 {"id": "18037876_3","context": "Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "sustained"},{"annotation": "Effect", "text": "ventricular tachycardia"},{"annotation": "Treatment", "text": "thalidomide"},{"annotation": "Treatment.Disorder", "text": "primary plasma-cell leukemia"},{"annotation": "Treatment.Drug", "text": "thalidomide"}]}]}
 {"id": "10579985_3","context": "The second is a 29-year-old man with CD in whom nodular sclerosing Hodgkin's lymphoma was diagnosed 3 weeks after infusion with infliximab.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "infusion with infliximab"},{"annotation": "Treatment","text": "infliximab"},{"annotation": "Treatment.Drug","text": "infliximab"},{"annotation": "Effect","text": "nodular sclerosing Hodgkin's lymphoma"},{"annotation": "Treatment.Disorder","text": "CD"},{"annotation": "Subject","text": "a 29-year-old man"},{"annotation": "Subject.Disorder","text": "CD"}]}
 {"id": "16317298_6","context": "We suggest discontinuing gemcitabine if radiation recall is observed.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "radiation recall"}, {"annotation": "Effect", "text": "discontinuing gemcitabine"}]},{"type": "Potential_therapeutic_effect", "annotations": [{"annotation": "Trigger", "text": "discontinuing gemcitabine"}, {"annotation": "Treatment", "text": "gemcitabine"}, {"annotation": "Treatment.Disorder", "text": "radiation recall"}]}]}
 {"id": "18523232_4","context": "OBJECTIVE: To report the occurrence of acute cytolytic hepatitis in a patient exposed to pulse itraconazole therapy for 24 weeks and provide a concise review of the literature on cases of itraconazole-induced hepatitis.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "exposure to pulse itraconazole therapy for 24 weeks"},{"annotation": "Effect","text": "acute cytolytic hepatitis"},{"annotation": "Treatment","text": "pulse itraconazole therapy"},{"annotation": "Treatment.Drug","text": "itraconazole"},{"annotation": "Treatment.Duration","text": "24 weeks"},{"annotation": "Treatment.Disorder","text": "acute cytolytic hepatitis"}]},{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "exposure to pulse itraconazole therapy for 24 weeks"},{"annotation": "Effect","text": "acute cytolytic hepatitis"},{"annotation": "Treatment","text": "pulse itraconazole therapy"},{"annotation": "Treatment.Drug","text": "itraconazole"},{"annotation": "Treatment.Duration","text": "24 weeks"},{"annotation": "Treatment.Disorder","text": "acute cytolytic hepatitis"}],"annotations": [{"annotation": "negated","text": "yes"}]}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation": "attribute","text": "negated"}],"annotations": [{"annotation":
 {"id": "7712052_6","context": "These findings should lead to further study of the role of lithium in the treatment of this symptom complex in patients with PTSD.","events": [{"type": "Adverse_event", "annotations": [{"annotation": "Trigger", "text": "PTSD"}, {"annotation": "Treatment", "text": "lithium"}, {"annotation": "Treatment.Disorder", "text": "PTSD"}, {"annotation": "Effect", "text": "symptom complex"}, {"annotation": "Treatment.Drug", "text": "lithium"}, {"annotation": "Treatment.Drug", "text": "PTSD"}, {"annotation": "Treatment.Combination.Trigger", "text": "and"}, {"annotation": "Treatment.Combination.Drug", "text": "lithium"}, {"annotation": "Treatment.Combination.Drug", "text": "PTSD"}]}]}
 {"id": "6928097_1","context": "She was placed on adjuvant Adriamycin (doxorubicin) chemotherapy, but 6 months later died of Adriamycin toxicity.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "Adriamycin"},{"annotation": "Effect","text": "toxicity"},{"annotation": "Treatment","text": "Adriamycin (doxorubicin) chemotherapy"},{"annotation": "Treatment.Drug","text": "Adriamycin (doxorubicin)"},{"annotation": "Treatment.Duration","text": "6 months"},{"annotation": "Treatment.Disorder","text": "Adriamycin toxicity"},{"annotation": "Negated","text": "Adriamycin"}]}]
 {"id": "12477460_2","context": "BACKGROUND: Ovarian cancer arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy is rare.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "arising"},{"annotation": "Treatment","text": "tamoxifen therapy"},{"annotation": "Treatment.Disorder","text": "ovarian cancer"},{"annotation": "Treatment.Disorder","text": "endometriotic cyst"},{"annotation": "Treatment.Drug","text": "tamoxifen"}]}],"subject": {"age": "postmenopausal","gender": "woman","population": "1","race": "not specified","disorder": "ovarian cancer"}}
 {"id": "15368548_1","context": "L-asparaginase-induced pancreatitis is an uncommon but potential lethal complication of the treatment of leukemia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "pancreatitis"},{"annotation": "Treatment","text": "L-asparaginase"},{"annotation": "Treatment.Disorder","text": "leukemia"},{"annotation": "Treatment.Drug","text": "L-asparaginase"}]}]
 {"id":"21515865_3","context":"An 89-year-old man receiving long-term anticoagulation with warfarin sodium (total weekly dosage of 19 mg) arrived at the anticoagulation clinic for his monthly visit.","events":[{"type":"Adverse_event","annotations":[{"annotation":"Effect","text":"arrival"},{"annotation":"Treatment","text":"long-term anticoagulation with warfarin sodium"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Subject","text":"an 89-year-old man"},{"annotation":"Subject.Age","text":"89 years old"},{"annotation":"Subject.Population","text":"1"},{"annotation":"Subject.Race","text":"not specified"},{"annotation":"Subject.Disorder","text":"anticoagulation"}]},{"type":"Potential_therapeutic_effect","annotations":[{"annotation":"Effect","text":"arrival"},{"annotation":"Treatment","text":"long-term anticoagulation with warfarin sodium"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"Treatment.Time_elapsed","text":"not specified"},{"annotation":"Treatment.Duration","text":"long-term"},{"annotation":"Treatment.Disorder","text":"anticoagulation"},{"annotation":"Treatment.Drug","text":"warfarin sodium"},{"annotation":"Treatment.Dosage","text":"19 mg"},{"annotation":"Treatment.Frequency","text":"not specified"},{"annotation":"Treatment.Route","text":"not specified"},{"annotation":"
 {"id": "12851279_14","context": "Treatment with tifacogin had no effect on all-cause mortality in patients with severe sepsis and high INR.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "Treatment"},{"annotation": "Treatment","text": "tifacogin"},{"annotation": "Treatment.Drug","text": "tifacogin"},{"annotation": "Treatment.Duration","text": "all-cause mortality"},{"annotation": "Treatment.Disorder","text": "severe sepsis and high INR"},{"annotation": "Treatment.Disorder","text": "severe sepsis"},{"annotation": "Treatment.Disorder","text": "high INR"},{"annotation": "Treatment.Duration","text": "all-cause mortality"},{"annotation": "Treatment","text": "tifacogin"},{"annotation": "Treatment","text": "tifacogin"},{"annotation": "Treatment","text": "tifacogin"}]}
 {"id": "6572542_1","context": "Although lung specimens were lacking from these three patients, it is suggested that the pulmonary toxicity of CCNU may be dose-related.","events": [{"type": "Potential_therapeutic_effect","annotations": [{"annotation": "Trigger","text": "suggested"},{"annotation": "Treatment","text": "pulmonary toxicity of CCNU"},{"annotation": "Treatment.Disorder","text": "CCNU"},{"annotation": "Treatment.Drug","text": "CCNU"},{"annotation": "Treatment.Duration","text": "dose-related"}],"attributes": [{"annotation": "negated","text": "false"}]}
 {"id": "11452245_11","context": "Concomitant use of clarithromycin or other potent inhibitors of CYP3A4 with repaglinide may enhance its blood glucose-lowering effect and increase the risk of hypoglycemia.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "comcomitant use of clarithromycin or other potent inhibitors of CYP3A4 with repaglinide"},{"annotation": "Effect","text": "hypoglycemia"},{"annotation": "Treatment","text": "repaglinide"},{"annotation": "Treatment.Drug","text": "repaglinide"},{"annotation": "Treatment.Drug","text": "clarithromycin"},{"annotation": "Treatment.Drug","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination.Trigger","text": "with"},{"annotation": "Treatment.Combination.Drug","text": "clarithromycin"},{"annotation": "Treatment.Combination.Drug","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination.Drug","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treatment.Combination","text": "and"},{"annotation": "Treatment.Combination","text": "clarithromycin"},{"annotation": "Treatment.Combination","text": "potent inhibitors of CYP3A4"},{"annotation": "Treatment.Combination","text": "repaglinide"},{"annotation": "Treat
 {"id": "1888256_1","context": "Drug-induced fever due to diltiazem.","events": [{"type": "Adverse_event","annotations": [{"annotation": "Trigger","text": "induced"},{"annotation": "Effect","text": "fever"},{"annotation": "Treatment","text": "diltiazem"}]}]}
